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TALKING TO RELATIVES ABOUT GENENTIC TESTING FOR BRCA1/2 AND ITS RISK IMPLICATIONS: 
AN ON-GOING PROCESS 
by Kimberley-Clair Chivers Seymour 
 
Background: Access to genetic cancer risk information can be highly dependent on whether 
familial  risks  are  discussed  within  the  family.  Despite  its  essential  role  in  ensuring  family 
members have access to genetic services, there are a number of gaps in the knowledge available 
on people’s experiences regarding talking to their relatives about genetic testing for BRCA1/2 
and its risk implications. In particular, research to date has focused far more on with whom and 
why (motivations) family communication regarding genetic testing occurs, rather than when or 
how it is occurring.  
 
Method: The study is qualitative in nature, employing in-depth interviews and constructing eco-
maps as a method of identifying relevant family members and guiding the researcher through 
the family structure and relationships. These methods were chosen in line with an interpretive 
description methodology to ensure depth and richness in analysis and reporting of findings. 
 
Results:  The Key Findings are as follows: 
1.  Communication between emotionally close relatives is different to communication with 
emotionally  distant  relatives;  with  emotionally  close  family  and  friends  it  is  about 
sharing and supporting; whereas with emotionally distant family it is about gaining and 
imparting information. 
2.  A family’s engagement in communication regarding genetic testing is implicitly linked to 
their experiences of cancer burden, and how openly this is discussed in the family. 
3.  There is a lack of understanding of risks to men and their offspring based on perceptions 
of hereditary breast and ovarian cancer being a female disease.  
4.  Emotionally distant and male relatives are only contacted selectively. Those undergoing 
genetic testing for BRCA1/2 are not good at identifying all at-risk family members in 
order to share the implications of the genetic test with them. 
5.  As far as the family are concerned, members do not have the right to make an informed 
decision to decline. 
6.  Plans for telling people in the future, especially children, is a cause of worry and concern 
for those undergoing testing and needs further support, especially in the longer term. 
 
Conclusions:  Developing  interventions  to  help  manage  problems  associated  with  family 
communication  regarding  genetic  testing  for  cancer  risk  should  be  a  top  research  priority, 
especially as the numbers of people affected by these issues is set to rise as more genes are 
discovered.  The  longitudinal  view  identified  gives  deep  insight  into  how  and  when  genetic 
testing for BRCA1/2 are discussed within these families, allowing future interventions to be 
targeted where they are most helpful. 
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Glossary & Abbreviations 
 
Autosomal dominant - a trait that is expressed whenever the gene is present and unrelated to 
the sex of the individual. The condition will be transmitted to children with a 50 per cent chance 
of an affected child for each pregnancy. 
BRCA1/2 - Normal genes that can carry a mutation that may increase a person's risk of 
developing breast cancer. 
Chromosomes - Long strings of genetic material made up of DNA and accessory proteins. The 
DNA contains the approximately 30,000 to 100,000 genes that make up the human genome. 
Human cells contain 23 pairs of chromosomes (46 in total), with mother and father each 
contributing one chromosome to each pair. 
Diagnostic genetic testing (DGT) - Testing individuals to identify defective genes capable of 
causing heritable conditions after diagnosis of disease.  
DNA (deoxyribonucleic acid) - a long linear polymer found in the nucleus of a cell and formed 
from nucleotides and shaped like a double helix; associated with the transmission of genetic 
information. 
First-degree relative (FDR) - a close blood relative, who includes the individual's parents, full 
siblings, or children. 
Genetic counselling (GC)  - The provision of advice to families about the nature and likelihood of 
inherited disorders and the options available in terms of prevention and management. 
Germline - Pertaining to the cells from which gametes are derived. When referring to species, 
the cells of the germline, unlike somatic cells, bridge the gaps between generations. 20 
 
HNPCC (Hereditary nonpolyposis colorectal cancer) - An inherited disorder in which affected 
individuals have a higher-than-normal chance of developing colorectal cancer and certain other 
types of cancer, often before the age of 50. 
Index case - the family member with the earliest documented case of a genetic disease. 
Mutation - changes in the DNA sequence of a cell's genome and are caused by radiation, viruses, 
transposons and mutagenic chemicals, as well as errors that occur during meiosis or DNA 
replication. 
Oophorectomy - the surgical removal of an ovary or ovaries. 
Mastectomy - the surgical removal of one or both breasts, partially or completely. 
Penetrance - the proportion of individuals carrying a particular variation of a gene (allele or 
genotype) that also express an associated trait (phenotype). 
Predictive genetic testing (PGT)-  Presymptomatic genetic testing is used to determine whether 
persons who have a family history of a disease, but no current symptoms, have the gene 
alterations associated with the disease. 
Second-degree relative (SDR) -  a blood relative which includes the individual's grandparents, 
grandchildren, aunts, uncles, nephews, nieces or half-siblings. 
Somatic mutations - Alterations in DNA that occur after conception. Somatic mutations can 
occur in any of the cells of the body except the germ cells (sperm and egg) and therefore are not 
passed on to children. These alterations can (but do not always) cause cancer or other diseases. 
Tertiary care - specialised consultative care, usually on referral from primary or secondary 
medical care personnel, by specialists working in a centre that has personnel and facilities for 
special investigation and treatment. 21 
 
Third-degree relative (TDF)  - a blood relative who includes the individual’s first-cousins, great-
grandparents or great grandchildren. 
Uninformative - A negative test result in an individual where a clearly deleterious mutation has 
not been found in any family members. The genetic risk status of such an individual must be 
interpreted in the context of their personal and family history. Also called indeterminate and 
inconclusive. 
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Chapter 1 – Introduction 
 
Personal Statement and Thesis Overview 
 
Human genetics, and in particular the genetic basis of disease, has fascinated me since I first 
learned about Gregor Mendel and his sweet-peas in the first year of secondary school. I went on 
to read for a BSc in Medical Biochemistry and Human Genetics at the University of Sheffield; and 
then an MSc in Human Genetics (Biosciences) at the University of Leeds. Throughout my studies 
it became increasingly apparently to me that my future was not going to be in lab-based genetic 
research. I was funding my way through University by working as a Health Care Assistant in the 
NHS, and doing volunteer work with the Samaritans and other charities. It seems much more 
logical to pursue a career as a health-based researcher utilising my communication and people 
skills.  
 
My research career started with my appointment as a ‘Clinical Researcher’ for the Kent and 
Medway Cancer Network. Two very dynamic consultants in the Colorectal Surgery Department 
of the East-Kent NHS Hospital Trust had been conducting research into the appropriateness of 
colonoscopy referrals. I joined their team to conduct a piece of research to assess compliance of 
the Surveillance Colonoscopy Waiting list across the Cancer Network. We compared referrals 
against the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British 
Society of Gastroenterology (BSG) guidelines for colonoscopy follow up and measured the 
impact of adjusting referrals to be in-line with these guidelines. This study involved a large 
patient cohort from the Kent and Medway Cancer Network, which included seven hospitals 
across four NHS Hospital Trusts with an estimated population of 1.8 million. The work was 24 
 
largely quantitative with a real emphasis on pragmatic research that helped patients by 
improving services.  
 
In 2006, I joined the University of Southampton, Faculty of Health Sciences’ Cancer, Palliative 
and End of Life Care (CPELC) Research Group; funded by a Cancer Research UK studentship.  The 
work of the CPELC is focussed on carrying out research to enhance the lives of individuals 
affected by cancer, other life-limited conditions and those at the end of life. At the time, my 
experiences were based mainly on lab-based and quantitative research but I was keen to extend 
my expertise to incorporate knowledge of the qualitative research field.  
 
The overall structure of this thesis takes the form of nine chapters. Chapter One sets the scene 
and Chapter Two synthesises and critiques the literature available to date, with a view to 
identifying the gaps within the literate that warrant further study. Chapter Three begins by 
setting out the research question, aims and objectives, and then goes on to describe the 
theoretical perspective and methodology. Chapter Four lays out the methods used throughout 
the study. Chapters Five to Eight present the findings of the research, focusing on the four key 
stages of talking about genetic testing and its implications with relatives that have been 
identified during the analysis. Finally, Chapter Nine gives a summary and discussion of the key 
findings, and looks at the limitations and implications of the work. Appendices and a glossary of 
key terms and abbreviations can be found towards the end of the thesis. 
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1.1  Introduction 
 
BRCA1/2 genetic mutations increase the risk of developing cancers, in particular breast and 
ovarian cancers (Miki et al., 1994;Wooster et al., 1995). These mutations can be carried by men 
and women without any symptoms. Mutations can be identified through genetic testing before 
any cancer symptoms appear and thus an individual’s risk of developing breast or ovarian cancer 
can be calculated (McKelvey, Jr. and Evans, 2003). Mutation carriers can then manage this risk 
by engaging in risk-reducing strategies or regular surveillance (Bennett et al., 1999). However, 
genetic risk information relating to other members of the family, especially first degree 
relatives,
1 will be uncovered in this process (Claes et al., 2003). For example, each offspring of a 
BRCA1/2 mutation carrier will have a 50% chance of carrying the same mutated gene (Brody and 
Bowles, 1998).  
 
Individuals tested to see if they carry a BRCA1/2 mutation in the United Kingdom (UK) are 
usually encouraged to disclose test results and any potential risk information to other family 
members so that they, too, can consider genetic testing and risk management strategies 
(Lucassen, 2007). Those undergoing genetic testing may also share their results with family 
members for other reasons, for example, to seek emotional support or to help make decisions 
about risk management (Hughes et al., 2002). It is hoped that educating other family members 
about their potential genetic risk and providing relevant information about predictive genetic 
testing will increase the relatives’ ability to make informed decisions, thereby leading to early 
detection and prevention and, hopefully, to fewer breast/ovarian cancer deaths within these 
families (Sermijn et al., 2004). The limited evidence available suggests that talking to relatives 
about genetic testing and genetic risks can be difficult for individuals (Green and Thomas, 
1997;Julian-Reynier et al., 2000b;Daly et al., 2003;Wagner et al., 2003;Foster et al., 2004b;Van 
                                                           
1 A close blood relative which includes the individual's parents, full siblings, or children. 26 
 
Oostrom et al., 2006;D'Agincourt-Canning, 2001). Because of this, there have been many calls 
for interventions to support family communication regarding genetic testing (refer to section 
1.2.8). 
 
This first part of this chapter presents an introduction to genetic testing for hereditary breast 
and ovarian cancer risk (sections 1.2.1-1.2.3); the importance of family communication regarding 
genetic testing, including the ethical issues related to non-disclosure (sections 1.2.4-1.2.7); and 
the calls for further research and development of interventions (section 1.2.8). The second part 
of the chapter will examine the literature on family communication regarding genetic testing in 
more detail, with a view to identifying gaps in the literature that might become the target for 
future interventions to enhance such communication, or where further research is needed. The 
focus of the literature presented is on who those undergoing genetic counselling and genetic 
testing talk to (section 1.3.1); why they talk to family members, and why they do not  (section 
1.3.2); when this communication occurs (section 1.3.3); and how the topic is discussed (section 
1.3.4).  
 
 
1.2  Background  
 
1.2.1  Hereditary Breast and Ovarian Cancer 
 
Each individual has 23 pairs of chromosomes, housing almost three billion base pairs of DNA
2 
that contain about 30,000-40,000 protein-coding genes (Weidenhammer and Tsongalis, 2005). 
Every person inherits two copies of each chromosome and, therefore, two copies of each gene – 
                                                           
2 Deoxyribonucleic acid: the hereditary material in humans and almost all other organisms. 
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one copy from their mother and one copy from their father (Weidenhammer and Tsongalis, 
2005). Genetic alterations within these genes, known as mutations, can cause or predispose an 
individual to a specific disease and can occur in two ways:  
1.  They are inherited from a parent - hereditary mutations or germ-line mutations; or  
2.  They occur in the DNA during an individual’s lifetime - somatic mutations. 
 
When a particular type of cancer affects a number of family members across several 
generations, especially at a younger age than is usual, it is possible that relatives share an 
inherited alteration in a gene which makes them genetically susceptible to that cancer 
(Weidenhammer and Tsongalis, 2005). Individuals, who are known to be ‘at risk’ for certain 
familial conditions, can now be tested to ascertain whether they have inherited disease-causing 
mutations (Claus et al., 1996). 
 
Breast cancer has been the most common cancer in the UK since 1997, with over 45,800 new 
cases diagnosed each year (Cancer Research UK, 2011b). Breast cancer can affect both males 
and females, although it is rarer in men (Cancer Research UK, 2011b). The familial nature of 
breast cancer has long been recognised; in fact, one of the earliest recordings of the familial 
nature of breast cancer can be dated back to literature from Ancient Rome to around 100 AD 
(Ackerknecht, 1965). Women with a mother, sister or daughter diagnosed with breast cancer 
have almost double the risk of being diagnosed with breast cancer themselves (Cancer Research 
UK, 2011b). Approximately one in every ten incidences of breast cancer can be linked to 
mutations in specific genes, which can be passed down through the family (Claus et al., 1996).  
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1.2.2  The BRCA Genes 
 
In the mid-1990s, two high penetrance
3 breast cancer susceptibility genes called BRCA1 (Miki et 
al., 1994) and BRCA2 (Collins et al., 1995;Wooster et al., 1995) were discovered. Normally, the 
BRCA genes help to prevent cancer by encoding proteins that keep cells from growing 
abnormally (Ormiston, 1995). However, if the cell growth mechanisms are not regulated, as is 
the case when a BRCA1/2 mutation is present, the cell can replicate unrestrictedly leading to 
tumour development (Bennett et al., 1999). Genetic mutations within these genes are thought 
to account for approximately 5-10% of breast and ovarian cancers (Claus et al., 1996). 
 
The average lifetime risk for women in the UK general population is a one in nine chance of 
developing breast cancer (Cancer Research UK, 2011a) and a one in 50 chance of developing 
ovarian cancer (Cancer Research UK, 2011c). Around 300 cases of male breast cancer are 
diagnosed each year (Cancer Research UK, 2011b). Women with a mutation in the BRCA1 gene 
have between a 45% and 87% risk of developing breast cancer by the age of 70 (Thompson and 
Easton, 2002), between a 36% and 66% risk of ovarian cancer (Thompson and Easton, 2002), and 
a 95% risk of developing either in their lifetime (Easton et al., 1994;Ford et al., 1994). Mutations 
in the BRCA2 gene are associated with between a 31% and 56% risk of acquiring breast cancer, 
and a 2% to 19% risk of ovarian cancer (Antoniou et al., 2003).  
 
When compared to the general population risk, the evidence suggests that female carriers of 
BRCA1/2 mutations are likely to develop these cancers at a younger age, often before the onset 
of menopause, and are at a higher risk of bilateral breast cancer (Ford et al., 1998). Furthermore, 
a study found the risk of breast cancer in male BRCA2 carriers from multiple case breast and/or 
                                                           
3 Genetic penetrance describes the frequency, under given environmental conditions, at which a specific 
phenotype (observable characteristics or traits) is expressed by those individuals with a specific genotype 
(genetic makeup). Therefore, high penetrance genes are expressed almost irrespectively of environmental 
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ovarian cancer families to be 80-fold higher than in the general population (Thompson and 
Easton, 2001). 
 
BRCA1/2 mutations are also thought to be associated with potentially increased risk of other 
cancers. Thompson & Easton (2002) found that the risk of cancers at alternative sites, including 
the pancreas, uterine body and cervix, in BRCA1 carriers was small. However, BRCA2 mutations 
have been shown to be associated with 6% of families with moderate and high-risk pancreatic 
cancer (Couch et al., 2007). In other studies, mutations in BRCA2 have been found to be 
associated with increased risk of prostate cancer (Douglas et al., 2007). Specific founder 
mutations have also been linked to particular ethnic groups, such as Ashkenazi Jews, and to 
clusters within families in the Netherlands, Iceland, Sweden and Quebec (Vezina et al., 
2005;Peelen et al., 1997;Arason et al., 1998;Einbeigi et al., 2001). 
 
Cancer susceptibility due to BRCA1/2 mutations is inherited in an autosomal dominant pattern. 
This refers to the fact that only one of a pair of genes needs to be mutated to cause the cancer 
susceptibility. Since we have two copies of every gene (one inherited from our mother and the 
other from our father), any individual who has an autosomal dominant condition has a 50% 
chance of having a child (male or female) that will also carry the genetic mutation 
(Weidenhammer and Tsongalis, 2005). If a family member tests positive for a BRCA mutation, all 
first degree relatives (FDR) are at a 50% risk of carrying the same mutation, while second degree 
relatives (SDR) are at a 25% risk (McKelvey, Jr. and Evans, 2003). However, the majority of 
cancers involve complex, multi-factorial interaction between environmental and genetic 
components, which is not yet fully understood (Ramos and Olden, 2008). This means that, even 
when someone carries the mutated gene, there is no guarantee they will actually go on to 
develop cancer or, if they do, when this is likely to occur (Esplen et al., 2001;Evans et al., 2001). 
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1.2.3  The Role of Genetic Testing in Determining Cancer Predisposition 
 
Genetic testing is the identification of alterations or mutations in a person’s genome associated 
with an increased risk of disease (McKelvey, Jr. and Evans, 2003). However, it is not suitable in 
every case: its value is dependent on the nature of the disease being tested, the availability of an 
effective treatment and/or the cost and efficiency of surveillance and screening measures (Evans 
et al., 2001). For example, an important predictor for autosomal dominant early-onset familial 
Alzheimer's disease is mutations in the PSEN1 and PSEN2 FAD genes. However, with the 
unpredictable psychological consequences, risk of errors in an interpretation of mutation 
penetrance, as well as there being no effective prevention strategies at this time, testing is 
deemed by many as unethical and is not recommended (Kowalska, 2004). For conditions such as 
breast cancer and colorectal cancer, however, where more effective risk management and 
prevention strategies are available, genetic testing is far more acceptable and more readily 
available (Esplen et al., 2001;Evans et al., 2001).  
 
BRCA1 is a large gene comprising 5,592 nucleotides that, together with the non-coding regions, 
spreads over about 100,000 DNA bases (Shattuck-Eidens et al., 1995). To improve the sensitivity 
of the test, genetic testing usually starts by identifying the family-specific mutation through the 
testing of a family member who has already been affected with breast or ovarian cancer. This is 
known as ‘mutation search’ or ‘diagnostic genetic testing’ (DGT) (Lerman and Shields, 2004). 
Then, if a genetic mutation is found, testing can be offered to relatives unaffected by cancer in 
the form of ‘predictive genetic testing’ (PGT) as it is now simply a matter of searching for that 
known mutation, making it possible to accurately distinguish between mutation carriers and 
non-carriers (Lerman and Shields, 2004). Unlike traditional medical diagnostic testing, which 
defines something about a patient’s current state, this testing can be carried out prior to any 31 
 
symptomatic disease development to predict the future likelihood of developing a genetic-based 
disease or disability (Evans et al., 2001). 
 
Those who opt for diagnostic genetic testing either receive a (mutation) positive test result, 
where they are found to carry a mutated BRCA gene, or they receive an 
uninformative/inconclusive test result, which indicates that a genetic mutation has not been 
found within the BRCA genes but a genetic susceptibility is still suspected (Van Dijk et al., 2006). 
Those who opt for predictive genetic testing either receive a (mutation) positive test result as 
proven carriers, or a (mutation) negative test result as a proven non-carrier of that mutation 
(Lerman and Shields, 2004). Genetic testing for BRCA1/2 holds considerable potential for 
reducing morbidity and mortality of breast and ovarian cancers through accurate assessment of 
an individual’s risk, the subsequent targeting of screening to detect cancer early, and 
preventative strategies, as well as having important implications for blood relatives and future 
generations (McKelvey, Jr. and Evans, 2003). 
 
Figure 1 outlines the process of genetic counselling and genetic testing for BRCA1/2 at the 
Genetic Service where this research was based.  32 
 
 
 
 Figure 1: Process of genetic counselling and genetic testing for BRCA1/2 
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1.2.4   The Importance of Family Communication Regarding Genetic Testing 
 
Family communication regarding genetic testing for cancer risk is important for three reasons:  
Firstly, the information about the family history of cancer and other family members provided to 
the geneticist during the genetic counselling process is vitally important. The geneticist uses this 
information to assess whether or not there is a risk of a mutation within the family. If the 
information supplied is inaccurate or has gaps, then the geneticist cannot make an accurate 
assessment and counsel accordingly. Thus, the information the person undergoing genetic 
counselling is able to obtain about their family history from other family members is crucial and 
family communication is of key importance (Green et al., 1997)  
 
Secondly, a genetic test result does not only uncover genetic information about the individual 
being tested, but also brings to light potential risk for relatives (Claes et al., 2003). Educating 
other family members about their potential genetic risk and providing relevant information 
about predictive genetic testing might increase the relatives’ ability to make informed decisions, 
thereby leading to early detection and prevention and, hopefully, to fewer breast/ovarian cancer 
deaths within these families (Sermijn et al., 2004). Due to patient confidentiality regulations, the 
usual practice adopted in most clinical settings is to discuss with the individual opting for genetic 
testing the implications of the test results for other family members; this is so they have the 
opportunity to contact relatives directly to disseminate the genetic risk information and to 
encourage at-risk relatives to seek genetic counselling (Finlay et al., 2008;Croyle and Lerman, 
1999;Croyle and Lerman, 1999;Patenaude et al., 2006;Wilson et al., 2004).  
 
Finally, there is evidence to suggest that receiving a BRCA1/2 mutation test result may be 
emotionally demanding and decisions have to be made regarding risk management; therefore, it 
is likely some patients will communicate their results to family members in order to gain 34 
 
emotional support or advice in the next steps such as surveillance and surgical decisions (Hughes 
et al., 2002;McGivern et al., 2004). A recent study by Van Oostrom (2007)(56) found that 
communication regarding hereditary cancers and genetic testing within families was vital to the 
psychological adjustment to cancer susceptibility genetic testing. Those who were reluctant or 
hesitant to communicate reported significantly more psychological distress up to six months 
after the disclosure of their genetic test results.  
 
 
1.2.5   Transmission of Genetic Information 
 
For the most part, the literature suggests that the majority of people will want to discuss their 
test results within their family. This has been associated with feelings of duty, responsibility and 
obligation (Foster et al., 2004a) (refer to section 1.3.2. for further discussion). For example, 
several studies have reported that parents regard the disclosure of genetic information to their 
children as their personal responsibility rather than the responsibility of health professionals 
(Claes et al., 2003;Forrest et al., 2003;Hallowell et al., 2005a). Data presented by Green et al. 
(1997) suggests that those undergoing genetic testing recognise a duty upon themselves to 
inform relatives of genetic risks. Foster et al. (2002) also found most of the women in their study 
that had undergone predictive genetic testing felt they had an obligation to take action to 
balance their risk of developing cancer, and also had a duty to inform others and encourage 
others to do the same. According to Foster et al. (2002), women were thinking of the test as a 
‘family affair’ rather than as an individual endeavour. In this way, women felt obliged to consider 
other family members in their decision to have predictive genetic testing and encouraged, or 
intended to encourage, other relatives to be tested. 
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On the other hand, disclosure of such risk information to relatives has been described as one of 
the most complex areas for those undergoing genetic testing for cancer risk, in particular carriers 
(Clarke et al., 2008). They are faced with the dilemmas of deciding who, what, when, how, and 
indeed whether, to tell relatives (including children) about their genetic status {Forrest, 2003 12 
/id;Green, 1997 457 /id;Hallowell, 2003 10 /id;Skirton, 1998 759 /id;Foster, 2004 427 
/id;Hallowell, 2005 1 /id}. The literature suggests individuals can find the process of disclosing 
test results and potential risk information to their families difficult and that it can cause them 
considerable anxiety (Foster et al., 2004a;Green and Thomas, 1997;Julian-Reynier et al., 
2000b;Daly et al., 2003;Wagner et al., 2003;D'Agincourt-Canning, 2001;Van Oostrom et al., 
2006;Forrest et al., 2003). In fact, according to Patenaude et al. (2006), given the nature of 
modern families and the complexity of the information itself, this communication can even be 
deemed impossible in some circumstances. 
 
 
1.2.6   Non-disclosure 
 
The literature suggests that relevant genetic information may be withheld from family members, 
especially more distant relatives, by others in the family (Forrest et al., 2003;Keenan et al., 
2005;Wilson et al., 2004). Reasons for not disseminating to certain relatives given in the 
literature may be described as either personal or disengaged. For example, personal reasons for 
not communicating with a particular relative may include feeling concerned that the news of a 
BRCA1/2 mutation would alarm or upset others. An example of this would be a woman in one 
study who reported deliberately lying to her family about her positive mutation status in order 
to prevent her father from the guilt of having passed the mutation to her (Loud et al., 2006). 
Such reasons present a dilemma for those undergoing genetic testing between wanting to 
provide potentially life-saving information to their relatives but without causing any emotional 36 
 
harm or upset (Hallowell et al., 2003;Hallowell et al., 2005a;Hallowell et al., 2005b;Hughes et al., 
2002;Bradbury et al., 2007;Green et al., 1997). 
 
 Conversely, disengaged reasons may include: not personally knowing someone, contact 
difficulties, and not feeling emotionally close to them (McGivern et al., 2004;Claes et al., 
2003;Daly et al., 2001;Forrest et al., 2003;Green and Thomas, 1997;Hughes et al., 
2002;MacDonald et al., 2007). Factors such as family rifts and tensions, divorce, separation and 
adoption are likely to exacerbate the reasons for non-disclosure (Forrest et al., 2003;Green et 
al., 1997). As will be discussed in 1.3.1, there is a substantial amount of evidence that says 
individuals are significantly more likely to communicate with first-degree relatives and those 
they feel emotionally close to. However, withholding relevant genetic information to a 
potentially at-risk relative may result in them being denied the opportunity to seek medical 
advice when they would have chosen to do so (Keenan et al., 2005).  
 
 
1.2.7   Ethical Issues for Genetic Health Care Professionals 
 
The fact that the content of your genes may directly affect your mother, father, brother, sister 
and your children is a relatively new concept in medicine and carries a new set of ethical 
dilemmas (McKelvey, Jr. and Evans, 2003). As Kenen et al. (2004b) state: ‘The health care 
profession’s code includes the ethical principles of beneficence - to do good - and 
nonmaleficence - to do no harm. The professionals in the cancer genetic clinic sometimes have 
to walk a fine line between these two ethical obligations- to see that relatives of the client 
receive information about their possibly increased familial risk of developing breast/ovarian 
cancer without infringing on these same individuals’ rights to privacy and their right to ‘not 
know’’ (p. 343). 37 
 
 
In principle, confidentiality agreements prevent clinicians from disclosing to any relatives health 
information that becomes apparent in the course of a patient’s diagnosis or treatment. 
However, knowing that access to cancer risk information can be highly dependent on whether 
BRCA1/2 test results are discussed within the family (Hughes et al., 2002), does this mean they 
hold a moral duty to inform such a person of their risk? (Dickens et al., 1996).  
 
Respect for patient confidentiality is an essential feature of good medical practice (Lucassen and 
Parker, 2004). But for medical genetics, ethical and moral issues arise when defining who the 
‘patient’ is. Practising genetic medicine by definition involves families. Genetic practitioners hold 
patient confidentiality with the individual they are testing (Dickens et al., 1996;Hallowell et al., 
2005a). However, in the process of treating that individual, they are likely to uncover genetic risk 
information relating to other members of the biological kinship, especially first degree relatives 
(D'Agincourt-Canning, 2001). This can raise challenges for clinicians in practice. Lucassen et al. 
(2007) argue that patients have a right to privacy, but this is not the same as sole ownership of 
information.  
 
For many genetic practitioners, difficulties arise when genetic testing of one family member 
reveals something about the genetic code held by others. If practitioners opt to take an 
‘individual ownership’ stance regarding genetic information, as is traditional in western 
medicine, risk information may not be passed on to relevant family members, thus potentially 
causing harm. Alternatively, the ‘joint account mode’ argues that, since genetic information is 
shared, confidentiality does not hold in the same way and information should be available to all 
account holders; in other words, all relevant family members, unless there is a good reason to 
do otherwise (Lucassen, 2007).  
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In 1993, UK Nuffield Council on Bioethics(73) recommended that, if genetic counsellors are 
unable to persuade those undergoing genetic testing to share important information with other 
family members for whom there may be serious implications, they should be free to override the 
individuals' desire for confidentiality (Nuffield Council on Bioethics, 1993). Richards and Green 
(1996) argue that such a principle runs the risk of bringing both genetic counselling and medical 
confidentiality into disrepute, as well as failing to take family processes into account. It cannot 
be assumed that family members necessarily want to receive that information (Richards and 
Green, 1996). The House of Commons Science and Technology Committee's report also rejected 
the Nuffield Council's conclusions: ‘If counselling cannot persuade someone to consent to share 
information with their relatives the individual's decision to withhold information should be 
paramount’ (paragraph 228) (House of Commons Science and Technology Committee, 1995).  
 
Individuals who are reluctant to pass on information to relatives may be ‘persuaded’ to do so by 
professionals who feel that such information should be transmitted by family members 
(Petersen and Bunton, 2002); however, these actions may be perceived as against the ‘non-
directive’ principles that govern genetic counselling (Norrgard, 2008). Broaching how genetic 
information will be shared requires sensitivity and relevant communication, both on behalf of 
the health care professionals and within the family (Lucassen, 2007). However, when families do 
not agree to, or are unable to, contact others at risk, clinicians may be left knowing there are 
potential harms to others that might be prevented (Offit et al., 2004;Patenaude et al., 
2006;Keeling, 2004;Julian-Reynier et al., 2000a;Leung et al., 2000;Harris et al., 2005).  
 
The issues with confidentiality mean talking within the family about a family history of cancer, 
associated risks and genetic testing, and it is very important to ensure all family members have 
access to genetic services (Hughes et al., 2002). It can, however, be potentially difficult for 
concerned individuals and their relatives. As more genes are discovered, there is likely to be an 39 
 
increase in the numbers of people affected by these issues and so the development of 
interventions to help people manage problems associated with the process is an important 
research priority.  
 
 
1.2.8  Calls for Research 
 
Understanding how families communicate about hereditary risk information is particularly 
important when considering the role of providers in enhancing family communication and in 
planning for genetic services (Patenaude et al., 2006). Wiseman et al. (2010) conclude that 
‘genetic counselling practice could benefit from further understanding of the complex ways in 
which families communicate about genetic risk information in order to deliver high quality 
counselling services by enabling clinicians to modify and shape their messages as well as identify 
and raise communication issues directly with patients’ (p. 701). 
 
Early studies on family communication about genetic risk information assumed a sender-receiver 
model of communication (Wiseman et al. 2010). In other words, the individual undergoing 
genetic testing would simply tell all their family members of the genetic test (Wilson et al. 2004). 
Subsequent research suggests that family communication in this area is highly selective, both in 
respect of who is told about genetic risk and what they are told (Gaff et al. 2007). Much of the 
research surrounding family communication regarding genetic testing has been exploratory in 
nature
4 and/or concentrated on communications that occurred shortly after receiving the result 
(Finlay et al., 2008;Wilson et al., 2004). What is more, the focus is limited to motivations for 
communication, who was told, and barriers to communication (Wiseman et al., 2010).  
 
                                                           
4 Which is not surprising given the nature of the research questions which have largely been about 
understanding experiences of those undergoing genetic testing. . 40 
 
There have been many calls for further research on how families communicate and for the 
development of interventions, and other ways, to support family communication regarding 
genetic testing (Clarke et al., 2008;Crotser and Dickerson, 2010;Chivers Seymour et al., 
2010;Clarke et al., 2005;Douglas et al., 2009;D'Agincourt-Canning, 2001;Mellon et al., 
2006;Butow et al., 2003;Claes et al., 2003;Forrest et al., 2010;Patenaude et al., 2006;Forrest et 
al., 2003;Gaff et al., 2007a;Gaff et al., 2005;Hughes et al., 1999;Hughes et al., 2002;Holt, 
2006;Segal et al., 2004;Tercyak et al., 2007;Vos et al., 2011;van Roosmalen et al., 2004;Wagner 
et al., 2003). For example, Foster et al. (2004a), like many others, suggest that women tested for 
BRCA1/2 need particular support in how to communicate with relatives about testing and 
clarification. 
 
According to Campbell et al. (2007), an understanding of the context of the research, such as the 
wider socio-economic background, the health service systems, the characteristics of the 
population, the prevalence or severity of the condition studied, and how these factors change 
over time, is crucial to the development and evaluation of any health care intervention. 
Understanding the context allows researchers to examine how a problem is caused and 
sustained, whether it is likely to be susceptible to intervention, and how any intervention could 
work. Therefore, this next section will examine the literature on family communication regarding 
genetic testing in more detail. The emphasis will be on who those undergoing genetic 
counselling and genetic testing talk to; why they talk to family members (and why not); when 
this communication occurs; and what is discussed. The aim is not only to learn about patterns of 
family communication about genetic test results, but also to determine if there are gaps in the 
literature where more research is needed, which might become the target for future 
interventions to enhance family communication regarding genetic testing for cancer risk.  
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1.3  Family Communication Regarding Genetic Testing Research 
 
1.3.1  Who Do Those Undergoing Genetic Testing For BRCA1/2 Talk To?  
 
To date, most studies on who those undergoing genetic counselling and genetic testing talk to 
have focussed on communication with one particular family member, or group of family 
members. For example, communication with: siblings (Wagner et al. 2003), sisters (Hughes et al. 
2002; Bodd et al. 2003); offspring (Tercyak et al. 2002; Clarke et al. 2008; Tercyak et al. 2001; 
Tercyak et al. 2007); young children (Bradbury et al. 2007); adult children (Wagner et al. 2003); 
daughters (Bodd et al. 2003); those offering support or information (Green et al. 1997); or first-
degree relatives only (Sermijn et al. 2004; Barsevick et al. 2008; Patenaude et al. 2006; Julian-
Reynier et al. 2000). 
 
Studies have consistently demonstrated that family communication about genetic counselling 
and testing is highest with first-degree relatives (FDRs) (Koehly et al. 2003; Claes et al. 2003; 
Wagner et al. 2003; McGivern et al. 2004; Finlay et al. 2008; Blandy et al. 2003; Patenaude et al. 
2006). In a retrospective study designed to examine the process of communicating a positive 
BRCA1 or BRCA2 genetic test result to male and female, first, second, and third-degree relatives, 
McGivern et al. (2004) found the proportion of informed parents, siblings, and offspring was 
nearly twice that of more distant relatives including nieces, nephews, aunts, uncles, 
grandchildren, and cousins (88% versus 45%; P = 0.02). As well as FDRs, the literature suggest 
people generally pass on genetic risk information to family members they feel emotionally close 
to (Chivers Seymour et al. 2010; Julian-Reynier et al. 2000; Hughes et al. 2002; Claes et al. 2003; 
Peterson et al. 2003). According to Patenaude et al. (2006), demographic, health-, and test-42 
 
related factors also predict genetic test result communication to FDRs. For example, gender 
and/or results status:  
 
Gender 
Research has consistently demonstrated that disclosure of BRCA1/2 genetic test results for 
cancer risk is highest to female, compared to male, FDRs (Claes et al. 2003; Wagner et al. 2003; 
Sermijn et al. 2004; Barsevick et al. 2008; Julian-Reynier et al. 2000). Although the risk of 
developing breast and ovarian cancer risk is considerably greater for female carriers of BRCA1/2 
mutations, there are a number of cancer risks to male carriers (Douglas et al. 2007; Liede et al. 
2004). There are also risk implications for the female offspring of male carriers due to the 
autosomal dominant patterns of inheritance (Weidenhammer and Tsongalis 2005). Patenaude et 
al. (2006) did find that brothers were told more often about a sister's BRCA1/2 test result in 
families where the mutation was inherited through the paternal side of the family. They propose 
that this reflects a misperception that BRCA1/2 hereditary risk differentially affects men in 
paternal lineage families. However, as the authors note, social reasoning rather than scientific 
reasoning is not uncommon in the lay understanding of genetics. For example, Richards & 
Ponder (1996) found that lay people thought that their stronger emotional bonds with their 
children meant they shared more of their genes with their children than with their siblings. 
Nevertheless, the gender of relatives is not a complete predictor of family communication, as 
shown by the fact that 14% of participants’ sisters were not told at all (Patenaude et al. 2006).  
 
Disclosure of genetic information is often described as a gendered activity (D'Agincourt-Canning, 
2001). Women have been described as the ‘kin-keepers’ of genetic knowledge (Green et al., 
1997) and have been shown to play a greater role in communicating about inherited cancers, 
particularly breast cancer, compared with men (Marteau and Richards, 1996). There is evidence 
to suggest that women talk about family cancer more than their male relatives, and mothers are 43 
 
key providers of information, even if their husband is the one at-risk (Green et al., 1997;Koehly 
et al., 2003;McAllister, 1999). 
 
Results status 
The literature indicates that tested individuals typically disclose their results to at least one 
relative, whether the genetic test results are positive, negative, or inconclusive (McGivern et al. 
2004; Wagner et al. 2003; D'Agincourt-Canning 2001; Patenaude et al. 2006). Patenaude et al. 
(2006) found that, for the 273 women who completed a family communication measure four 
months after receiving their BRCA1/2 genetic test result, receiving a positive versus true-
negative test result was not a significant factor in the telling of FDRs, except in the telling of 
results to children. However, inconclusive results (variant or negative without known familial 
mutation) were shared less frequently than conclusive (definitively positive or negative) results, 
although the difference only reached significance for communication to sisters (Patenaude et al. 
2006). In a study of 43 pairs of sisters, Hughes et al. (2002) also reported that women tested for 
BRCA1/2 conveyed positive results to sisters more often than they conveyed inconclusive 
results. In addition, Claes et al. (2003) found distant relatives were more likely to be told about 
conclusive rather than inconclusive BRCA1/2 genetic results.  
 
Patenaude et al. (2006) theorise that inconclusive results are less likely to be disclosed to 
relatives, either because the complexity of the message increases as the conclusiveness declines, 
or because of a perception that telling relatives about an inconclusive result would be of little or 
no use to relatives. However, a more in-depth study of participants’ reasons for not-disclosing 
would be required to confirm these theories. Koehly et al. (2003) suggest that family culture may 
play a more important role in determining whether or not discussions occur compared with 
mutation status. In their study using social network analysis of communication about Hereditary 
Nonpolyposis Colorectal Cancer (HNPCC) genetic testing, mutation status was not a significant 44 
 
predictor of discussions about genetic testing and counselling when kinship (ties) and family 
functioning relationships (evaluated by the constructs of communication, cohesiveness, affective 
involvement, leadership, and conflict) were included in the model of analysis.  
 
In summary, the literature suggests that communication is most likely to occur with FDR, those 
who are emotionally close, and female relatives, but does not explain why this is. Whilst much 
research on who those undergoing genetic testing for cancer risk communicate with has been 
published, very few studies have looked at family communication across the whole family 
kinship. Instead, studies tend to restrict exploration to distinct sub-groups of relatives. Those 
that have included communication to first, second, and third-degree relatives, such as McGivern 
et al. (2004), have imposed other restrictions, such as only including communication of positive 
BRCA1/2 genetic test results.  
 
 
1.3.2  Why Do Those Undergoing Genetic Testing For BRCA1/2 Talk To Others? 
 
Several studies have investigated people’s motives for undergoing genetic testing for BRCA1/2 
and other late onset cancers, such as HNPCC. The literature indicates that these motives are 
driven by a number of factors, including: a desire to reduce anxiety and uncertainty (Metcalfe et 
al. 2000; Watson et al. 2004; Wroe et al. 1998); wanting to know if more screening tests are 
needed (Esplen et al. 2001); a desire for increased certainty of own potential risk of developing 
disease (Foster et al. 2002; Metcalfe et al. 2000); and understanding risk for children or other 
family members (Esplen et al. 2001; Foster et al. 2002; Lerman et al. 1995; Lynch et al. 1997; 
Dudok de Wit 1997). It should be noted that most studies examining motivation for genetic 
testing for cancer risk include small, self-selected and homogenous sample populations, 45 
 
including predominantly white individuals. Some studies also had several participants from the 
same family, possibly producing family-specific effects. 
 
That said, pursuing genetic testing with the expressed interest of learning about the potential 
risk to other family members would also suggest a motive to engage in family communication 
regarding the genetic testing (Segal et al. 2004). In a retrospective study examining the process 
of communicating a positive BRCA1/2 genetic test result to male and female first, second, and 
third-degree relatives, McGivern et al. (2004) found the most important reasons for discussing 
the genetic test results were (1) to inform the relatives of their risk, (2) to suggest that they be 
tested, and (3) to fulfil a perceived duty to inform.  
 
Much of the literature relates to those undergoing genetic testing for BRCA1/2 who feel they 
have some moral duty to inform their family members about their testing and its results (Clarke 
et al. 2008; McGivern et al. 2004; D'Agincourt-Canning 2001; Chivers Seymour et al. 2010; Gaff 
et al. 2007). For example, Green et al. (1997) conducted a study looking at communication issues 
encountered by women attending a genetic counselling clinic because of a family history of 
breast and/or ovarian cancer. Their findings suggested that those undergoing genetic testing 
recognised a duty to inform relatives of their genetic risks and that some were prepared to go to 
some lengths to meet that responsibility. Ritvo et al. (1999) propose that, due to the autosomal 
dominant inheritance pattern, mothers who carry BRCA1/2 mutations are particularly sensitive 
to the vulnerability of their female offspring because of their own experiences in relation to the 
previous family history of disease, and so are motivated to communicate with them.  
 
Other reasons for communicating with relatives about genetic testing are based on needing 
information and/or support. Green et al. (1997) found that going for genetic counselling may 
itself be a result of family discussion about the disorder; but, whether or not this was the case, 46 
 
nearly all those who were undergoing genetic counselling for a family history of breast and/or 
ovarian cancer had contacted someone in the family for information about the disease. Mothers 
in particular, if they were still alive, were key figures in supplying family information. This was 
not only because they often had the requisite information, but also because they were the link 
with other relatives of the previous generations (Green et al. 1997). There is evidence to suggest 
that open communication regarding hereditary cancer and partner support may be important 
buffers against hereditary cancer distress (Van Oostrom et al. 2007). Previous research has 
shown that communicating with family members is a strategy used by breast cancer patients to 
cope with their cancer diagnosis (Hilton 1994). Therefore, needs for social support may motivate 
family communication on the subject (Hughes et al. 2002). 
 
In a recent qualitative systematic review of factors that promote and impede family 
communication regarding genetic testing for cancer risk (refer to Chapter Two), Chivers Seymour 
et al. (2010) identified that individuals are most likely to engage in family communication if they: 
undergo genetic testing with the intention of gaining information for other family members as 
well as for themselves; have a sense of duty to warn others of potential risk; have taken time to 
process the information before telling others; have close relationships with their relatives; and 
have been encouraged and supported by his/her genetic practitioner to engage in family 
communication. 
 
Studies have also been able to give insight into why those undergoing genetic testing may not 
talk to some, or all, relatives. Green et al. (1997) reported that, whilst the majority of their 
sample, of 46 women attending a cancer genetics clinic, contacted at least one relative regarding 
counselling, most named a relative with whom they did not feel able to communicate on this 
subject. In these cases, communication, both obtaining and giving information, was impeded by 
adoption, divorce and remarriage, family rifts, and large age gaps between siblings (Green et al. 47 
 
1997). Other studies have found that little contact and/or emotionally distant relationships are 
major barriers to family communication regarding genetic testing for cancer risk (McGivern et al. 
2004; Chivers Seymour et al. 2010; Hughes et al. 2002; Finlay et al. 2008; Julian-Reynier et al. 
1996; Forrest et al. 2003). There is also balance between the perceived obligations of passing on 
information with that of not causing alarm which must be overcome (Green et al. 1997; Clarke et 
al. 2008; Peterson et al. 2003; Gaff et al. 2007). According to Chivers Seymour et al. (2010), the 
issue of feeling torn between the responsibilities to inform at-risk relatives but not wanting to 
cause them any harm or distress poses significant tensions to those undergoing genetic testing 
for cancer risk. Such tensions may increase the chances of non-disclosure.  
 
 
1.3.3  When Do Those Undergoing Genetic Testing For BRCA1/2 Talk To Others?  
 
The literature provides little evidence about when families communicate about genetic testing. 
Forrest et al. (2003) suggest that disclosure of genetic information is best described as a process, 
thereby implying a collection of actions rather than a single event (Gaff et al. 2007). Yet, what 
literature there is tends to specifically focus on when test results are disclosed rather than 
communication throughout the whole process of genetic counselling and genetic testing. For 
example, descriptive and correlation studies indicate that sharing test results occurs most often 
within a week of receiving the genetic test result with the majority of at-risk adult female family 
members (Claes et al. 2003; Wagner et al. 2003; Forrest et al. 2003; Hughes et al. 2002; 
McGivern et al. 2004; Patenaude et al. 2006; Segal et al. 2004; Petersen and Bunton 2002; 
Peterson et al. 2003). More importantly, however, few studies have explored the reasons behind 
why communication may occur at specific time points, or how it may differ throughout the 
journey of undergoing genetic counselling and genetic testing. Hughes et al. (2002) do suggest 
that BRCA1/2 test results are likely to be communicated to relatives quickly when support is 48 
 
needed. In a grounded theory study examining the experiences of BRCA1/2 carriers in 
communicating genetic information to their offspring, Clarke et al. (2008) found that disclosure 
happened in several distinct phases. These phases included a pre-disclosure phase, where 
participants contemplated sharing the news; a disclosure phase, where participants shared the 
genetic information; and, lastly, the impact of disclosure phase, where participants described 
their reflections after disclosure occurred (Clarke et al. 2008). Hamilton et al. (2005) also suggest 
that disclosures performed later tend to be more carefully planned.  
 
As discussed in 1.3.1, motivations to engage in family communication regarding genetic 
counselling and testing include the need to gain information and/or emotional support (Hughes 
et al. 2002; Green et al. 1997; Van Oostrom et al. 2007). The major limitation of looking at 
discussions with relatives only after the person has actually received their results is that the 
need for information and/or emotional support is not restricted to post- test result. In fact, 
because a significant amount of information on the family history of cancer is needed during the 
early genetic counselling sessions, and decisions then have to be made regarding whether or not 
to actually have the test, including other relatives in order to gain information, emotional 
support is most likely to occur early in the process (refer to section 1.2.1). According to Gaff et 
al. (2007), ‘There would also be value in considering the family communication processes that 
lead to an understanding of risk, which may occur over a long period of time rather than in the 
context of conveying a piece of information’ (p. 1009). Further research is needed to reflect this, 
so interventions to support family communication regarding genetic testing can be appropriately 
targeted to when they are most useful.  
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1.3.4  How Do Those Undergoing Genetic Testing For BRCA1/2 Talk To Others?  
 
Studies have found that uptake of genetic counselling and/or genetic testing by potentially at-
risk relatives is consistently low (Blandy et al. 2003; Landsbergen et al. 2005; Sanz et al. 2010; 
Claes et al. 2003; Peterson et al. 2003; McGivern et al. 2004; Ormond et al. 2003; Ayme et al. 
1979). Of those studies that have determined the rate of uptake of genetic counselling/testing 
by relatives informed about testing, the percentage of those informed who underwent testing 
ranged from 13% (Ormond et al. 2003) to 57-64% (Peterson et al. 2003).  
 
Interestingly, one study in the Netherlands (Landsbergen et al. 2005) found uptake levels for 
predictive BRCA-mutation testing of just 36%, by first- and second-degree relatives of 50 female 
index
5 patients, could not be explained by demographic or counselling characteristics, nor by 
cancer-related history. Rather, the authors concluded that uptake in BRCA1/2-mutation families 
is related to emotional and behavioural communication characteristics of index patients 
(Landsbergen et al. 2005). Blandy et al. (2003) and Foster et al. (2004a) have expressed concerns 
that, how well the information given by the geneticist is understood and retained by those who 
are talking to their relatives about genetic testing, may be a barrier to informing relatives. The 
knowledge about the risk of transmission of BRCA1/2 mutations by women was found to be 
positively and significantly associated with the testing decision among first-degree relatives by 
Blandy et al. (2003). These findings reiterate the need to have a full understanding of not only 
when and with whom information about genetic testing is being shared, but also how it is being 
done and what is being said.  
 
In 2003, Peterson et al. conducted a retrospective, cross-sectional, qualitative study to evaluate 
how information about the identification of an HNPCC gene mutation was disseminated in five 
                                                           
5 The family member with the earliest documented case of a genetic disease. 50 
 
families where at least one member had undergone genetic counselling and testing for cancer 
risk (Peterson et al. 2003). This was conducted as part of a multiphase study of psychosocial 
aspects of genetic counselling and testing for HNPCC (Vernon et al. 1997). Of the 63 biological 
relatives invited to take part in the qualitative study, 29 agreed to participate, and ten of the 31 
invited spouses agreed to participate (Peterson et al. 2003). The primary finding regarding how 
the families talked about genetic testing was that, provided someone in the family knew how to 
contact relatives, communication followed the norms used for conveying other non-urgent 
family news. As was discussed in section 1.3.1, the news was first shared with emotionally close 
and first-degree relatives, i.e. with their spouses, children, and siblings. None of the families 
organised a specific effort or event, such as a family letter or a family meeting, to communicate 
genetic information to other family members. Instead, the information was conveyed on a one-
to-one basis through usual contacts with other family members, such as telephone calls and 
social activities (Peterson et al. 2003). It is important to note that, in this study, the probands 
(the first person in the family to undergo the genetic test), who were instrumental in first 
bringing news of a mutation to the rest of the family, were cancer survivors themselves. This fact 
may have mitigated the potentially threatening nature of this news and facilitated more open 
discussion about it; however, further research is needed to explore this. 
 
Whilst the authors claim that the purpose of the paper is to describe how information about an 
identification of a mutation was disseminated within the family, the findings actually focus more 
on when and under what circumstances this information was shared, and how family members 
reacted to and acted on this information (Peterson et al. 2003). As was found in other literature 
in section 1.3.2, the focus is on dissemination of test results; and, where more general 
discussions about genetic counselling are included, these focus on how relatives can access 
testing. No exploration of how the subject is approached and discussed during the earlier stages 
of the process is included. Exploration about how those undergoing genetic counselling and 51 
 
genetic testing for BRCA1/2 communicate with second and third-degree relatives is also 
important, as there is further evidence to suggest that informing more distant relatives is often 
carried out in a less systematic and more selective manner (Julian-Reynier et al. 2000; Hughes et 
al. 2002; Claes et al. 2003). 
 
In a postal questionnaire regarding familial communication of BRCA1/2 results sent to mutation 
carriers in Pennsylvania, USA, by Finlay et al. (2008), participants (n=115) were asked about: 
methods of disclosure, including whether they relied on other family members to disseminate 
risk information; what was included in disclosure discussions; and whether they recommended 
testing at-risk relatives. The results found 88 (77%) disclosed their positive BRCA1/2 mutation 
status to all at-risk family members, while 27 (23%) survey participants disclosed to at least one, 
but not all, at-risk family members. The most common methods for disclosure of positive test 
results were discussions in person (87.0%) or over the telephone (76.5%). Writing letters or e-
mails describing the results were less frequent methods of disclosure. Interestingly, there were 
no statistically significant differences between methods used by people who disclosed to all at-
risk relatives versus those who disclosed to only some at-risk relatives. In addition, gender did 
not influence the methods used for disclosure. Topics discussed with family members included: 
chance of having a mutation (reported as discussed with one or more relatives by 85.2% of 
participants); cancer risk for people with a mutation (88.7%); screening guidelines for people 
with a mutation (70.4%); changes in medical care for people with a mutation (69.6%); 
preventative surgery or medical options to reduce risk (78.3%); and/or information about 
genetic discrimination (43.5%). A total of 89% of those surveyed either strongly recommended 
or suggested genetic testing to their relatives during disclosure conversations. Despite these 
recommendations, uptake of testing in at-risk relatives was only 57% (although uptake data is 
limited in that they are based on survey participants’ knowledge of relatives’ testing behaviour, 
not on actual test results). Due to the research methods chosen, i.e. postal surveys, the work 52 
 
was unable to discover any factors that significantly contributed to participants’ desire to talk 
about genetic risk with family members, which would be useful information to obtain. 
 
Green et al. (1997) also found that information regarding genetic test results for BRCA1/2 was 
most likely to occur when family members met face to face, and to be integrated into 
communication that would be taking place in any case. Concern about the possible alarmist 
effect of contacting relatives solely for the purpose of telling them of their, or their children's, 
possible cancer risk, meant letters and phone calls were not considered suitable ways of giving 
information to relatives who are not in close contact. Instead, people waited until a family 
gathering occurred for some other reason, or to include the information with a regular 
communication, like a Christmas card (Green et al. 1997). However, this research was conducted 
well before the widespread introduction of mobile phones and emails, which has no doubt 
changed the nature of how families communicate (Kennedy et al. 2008).  
 
How families talk about cancer and the family history of cancer may also affect how they 
communicate about genetic counselling and genetic testing for cancer risk. Mellon et al. (2006) 
conducted focus groups with family dyads, consisting of breast or ovarian cancer patients and 
close female relatives, and found some families talked openly about cancer and risk information, 
while others did not talk about the cancer at all after the initial diagnosis and treatment was 
finished (Mellon et al. 2006). McAllister (2002) found family communication can have significant 
effects on engagement with cancer risk; for example, ‘When the family does not discuss the 
family history, family members can forget about it and remain partially engaged’ regarding the 
process of genetic testing (McAllister 2002, p. 497). Further investigation would be warranted to 
see if there is a link between how families discuss cancer, and their family history of cancer, and 
how they discuss genetic counselling and genetic testing. For example, it might be hypothesised 53 
 
that, where families communicate very openly about cancer, they may be more open in talking 
about genetic testing as well.  
 
 
1.4  Conclusion 
 
The literature presented in this chapter has demonstrated that, because of the issues with 
confidentiality, talking about a family history of cancer, associated risks and genetic testing 
within the family can be very important in ensuring all family members have access to genetic 
services. It can, however, be potentially difficult for concerned individuals and their relatives. As 
more genes are discovered, there is likely to be an increase in numbers of people affected by 
these issues and so the development of interventions to help people manage problems 
associated with the process should be a top research priority.  
 
Despite a wide range of literature, it is clear that the nature of interactions regarding genetic 
information remains poorly understood (Gaff et al. 2007). Research to date has focused far more 
on with whom and why (motivations) those undergoing genetic testing talk to their family, 
rather than when or how it is occurring. What is more, the research tends to focus on 
communication with specific family members at the point of result disclosure only. During this 
chapter, the following areas where further research is needed have been identified:  
 
1.  Research examining when those undergoing genetic testing for BRCA1/2 talk to their 
relatives, throughout the whole process of genetic counselling and genetic testing, not 
just disclosure of test results. 
2.  Research focusing on how those undergoing genetic testing for BRCA1/2 talk to their 
relatives about genetic testing for cancer risk, and what is communicated. 54 
 
3.  Research looking at talking to the whole family, not just with first-degree relatives or 
specific family members.  
4.  Research investigating whether there is a link between how openly families talk about 
cancer in the family; and talking about genetic testing and its risk implications.  
5.  Research examining whether those undergoing genetic testing have understood the 
genetic information in order to relay it successfully to other family members.  
6.  Research looking at whether the use of modern technologies, such as mobile phones 
and emails, has changed how those undergoing genetic testing for BRCA1/2 talk to their 
relatives.  
7.  Research observing whether those undergoing diagnostic genetic testing, i.e. cancer 
survivors, communicate differently from those undergoing predictive genetic testing, i.e. 
who have not had cancer. 
 
Having identified gaps in the literature on how those undergoing genetic testing for BRCA1/2 
talk to their relatives, it is necessary to consider how they may be addressed and the design of 
the research. These seven areas are more concerned with the process rather than the outcome 
(Munhall and Boyd, 1993). They are looking to describe, explore, and explain the phenomena 
being studied (Marshall and Rossman, 1995). This would suggest that a qualitative method of 
inquiry, that seeks to understand social phenomena within the context of the participants' 
perspectives and experiences (Merriam, 2002), would be most appropriate for their 
exploration.
6  
 
                                                           
6 Rather than a quantitative inquiry which, according to Creswell (1994), would be ‘based on 
testing a theory composed of variables, measured with numbers, and analysed with statistical 
procedures, in order to determine whether the predictive generalizations of the theory hold 
true’ (p. 2). 
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Qualitative research has the advantage in that it offers rich, subjective accounts of a 
phenomenon of interest (Munhall and Boyd, 1993). However, designing a study that aims to 
address all of the seven areas of research identified above risks losing that in-depth exploration. 
Hence, there was a need to select and refine the research area and research questions.  
   
With this in mind, before going any further, it was necessary to have a complete understanding 
of what qualitative research had already been conducted concerning family communication 
regarding genetic testing for BRCA1/2. Therefore, in order to inform the selection and 
development of the research questions underpinning this research, the next activity involved the 
conduct of a systematic review and meta-synthesis of the qualitative literature. This review 
addressed the question ‘What facilitates or impedes family communication following genetic 
testing for cancer risk?’ and is discussed fully in the next chapter. 
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Chapter 2 – Systematic Review and Meta-
synthesis 
 
What facilitates or impedes family communication following genetic testing for cancer risk? 
 
2.1   Introduction  
 
The literature reviewed in Chapter One demonstrates how access to genetic cancer risk 
information can be highly dependent on whether familial risks are discussed within the family 
(Hughes et al., 2002). Despite its essential role in ensuring family members have access to 
genetic services, there are a number of gaps in the knowledge available on people’s experiences 
talking to their relatives about genetic testing for BRCA1/2 and its risk implications, as identified 
in section 1.3.1, which would warrant further investigation. 
 
The objective of this chapter is to systematically review and meta-synthesise the primary 
qualitative research regarding family communication following genetic testing of cancer risk, in 
order to: 
-  Ascertain what qualitative research had already been conducted concerning family 
communication regarding genetic testing for BRCA1/2; 
-  Identify barriers and/or facilitators that arise when communicating with relatives about 
undergoing genetic testing for cancer risk; 
-  Inform the direction and focus of this study and aid refinement of the research 
question(s).  
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2.2   Qualitative Systematic Reviews 
 
The decision was taken to pursue a qualitative line of inquiry, because the intention was to 
further explore the experiences and process of sharing genetic information with relatives and 
the challenges that can present. Qualitative research, rather than quantitative research, is more 
suited to this as the emphasis is on meanings, experiences, and views of participants (Pope and 
Mays, 1995). However, in the past, there have been criticisms regarding incorporating 
qualitative studies into systematic reviews.  
-  A systematic review aims to ‘apply pre-defined strategies to identify, appraise and 
synthesise research findings from primary studies to provide empirical answers to 
targeted clinical questions’ (Gysels and Higginson, 2007). They are characterised by 
specific features, including: 
-  an explicit study protocol, addressing a pre-specified, highly focused question(s);  
-  explicit methods for searching and identifying studies;  
-  an appraisal of the studies’ scientific quality; and 
-  clear methods, including descriptive summary or meta-analysis, to combine the 
findings across a range of studies (Egger et al., 1995). 
As such, systematic reviews and data synthesis are important tools in developing an evidence 
base for health care (Jones, 2004).  
 
In 1979, Archie Cochrane published an essay in which he suggested that ‘It is surely a great 
criticism of our profession that we have not organised a critical summary, by specialty or 
subspecialty, adapted periodically, of all relevant randomised controlled trials’ (Cochrane, 1979). 
Since the 1970s, the gained momentum of the evidence-based policy and practice movement 
has promoted the use of systematic reviews. However, the ‘hierarchy of evidence’ approach 
adopted by the Cochrane Collaboration has historically favoured the randomised controlled trial  
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(RCT) design, thus excluding consideration of other quantitative and qualitative study designs 
(Jones, 2004). According to Dixon-Wood and Fitzpatrick (2001), the reluctance to extend the 
existing remit of systematic reviews to include qualitative research was due to a fear it would 
signal an unwelcome return to the haphazard and biased era of the traditional review. 
 
One major criticism of the ‘hierarchy of evidence’ approach is that such systematic reviews are 
unhelpful and inappropriate for answering complex questions (Dixon-Wood et al., 2006). The 
limitations of only counting ‘evidence’ as evidence when it comes from RCT-based systematic 
reviews, and only when it answers ‘what works?’ questions, are increasingly recognised (Dixon-
Wood and Fitzpatrick, 2001). In response to this, guidelines from the NHS Centre for Reviews 
and Dissemination (CRD) explicitly recognised the need for systematic review methodology to 
incorporate more diverse forms of quantitative and qualitative evidence (NHS Centre for 
Reviews and Dissemination, 2001). Qualitative research has an especially valuable role to play in 
answering questions that are not easily addressed exclusively by experimental methods (Dixon-
Wood et al., 2001).  
 
Sherwood (1999) suggested that combining qualitative studies in a review makes the findings 
more substantial because they draw on a broader range of participants and descriptions. They 
have the potential to make an important contribution and influence health care decisions 
because they explore the beliefs, expectations and understandings of participants (Evans and 
Pearson, 2001). As a result, a new interpretation the phenomenon under study is produced 
which contributes to the further understanding of the topic (Evans and Pearson, 2001). 
However, that is not to say there are not concerns about potential limitations of qualitative 
systematic reviews, such as: 
1.  The need for rigour in identifying research. It can be difficult to search for and identify 
appropriate qualitative studies as there is not an equivalent to the Cochrane controlled  
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trials register, and because indexes and search filters can be lacking (Dixon-Wood et al., 
2001). 
2.  Appraising quality of qualitative studies. It is difficult to construct a hierarchy of 
evidences for types of qualitative research studies; and there are no universally agreed 
criteria for judging a paper’s quality, deciding whether or not it should be included 
and/or how to weight it (Dixon-Wood et al., 2001). 
3.  Secondary summary and synthesis. This is made difficult by the number of data types 
and different methods for data collection, widely varying theoretical perspectives and 
diverse analytic approaches (Dixon-Wood et al., 2001). 
 
However, in the literature there is evidence to support how methods of systematic review and 
meta-synthesis can be applied to qualitative research and the importance of such work (Dixon-
Wood and Fitzpatrick, 2001;Dixon-Wood et al., 2001;Dixon-Wood et al., 2006;Evans and 
Pearson, 2001;Jones, 2004). To overcome these limitations, researchers have developed and 
adapted the rationalist systematic review methodologies to allow them to be applied to 
qualitative research. For example, the analysis and synthesis of qualitative studies is commonly 
termed meta-synthesis. It refers to the synthesis of findings from different types of qualitative 
research, allowing critical review and analysis (Sherwood, 1999). Unlike meta-analysis, which is 
associated with quantitative systematic reviews, the goal is to be interpretive rather than 
aggregative. It aims to provide increased understanding of a phenomenon rather than providing 
definitive evidence on the effectiveness of an intervention (Evans and Pearson, 2001). It is this 
aim that made a systematic review and meta-synthesis of qualitative research appropriate to 
meet the objectives of this chapter.  
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2.3  Methods 
 
The methods used for this systematic review and meta-synthesis followed those described by 
Jones (2004). Relevant studies were appraised for quality and relevance by three independent 
researchers (the PhD student and two academic supervisors), using a quality assessment tool 
(Appendix 1) adapted from Hawker et al. (2002). These two sources were selected because they 
provided clear explanations of methods and examples of successful systematic reviews in 
Cancer, Palliative and End of Life Care research. 
 
 
2.3.1    Identifying Relevant Studies 
 
Egger and Smith (1998) argue that the prominent feature of rationalist systematic review 
methodology is an explicit search strategy for identifying relevant evidence. In particular, the 
account provided of search methods should be easily reproducible. Criteria of eligibility are used 
during the conduct of systematic reviews to ensure only studies addressing the specific topic of 
interest are included in the review (Evans and Pearson, 2001). This systematic review identified 
published primary qualitative research studies where: 
-  participants or a close family member (spouse, partner, parent or sibling) had undergone 
genetic testing for cancer risk;  
-  findings included data relating to aspects which facilitated or impeded family 
communication following testing; and  
-  those aspects were either stated by the authors or appeared from the published data to 
be an important element in the study findings.  
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Studies using mixed methods were included only if the qualitative findings were reported and 
discussed separately from the quantitative findings, so the data could be incorporated into the 
meta-synthesis with the other papers included. Studies from any country were eligible for 
inclusion, allowing comparisons between countries if appropriate. Studies were excluded if they:  
-  focused on other forms of genetic testing, such as carrier testing7  
-  focused on genetic testing for other conditions than adult onset cancer; or 
-  were not written in English, as resources for translation were not available. 
 
 Primary qualitative research studies were taken to be studies which used methodologies 
associated with qualitative research, such as: phenomenology, ethnography or grounded theory; 
and those methods more often linked to qualitative research, such as: in-depth interviews, focus 
groups, observations, and reflective diaries to explore participants’ experiences (Jones, 2004).  
 
The dates searched were from the existence of each database until January 2008. The searches 
have not been repeated to update the content of the systematic review in preparation for thesis 
submission, as the objective of the review was to inform the future direction of this study during 
its early stages and to aid the development of the research questions. Any literature published 
since then is, therefore, not relevant to this chapter; however, such literature was reviewed in 
preparation for the discussion in Chapter Eight.  
 
 
2.3.2    Search Strategy  
 
Studies were identified primarily through searches of relevant electronic databases (Table 1). 
Groups of terms relating to four specific parameters were combined: (1) family (e.g. ‘relations’, 
                                                           
7 A test designed to detect carriers of an altered gene for a particular recessive disease, such as sickle cell 
trait.  
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‘relatives’, ‘kin’, ‘children’, ‘offspring’, ‘siblings’, ‘parents’); (2) communication (e.g. ‘talking’, 
‘transmission’, ‘sharing’, ‘discussing’, ‘informing’); (3) genetic testing (e.g. ‘predictive’ or 
‘diagnostic’); and (4) qualitative (e.g. ‘phenomenology’, ‘ethnography’, ‘grounded theory’, 
‘interviews’, ‘observations’, ‘focus groups’, ‘field studies’, ‘case studies’). Some experimentation 
was required to develop an appropriate search strategy that allowed effective identification of 
relevant studies (Table 2).  
 
 
 
 
 
 
Table 1: Electronic databases searched for systematic review 
  
   
Database  Version  Dates Searched 
CINAHL  Ovid/Silver Platter  1982-Dec 2007 
Embase  Ovid  1996-Jan 2008 
Medline  Ovid ®  1996-Jan 2008 
British Nursing Index  Ovid  1994-Jan 2008 
PsycINFO  Ovid including PsycARTICLES  2000-Jan 2008  
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1  genetic test$.mp. 
2  predictive genetic test$.mp. 
3  diagnostic genetic test$.mp. 
4  1 or 2 or 3 
5  communicat$.mp. 
6  discuss$.mp. 
7  shar$.mp. 
8  talk$.mp. 
9  inform$.mp. 
10  5 or 6 or 7 or 8 or 9 
11  4 and 10 
12  famil$.mp. 
13  kin$.mp. 
14  relative$.mp. 
15  parent$.mp. 
16  sibling$.mp. 
17  offspring$.mp. 
18  child$.mp. 
19  relations.mp.  
20  12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 
21  11 and 20 
22  qualitative.mp. 
23  phenomenol$.mp. 
24  ethnon$.mp. 
25  grounded theory.mp. 
26  interview$.tw. 
27  observation$.tw. 
28  focus group$.tw. 
29  field studies.tw. 
30  case stud$.tw. 
31  22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 
32  31 and 11 
33  31 and 21 
34  32 or 33 
 
Key to abbreviations, as used in Ovid: 
  $, tructionation 
  mp= ti, ab, hw, it, sh, tn, ot, dm, mf, nm, tc, id 
  hw = word in subject heading 
  ti = words in title 
  tw = textwords 
 
 
Table 1: Final OVID search strategy used for systematic review 
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2.3.3    Sifting and Sorting  
 
Sifting was carried out in three stages: first by title (n=327), then by abstract (n=92), and finally 
by full text (n=28), excluding studies that did not satisfy the inclusion and exclusion criteria at 
each stage. Each paper was independently reviewed by the PhD student and at least one 
supervisor at each stage and data were extracted with the help of a standard pro forma 
(Appendix 2). 
 
Twenty-eight papers (8.6% of the total number of hits) were read in full; only 10 (30%) of these 
met the study inclusion criteria (Figure 2). Four further studies were identified by the process of 
citation pearl-growing (Hartley, 1990), whereby the reference list of all studies which met the 
inclusion criteria were hand-searched for relevant studies. Therefore, a total of 14 papers are 
included in the final meta-synthesis (Table 3). 
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 Figure 2: Summary of study selection and exclusion for all electronic literature searches 
   
235  
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2.3.4    Assessment of Quality 
 
The quality and relevance of each paper was then assessed using a Quality Assessment Tool 
(QAT) adapted from Hawker et al. (2002). To assess each paper fairly and to ensure consistency, 
Hawker et al. (2002) rate each sub-section as either ‘good’, ‘fair’, ‘poor’, or ‘very poor’ based on 
clearly defined criteria. This tool was then further adapted to give a numerical score of 0-3 
points to make it easier to display results (Appendix 1). Once again, each was independently 
assessed by the PhD student and at least one supervisor. The team then met to discuss scores. 
Generally, there was strong agreement between reviewers, demonstrating that the criteria for 
each score were well-defined. Any disagreements in scores were resolved by consensus 
following a group discussion. (The final scores can be found in Table 3.)  
 
There are two points worth noting here. Firstly, one of the supervisors involved, Dr Claire Foster, 
was an author on several of the papers included in the final review. To ensure fairness, she did 
not review any of the papers that she had been involved in; in these cases, these reviews were 
completed by the PhD student and the other supervisor. Secondly, it is important to recognise 
that the ‘transferability and generalisabilty’ criterion of the QAT is of limited appropriateness to 
some methodologies, for example, the first stage of a grounded theory study. However, 
appraisal of the evidence is an important activity in the systematic review method to reduce the 
possibility of bias (Dixon-Wood et al., 2001).   
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Table 2: Summary of descriptive data for studies included in systematic review 
Study  Country  Cancer  Data 
Collection 
Total 
Participant
s 
(N= ) 
Gender  Cancer Status  Participants  Mean 
Age 
(y) 
Quality  
assessment  
tool Rating 
(n/36) 
 
Mal
e
 
 
F
e
male
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T
 /
 
A
ff
e
c
te
d
 
PGT
 /
 
Un
aff
e
c
te
d
 
Pa
ti
e
n
t
 
Pa
rt
n
e
r
 
O
ff
s
p
ri
n
g
 
(Forrest et al., 
2003) 
UK  HBOC 
HD 
Interviews  28 
(56 incl HD) 
0  21  
+partners 
X     
(21) 
 
(7) 
X  ?  33 
(Hallowell et 
al., 2005a) 
UK  BRCA  Interviews  29  17 
+partners 
0  X     
(17) 
 
(8) 
 
(4) 
54  32 
(Foster et al., 
2004a) 
UK  HBOC  Interviews  15  0  15  X      X  X  46  31 
(Gaff et al., 
2005) 
Australia  HNPCC  Telephone 
Interviews 
12  5  7    X    X  X  41  24 
(Hallowell et 
al., 2003) 
UK  BRCA  Interviews  30  0  30    X    X  X  53  24 
(Kenen et al., 
2006) 
UK  BRCA  Focus Groups  13  0  13    X    X  X  ?  24 
(Hallowell et 
al., 2002) 
UK  BRCA  Interviews  30  0  30    X    X  X  55  23 
(Peterson et 
al., 2003) 
USA  HNPCC  Interviews  39  15  24   
(6) 
 
(?) 
 
(?) 
 
(?) 
 
(?) 
53  22 
(Mesters et al., 
2005) 
Netherlands  HNPCC  Interviews  30  8  22        X  X  43  21 
(Carlsson and 
Nilbert, 2007) 
Sweden  HNPCC  Interviews  19  9  10   
(8) 
 
(11) 
  X  X  47  15 
(Claes et al., 
2003) 
Belgium  BRCA  Interviews  63  1  62    X    X  X  51  14 
(D'Agincourt-
Canning, 
2001) 
Canada  BRCA  Interviews  36  5  31  ?  ?    X  X  53  14 
(Bonadona et 
al., 2002) 
France  BRCA 
HNPCC 
Interviews  23  6  17    X    X  X    13 
(Hamilton et 
al., 2005) 
USA, Canada, 
Denmark 
HBOC 
HD 
Interviews 
(incl email) 
17 
(29 incl HD) 
?  ?  X      X  X  44  13 
HBOC = Hereditary breast and ovarian cancer; HD = Huntington’s disease, BRCA = High risk breast and ovarian cancer genes; HNPCC = Hereditary non-polyposis colorectal 
cancer; DGT= Diagnostic genetic testing; PGT = Predictive genetic testing; (?) = Data not provided by author.   
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 The 14 studies included in this review were of variable quality. The graph in Figure 3 shows the 
number of papers scoring Good (3 points), Fair (2 points), Poor (1 point) and Very Poor (0 points) 
for each category within the QAT. There is an argument that it is not possible to exclude studies 
based on methodological flaws as standards of ‘good’ research change over time, and because a 
researcher’s judgement is biased by her or his own area of research, training and individual 
preference (Jones, 2004). Therefore, no studies were excluded on the basis of their quality 
assessment score; however, it should be noted that quality scores ranged from 13 to 33 (n/36). 
 
 
 Figure 3: A graph showing the number of papers scoring Good, Fair, Poor and Very Poor for each 
category of the Quality Assessment Tool 
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2.3.5    Data Extraction and Analysis 
 
To try to provide the data and the participant’s voice in their purest form for meta-synthesis, 
only the ‘results’ section of each paper was used. This was felt to be important so as not to strip 
studies of their original meaning and specific context, as would have been the case if, for 
example, only participants’ quotes had been used. Study findings were meta-synthesised and 
analysed using Ritchie and Spencer's Framework approach (Ritchie and Spencer, 1994). This 
method was developed in the 1980s by the Qualitative Research Unit at the National Centre for 
Qualitative Research (UK) as a method of analysing qualitative research data. It has been 
successfully used by others for analysis of systematic review data (Jones, 2004;Lloyd Jones, 
2005).  
 
This approach was chosen because it provides a clear series of steps, designed to help first-time 
researchers to manage the large amount and complex nature of qualitative data easily. It is best 
adapted to research that has specific questions, a limited time frame, a pre-designed sample and 
a priori issues (Srivastava and Thomson, 2009). This systematic review started with a specific 
research question designed to inform the study. The time frame was limited in that it needed to 
be done fairly quickly in order for the study to progress forward. The sample was pre-designed 
by nature of the research question and objectives; for example, the sample was qualitative 
research that explored family communication regarding genetic testing. A priori issues had been 
informed by exploration of the literature when preparing the background to the study (Chapter 
One).  
 
The key advantages to a Framework approach, making it suitable for this study, are that it is: a) 
heavily based in, and driven by, the original data collected; b) dynamic: in that it is open to 
change, addition and amendment throughout the analytical process; c) systematic: allowing  
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methodological treatment of all similar units of analysis; d) comprehensive: allowing a full, 
rather than partial or selective, review of the material collected; and e) it allows within-case and 
between-case analysis  (Srivastava and Thomson, 2009). It involves a systematic process of five 
phases: familiarisation, identifying a thematic framework, indexing, charting and mapping, and 
interpretation, all of which are described in more depth below. The approach was designed for 
use in applied qualitative research to inform social policy, allowing for rigorous and transparent 
data management. It does not purely rely on the emergent properties of a relatively small body 
of data, but also draws on the aims and objectives of the pre-defined research question and 
knowledge gained from the existing literature (Ritchie and Spencer, 1994). The stages followed 
were: 
 
1. Familiarisation 
The aim of the familiarisation phase is to gain an overview of the data and to begin listing key 
ideas and recurrent themes. This was achieved by reading and re-reading each paper’s results 
section several times and noting down the key emerging issues.  
 
2. Identifying a Thematic Framework 
The thematic analysis focused on identifiable themes and patterns. Initially, the framework was 
based on the key issues identified during the familiarisation phase and a priori themes.  
 
3. Indexing 
Indexing involved the systematic coding of all the ‘results’ section of each paper using the 
thematic framework. Once identified, the key themes and sub-themes were numbered and 
indexed, thereby creating a thematic framework within which the data were sifted and sorted. 
During this time, the index was refined and modified. The initial framework was then applied to 
the results section of each paper and refined to incorporate additional emergent themes.  
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Indexing references were recorded and stored using the Nvivo8 data management software. The 
reliability and consistency of the analysis of the data were confirmed by independent 
assessment of the papers by at least one supervisor. 
 
4. Charting  
Following from this, charts (or tables) were created for each theme to show a summary of the 
data across the included papers. A matrix-based approach was adopted, with the columns of the 
matrix representing themes and the rows quotes from the paper. The charts display the range of 
experiences for each main theme across the data as a whole, and in doing so facilitated the task 
of the final phase of the analysis: mapping and interpretation.  
 
5. Mapping and Interpretation  
In this final phase, each theme was explored for patterns and contradictions across the papers’ 
results. A realist approach was used, whereby participants’ quotes in the papers were taken to 
be representative of their true feelings, experiences and beliefs. The analysis then moved 
beyond description to interpretation, in the context of existing research.  
 
 
2.4   Results 
 
2.4.1    Methodological Issues and Limitations  
 
As with all systematic reviews, there are limitations based on the scope of the review. First, 
some relevant papers may have been excluded due to the manner of searching. Second, the 
quality of any systematic review or meta-synthesis is dependent on the quality of the studies  
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included (Jones, 2004). There was considerable heterogeneity in the study populations, methods 
used and style of writing across journals, making it more challenging to assess quality and to 
pool data for meta-synthesis. However, the impact of this issue was minimised by the 
standardised quality assessment tool. Fourth, the papers included only relate to hereditary adult 
onset breast and colorectal cancers, which may present a bias. Four dealt with predictive genetic 
testing, six with diagnostic genetic testing, three with both, and one did not specify which type. 
Fifth, the results sections of each paper are subject to the bias of the original authors and will be 
dependent on their original research questions. For example, the research training and 
theoretical perspective of each author or research team will have influenced the way in which 
they carried out their research. Factors such as which journal the paper was published in will 
have affected the word limit and, therefore, the amount of the collected qualitative data that 
could be reported on. Finally, while there are 14 articles reviewed, there are only ten different 
research teams whose views are being presented, as Hallowell and Foster are cited on each 
other's work, and five of the 14 articles are by one or the other of these authors. 
 
 
2.4.2    Identified Themes 
 
The data analysis identified six major themes that influence family communication following 
genetic testing for late-onset hereditary cancer: (1) the informant’s feelings about telling 
relatives about genetic testing; (2) the perceived relevance of the information to other family 
members and their anticipated reactions; (3) the ‘closeness’ of relationships within the family; 
(4) family rules and patterns (e.g. who is best placed to share information with whom); (5) 
finding the right time and level of disclosure; and (6) the supportive role of health care 
professionals. The challenges and facilitators are summarised during the discussion as per the 
research question.  
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Theme 1: Reactions to Role of ‘Informant’ 
 
Several studies explored motivations for undergoing genetic testing and reported that 
participants wanted to gain information for others, for example offspring, siblings and cousins. 
This seemed especially true for those undergoing diagnostic genetic testing (i.e. the participant 
had already had cancer):  
Interviewer: ‘You said that one of the reasons was to find out information for your 
daughters, were there any other reasons that you decided to proceed with testing?  
Oona: ‘Oh no, really just to help my daughters and any further family. I mean to me it’s 
immaterial now I know that I have got breast cancer, or had breast cancer.’ (Hallowell et 
al. 2003, p. 75) 
 
Being the recipient of information from the genetics team and then having the responsibility of 
passing it on to other family members was seen as emotionally demanding. The issue of feeling 
torn between their responsibilities to inform at-risk relatives… 
Susan: ‘I think people have the right to know… if, for example, they hadn’t known and 
then they found it [cancer] later, I think they would be angrier, and say well why didn’t 
you tell me about this? Especially if somebody close to me dies. Well, why didn’t I? You 
know, you basically could have saved a life.’ (D’Agincourt-Canning 2001, p. 238) 
…but not wanting to cause them any harm or distress poses tensions to the role of the 
informant: 
Mary: ‘Other members of the family I haven’t done anything with, because how do you 
approach them? Because    [to] my mother, her sisters, and brothers ‘cancer’ is a death 
word… the ones who are further away I haven’t approached. One, because I don’t see 
them very often. Two, how do I do it? This is the dilemma. Do you ring people up, write  
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to the people, go and see them and say ‘look there is this chance’? I think if it was me, I 
would want to know… because then you can do bits and pieces. But if you are the bearer 
of this news, I think you are torn. You don’t know what to do for the best.’ (Hallowell et 
al. 2003, p. 77) 
 
Other feelings included apprehension about the potentially harmful nature of the information; 
the accurate transmission of technical information; the fact that kin would be faced with difficult 
risk management decisions; dealing with relatives who did not want to receive such information; 
feelings of isolation and burden; and being the bearer of ‘bad news’. There was evidence that 
some had not reflected on the implications of passing on information to their relatives until 
quite late in the process:   
Verity: ‘I didn’t think backwards I only thought forwards. I only thought about my 
offspring and their offspring. I really didn’t consider my brother or, no I didn’t... I didn’t 
give any thought to that really until I spoke to Dr X and they started explaining… and 
then suddenly I thought ‘oh crumbs’ you know, that’s why I say it’s like throwing a stone 
into a pond and the circles start coming out’ (Hallowell et al. 2002, box 4). 
 
Not everyone found the process of communicating to relatives troublesome. Some, particularly 
females, had found it straightforward:  
Female participant: ‘It wasn’t an issue… This issue has been discussed in many family 
conversations over a long period of time [20 yrs], as part of my treatment too, it’s been 
a topic of discussion… This has been a long term process for us, it didn’t come out of the 
blue. It’s just part and parcel of an ongoing process’ (Gaff et al. 2005, p. 136). 
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Theme 2: Perceived Relevance and Anticipated Reactions 
 
Genetic test results were viewed as more relevant to some family members than others. These 
judgements were based on a number of considerations including gender, age, genetic 
relationship (for example, cousins, siblings) and anticipated reactions. For example, parents 
were often considered ‘too old’ and children considered ‘too young’ for the burden of 
information: 
Participant: ‘I did not need to notify any one. My children are too young to understand. 
This question does not apply to me.’ (Mesters et al. 2005, p. 165) 
 
For BRCA1/2, there was also evidence that the information was perceived to be of more 
relevance to female rather than males relatives:  
Participant: ‘I mean obviously if I had daughters I’d have maybe been more anxious 
about it but… I’ve had three boys [who don’t really need to know].’ (Forrest et al. 2003, 
p. 323) 
Jane, 55 years: ‘I don’t even know how it affects them [sons] at all. You know, I don’t 
know whether um, if the gene was there then they may get bowel cancer or whether 
they could get some other cancer or whether it wouldn’t sort of affect them and they 
might just pass it on. I really don’t know. I don’t know anything about it at all’(57). 
(Foster et al. 2004, p. 446) 
 
The decision to disclose or not was often based on the anticipated reactions of family members 
or their perceived receptivity. For example, Hamilton et al. (2005) state that participants decided 
whether to disclose genetic test results by assessing family members' vulnerability and 
receptivity to the information. Assessments of vulnerability and receptivity were related not to 
the disease or test outcomes, but to the life situation and personality of the family member.  
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Parents and children were assessed regarding their vulnerability. One participant talked about 
her mother: 
‘The previous couple of years had been very difficult (my diagnosis, my grandmother’s 
death, and my father’s death all occurred within a 7-month period) and while I don't 
believe in keeping secrets, I also didn't want to raise my mother’s anxiety (and blood 
pressure) more than necessary.’ (Hamilton et al. 2005, p. 20) 
 
Theme 3: Closeness of Relationships 
 
Emotional, genetic and demographic distance plays a role in family communication following 
genetic testing. The desire to help the family become aware of choices that could improve their 
health commonly motivated people, and the availability of predictive testing was seen as good 
news. Emotional ties, rather than the genetic relationship, often influenced who was told about 
predictive testing. 
The responsibility for passing on information includes close family members as well as family 
members who live far away, perhaps in other countries. A particular difficulty can be 
experienced in conveying information about a hereditary predisposition for cancer to family 
members with whom one has only sporadic contact.  
There was evidence that genetically-close relatives such as children, siblings and parents were 
more likely to be informed about diagnosis or test results than distant relatives. This was often 
accompanied by an assumption that someone else would have informed the more distant 
relatives. Little or superficial contact with distant relatives, and difficulties related to overcoming 
pre-existing conflicts or rifts in the family, impeded communication:  
Husband: [She] has got two brothers and they all know about it. Well one does, they 
don’t speak to the other one. (Forrest et al. 2003, p. 323)  
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Participant: My daughter got tested, but she never went back for the test results. This 
created tension in our family, so we did not take it any further. My brother and his 
family have no idea. (Mester et al. 2005, p. 165)  
 
Theme 4: Family Rules and Patterns 
 
Genetic testing is described as a family affair often influenced by the family’s collective 
experiences of cancer. ‘Rules’ of family interactions and authority dictate family life and, 
therefore, communication patterns. There were several examples where the authority to 
disclose followed ‘vertical’ patterns through the family (e.g. from parent to child) rather than 
‘horizontal’ (e.g. from cousin to cousin). For example, a grandparent is perceived to have more 
authority than an aunt or uncle.  
‘You see, when my sister died my brother was completely torn apart… But he just won’t 
allow anything to touch him like that again, and in a way, [it’s] his way of dealing with it, 
he just doesn’t go there… So my [deceased] sister’s children don’t know yet, but my 
sister’s mother-in-law knows, and she has an excellent relationship with them. And 
when the time is right she will brief them and we’ll start moving things forward.’ (Forrest 
et al. 2003, p. 321) 
 
Also evident was the gendering of disclosure within families, where women often appeared to 
take responsibility for initiating contact with a genetic counsellor and for passing on information 
within the family.  
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Theme 5: Timings 
 
Genetic testing presented a dilemma about when and how to tell relatives. It was important to 
find the ‘right’ time and be able to manage the time and content of disclosure, not only for the 
benefit of the recipient but also the informant. Death and disease in the family made it difficult 
to initiate discussions. Some needed time to absorb the information and make decisions, while 
others found sharing their information helped them do this. 
Others wanted to delay talking to their relatives until they had received all the information 
themselves. For example, some participants would wait until they had received their own test 
results before telling relatives about their involvement in genetic testing; or, in some cases, 
waiting until the recipient was in a ‘better place’ to deal with the information: 
‘I have not told my son. He is 23 - old enough to know-but not ready to hear it yet. He is 
in a very stressful place trying to finish graduate school. He doesn't need to have further 
complications to his life right now.’ (Hamilton et al. 2005, p. 20) 
 
Theme 6: Role of Health Care Professionals  
 
There were mixed views regarding the role of health care professionals in telling relatives about 
genetic testing. Some felt it was their responsibility rather than that of the health care 
professional to communicate family risk, as they knew the family better, whereas others wished 
a professional could speak to their relatives on their behalf:   
Donna: ‘I just wish there was somebody—somebody else that could come and talk to 
them, you know, talk to my family. ‘Cause you don’t want to keep telling them things 
that hurts them.’ (Kenen et al. 2006, p. 156) 
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However, there was clear evidence that health professionals can aid family communication 
following genetic testing: 
‘My sister’s physician underlined the importance, so we did it together. It felt like doing 
the right thing.’ Thus, although there was an intrinsic motivation to disclose information 
to one’s family, it helped if external cues were present that gave people the feeling that 
what they were doing was okay. (Mester et al. 2005, p. 164) 
 
Several expressed a desire for health professionals’ input to legitimise risk information, and a 
tendency to rely on them for technical information was noted: 
‘I mean I could say to the kids I have these flags and markers and everything which do 
confuse me. I could be giving them the totally wrong information and leading them up 
the garden path… I mean you could tell them to a certain degree that you may have this 
genetic problem, but if you want to know more information, then your best bet is to 
contact the genetic clinic because they have all the details, they know what they are 
looking for.’ (Forrest et al. 2003, p. 320) 
 
 
2.5   Discussion 
 
This is the first systematic review of qualitative studies exploring communication to potentially 
at-risk relatives following genetic testing for hereditary adult-onset cancers. The findings 
indicate six themes, representing both facilitating factors and challenges, that influence family 
communication: (1) the individual’s reactions to the ‘role of being the informant’; (2) the 
perceived relevance of the information for individual family members and anticipated reactions; 
(3) the closeness of the relationship between the informant and recipients; (4) the family rules  
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and patterns that influence their interactions; (5) the informant’s management of the timing and 
content of information shared with relatives; and (6) the role played by health care 
professionals.  
 
In summary, the data included in this systematic review and meat-synthesis would suggest that 
factors likely to promote family communication regarding genetic testing for cancer risk include: 
if the motivations for undertaking genetic testing included finding out potential risk information 
for other family members; regular discussion of the topic as part of the family’s collective 
experiences of cancer; seeing genetic testing as a positive thing and a desire to make other 
family members aware of choices to improve health; having close relationships; being able to 
manage the time and content of discussions to allow the informant to feel prepared and in 
control (interestingly, this also appears in the challenges list); and positive input from health care 
professionals, in particular their endorsement, legitimising the word of the informant and 
providing more technical information.  
 
A profile of the contextual factors from this analysis predicts that individuals are most likely to 
engage in family communication if they:  
-  undergo genetic testing with the intention of gaining information for other family 
members as well as for themselves; 
-  have a sense of duty to warn others of potential risk;  
-  have taken time to process the information before telling others; 
-  have close relationships with their relatives; and  
-  have been encouraged and supported by his/her genetic practitioner to engage in family 
communication.  
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Several challenges were also identified that could potentially act as barriers to family 
communication regarding genetic testing, including: feelings of burden and responsibility; 
misguided perceptions of who could be affected (for example, perceiving breast cancer as a 
predominately ‘female’ disease); not having a close relationship; geographic distance; 
assumption that others will inform certain family members; death and disease within the family; 
and a desire that a health care professional would take on the role of informant. These are 
potential areas where future interventions to aid family communication regarding genetic 
testing for cancer risk could be targeted.  
 
These findings are consistent with other research not included in this systematic review. As 
discussed in Chapter One, several studies have demonstrated that there is an increased 
likelihood that family members discuss genetic counselling and testing with their first-degree 
relatives and their spouses, whereas discussions are less likely to occur with more distant 
relatives (Claes et al., 2003;Koehly et al., 2003). Koehly et al. (2003) found mutation status was 
not a significant predictor of whether discussions occurred. This suggests family culture may play 
a more important role in determining family communication rather than the results of the 
genetic test itself. The nature of family relationships, in particular, is likely to have an impact on 
the dissemination of information within the family and the support available to those tested. 
These may include: the nature of pre-existing relationships; divorce; remarriage; the patterns of 
interactions; family tensions and rifts (Forrest et al., 2003;Green and Thomas, 1997). 
 
One of the recurrent themes throughout was that of informing children about genetic testing 
and potential risk. While parents had often made the decision not to inform children at the time 
because they were deemed ‘too young’ or perceived unready for the information, several 
participants reported difficulties in deciding when ‘the right time’ was. As Forrest et al. (2003)  
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noted, this appears linked to perceptions of when action to prevent cancer was needed, or when 
the first key life decisions that may be affected by the disease needed to be made. 
 
Whilst the objective of this review was to look at the implications for the research study and its 
direction, the review findings have implications for clinical practice. While the role of a genetic 
counsellor is primarily to facilitate informed decision-making about genetic testing, improve 
adjustment to genetic test results, and aid informed decisions about cancer prevention, 
surveillance and treatment (Hughes et al., 2002), these findings suggest their role in aiding 
communication with relatives is vital. There was evidence that the endorsement of the health 
care professional can be an important stimulus to talking to relatives (Mesters et al., 2005). In 
these studies, health professionals were also relied upon as a source of technical information or 
to legitimise the word of the informant. These findings support the use of aids to 
communication, such as family letters and information sheets, and the development of other 
interventions to aid family communication. 
 
 
2.6   Conclusion 
 
This systematic review and meta-synthesis gives insight into the challenges that those engaged 
in family communication regarding genetic testing for cancer risk face (Chivers Seymour et al., 
2010). In particular, it provides information on who is most likely to engage in such activities and 
why. It supports the fact that research tends to focus on disclosure as a single act at the point of 
receiving a genetic test result. The findings reinforce the conclusion of Chapter One: that there 
are still specific gaps in the literature, particularly around how and when families talk about the  
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topic, that should be addressed before steps can be taken in order to find ways of supporting 
family communication regarding genetic testing. As Gaff et al. (2007b) state:  
‘If genetic services are going to continue to rely on family communication to transmit 
information about hereditary cancer risk or genetic testing, or conversely if they seek 
greater participation in this process, it is vital to go beyond identifying factors that 
influence who in the family will be told and gain an understanding of the process of 
communication and its consequences’ (p. 1000).  
 
Therefore, the next stage of the research was to conduct a qualitative study of how those who 
have had a genetic testing for BRCA1/2 talk to relatives using in-depth interviews with people 
who had undergone genetic testing. This work goes beyond previous work, which primarily 
looked at who individuals tell and why, by focusing on how these families discuss genetic testing 
for cancer risk and when this communication occurs. Chapter Three will set out the research 
question, aims and objectives, and describe the qualitative study in theoretical (Research 
Methodology) and practical terms (Research Methods). 
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Chapter 3 – Research Process 
 
3.1   Introduction  
 
Chapter One introduced the topic under investigation and critically examined the literature on 
family communication regarding genetic testing for BRCA1/2. At the end of the chapter, seven 
areas were identified where further research is needed in order to have a fuller understanding 
people’s experiences of family communication regarding genetic testing for BRCA1/2 (refer to 
section 1.3.1). These areas of research relate to gaining further understanding of people’s 
experiences of the phenomenon under study and therefore advocate pursuing a qualitative line 
of inquiry. In order to inform the selection and development of the research questions, Chapter 
Two then presented a systematic review and meta-synthesis of the qualitative literature to date, 
and focused on barriers and facilitators that arise when communicating with relatives about 
undergoing genetic testing for cancer risk. This review particularly highlights that, although 
extensive research has been carried out by looking at with whom and why (motivations) those 
undergoing genetic testing talk to their family, the research to date does not adequately cover 
how and when families talk about the topic. The ‘how’ refers to what they talk about; how the 
topic is introduced and managed; and what methods and patterns of communication are used. 
The ‘when’ refers to the time points that these communications occurs and how they differ 
throughout the whole process of genetic counselling and genetic testing. Therefore, from the 
seven gaps in the literature identified in section 1.3, it is the ‘how’ and ‘when’ that will form the 
primary focus of this present study. 
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Building on that work, this chapter begins with the selection and rationale of the research 
question and aims for this study. The rest of the chapter and the following chapter will then go 
on to describe the qualitative study in theoretical (Research Methodology) and practical terms 
(Research Methods). 
 
 
3.2  Research Question 
 
Research to date has focused far more on with whom and why (motivations) family 
communication regarding genetic testing occurs rather than when or how it is occurring. What is 
more, the research tends to focus on communication with specific family members at the point 
of result disclosure only. Therefore, the work presented in this thesis will address the following 
research question:  
 
How and when do those undergoing genetic testing for BRCA1/2 talk to their relatives about a 
family history of cancer, associated risks and genetic testing? 
 
 
3.3   Research Aims 
 
The aim is to gain insight into participants’ experiences of discussing their genetic testing, their 
test results and potential risk information following genetic testing for BRCA1/2  with their 
family (not just with first-degree relatives or specific family members ), with particular focus on 
how these families discuss genetic testing for cancer risk and when. There will be an  
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appreciation of family communication as a process rather than as a discrete event. Therefore, 
the research will examine when, from the perspective of a family member undergoing genetic 
testing, family communication regarding genetic testing occurs, throughout the whole process of 
genetic counselling and genetic testing, not just disclosure of test results. 
 
The resultant study, as described in the remaining chapters, was qualitative in nature, employing 
in-depth interviews as the method for data collection and utilising the technique of constructing 
eco-maps (Ray and Street, 2005) as a method of identifying relevant family members and 
guiding the researcher through the family structure and relationships. These methods were 
chosen in line with the interpretive description methodology to ensure depth and richness in 
analysis and reporting of findings.  
 
 
3.4  Research Methodology  
 
According to Joubish et al. (2011), the design of any research study begins with the selection of a 
topic and a paradigm: ‘A paradigm is essentially a worldview, a whole framework of beliefs, 
values  and  methods  within  which  research  takes  place.  It  is  this  world  view  within  which 
researcher works’ (Joubish et al., 2011) (p. 2083).  
 
The previous chapters have summarised the selection of the topic under study and aligned the 
research  within  a  qualitative  paradigm.  All  research  questions  are  theoretical  in  that  they 
advocate positions on what the world is and how it can be known (Silverman, 2000a). Therefore, 
before engaging with any research, and throughout the process itself, it is important to take the 
opportunity to consider the foundations of the work. This section, Research Methodology, will  
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discuss the theoretical assumptions implicit within the research questions and the decision to 
conduct a qualitative interpretive descriptive study.  
 
When one consults the research literature, much of the terminology in this field is not always 
used consistently; therefore, it is necessary to outline some of the literature on frameworks for 
the Process of Research, examining in more detail different epistemological, theoretical and 
methodological approaches to research. This will lead on to a justification for the study within a 
qualitative  interpretive  paradigm  and  an  interpretive  description  methodology.  The 
methodologies and methods chosen must depend on the nature of the project, the type of 
information needed, the context of the study and the availability of resources, for example, 
time, money, and human (researcher) input (Silverman, 1997). However, as Denscombe (2003) 
states: ‘The crucial thing for good research is that the choices are reasonable and that they are 
made explicit as part of any research report’ (p. 3). 
 
 
3.4.1   Qualitative Research Paradigm 
 
In social science, the principal research designs are either qualitative or quantitative in nature, or 
a combination of the two (mixed methods). Probably the most basic differentiation between a 
qualitative and quantitative paradigm is the importance of quantifiable data. Generally, 
quantitative research is associated with numbers, measurements and statistical reasoning. 
However, the heart of the quantitative-qualitative ‘debate’ is not methodological but 
philosophical (Krauss, 2005). Quantitative research expresses the assumptions of a positivist 
theoretical perspective (refer to section 3.4.4.), which holds that behaviour can be explained 
through objective facts, and knowledge is discovered and verified through direct observations or 
measurements of phenomena (Firestone, 1987). Quantitative approaches lend themselves to,  
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and are more often associated with, larger sample sizes that aim to be representational of the 
study population and provide research that can be replicated or repeated. As such, it would not 
be feasible or desirable to obtain vastly in-depth data from such research.  
 
On the other hand, qualitative research is exploratory in nature, offering understanding and 
answers to the ‘how’, ‘why’ and ‘what is’ questions about human behaviour and the basis that 
underpin such behaviours (Denzin and Lincoln, 2003). The term ‘qualitative research’ may 
encompass a wide range of data, data collection, interpretation and/or analytical approaches 
and methodologies (Van Maanan, 1979) and it is important for a researcher to select the 
qualitative research approach that will best answer their own research question (Ploeg, 1999). 
However, there is fairly wide consensus that it is ‘a naturalistic, interpretative approach 
concerned with understanding the meanings which people attach to phenomena (actions, 
decisions, beliefs, values etc.) within their social worlds’ (Snape and Spencer, 2003). Qualitative 
researchers believe that the best way to understand any phenomenon is to view it in its context; 
therefore, one of the central roles of qualitative research is to provide levels of richness, depth 
and profundity not necessarily available with other research paradigms, thus making it the most 
suitable choice for this present study. 
 
According to Mays and Pope (1995), the three main criticisms of qualitative research in the 
health field are:  
1.  That qualitative research is merely an assembly of anecdote and personal impressions, 
strongly subject to researcher bias - in other words, it lacks validity and reliability.   
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2.  That qualitative research lacks reproducibility - the research is so personal to the 
researcher that there is no guarantee that a different researcher would not come to 
radically different conclusions. 
3.  That qualitative research lacks generalisability. 
 
There are those who have argued that terms like ‘validity’ and ‘reliability’ come from a positivist 
quantitative paradigm and should, therefore, be rejected in relation to qualitative inquiry 
(Altheide and Johnson, 1994;Leninger, 1994;Peck and Secker, 1999;Whittemore et al., 2001). 
However, others, such as Morse (1999), have cautioned that rejecting these terms would mean 
rejecting the core scientific concept of rigour, which risks undermining the valued contribution 
of qualitative research to the advancement of knowledge. Rigour is the means by which 
researchers demonstrate integrity and competence: ‘it is about ethics and politics, regardless of 
the paradigm’ (Tobin and Begley, 2004). 
 
As in quantitative research, the basic strategy to ensure rigour in qualitative research is 
systematic and self-conscious research design, data collection, interpretation, and 
communication (Mays and Pope, 1995). So, in order to overcome the criticisms outlined above, 
the finding of this research must be an authentic and trustworthy reflection of how participants 
talk to relatives regarding genetic testing for BRCA1/2. In line with interpretive description 
methodology (refer to section 3.5), several strategies were taken to ensure methodological 
rigour. For example, consideration of Lincoln and Guba’s (1985; 1994) framework: credibility, 
transferability, dependability, confirmability (Lincoln and Guba, 1985) and authenticity (Guba 
and Lincoln, 1994). The application of this framework will be discussed in detail in section 4.9. 
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Nordgren et al. (2008) argue that generalisability, as we would normally make sense of it in a 
clinical trial, is impossible in qualitative research, because the phenomena are intimately tied to 
the times and contexts in which they are found. It may, however, be replaced by concepts of 
applicability (Guba, 1981), transferability (Lincoln and Guba, 1985) and case-to-case transfer 
(Firestone, 1993). Generalisability, from this perspective, is analytic rather than empiric 
(Nordgren et al., 2008) and researchers should supply sufficient detail in the description so the 
reader can make an informed judgement of whether the original study setting and their own are 
sufficiently similar in order to ‘apply’ the findings (Murphy et al., 1998). 
 
For example, it is hoped that the findings of this study will be useful for anyone who has 
professional encounters with those undergoing genetic testing for BRCA1/2. The findings may 
provide professionals and researchers with a better understanding of how and when these 
families discuss the family history of cancer, associated risks and genetic testing. The findings 
may also offer a theoretically informed starting point for clinical questions that merit further 
investigation (quantitative or qualitative); for example, ‘How can we support family 
communication regarding genetic testing for BRCA1/2?’ Hence, the findings, which will be 
derived from the patient’s own perspectives, may work as frames of interpretation for those 
supporting these individuals (Nordgren et al., 2008). The theoretical perspective underpinning 
this research will be discussed in section 3.4.4.  
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3.4.2  The Qualitative Research Process 
 
The ‘Process of Research’ (or ‘Research Process’) refers to the different approaches to research 
at different levels. Carter and Little (2007) argue that ‘three fundamental facets of research – 
epistemology, methodology and method – should provide the framework for planning, 
implementing, and evaluating the quality of qualitative research’ (p. 1316).  
 
Epistemology is a branch of philosophy concerned with the nature of knowing. For example, 
epistemology aims to address questions such as: ‘What do we know?’, ‘How is knowledge 
acquired?’ and ‘How do we know what we know?’ (Grad, 2009). Methodology provides the 
justification for the methods by way of analysis of assumptions, principles and procedures in a 
particular approach to the inquiry (Schwandt, 2001), but are not the methods themselves 
(Kaplan, 1964). Whereas, methods are the ‘research action’ (Carter and Little, 2007), or the 
techniques used to gather evidence (Harding, 1987). As Carter and Little (2007) describe it: 
‘Methodology justifies method, which produces data and analysis. Knowledge is created from 
data and analysis. Epistemology modifies methodology and justifies the knowledge produced’ (p. 
1317). This relationship is depicted in Figure 4
8.    
                                                           
8 Permission to reprint copyright material kindly granted by SAGE publications.  
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 Figure 4: The Simple Relationship between Epistemology, Methodology and Method (Carter and Little 
2007: 1317)  
 
 
Crotty (1998) adds a fourth element for the research process, which is theoretical perspective. 
This is ‘the theoretical stance informing the methodology and thus providing a context for the 
process and grounding its logic and criteria’ (p. 3). As with Little and Carter’s framework, Crotty’s 
four elements inform one another.  
 
This section will explore each of these four elements in more detail.  
 
 
3.4.3  Epistemology: Justifying Knowledge 
 
Epistemology is one of the core branches of philosophy. It concerns itself with the nature, 
acquirement and limitations of knowledge. For example, epistemology primarily addresses three 
questions: ‘What is knowledge?’, ‘How is knowledge acquired?’ and ‘What do people know?’  
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Oka and Shaw (2000) contend that a lack of appreciation of the philosophical backgrounds of 
qualitative research often leads to confusion when analysing qualitative data and, therefore, 
argue it is essential for qualitative researchers to be aware of the influence of philosophy on 
strategies of research. There are a number of epistemological stances demonstrated in the 
literature; however, Crotty (1998) identifies the three core ones as:  
 
1.  Objectivism: holds that meaning, and therefore meaningful reality, exists as such 
without the operation of consciousness. For example, an object is that object whether 
anyone is aware of existence or not. ‘Objectively’ carries the intrinsic meaning of itself. 
When we recognise it as a particular object, we are simply discovering a meaning that 
has been there all along. Objectivism is founded within the principles of positivism. 
 
Positivism, as a philosophical system, holds that knowledge must be scientific to be 
valid; therefore, such knowledge can only be derived from the strict scientific methods 
of the ‘natural science’. According to positivism, all research can be conducted 
objectively and independently of the researcher’s values or perspectives. As such, 
positivism and objectivism are most often associated with quantitative research. 
 
2.  Subjectivism: here, meaning is imposed on the object by the subject from somewhere 
else. In other words, with the exception of existence, the object makes no contribution 
to the generation of meaning. 
 
3.  Constructivism: knowledge and meaningful reality is dependent on human engagement 
with the world, in and out of which meaning is constructed. Therefore, it is the 
interaction between object and subject that constructs meaning, and meaning cannot  
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exist without one or the other. As such, different people may construct meanings of the 
same phenomenon in different ways and, therefore, there cannot be one ‘true’ or ‘valid’ 
interpretation. An example of constructivism would be Interpretivism or Post-positivism.  
 
As the prefix indicates, post-positivism is a meta-theoretical viewpoint to positivism. It 
recognises that human beings cannot perfectly understand reality but, with rigorous 
methods, researchers can reach an understanding of the social world whereby 
explanations are offered at the level of meanings rather than cause (Snape and Spencer, 
2003). The methods of the ‘natural science’ are deemed inappropriate, as the social 
world is not governed by law-like regularities, and the researcher and participants are 
recognised to impact on each other.  
 
Another epistemological debate to be considered is the way in which knowledge is acquired and 
the relative merits of inductive and deductive methods of scientific enquiry. Snape and Spenser 
(2003)(142)(17) define the difference as: 
‘Induction looks for patterns and associations derived from observations of the 
world; deduction generates propositions and hypotheses theoretically through a 
logically derived process’ (p. 14). 
 
Quantitative inquiry uses the latter, with ‘emphasis on hypothesis testing, causal explanation, 
generalization and prediction’ (p. 14), whilst inductive approaches to design, fieldwork and 
analysis are more commonly associated with qualitative inquiry, concentrating on understanding 
‘rich description and emerging themes and concepts’ (p. 14). However, there are no exact rules; 
indeed, Snape and Spenser (142)(2003) go on to argue that both induction and deduction are 
involved at different stages of the qualitative research process (p. 24).  
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 The implicit reasoning in this present study, as a piece of qualitative work, is held to be 
interpretistic and inductive, as an understanding of how people really behave and what people 
actually mean when they describe their experiences, attitudes, and behaviours is integral to 
answering the research question (refer to section 3.2). Therefore, this research study was 
conducted from within an interpretive perspective. Guba and Lincoln (1994), who prefer the 
label of constructivist, characterises this perspective as commitment to: 
- A relativist ontology: where realities exist as situated constructions;  
- A subjectivist epistemology: where the findings are recognised to be a product of the 
interaction between the research subject, be that participants, groups, cultures or 
situations, and the researcher; and  
- A hermeneutic, dialectic methodology: concerned with interpretation and refinement.  
 
 
3.4.4  Theoretical Perspective: Justifying methodology 
 
A theoretical perspective provides the context for the process and grounds its logic and criteria. 
Several authors have noted the lack of theoretical models relating to predictive genetic testing 
and, in particular, high-risk families (Cull et al., 1999;McAllister, 2001;McAllister, 2002;Rees et 
al., 2001;Reeves et al., 2000).  
 
As discussed in Chapters One and Two, the literature is increasingly recognising that talking to 
one’s family about genetic testing and its risk implications is significantly more than disclosing 
test results as a discrete activity (Gaff et al., 2007a). Rather, it is a process that may occur 
throughout the whole journey of genetic counselling and genetic testing. As we move away from 
the assumed sender-receiver model of communication (Wiseman et al. 2010) and towards more  
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of a ‘family affair’ (Foster et al., 2002), a family systems perspective is been proposed as a 
potentially useful framework for understanding family issues in genetic testing (Ross et al., 
1990). 
 
Previous studies have used Family Systems theories in the analysis or explanations of findings 
relating to genetic testing (Blandy et al., 2003;Foster et al., 2004a;Kenen et al., 2004b;McGivern 
et al., 2004;Mellon et al., 2006;Peterson et al., 2003;Bakos et al., 2008;Carlsson et al., 
2004;Clarke et al., 2008;Wilson et al., 2004;Harris et al., 2010). According to Wiseman et al. 
(2010), the use of Family Systems and other social and political theories has enabled researchers 
to suggest that individual and wider contexts such as gender, culture and biology affect 
communication within families (p. 701).  
 
According to Broderick (1993), Murray Bowen’s Family Systems Theory is a theory of human 
behaviour that views the family as an emotional unit and describes the complex interactions 
within the unit using systems thinking. It assumes that family members are intensely connected 
and reactive to changes in each other’s functioning. As such, the theory suggests that individuals 
cannot be understood in isolation from one another, but rather as a part of their family 
(Broderick, 1993;Peterson, 2005). In other words, the Family Systems approach proposes that 
behaviour may have as much to do with the ‘systems’, the family, and the patterns that are 
established within that system, as it does to do with the personality of the individuals within the 
system. So, behaviours can only be understood by looking at the relationships and interactions 
among all family members (Broderick, 1993). Critiques of the family systems theory have raised 
concerns about empirical limitations associated with its generating descriptive rather than 
explanatory abilities (Gavazzi and Gavazzi, 2011).  
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Peterson (2005) proposes that a family systems perspective is a most suitable framework for 
conducting family-based research in hereditary risk and genetic testing because it accounts for 
the reciprocal nature of family relationships, the broader social context in which families exist, 
and the multiple dimensions that comprise family functioning. Peterson’s version of the family 
systems model for family-based genetic research uses three domains that, according to Walsh 
(1998), are characteristic of well-functioning families: organisation and structure of family 
relationships, family communication, and health-related cognitions and beliefs shared within 
families. These three domains influence how families respond to external stressors, such as 
chronic illness; changes in the family unit as whole will in turn affect individuals (Djurdjinovic, 
1998;Rolland, 1994). According to Peterson (2005), these domains may help guide the selection 
and organisation of variables in family-based research and intervention development regarding 
genetic testing. 
 
For example, Harris et al. (2010) used Peterson’s version of the family systems model to 
investigate cancer risk communication within melanoma families by examining the relationship 
between familial organisation and structures, shared health-related beliefs, and communication 
in families at increased risk of developing melanoma. Following Peterson’s model, they 
hypothesised that a family’s organisational and structural characteristics, especially adaptation, 
coping and cohesion, plus shared familial beliefs about melanoma, would together predict the 
frequency and style of family communication about melanoma risk (Harris et al., 2010). 
According to the authors, all family organisational variables (family coping, adaptation and 
cohesion) and familial health beliefs were found to be associated with an open style of 
communication. Those individuals reporting more active styles of coping and higher levels of 
adaptation and cohesion were more likely to have open communication about melanoma within 
their family.  
 
99 
 
Family Organizational & Structural Characteristics 
The delineation of clear boundaries and subsystems 
that define members and their autonomous roles 
within the family unit is a structural characteristic of 
healthy families (Peterson, 2005). 
 
Reactions to a family crisis, such as diagnosis of 
cancer or a genetic test result, are of particular 
importance in defining the strength and nature of 
relationships (McGoldrick and Gerson, 1985). 
 
For BRCA1/2 and other familial cancers, the family 
structure may be particularly important to how 
health information is diffused and disseminated; 
how family members support each other through 
crises; and how family members are encouraged to 
pursue genetic counselling and genetic testing 
(Koehly et al., 2003). 
 
Definitions of family membership and/or family roles 
and leadership may shift depending on who 
becomes involved in… 
Family Health Beliefs about 
Breast and Ovarian Cancer 
 
Families tend to have a series of shared health 
beliefs and attitudes that develop over several 
generations, influenced by cultural expectations, 
collective experiences and traditions. These beliefs 
are often expressed in the families’ rituals and 
routines, and may be affected by illness (Sobel and 
Cowan, 2000). 
Knowledge and beliefs will influence how individuals 
and the family as a whole interpret risk information, 
gained through either personal experience or as a 
result of genetic counselling, for an inherited 
condition, like BRCA1/2. 
For example, Babb et al. (2002) found that women 
at risk of developing hereditary ovarian cancer, with 
a significant family history, were more likely than 
women with no experience of cancer to take more 
drastic preventative measures such as prophylactic 
oophorectomy. Such findings suggest that medical 
decisions and other outcomes may be driven by 
personal and family beliefs about cancer (Peterson, 
2005;Werner-Lin, 2008); these, in turn, will affect…  
Family Communication about Breast and Ovarian Cancer Risk 
Building on this, the theoretical perspective of this doctoral study holds that how and when 
those undergoing genetic testing for BRCA1/2 talk to their relatives about genetic testing will be 
influenced by their family’s organisational and structural characteristics, plus shared familial 
beliefs, as shown in Figure 5.  
 
 
 
 
 
 
 
 Figure 5: The conceptual model of the relationship between family functioning and family 
communication; adapted from Harris et al.’s (2010) conceptual model for analysing the relationship 
between family functioning and family communication about melanoma risk 
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Given its basis within a Family Systems perspective, it could be presumed that, in order to use 
such a conceptual model to look at how those undergoing genetic testing for BRCA1/2 talk to 
their family, it would be necessary to conduct research with the family as a whole rather than an 
individual within the family. However, whilst talking about genetic testing and its risk 
implications may be a ‘family affair’, as part of the process the individuals undergoing the 
genetic testing for BRCA1/2 may need to interact with their families in a new and unfamiliar 
manner (Peterson, 2005). Moreover, conceptualising families in research poses a number of 
challenges; for example, the family is a subjective concept that can vary by ethnicity and culture, 
and its structure can be described in terms of biological as well as social relationships (Peterson, 
2005).  
 
Therefore, in order to explore the how and when those undergoing testing talk to their family, it 
is important to capture the experience of the individual, and their definition of who constitutes 
their family, within that. Carter and MGoldrick (1989) argue that it is extremely difficult to think 
of the family as a whole because of the complexities involved; essentially, ‘a family is more than 
just the sum of its parts’ (p. 4). The ‘Family Life Cycle’ theory (Carter and McGoldrick, 1989) 
offers an understanding of what happens in families in terms of the flow of life over generations, 
and can be used to examine variables that affect the course of family development including 
chronic illness. Importantly, at the centre of the ‘Family Life Cycle’ sits the view that you cannot 
understand the family without understanding the experience of the individual.  
 
The family life cycle perspective can be used as conceptual framework to study how individuals 
within a family, and by association the family as a whole, adapt to chronic illness in order to 
improve care provided by nurses and other health care professionals (Newby, 1996). It provides 
a conceptual framework from which to view pathology within both the individual and the family. 
Essentially, the view is that the individual life cycle takes place within the family life cycle, which  
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is in the primary context of human development. Families are shaped by people who share a 
history and a future together and, although the family process is by no means linear, it exists in 
the  linear  dimension  of  time.  As  such,  families  can  be  described  as  ‘living  systems  moving 
through time’.  
 
The family life cycle is a complex phenomenon, but the theory is based on the emotional and 
intellectual stages passed through from birth to death as a member of a family. The progress 
from one life cycle stage to another is referred to as ‘transition’. Relationships with parents, 
siblings and other family members go through transition points as one moves along the life 
cycle, just as parent-child or spouse relationships do. At each stage, there are challenges to 
family life that cause the individual family members, as well as the family as a whole, to develop 
or gain new skills to help them work through and adapt to the changes encountered. These are 
referred to as ‘developmental processes’. The evidence suggests that family stresses, which are 
likely to occur around life-cycle transition points, frequently create disruptions of the life cycle 
and produce symptoms and dysfunction. The greater the anxiety generated in the family at any 
transition point, the more difficult or dysfunctional the transition will be.  
 
According to Dudok de Wit et al. (1997), in BRCA1 families and families with extensive 
experience of hereditary disease, normative change may be overshadowed by the presence or 
threat of illness and untimely death. For example, early childhood experiences, or experiences 
coinciding with the onset of puberty, of a loved one being diagnosed with cancer can have an 
extensive impact on psychosocial and sexual development throughout adolescence and into 
adulthood (Werner-Lin, 2008). Typical tasks of early adulthood, such as finding a partner and 
planning a family, may be contemplated against the backdrop of an expected illness timeline 
(Werner-Lin, 2007). 
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Carter  and  McGoldrick  (1989)  describe  the  flow  of  anxiety  as  being  both  ‘vertical’  and 
‘horizontal’, as shown in  Figure 6
9. The vertical stressors on the system are all  the family’s 
attitudes, taboos, expectations, labels and loaded issues which we grow up with, and which are 
transmitted down the generations of a family; for example, in the case of BRCA1/2, how cancer 
is perceived and dealt with by the family (Werner-Lin, 2008). The horizontal stressors on the 
system are those that the individual and the family encounter as they move forward through 
time.  These  include  developmental  stressors,  for  example:  coping  with  the  changes  and 
transitions of the family life cycle, and unpredictable events that may disrupt the life cycle 
process, for example: untimely death, chronic illness, or wars. 
 
According to Carter and McGoldrick (1989), ‘the level of anxiety engendered by the stress on the 
vertical and horizontal axes at the points where they converge is the key determinant of how 
well the family will manage its transition through life and when the horizontal (developmental) 
stress intersects with a vertical (transgenerational) stress there is a quantum leap in anxiety in 
the  system’  (p.  9).  Each  family  member  affects  the  others  and  the  added  element  of 
intergenerational dynamics further complicates the interactions (Ferguson, 1979).  
 
 
                                                           
9Permission to reprint Copyright material kindly granted by Pearson Education, Inc. Upper Saddle River, 
NJ.  
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Figure 6: Horizontal and Vertical stressors on the individual and family life cycles. Taken from Carter and 
McGoldrick (1999, p. 9)  
 
 
The major strength of the family life cycle perspective is the ability to view the dynamic nature 
of the family over long periods of time. However, it does make certain assumptions: that it is the 
stage  in  family  development  rather  than  the  age  that  is  important;  whilst  individual 
development is important, the development of the family as a group of interacting individuals is 
more  important;  transition  from  one  stage  to  another  is  going  to  happen;  families  and 
individuals progress through a series of similar developmental stages and face similar transition 
points and developmental tasks; and, finally, to understand the family we must consider the 
challenges they face in each stage, how well they resolve them and how well they transition to 
the next stage. As such, it has been criticised for being unable to account for different family 
forms, gender, ethnic and cultural differences, and for not being culturally relevant or sensitive 
to other lifestyle choices.   
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Although  chronic  illness  has  a  profound  effect  upon  the  individual  concerned,  an  immense 
responsibility is simultaneously imposed upon the family (Shaw and Halliday, 1992). As such, 
chronic illness increases family stresses and requires family members to continually adapt. In 
return, chronic illness creates challenges to health care professionals, who must also adapt to 
understand and meet the changing needs of both the family as a whole and the individuals 
involved (Newby, 1996). The family’s response to chronic illness will vary according to: the age 
and the developmental stage of the ill individual; the family’s strength and coping mechanisms; 
and family life cycle stage (Newby, 1996). Families with hereditary breast and ovarian cancer 
may  be  confronted  with  regular  cancer  diagnosis  and  untimely  deaths  from  generation  to 
generation (vertical stressors). Because of the autosomal dominant hereditary and penetrance 
patterns, there is a constant uncertainty about which family individual members cancer may 
affected, or when or what the outcome will be (horizontal stressor) (Werner-Lin, 2008). 
 
Combrinck-Graham  (1985)  presented  a  Developmental  Model  of  Family  Systems  that 
emphasised  changes  in  family  shape  through  the  individual  life  cycle.  The  family  system  is 
described  as  oscillating  through  time  between  periods  of  family  closeness  (centripetal)  and 
periods  of  family  disengagement  (centrifugal).  According  to  Rolland  (1987),  the  concept  of 
centripetal and centrifugal modes is useful in linking the illness life cycle to the individual and 
family life cycles. In most cases, chronic disease exerts a centripetal pull on the family system. 
Symptoms,  loss  of  function,  the  demands  of  shifting  or  new  illness-related,  practical  and 
affective roles, and the fear of loss through death all serve to refocus a family inwardly. If the 
onset of an illness coincides with a centrifugal period for the family, it can derail the family from 
its  natural  momentum.  Therefore,  the  Family  Life  Cycle  perspective  brings  the  individual 
undergoing genetic testing back to the centre of the study; however, in order to explore their  
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experiences of talking to their relatives, it is important to recognise, and gather data, on their 
family context. One way to achieve this is through the introduction of an eco-map or genogram.  
 
Daly et al. (1999) constructed genograms for 38 high-risk women to pilot the efficacy of using 
genograms for assessing family relationships. They compared the degree of family cohesion as 
depicted by the genogram, with scores obtained on the standardised Social Adjustment Self-
Report (SASSR); from this, they reported a positive correlation (p=0.01), thus demonstrating the 
validity of the genogram. That is, ‘the higher the percentage of close and very close relationships 
represented on the genogram, the greater the social adjustment recorded on the SASSR 
subscales’ (Daly et al., 1999). This method allowed them to convert qualitative data into a 
graphical representation of family dynamics that may be used in comparative and longitudinal 
research and counselling settings. However, the authors do recognise that there are limitations. 
Namely, interviewer bias and the subjective nature of the information recorded in the genogram 
by the counsellor, although some of this may have been limited by standardising both the 
content and the structure of the questions asked and adhering to defined symbols and 
nomenclature. There is also the possibility that women involved answered questions about their 
familial relationships in a socially acceptable way in order to present themselves and their 
families in a positive light (Daly et al., 1999). 
 
Genogram construction was originally rooted in Murray Bowen’s Family Systems Theory 
(McGoldrick and Gerson, 1985). According to this perspective, behaviour patterns within families 
are often stable and transmissible over time. Therefore, genogram construction can be used to 
examine patterns of function and relationships from one generation to the next (Daly et al., 
1999). How eco-maps were used in this study will be discussed in section 3.4.4. 
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To summarise, the resultant study, as presented in this doctoral thesis, was qualitative and 
grounded in a conceptual model adapted from Peterson’s (2005) family systems model, for 
conducting family-based research in hereditary risk and genetic testing, as well as Carter and 
McGoldrick’s (1989) ‘Family Life Cycle’, which allows the study of how individuals within a family, 
and by association the family as a whole, adapt to chronic illness. The technique of constructing 
eco-maps (Ray and Street 2005) was employed as a method of identifying relevant family 
members and guiding the researcher through the family structure and relationships.  
 
 
3.4.5  Methodology: Justifying Method 
 
The goal of qualitative research is the development of concepts that help us to understand social 
phenomena in natural (rather than experimental) settings, giving due emphasis to the meanings, 
experiences, and views of all the participants (Pope and Mays, 1995). To achieve this, several 
theoretical approaches to conducting qualitative research have been developed, for example 
phenomenology, grounded theory, ethnography and their variations (Avis, 2003). These 
describe, either explicitly or implicitly, the purpose of the qualitative research, the role of the 
researcher(s), the stages of research, and the method of data analysis. The aim of this present 
study is to examine how and when participants talked to their relatives about genetic testing 
and the risk implications; this could be done via several different methodologies and, thus, 
methods. However, the choice of methodology will shape the exact nature of the research 
questions and the study design.  
 
For example, if the research was approached using an ethnographic methodology, then the 
question would move to studying family communication regarding genetic testing in, or as, a 
culture, perhaps examining the culture at the genetics service and place of family  
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communication regarding genetic testing within it. If, on the other hand, a grounded theory 
methodology was used then the aim would now be to develop a substantive theory. However, 
with a phenomenological approach, the emphasis would shift to one of seeking to uncover the 
essence or meaning of the experiences of those people undertaking family communication 
regarding genetic testing. So, whilst the methodology affects the research questions and the 
study design, conversely, they themselves will influence the choice of methodology.  
 
Avis (2003) argues that, because positivism encapsulates the epistemological assumption that 
the foundation of genuine knowledge is from empirical science based in verification, objectivity 
and reproducibility, qualitative researchers feel obliged to justify their different ethical, 
ontological and epistemological commitments by adhering to one of three traditional 
methodological approaches, namely phenomenology, grounded theory or ethnography. 
According to Thorne et al. (1997), in the past, methodological variations from these traditions 
have not been encouraged, particularly in the field of nursing research, as it was deemed 
‘sloppy’ research (Morse, 1989a). The result is a danger of claiming to reveal lived experience by 
‘doing phenomenology’ but using an ‘ethnographic interview’ method and then applying 
‘grounded theory analytical approaches’, such as constant comparison (Thorne et al., 1997). 
 
 
3.5  Interpretive Description as a Methodology 
 
In response to an expressed need for an alternative method for generating grounded knowledge 
pertaining to clinical nursing context, Thorne et al. (1997) developed interpretive description.  
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Interpretive description, as presented by Thorne et al. (1997;2004b), is grounded in an 
interpretive paradigm. It acknowledges the constructed and contextual nature of much of the 
health-illness experience, yet also allows for shared realities.
10 As a methodological approach, it 
is designed to specifically fit the kind of complex experimental questions that nurses and other 
applied health researchers might be inclined to ask (Thorne et al., 2004b). Key characteristics of 
naturalistic (qualitative) inquiry, such as those described by Lincoln and Guba (1994), provide the 
philosophical underpinnings for the research design, including:  
  There are multiple constructed realities that can be studied holistically. Thus, reality is 
complex, contextual, contrasted and ultimately subjective. 
  The inquirer and the ‘object’ of inquiry interact to influence one another; indeed, the 
knower and the known are inseparable. 
  No a priori theory could possibly encompass the multiple realities that are likely to be 
encountered; rather, resulting theory must emerge or be grounded in the data.  
 
The purpose is to capture themes and patterns within subjective perceptions and to generate an 
interpretive description capable of informing clinical understanding (Thorne et al., 2004b). 
 
An interpretive description methodology has been successfully used in health and social 
research, including but not exclusively: examining the experiences of women diagnosed with 
breast or ovarian cancer who received inconclusive BRCA1/2 genetic test results (Maheu and 
Thorne, 2008); exploring communications throughout the cancer trajectory from the perspective 
of patients (Thorne et al., 2010); identifying health care communication issues in multiple 
sclerosis (Thorne et al., 2004c); mapping patterns of practice of arts therapists working with 
                                                           
10 An assumption that reality, and hence the phenomenon under study, are constructed both within the 
individual and through social interaction. Consequently, multiple, dynamic, and potentially contradictory 
realities are assumed to exist. These realities are best understood through collaboration between 
researcher and participants in which the social worlds of the participants are brought together through 
the researcher (Rosenwald, 1988).  
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older people who have Dementia in the UK (Burns, 2009)
11; an inquiry into the moral experience 
of clinicians in humanitarian work (Hunt, 2009a);
12 and exploring Aboriginal women's 
experiences of cervical cancer screening (Duchcherer, 2010). 
 
Unfortunately, as a relatively new qualitative methodology, there has been little discussion in 
the literature of the particular merits and limitations of this methodological framework at this 
time. However, Hunt (2009b) has published an experience of using interpretive description as a 
methodology that aims to identify and discuss strengths and challenges that can arise in its 
application. Strengths identified include a coherent logic and structure, an orientation toward 
the generation of practice-relevant findings, and attention to disciplinary biases and 
commitments. Challenges include limited examples of its use for situating the methodology 
because it is new, challenges in employing a lesser-known methodology, and uncertainty 
regarding the degree of interpretation to seek (Hunt, 2009b). 
 
With regards to this last challenge identified by Hunt, the terms ‘‘interpretive’’ and 
‘‘description’’ seem contradictory in qualitative research. Qualitative ‘description’ may be 
perceived as superficial analysis when compared with the in-depth ‘interpretation’ that 
qualitative researchers aim for (Pope et al., 2000). Interpretive description should not be 
mistaken for qualitative description or pattern analysis. The main difference between 
interpretive description and qualitative description lies in the data analysis, where interpretative 
description goes beyond a simple description and aims to provide an in-depth conceptual 
description and understanding of a phenomenon, whereas qualitative description stays closer to 
the data obtained (Neergaard et al., 2009). The analytic procedures in interpretive description 
                                                           
11 PhD thesis. 
12 PhD thesis.  
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capitalise on such processes as synthesising, theorising and recontextualising, rather than simply 
sorting and coding.  
 
The important thing to note is that an interpretive description does not just provide an in-depth 
description of the phenomenon under study. As stated by Thorne et al. (2004b), interpretive 
description uses inductive analytic approaches to ‘seek understanding of clinical phenomena 
that illuminate their characteristics, patterns and structure…’ (p. 6). In other words, it aims to 
create a qualitative description that can be characterised as interpretive. There is an interpretive 
orientation, however, in that it is not intended to yield new theory or high-order abstractions; 
instead, researchers should pursue the interpretation to the degree that it will yield useful 
insights to guide clinical practice (Hunt, 2009b). 
 
The general principles of interpretive description as a form of qualitative inquiry, with solid 
grounding in practice knowledge and nursing science, are embedded within five key 
components: the analytical framework, the sample selection, the data sources, the data analysis 
and rigour.  
 
 
3.5.1   Analytic Frameworks  
 
Unlike traditional phenomenological inquiry, when conducting interpretive description research, 
‘existing knowledge’ should be considered the ‘foundational forestructure’ to a new inquiry 
(Schultz and Meleis, 1988), so that findings can be developed on the basis of thoughtful linkage 
to others’ work (Mitchell and Cody, 1993). Interpretive description presumes there will be some 
theoretical knowledge, clinical pattern observation and scientific basis within which all studies of  
 
111 
 
human health and illness phenomena are generated. A critical review of current knowledge 
forms the basis for the preliminary ‘‘analytical framework’’ with which the investigator makes 
sampling, design and early analytical decisions. An analytical framework of this nature stems 
from critical analysis of research literature and/or clinical interpretation, and provides a starting 
point for research design and the inductive reasoning for interpretation of meanings within the 
data (May, 1989). Because it represents a starting point for the research rather than an 
organising structure for what is found, it will typically be challenged as the inductive analysis 
proceeds (Thorne et al., 1997).  
 
For this study, an analytic framework, in the form of a summary of findings and identification of 
gaps, was developed through a critical analysis of research literature, which is presented in this 
thesis in the form of background literature (Chapter One) and a systematic review and meta-
synthesis (Chapter Two). The searching, reading and critiquing of the literature related to family 
communication regarding diagnostic and predictive testing for hereditary cancers were the first 
activities undertaken as part of this research. As discussed at the beginning of this chapter, the 
findings identified areas where little research evidence was available and subsequently informed 
the development of the research question, aims and objectives of this study. The knowledge 
gained during these activities also shaped the interview guide used during the qualitative 
interviews (Appendix 3) and allows the findings to be discussed in relation to previous research 
in the field (Chapter Nine). 
 
 
3.5.2   Sample Selection  
 
Sampling and data collection methods should be derived from specific research questions, 
informed by the framework of what is already known about the phenomenon from a range of  
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sources (Thorne et al., 2004b). Samples are purposively, often theoretically, generated, thus 
reflecting an awareness of expected  and emerging variations within the phenomena being 
studied (Thorne et al., 2004b).  
 
Theoretical sampling is built into the design of interpretive description research, with particular 
emphasis on obtaining maximal variation on the themes that emerge from the inductive analysis 
itself (Glaser, 1978;Sandelowski, 1995a), the argument being that usually the positions or 
experiences that each participant or informant might represent cannot be known until data 
collection is underway (Thorne et al., 1997). Unfortunately, there are many variations of 
qualitative sampling described in the literature and much confusion, as the terms ‘purposeful’ 
and ‘theoretical’ are often viewed as synonymous and used interchangeably (Coyne, 1997). 
Theoretical sampling is the principal strategy for grounded theory methodology, as it calls for 
building interpretative theories from the emerging data and selecting a new sample to examine 
and elaborate on this theory (Marshall, 1996).  
 
The decision not to use a theoretical sampling strategy of this nature for this study was taken for 
two reasons. Firstly, the data protection regulations when conducting research with NHS 
patients meant that it was not possible for the researcher to access patient information in order 
to screen for eligibility into the study. For example, if during the ongoing data analysis it had 
become a requirement to select only those who had a brother, there would have been no way of 
identifying these patients as the researcher did not have access to patient notes, if indeed that 
information was even available within the notes. And, whilst it may have been possible for the 
staff at the genetic service to identify suitable participants, it would have been a time-consuming 
activity and placed an unnecessary burden on the service. The second reason for not using 
theoretical sampling was because the nature of the PhD studentship meant there was a time 
constraint for conducting the interviews. So, a sampling strategy that allowed the identification  
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of potential participants, recruitment, interviewing and transcribing to happen simultaneously 
was beneficial. 
 
However, the analytic framework developed as part of the initial literature scoping and critical 
appraisal activities had already identified several limitations in the research on family 
communication regarding genetic testing for BRCA1/2. Specifically, the research tends to focus 
on communication at the point of result disclosure by those who had undergone a particular 
type of testing (for example, predictive genetic testing only), or received a particular genetic test 
results (for example, including only those who had received a positive BRCA1/2 test result) with 
a specific family member (for example, a sister). To really understand how these families discuss 
genetic testing for cancer risk, and when this communication occurs, it would therefore be 
necessary to recruit from the following: those who had undergone both diagnostic and 
predictive genetic testing; both men and women; those with a variety of result statuses; and 
from a variety of ages. Therefore, a method of purposive sampling was employed to include a 
sample who could best help understand the studied phenomenon through their personal 
experiences (Crossley, 2007). The methods used for sampling will be discussed more fully in 
section 4.2. 
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3.5.3   Data Sources 
 
In keeping with many qualitative methodologies, interpretive description is based on the belief 
that people who have lived with certain experiences are the best sources of expert knowledge 
regarding those experiences (Morse, 1989b). Thorne et al. (1997) also suggest that appropriate 
collateral data sources, such as lay print or other media information, as well as case reports and 
clinical papers, are often readily available for qualitative researchers interested in expanding the 
scope of their inquiry and broadening the reach of their theoretical sample, without incurring 
the excessive monetary and time costs of intensive interviewing and participant observations. 
Throughout the study, the researcher made regular visits to the Genetics Service where the 
research was based and collected various patient-information sheets. Popular media items, for 
example television programmes or newspaper articles on genetic testing for cancer risk, were 
constantly reviewed. These data sources were not directly incorporated into the study findings; 
but, instead of regularly reviewing them, for example throughout the data analysis process, the 
researcher aimed to immerse herself within the world under study and to encourage thinking 
and interpretation through the eyes of the participants. 
 
For this doctoral study, data were collected in one-time, individual, semi-structured interviews. 
The in-depth interviews were chosen because they are a relatively flexible data collection 
method: allowing the researcher to prompt for more information, and the participants to 
explore their own thoughts, react to questions spontaneously and honestly, and articulate their 
ideas slowly whilst reflecting on them (Holloway and Wheeler, 2002). Eco-maps (Ray and Street, 
2005) were used as a secondary data source in this inquiry. They provided a method of 
identifying relevant family members and guiding the researcher through the family structure and 
relationships (refer to section 4.5). 
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3.5.4   Data Analysis  
 
Interpretive description uses inductive analytic approaches to seek an understanding of clinical 
phenomena that illuminates the characteristics, patterns, and structure in some theoretically 
useful manner (Thorne et al., 2004b). The final product from an interpretive description ‘is a 
coherent conceptual description that taps thematic patterns and commonalities believed to 
characterise the phenomenon that is being studied and also accounts for the inevitable 
variations within them’ (Thorne et al., 2004b). The product should also have application 
potential, ‘in the sense that a clinician would find the sense in them and they would therefore 
provide a backdrop from assessment, planning and interventional strategies (Thorne et al., 
2004b). 
 
Interpretive description should involve a rigorous analytical process that involves carefully 
navigating within and beyond the analytical framework with which the research started, in order 
to fully engage the process of inductive reasoning, including testing and challenging preliminary 
interpretations, and conceptualising an ordered and coherent final product (Thorne et al., 
2004b). Many textbooks and papers describe different methods for the analysis of qualitative 
data often based on different research methodologies; however, there are some common 
features to analytic practices that may be used across different qualitative research types, a 
classic set include (Miles and Huberman, 1994): 
  Affixing codes to a set of field notes drawn from observations or interviews. 
  Noting reflections or other remarks in the margins. 
  Sorting and sifting through these materials to identify similar phases, relationships 
between variables, patterns, themes, distinct differences between subgroups, and 
common sequences.   
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  Isolating these patterns and processes, commonalities and differences, and taking them 
out to the field in the next wave of data collection. 
  Gradually elaborating a small set of generalisations that cover the consistencies 
discerned in the database. 
  Confronting those generalisations with a formalised body of knowledge in the form of 
constructs or theories.  
 
The method used for the data analysis of the in-depth interviews was based primarily on the 
work of Miles and Huberman (1994). This will be fully outlined during the next chapter (refer to 
section 4.7).  
 
Interpretive description requires analytical techniques that encourage repeated immersion in 
the data prior to coding, classifying or creating linkages (Thorne et al., 1997), with an emphasis 
on synthesising, theorising and recontextualising rather than simply sorting and coding (Morse, 
1994). In order to address the dialectic between individual cases and common patterns, the 
researcher must intimately know the individual cases, and produce explanations of overall 
findings that can be applied back to the individuals (Thorne et al., 1997). Strategic periods of 
immersion in the field interspersed with periods of immersion within the data are recommended 
to encourage refinement of the inquiry, as well as testing of developing conceptualisations and 
emerging theories (Lofland, 1976;Strauss, 1987).  
 
To allow ‘immersion in the field’, regular visits were made to the Genetic Service during the time 
when interviews were being conducted and data analysed. This included observing some genetic 
clinic consultations (after recruitment had been completed so as not to come into contact with 
potential participants). This allowed the researcher to keep in touch with the clinical staff and 
witness first-hand the process of genetic counselling and testing that the participants had been  
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through in order to put the experiences into context. Searching for and reading of emerging 
literature also continued during this time.  
 
 
3.5.5   Rigour and Validity 
 
As with other qualitative methodologies, issues of rigour and credibility are an important 
consideration when creating an interpretive description (Thorne et al., 2004b). According to 
Thorne et al. (1997), an interpretive description requires the researcher to record their analytical 
journey, for example keeping a reflective journal and/or field notes. Research reports should 
provide sufficient information for the reader to be able to follow the analytic reasoning process 
and to judge the degree to which the analysis is grounded within the data. Steps should also be 
taken to ensure the theoretical validity of the findings (Brink and Wood, 1989). Typically, 
repeated interviewing, in which developing conceptualisations can be subjected to challenges or 
refinements, is built into the design of an interpretive description. Thorne et al. (1997) believe 
that taking the raw data (for example, the interview transcripts) back to participants for a 
credibility check is generally insufficient for these purposes and may create contradictions 
(Sandelowski, 1993). Instead, they recommend presenting the initial conceptualisations, 
representing the entire sample rather than the individual research participant, to individual 
research participants for their critical consideration. They believe this strategy creates optimal 
conditions for challenging the emergent theories and refining the theoretical linkages (Thorne et 
al., 1997). 
 
Time constraints, as well as the lack of ethical approval or participant consent to present the 
initial conceptualisations to the research participants during the early stages of the study, meant 
this was not feasible. According to Maheu and Thorne (2008), another way of considering the  
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validity of findings in an interpretive description study is by reflecting on how they match or 
enlarge the clinical hunches of expert clinicians familiar with the study phenomenon. Therefore, 
in order to have confidence in the theoretical validity of the findings, the conceptual framework 
and research findings were regularly presented to the clinical team at the Genetic Service and at 
national conferences
13 at various points during the analytical process. Their feedback and 
discussions helped shape the work and gave insight into how the work related to their and their 
patients’ experiences of family communication regarding genetic testing for BRCA1/2 in their 
clinical practice.  
 
 
3.6  Conclusion  
 
Having established the foundations of the study, decisions have to be made about the research 
practice; in other words, the methods. As has already been described, the epistemological, 
theoretical and methodological positions are all interrelated; and all influence, and are 
influenced by, the choice of the method. There is no one ‘correct’ method associated with any 
one type of research; there are, however, options more sympathetic to the type of research 
question and study aims. For example, interview data would provide a deeper understanding of 
experiences compared with a questionnaire-based method. The next chapter, Research 
Methods, will describe in-depth the methods used for data collection and data analysis.  
 
                                                           
13 National Cancer Research Institute (NCRI) Conference 2008 & 2009; the British Society of Human 
Genetics (BSHG) Conference 2008; and the International PsychoOnlogy Society (IPOS) conference 2011.   
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Chapter 4 - Research Methods 
 
4.1   Introduction 
 
The chapter will systematically describe and justify the methods chosen for the study. The aim of 
the study is to gain insight into participants’ experiences of discussing their participation in 
genetic testing, their test results and potential risk information following genetic testing for 
BRCA1/2 with their family; particular focus will be on how these participants discuss genetic 
testing for cancer risk with relatives and when this communication occurs. It was qualitative in 
nature, employing in-depth interviews as the method for data collection and utilising the 
technique of constructing eco-maps (Ray and Street, 2005) as a method of identifying relevant 
family members and guiding the researcher through the family structure and relationships. 
These methods were chosen in line with the conceptual framework (refer to section 3.4.4) and 
the interpretive description methodology (refer to section 3.5) to ensure depth and richness in 
analysis and reporting of findings.  
 
 
4.2  Population and Sampling 
 
One of the limitations of previous research in the field, as identified in Chapters One and Two, is 
that studies tend to limit themselves to particular groups of people, for example those who 
received a positive result from predictive genetic testing. Therefore, the aim was to be as 
inclusive as possible to gain a wide range of experiences.   
 
120 
 
 
The sample was drawn from individuals who had attended a clinical Genetic Service in the 
South-East of England and undergone diagnostic or predictive genetic testing for BRCA1/2, 
regardless of their result. Evidence in the literature suggests that, on average, it takes eight 
months for familial communication to occur following predictive genetic testing (Julian-Reynier 
et al., 2000b). After discussion with the clinical team at the Genetic Service about how many 
BRCA1/2 tests they conducted each year and the likely response rate, an upper limit of 18 
months was set. It was felt that this timeframe meant the experience of family communication 
regarding genetic testing for BRCA1/2 would be recent enough to be recalled accurately. The 
study, therefore, included those individuals who received their test results eight to 18 months 
prior to being invited to participate.  
 
Men and women were considered eligible for the study according to pre-set inclusion criteria as 
follows: 
  They had undergone genetic testing (diagnostic or predictive) for BRCA1/2 mutations;   
  With eight to 18 months having passed since receiving their results of the genetic 
testing; 
  They were asymptomatic for breast or ovarian cancer (to ensure their experience is not 
influenced by any present symptoms); 
  They were at least 18 years of age; and 
  They were able to understand and speak English (in order to give consent and be able to 
complete the interview successfully). 
 
No exclusion that might lead to discrimination because of gender, age, or social class was 
permitted; however, any potential participants who were known by the Genetic Service team to  
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have a psychiatric illness that was likely to be exacerbated by involvement in the study were 
excluded. 
 
The study was reviewed and given a favourable opinion by the NHS Trust Research and 
Development Office (R&D number: CAN0568) and the Isle of Wight, Portsmouth & South East 
Hampshire Research Ethics Committee (REC reference number: 07/H0501/100). Once all 
research governance and ethical procedures were completed, potential participants were 
selected via the clinical genetic laboratory computer database using purposive sampling. This 
database keeps records of all genetic testing done within the Genetic Service, and it was possible 
to search for patients according to type and date of testing. This was done by the staff at the 
Genetic Service, in line with data protection guidelines and stipulations of the Research Ethics 
Committee. Once the list had been generated, it was presented at the multi-disciplinary team 
meeting so the practitioners at the  Genetic Service could advise as to whether they knew of any 
reason why the potential participant should not be invited to participate in accordance with the 
inclusion or exclusion criteria; for example, a recent diagnosis of cancer. 
 
As the aim was not to generalise from the sample to the population, it was not necessary to 
select representative individuals. Instead, the method of purposive sampling was employed to 
include a sample who could best help understand the studied phenomenon through their 
personal experiences (Crossley, 2007). For example, to ensure the experiences of both those 
who had undergone diagnostic genetic testing and those who had undergone predictive genetic 
testing were represented, approximately equal numbers of each were invited to participate.  
 
The sampling strategy was to invite potential participants in batches of seven patients, with 
approximately equal numbers of those who had undergone predictive and diagnostic genetic 
testing in each batch, until the sample frame of approximately 30 participants was achieved.  
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Selection started with those closest to eight months having passed since testing. The exception 
to this was when inviting men. Considerably more women had undergone genetic testing for 
BRCA1/2 than men during the timeframe selected. This is not unexpected considering women 
have a significantly higher chance of developing breast cancer in their lifetime than men (Cancer 
Research UK, 2011a). Other research also shows that, although variable, rates of predictive 
testing in men are lower than in women (Bodd et al., 2003;Goelen et al., 1999;Julian-Reynier et 
al., 2000b). Therefore, in order to include the experiences of men, all potential male participants 
were invited at once, regardless of who had had their test first, or the type of testing.  
 
Sandelowski (1995b) suggests that determining an adequate sample size in qualitative research 
is ultimately a balance of judgement and experience in evaluating the quality of the information 
collected against the uses to which it will be put, the particular research method, the purposeful 
sampling strategy employed, and the research product intended. Patton (1990) maintains that 
no guidelines should exist for sample size in qualitative research, while sample sizes differ 
greatly in qualitative studies. That said, although there are no set rules, research texts often 
mention some kind of guidelines. For example, Kuzel (1999) suggests that 6-8 participants are 
needed when the sample consists of a homogeneous group, while 12-20 participants suffice for 
a heterogeneous sample. Charmaz (2006) suggests that 25 participants are ‘adequate for smaller 
projects’ (p. 114). Ritchie et al. (2003) suggest qualitative samples often ‘lie under 50’ (p. 84), 
whereas Green and Thorogood (2009) suggest little ‘new’ data ‘comes out of transcripts after 
you have interviewed 20 or so people’ (p. 120). In fact, Holloway and Wheeler (2002) report that 
most often the sample consists of between four and 40 participants; however, certain research 
projects contain as many as 200.  
 
For the 14 qualitative studies included in the Systematic Review and Meta-Synthesis (Chapter 
Two), the sample size ranged from 12 to 63 participants, with an average of 30.3 per study.  
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Therefore, a potential sample size of approximately 30 was determined as appropriate to 
address the research questions for this study. The aspiration was to have a sufficient number of 
participants to be able to present and represent a range of experiences, but not to have so many 
as to lose the required depth to the study. The plan was to allow data collection to reach data 
saturation (Holloway and Wheeler, 2002). 
 
The interpretive description methodology literature suggest sample size should be evaluated on 
an on-going basis to identify when sufficient density of the data has been achieved (Hunt, 
2009b). ‘Sufficient’ density of data collection, otherwise known as data saturation (Holloway and 
Wheeler, 2002), occurs when the researcher judges that no new data is being given by the 
participant to deepening the understanding of the phenomenon (Carnevale, 2002). Therefore, it 
may have been necessary to increase the proposed sample size, of approximately 30 
participants, if new data were still being introduced at the end of these interviews. 
 
 
4.3  Recruitment 
 
The process taken is outlined in Figure 7. Potential participants were invited to participate in the 
study by a letter from the Genetic Service (Appendix 4), outlining the study and enclosing the 
participant information sheet, which detailed what would be involved in the study (Appendix 5). 
A telephone number was given to contact the researcher to ask further questions about the 
research if required. There was an opt-in reply slip to return to the researcher with a stamped-
addressed envelope (Appendix 6).    
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 Figure 7: A summary of recruitment and participant interview process 
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Once the opt-in slip had been received, the researcher rang potential participants to arrange the 
interview at a time and place convenient to the participant. If a suitable venue, a private and 
comfortable room with no disruption or interference during the course of the interview, was not 
available in their homes, they were invited to attend the Faculty of Health Sciences (at either the 
Highfield or Portsmouth Campus), or another University location, where such rooms were 
available. Two of the participants chose to be interviewed at the University, both stating that 
they had busy households at home with teenage children on summer holidays and, therefore, it 
was unlikely to be a suitable interview environment.  
 
 
4.4  Consent  
 
On the day of the interview, the researcher ensured the participant had read the information 
sheet and gave them the opportunity to ask questions or seek clarification on any matter. 
Participants were advised they may withdraw from the project at any time without having to 
give a reason. Participants were then asked to complete and sign a consent form which indicated 
that they were fully informed of the process of participating in the study, provided consent for 
audio-recording and consented to the material from the interview being used in any subsequent 
dissemination activities, including publications, while at all times protecting the participant’s 
confidentiality (Appendix 7).  
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4.5  Data Collection 
 
With participants’ consent, the interviews were audio-recorded and lasted between 23 and 106 
minutes, with the median length being 54 minutes. Individual interviews were appropriate in 
order to create a space where participants felt able to talk freely about their views and 
experiences of the topic under discussion. This was further encouraged by assurances of 
anonymity and confidentiality for participants. The interviews had a semi-structured nature. This 
meant that, unlike more structured interview techniques, where the answer is often a choice of 
predetermined options, there was no forced consistency in people’s thinking (Wilkinson et al., 
2004). While there was a minimal list of open-ended questions and topics to be addressed, in 
the form of an interview guide (Appendix 3), there was flexibility for the participant to speak 
widely on issues and develop ideas (Denscombe, 2003). In line with the interpretive description 
methodology, the interview guide was developed as part of the analytic framework after an 
extensive review of the literature and discussion with genetic clinicians. This interview guide 
acted as a framework only, with the exact order of the questions posed varying according to the 
flow and direction of the conversation.  
 
Mathieson (1999) describes interviewing as a process of story building; ‘a process of two people, 
the narrator and the listener, with a structure that allows interpretation of meanings’ (p. 130). 
Face-to-face interviews provided in-depth insight into the emotions, experiences and feelings of 
the participants. Wilkinson, Joffe and Yardley (2004) stress the importance of awareness that the 
class, race, gender, age and social status of the interviewer will have an impact on the 
interviewee. While much of this cannot be disguised or avoided, the authors suggest that an 
open and friendly manner with emphasis on confidentiality and impartiality may overcome this. 
This was particularly important, as some of the participants may have felt that the issues being 
discussed were personal and/or sensitive, for example if they had made the decision not to  
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inform close relatives of their BRCA1/2 risk; therefore, it was necessary to build up rapport and 
trust with them through face-to-face contact. The interviewer aimed to be non-judgemental and 
non-directive at all times to allow open and honest information to be collected. 
 
The interviews were organised into three parts: 
4.5.1  Part One of Qualitative Interview 
 
In line with the theoretical basis of the research (refer to section 3.4.4), in order to gain an in-
depth understanding of how and when those undergoing genetic testing for BRCA1/2 discussed 
their experiences with relatives, it was necessary to gain some understanding of the participant’s 
social context and family relationships. In particular, it was important to examine their family 
organisational and structural characteristics, as well as health beliefs shared by family members 
as described in the conceptual model. 
 
Koehly et al. (2003) utilised a social network perspective to investigate the relationship between 
the familial culture and communication about genetic counselling and testing. Family functioning 
was evaluated by the constructs of communication, cohesiveness, affective involvement, 
leadership, and conflict. According to Koehly et al. (2003), by investigating the interpersonal 
relationships among a set of individuals, or actors, social network methodology can provide a 
detailed map of the social environment within which family members interact. This can facilitate 
an understanding of which aspects of the familial culture influence the discussion and 
participation in genetic counselling (Koehly et al., 2003). However, social network perspective is 
a methodology for research rather than a method for collecting data.  
 
A suitable method for data collection may have been to use standardised genogram 
construction, as demonstrated in previous research concerning genetic testing for cancer risk by  
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Daly et al. (1999). The genogram was first used by Murray Bowen in the late 1970s as part of the 
Family Systems Theory (McGoldrick and Gerson, 1985) and has been used widely in the practice 
of the family (Daly et al., 1999). Genograms are designed to provide insight into how the 
individual functions in the context of the family system and, likewise, how individuals interact as 
a functional whole (Hartman, 1978). In 1984, McGoldrick and Gerson then standardised 
genogram construction, thereby providing practitioners with a consistent and reliable structure 
for recording family dynamics (McGoldrick and Gerson, 1985). Daly et al. (1999) found that 
genograms could be used successfully to identify levels of family cohesion reported by women at 
high risk of developing familial breast and/or ovarian cancer attending counselling clinics. 
 
However, genograms are widely supported and used in genetic counselling practice (Eunpu, 
1997) to record family histories and, as such, are likely to be associated with clinical practice by 
participants, who will have all been through genetic counselling as part of their genetic testing 
for BRCA1/2. It was important to the researcher to try to separate the research interview from 
the clinical services offered by the Genetic Service in order to ensure that the research interview 
was an ‘impartial space’ where participants could speak freely about their experiences. This was 
achieved using eco- or communication-mapping: 
‘Eco-maps provide a visual means of facilitating discussions around the structure and 
strength of networks. Being able to represent the social networks visually through 
eco-mapping enabled people to identify each member of the network, examine the 
strength of each relationship and ascertain the sources of nurture and tension over 
time.’ (Ray & Street 2005: 545)(132)(6) 
 
The ecological map, or ‘eco-map', was developed and described by Hartman (1978) as a tool to 
represent social relationships and systems that constitute the interaction between both the  
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social and physical environments that people live in. The eco-map, designed to be either 
standalone or be used as a supplement to a genogram, is a tool used to illustrate how the family 
system is currently connected to outside resources, organisations and agencies. The term ‘eco-
map’ originates from ecology – the study of the connection between a living thing and its 
environment, and how that connection is maintained and enhanced (Ray and Street, 2005). 
Traditionally, the three key concepts for the construction of an eco-map are relationships, social 
networks and support (Ray and Street, 2005); however, this tool was developed further by 
Martino (2006), who describes the concept of a ‘communication eco-map’ which aims to merge 
geno- and eco-maps into one tool based on family communication patterns. The use of 
genograms and eco-maps in research is well described in the literature.  
 
Peters et al. (2006) examined the feasibility and acceptability of the collared eco-genetic 
relationship map (CEGRM)
14 in a familial cancer genetic research setting. The participant and the 
researcher constructed the CEGRM together and then the researcher used a semi-structured 
interview to guide the participant through the process of placing various colour-coded symbols 
on the pedigree, at the appropriate location. Twenty women (mean age 44 years) from BRCA1/2 
mutations-identified families found including a CEGRM into a research interview to be feasible 
and comfortable to do, and was efficiently accomplished in usually less than 30 minutes.  
 
Although the focus for this present study is how and when participants talked to their relatives, 
visually mapping who participants considered to be in their family network allowed: (a) a visual 
representation on which to base further discussion and exploration of the how and when; (b) 
information collected to be placed into a familial context, allowing easier examination of 
organisational and structural characteristics; (c) insight into how discussions on BRCA1/2  genetic 
                                                           
14 A CEGRM is a novel psychosocial assessment tool, which incorporates features of the genetic pedigree, 
family systems genogram and eco-maps designed to allow the clinically-oriented researcher to visually 
and conceptually organise information about study participants’ social interactions (Peters et al., 2006).  
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testing differed from normal communication patterns within the family; and (d) deeper 
understanding of what factors influence the decision to disclose, or not, to certain family 
members, including health beliefs shared by the family members. It also proved a useful exercise 
to building up rapport and trust with the participants, as found by Peters et al. (2006):  
 
‘Because the construction is interactive and non-threatening, it was largely engaging 
and enjoyable for both participant and researcher. This had the positive effect of 
lowering participants’ psychological defensiveness, levelling power differentials 
inherent in medical settings and increasing empathetic connections.’ (Peters et al. 
2006: 261) 
 
Eco-maps are not dissimilar to geno-maps or genograms used for representing family details in 
genetic clinics. However, they are not so regimented in their structure and add a dimension of 
social support systems; they can include any person (not just restricted to blood relatives), 
friends, family, support groups, communities or institutions (for example, work or church 
networks) that the participate deems to have a place on the map, depending on what is being 
explored. In this study, the idea was to build a ‘communication map’ (Martino, 2006) with the 
participant identifying those people they consider to be an important part of their life. Whom 
this constituted was up to the participant.  
  
As Koehly et al. (2003) state: ‘individuals’ perceptions of their family may also include spouses or 
life partners, adopted children, stepchildren, and, in some cases, very close friends, all of whom 
may be influential or important in communication and family functioning processes’ (p. 305). For 
the present study, the individual who was being interviewed set the boundaries of who was 
considered as part of the family, or who was important.  
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The following section will explain the process of constructing and operating a communication 
eco-map
15 used within the research interviews. The construction of an eco-map will be used as 
an example.  
 
Having fully explained the process, the researcher would start by writing the name of the 
participant in the centre of the map. The participant would then be asked, ‘Who do you consider 
important in your life?’ As the participant identified each member, the researcher drew them 
onto the map – as demonstrated in Figure 8. Geographic distances could be represented by 
positioning each member near or far away from the centre of the map, while family units that 
lived together could be enclosed in a circle. The researcher continued to ask follow-up questions 
such as ‘Is there anybody else you might speak to about things going on in your life?
16‘ This 
allowed the researcher to understand who the various family members and friends were, and 
their relationships, as the participant spoke about his or her experiences of genetic testing and 
the family communication surrounding it. 
 
 
                                                           
15 Subsequently referred to as an eco-map. 
16 Not specifically about genetic counselling or testing.  
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 Figure 8: Communication Eco-map one: the participant identifies who is important in their life 
 
 
In order to get a sense of the organisational and structural characteristics, and to identify the 
normal patterns of communication between the participant and the people they had identified, 
the family functioning construct of cohesion, or ‘closeness’, was measured. Cohesive 
relationships are supportive relationships that involve those whom the participant feels close to, 
and are characterised by, behaviours such as support-seeking during a crisis and/or minor 
everyday upsets, or the sharing of confidences (Koehly et al., 2003). The negative aspect of this 
construct is defined by a lack of cohesion - those to whom the respondent would not confide in 
or go to when he or she is upset (Koehly et al., 2003).  
 
Once members were identified, a semi-structured interview technique was used to guide the 
participant through the process of recoding cohesiveness, as demonstrated in Figure 9.  
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Participants were asked to score how close they felt they were to each person on the map and 
how open they felt their communication was with them. This was depicted using a multiple-line 
technique (Ray and Street, 2005;McGoldrick and Gerson, 1985), where three lines meant really 
close with open and honest communication and no lines meant did not really communicate. A 
straight line represented positive relationships, while dashed lines represented tenuous, 
stressful or conflict-laden relationships (Martino, 2006;McGoldrick and Gerson, 1985). At this 
stage, the emphasis was on whom they talked to as part of their normal life, rather than about 
their genetic testing. The exercise concluded by asking the participant if there was anything else 
he or she wanted to add. The constructed communication map provided an effective visual 
summary of complex qualitative data.  
 
 
 Figure 9: Communication Eco-map two: cohesion and openness of communication 
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4.5.2  Part Two of Qualitative Interview 
 
Once the map was completed, the researcher moved to the main (second) section of the 
interview. Participants were asked, ‘Could you tell me about your genetic testing and how that 
came about? I am particularly interested in how and when you spoke to others about it.’ The 
participants were invited to begin where they liked, with the promise of no interruptions from 
the researcher. In some cases, people were willing to talk for some time, while others requested 
or required prompts and guidance from the researcher. This initial question deliberately focused 
on their genetic testing so as to recognise ‘family communication’ as one part of the larger 
experiences of undergoing genetic counselling and testing, and not just about sharing test 
results.  
 
As the participant told their story, the researcher mapped any important structural and 
organisational characteristics, as well as the communication patterns about the genetic testing, 
on to the communication map. For example, in Figure 10, the orange arrows signify that Gina 
had shared their result information with that person; the arrowhead indicates the direction of 
information flow, and the numbers the order. The blue arrows are communications not 
initialised by the participant themselves; for example, Gina’s mother introduced BRCA1l2 and 
genetic testing to Gina and her siblings. The absence of an arrow would indicate no such 
communication has taken place; for example, Gina did not talk to her children.  
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 Figure 10: Communication Eco-map three: adding communication patterns about the genetic testing 
and structural/organisational characteristics 
 
 
However, in practice, during the first two interviews it became clear that inserting the arrows 
through the interview was unnecessary and often distracting. It shifted the focus away from 
allowing the participant to describe their experiences in depth to an almost quantifiable 
approach of whom on the map told whom and when, with no information about how or why it 
came about. Therefore, drawing the arrows was abandoned for the remainder of the interviews.  
 
 
4.5.3  Part Three of Qualitative Interview 
 
The third part of the interview began when the participant had finished telling their story. This 
involved the researcher seeking more detail, clarifying points and asking for examples about  
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particular issues that they may already have talked about, such as how they talked to certain 
family members and any difficulties or challenges they encountered. The researcher also 
explored family functioning, based on the theoretical perspective of the research, by probing 
health beliefs, coping strategies, family communication patterns, and affective climate.  
 
Immediately after the interview, the researcher made detailed field notes to capture the 
richness of data, which the transcript may not have conveyed; for example, tone, pace, non-
verbal communication, and subsequent meaning, such as humour, emotion, intensity (Carey and 
Smith, 1994). The researcher also made notes reflecting on the interview itself - how the 
researcher felt, what the interview was like, etc. These field and reflective notes were later 
attached to the interview transcript and reviewed alongside it during the data analysis. 
Supervision sessions were organised regularly throughout the data collection stages, so that the 
researcher had the opportunity to further debrief and reflect on the process. 
 
Following the interviews, the audio recordings were transcribed and pseudonyms allocated to 
protect participant and family members’ identity. 
 
 
4.6  Avoidance of Harm or Distress 
 
There was no anticipated risk of significant harm to participants taking part in this research, 
although it was recognised by the researcher that some of the participants may have felt that 
the topics covered were sensitive and/or personal. For example, some may have felt vulnerable 
exposing their decisions about whether or not to disclose test results and how they went about 
this, details of their family relationships and/or personal attitudes. During the consent process  
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and throughout the interview itself, participants were encouraged to only talk about things they 
were comfortable sharing and assurances were given about the confidentiality of participant’s 
contributions. It was also possible that a participant may have accidently disclosed something 
they had not considered or planned to disclose before the interview. Therefore, the researcher 
made a point of checking they were comfortable with everything they had discussed at the end 
of the interview and took a verbal consent (audio-recorded) from the participant that they were 
still happy for the things they had said to be included. The researcher also left a thank you letter 
with the participant with suggested sources of follow-up or support,
17 should the participant 
require it, as well as contact details for the researcher in case there was anything they wished to 
discuss at a later date.  
 
During some of the interviews, participants became upset and/or started to cry whilst sharing 
their experiences. On these occasions, the researcher tried to be empathic and kind. Offers were 
made to stop the interview, either for a brief time or in its entirety, but all participants wished to 
continue.  
 
 
4.7  Data Analysis 
 
Within an interpretive description methodology, the focus for data analysis should be on 
situating the findings within a framework of the existing body of knowledge and ensuring 
explanatory factors arising from the analysis are also located within that larger perspective. This 
can be achieved by strategies such as constant comparative analysis (Glaser, 1965) and iterative 
                                                           
17 The Genetic Service, Samaritans and Macmillan Cancer Support.  
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analysis (Thorne et al., 2004b). The following section will describe in depth how the qualitative 
interview data were analysed and the theories behind them. The process used was based 
primarily on the work of Miles and Huberman (1994). 
 
Miles and Huberman (1994) define analysis as consisting of three concurrent flows of activity: 
data reduction, data display, and conclusion drawing and verification.  
 
1.  Data Reduction 
This is the process of selecting, focusing, simplifying, abstracting and transforming the data that 
appears in written-up field notes and/or transcriptions. Miles and Huberman reason that data 
reduction is not something separate from analysis, but rather is part of the analysis. The 
decisions the researcher makes at this stage (for example, which segments of data to code and 
extract, which patterns best summarise a number of segments, which evolving stories to tell) are 
all analytical choices. Therefore, they describe data reduction as a form of analysis that 
sharpens, sorts, focuses, discards and organises data in such a way that ‘‘final’’ conclusions can 
be drawn and verified.  
 
2.  Data Display 
Miles and Huberman argue that, when researchers use only the extended text of written-up field 
notes or interview transcripts for data analysis, it can be easy to jump to hasty, partial, 
unfounded conclusions because the data is dispersed, sequential, poorly structured and often 
extremely bulky. ‘Humans are not very powerful as processors of large amounts of information; 
our cognitive tendency is to reduce complex information into selective and simplified gestalts or 
easily understandable configurations’ (Miles and Huberman, 1994). Therefore, it is essential to 
display the organised information into an immediately accessible, compact form so that the 
analyst can see what is happening. Typically, qualitative data are displayed in two ways:  
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networks, with a series of ‘nodes’ with links between them, or ‘matrices’, with defined rows and 
columns. The advantage of the matrix approach is that it lends itself to within-case and 
between-case (for example, between those undergoing diagnostic versus predictive genetic 
resting; or receiving a negative versus positive result analysis (Ritchie and Spencer, 1994). Again, 
like data reduction, this enterprise is not to be considered separate from the analysis: deciding 
how the data are best displayed is an analytic activity.  
 
3.  Conclusion drawing and verification 
It is during this final analytical activity that the researcher begins to decide what things mean. 
This is done by first noting regularities, patterns (differences/similarities), explanations, possible 
configurations, causal flows, and propositions; and then testing the emerging meanings for their 
plausibility, sturdiness and validity. Essentially, the researcher is trying to look at what is going 
on and how things are proceeding, but also why things occur as they do so they can understand 
and explain the phenomenon under study. Therefore, there is an analytical progression from 
describing to explaining the data. ‘Naturally there is no clear or clean boundary between 
describing and explaining; the researcher typically moves through a series of analysis episodes 
that condense more and more data into more and more coherent understanding of what, how 
and why’ (Miles and Huberman, 1994).  
 
 
4.7.1   Building a Conceptual Framework 
 
In order to reduce and display the data, it was necessary to first build a conceptual framework.  
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Familiarisation by immersion in the data 
This activity began with listening to the recordings of the interviews and the repeated reading 
and re-reading of the data transcripts, simultaneously creating a list of key ideas, emerging 
issues, key words and phrases, as well as noting similarities and differences between and within 
participants’ accounts. This is comparable with the method of constant comparison described by 
Strauss and Corbin (1990) and recommended for interpretive description by Thorne et al. 
(2004b). 
 
The constructed eco-maps were used as a secondary data source in this inquiry. It was important 
to keep returning to these throughout the process of data analysis. It allowed the analysis to be 
mindful of the whole of each participant’s story and its grounding within their family context, 
and not lose the coherence of each narrative during the process of comparative analysis. It also 
helped make visible the way their family make-up, including friends and support networks, 
might shape their experience of the phenomenon. The objective was to remain attentive to 
individual cases, while seeking to identify inductively what was common among the experiences 
of the participants. 
 
Identifying a conceptual framework  
This list was then printed out and cut up into individual strips of paper, a strip for each item. 
These were manually grouped together into separate categories, which allowed reflection as to 
what were the major components of the participants’ experiences and the relationships 
between them. This activity was informed by the analytical framework (Thorne et al., 
1997;Thorne et al., 2004b). However, it was important to remember that, if the original 
analytical structure was permitted to overwhelm the data collection and analysis processes, the 
research product would become nothing more than a ‘‘topical survey’’ (Thorne et al., 2004b). 
Thus, this initial analytic stage had to recognise the nature and shape of the preliminary,  
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theoretical scaffolding that had been used to construct the study, and gradually move away from 
it as an alternative conceptual emphasis and intrigue arose (Thorne et al., 2004a). 
 
During this activity, it became clear that the chronological flow of events was an important 
factor in the family communication regarding genetic testing. At each stage of the genetic 
counselling and testing process, including before and after, there were explicit patterns of 
communication. A conceptual framework of the data set was thus developed based on four 
distinct stages of the participants’ experiences, both in describing the process of undergoing 
genetic testing and the communication within the family (Figure 11). The four stages depicted a 
longitudinal view of family communication regarding genetic testing, which was particularly 
helpful for understanding the flow, location and connection of events surrounding family 
communication regarding genetic testing. 
 
 
 
Figure 11: Diagrammatic representation of the conceptual framework developed during the initial 
stages of the data analysis process. The framework was further developed and refined as the data 
analysis continued 
 
 
Stage 1:  
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Receiving 
results 
Stage 4: 
Following 
Up  
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Developing a coding frame 
 
Once identified, the four stages and the key components or themes within each were numbered 
and indexed, thereby creating a coding frame of the conceptual framework (Figure 12). This 
allowed data to be sifted and sorted.  
 
 
 
Stage 1  Family and personal history of cancer  Code 
Key 
components / 
themes 
  General family awareness  1.1 
  Motivations to pursue genetic testing  1.2 
  Experience of cancer  1.3 
 
Stage 2  Undergoing genetic counselling  Code 
Key 
components / 
themes 
  Gathering details of family history  2.1 
  Accessing DGT through PGT  2.2 
  Making decisions about GT (getting support & advice)  2.3 
  Materials to support communication  2.4 
  Learning about genetic risk  2.5 
 
Stage 3  Receiving results  Code 
Key 
components / 
themes 
  Telling those who are waiting to know  3.1 
  Keeping those in the know in the loop  3.2 
  Personal reaction to results and telling people  3.3 
 
Stage 4  Following Up  Code 
Key 
components / 
themes 
  Distant relatives  4.1 
  Those who did not want to know  4.2 
  Children  4.3 
  Talking to male relatives  4.4 
 
 
Figure 12: The final coding frame. Each key component or theme of the conceptual framework (central 
column) was assigned a unique code (far right column) ready for data coding 
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4.7.2   Data Reduction and Display 
 
In order to effectively reduce and display the data, a matrix was created based on the 
conceptual framework to display the data across all participants, similar to those described by 
Miles and Huberman (1994) and Ritchie and Spencer (1994). 
 
Coding the data 
Coding consists of researchers effectively conducting a detailed, taxonomic process of sorting 
and tagging data (Green et al., 2007). Basically, each transcript was re-read and each sentence, 
paragraph or section was assigned a code from the coding frame described above. During this 
time, the index was constantly refined and modified to incorporate additional emergent themes 
until every part of each transcript had been assigned a code from the conceptual framework.  
 
Charting  
Each matrix displayed one stage, with its columns representing the key-components or themes 
present in that stage. Each participant was assigned a row within each matrix. The coded 
sections were charted into the matrices, first as verbatim text from the original transcripts and 
then each cell was summarised (Figure 13). Whilst time-consuming, this two-step process of 
charting allowed this analytical activity to remain grounded in the participants’ experiences by 
using their own words. An extended example of the data matrix for four participants can be 
found in Appendix 8: 
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Figure 13: A segment of one of the final matrix displays used to sort and order the data as part of the 
data analysis process. The columns each represent a key-component or theme and each row a 
participant 
 
 
4.7.3   Conclusion Drawing and Verification 
 
The organisation of the data into matrices facilitated in-case and between-case examination, 
allowing relationships between key components and explanations for patterns within the data to 
be explored as well as outlining potential patterns, connections and relationships within the 
data. In line with the interpretive descriptive methodology, the aim was to take the analysis 
beyond qualitative description to an interpretive piece of work capable of informing clinical  
 
145 
 
practices. This was executed by detailed within-case analysis, comparisons between cases, 
repeated interrogation of the data and by generating hypotheses and testing them within the 
data, such as: ‘For one participant, discussion about there being something in the family causing 
these cancers occurred more often with siblings than parents. Is this true of all cases?’  
The emphasis at this stage was focussing on moving the analysis beyond just description to 
interpretation. To achieve this, the aims were to: 
  
1.  Explain specific phenomena within the data. This was done by asking questions such as:  
-  What underpins attitudes and health beliefs about cancer, familial risk and genetic 
testing? 
-  What are the implications for a particular behavior, for example, not including young 
children in discussions? 
-  What contributes to different outcomes or impacts? For example, are there certain 
groups of relatives consistently not being told about the genetic testing and, if so, 
why?  
   
2.  Explain associations between two or more key components. This was done by asking 
questions such as: 
-  Are there linkages in cases, such as two attitudes; an attitude and behaviour; an 
event and the factor underpinning it? For example, is there a link between feeling it 
is important to talk openly and honestly with family members about cancer in the 
family, and feeling it is important to make potentially at-risk relatives aware of a 
genetic test result?   
-  Are there linkages between cases? For example, do two participants, or two groups, 
show some of the same characteristics and, if so, why? For example, are there  
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similarities between how those receiving a negative test result share results with 
their first-degree relatives? 
 
 
4.8  Data Management 
 
All details of participants, including copies of reply slips and the consent forms, were kept in 
locked filing cabinets in a secure office space at the Faculty of Health Sciences (previously the 
School of Nursing and Midwifery). With the permission of the participants, all interviews were 
audio-recorded with a digital recorder. Written field notes and memos were also kept to record 
non-verbal communication and reflections on the interviews. Interview recordings were 
transcribed into text for data analysis. All recordings and transcriptions were kept on a password 
protected computer, which was backed-up daily. Written field notes, memos and printed 
transcriptions were kept in a locked filing cabinet separate from any identifying data. All primary 
data (audio-recordings, written field notes, memos and transcriptions) will be kept for 10 years 
from the end of the study in accordance with University policy.  
 
 
4.9  Qualitative Rigour 
 
The importance of rigour in qualitative research was discussed in section 3.3.1. The strategies 
taken to ensure methodological rigour in the study will be discussed here, as it is seen through 
‘key qualitative research concepts’ identified by Lincoln and Guba (1985; 1994), namely 
credibility, transferability, dependability, confirmability and authenticity, which have been  
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fundamental to the development of standards used to evaluate the quality of qualitative inquiry 
(Morse et al., 2002). These criteria are presented to be parallel with positivist criteria of rigour.  
 
Credibility (comparable with internal validity) relates to how well the researcher’s explanation 
fits the views provided by the study participants (Tobin and Begley, 2004;Schwandt, 2001). 
According to Lincoln (1995), credibility can be demonstrated through member checks, peer 
debriefing, prolonged engagement, persistent observation, and comprehensive audit trails. 
However, the appropriateness of procedures, such as member or dependability checks, have 
been challenged as being philosophically contradictory to the idea of multiple realities 
(Gallagher, 1995;Silverman, 2000b).  
 
As was discussed in section 3.5, one of the recommended means of considering the validity of 
findings in an interpretive description study is to compare them with the clinical hunches of 
expert clinicians familiar with the study phenomenon (Maheu and Thorne, 2008). Therefore, the 
conceptual framework and research findings for this study were presented to the clinical team at 
the Genetic Service and at national conferences at various points during the analytical process. 
This gave the researcher confidence in the credibility of the findings. 
 
Transferability (comparable with external validity) refers to the generalisability of inquiry (Tobin 
and Begley, 2004). It is important to recognise that ‘external validity’ is substantially different in 
qualitative inquiry than quantitative inquiry, as the naturalistic paradigm holds that there is no 
single correct or ‘true’ interpretation. As discussed in 3.4.1, to ensure transferability, the 
objective will be to supply a description of the research process in sufficient detail so the reader  
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can make an informed judgement of whether the original study setting and their own are 
sufficiently similar to ‘‘apply’’ the findings (Murphy et al., 1998).  
 
Dependability (comparable with reliability) describes the researcher’s responsibility to 
substantiate that every part of the research is transparent and methodical (Tobin and Begley, 
2004), as well as logical, traceable and clearly documented (Schwandt, 2001). Dependability was 
demonstrated through a rigorous audit trail, including a series of research note books, 
supervision records and comprehensive descriptions of all methods and procedures, where 
others can examine the researcher’s documentation of data, methods, decisions and end 
product. 
 
Confirmability (comparable with objectivity or neutrality) is concerned with establishing that 
data and interpretations of the findings produced are not exaggerated or fabricated by the 
researcher, but are clearly derived from the data (Tobin and Begley, 2004). Auditing, as 
described for dependability, can be, and was also, used to authenticate confirmability (Lincoln, 
1995). 
 
Authenticity is regarded as a feature unique to naturalistic inquiry (Schwandt, 2001). In 1994, 
Guba and Lincoln reworked their framework to incorporate a fifth criterion of authenticity, 
which relates to fairness (presenting all value differences, views, and conflicts); knowledge 
sharing (ontological and educative authenticity); and social action (catalytic and tactical 
authenticity). During the analysis and write-up, every effort was made to represent the views 
and experiences of each participant. Direct participant quotes from interview transcripts are  
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used to demonstrate points and to ensure findings are grounded within what the participants 
actually said.  
4.10  Conclusion 
 
The last two chapters have introduced the research question and then described the study in 
theoretical (Research Methodology) and practical terms (Research Methods). The demographics 
of the research participants and the findings are presented in the next chapter.  
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Chapter 5 – Characteristics of 
Participants; Analysis of Eco-maps; and 
Stage One Findings: Cancer in the Family 
 
5.1   Introduction 
 
The next four chapters present the results of data analysis. This was a qualitative study using an 
interpretive description methodology as described in Chapter Three. This inductive approach 
aims to capture themes and patterns within subjective perceptions in order to generate an 
interpretive description capable of informing clinical understanding (Thorne et al., 2004b). The 
objectives are to gain an insight into the participants’ experiences of discussing their 
participation in genetic testing, their test results, and potential risk information regarding 
genetic testing for BRCA1/2 with their family (not just with first-degree relatives or specific 
family members), with particular focus on how these families discuss genetic testing for cancer 
risk and when. There will be an appreciation of family communication as a process rather than as 
a discrete event. Therefore, the research will examine when family communication regarding 
genetic testing occurs, throughout the whole process of genetic counselling and genetic testing, 
not just disclosure of test results. 
 
A predominant feature of the data set that emerged during analysis was that participants’ 
experiences could be sub-divided into four distinct stages, to both describe the process of 
undergoing genetic testing and communication within the family. The presentation of the 
findings in these chapters will, therefore, follow these stages: Stage One: Cancer in the Family 
(Chapter Five); Stage Two: Undergoing Genetic Counselling (Chapter Six); Stage Three: Receiving  
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the Test Result (Chapter Seven); and Stage Four: Following up Longer Term (Chapter Eight). The 
four stages depict a longitudinal view of family communication regarding genetic testing. The 
aim of presenting the findings in this way is to reflect the flow of events and experiences of 
participants as they occurred. This will facilitate exploration of how and when these participants 
talked about their family history of cancer, their genetic testing and its implications to others 
around them.  
 
 
5.2    Characteristics of Participants 
 
Figure 14 outlines the number of potential participants at each stage of the sampling and 
recruitment process. One hundred and seventy-one people were identified through the Genetic 
Service as having had a genetic test for BRCA1/2 within the designated time frame.
18 Fourteen 
were excluded, as they did not meet the inclusion criteria (refer to section 4.2): four had passed 
away, two lived abroad, and eight were identified by the Genetic Counsellors as having recently 
received a cancer diagnosis or having some other condition that made them potentially too 
vulnerable, for example, suffering from Alzheimer’s. From the remaining 158, invitations to 
participate were sent out in batches of seven, following the sampling strategy described in 4.2, 
until the required sample size of approximately 30 participants was reached.  
 
Seventy-seven patients from the Genetic Service who met the inclusion criteria were sent letters 
inviting them to join the study. Twenty-nine individuals completed interviews, giving a response 
rate of 37.7% (29/77). Unfortunately, the audio recorder failed in one instance, so only the 
                                                           
18The study included individuals who had received their genetic test results eight to 18 months prior to 
being invited to participate (refer to section 4.2).  
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researcher’s hand-written notes are available from this interview. This participant’s experiences 
were compared to the others during the data analysis, but no direct quotes are used as they are 
not available. 
 
 Figure 14: Summary sampling and recruitment numbers    
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Figure 15 provides a summary of participants’ characteristics and Table 4 provides a summary of 
participants’ demographics. Of the 29 final participants, 27 were female and two male. The age 
range was 23-79 years with a mean age of 51.2 years. Thirteen had undergone diagnostic 
genetic testing: of which one had received a mutation-positive test result and 12 had received an 
inconclusive result (meaning a negative result in the absence of a known BRCA mutation, but a 
yet unknown genetic mutation is possible). Sixteen participants had undergone predictive 
genetic testing: of which six were found to be proven carriers (mutation-positive) and ten to be 
proven non-carriers (mutation-negative).  
 
Twenty-six out of the 29 had children. Between them, they had 18 adult daughters (over the age 
of 18 years old) whose mean age was 28 years (range 18-55 years old). They had 14 daughters 
under the age of 18 years, whose mean age was 12.6 years old (range 6-17 years old). There 
were 17 adult sons, whose mean age was 31.5 years (range 18-58 years old) and ten sons under 
the age of 18 years whose mean age was 9.7 years (range 2-15 years old).  
 
Twenty-four of the participants were married (including one civil partnership), two were 
divorced and two were single. There were three sets of relations: two sets of sisters (Maya and 
Nicole; Gillian and Kerry), and one aunt and niece (Kim and Faye). 
 
The average time from receiving their test result to being invited to participate was 402.1 days 
(13.4 months). Non-responders were of a similar age (median and range) and the ratio of 
females to males compared to responders (see Figure 14). Unfortunately, no further information 
is available on non-respondents due to data protection legislation.  
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 Figure 15: Summary of participants’ characteristics 
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Table 4: Summary of participants’ socio-demographics 
 
   
Gender 
Male  2 
Female  27 
Age Group 
20-29 years  2 
30-39 years  2 
40-49years  11 
50-59 years  8 
60-69 years  4 
70-79years   2 
Mean (years)  51 
Range (years)  23-79 
Relationship Status 
Married  23 
Civil Partnership  1 
Divorced  3 
Single  2 
Time between test and being invited to participate 
<10 months  6 
10-12 months  6 
13-15 months  11 
>17 months  6 
Average  13 
Occupation Group 
Management   4 
Education Professional  3 
Sales Assistant  4 
Support Worker (Health, Social or Education)  3 
Health or Social Care Professional  3 
Office/Administrative Support  5 
Media and Communications  1 
Retired  4 
Other  2  
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5.3  Analysis of Eco-maps  
 
In line with the theoretical basis of the research (refer to section 3.4.4), it was necessary to gain 
some understanding of the participant’s social context and family relationships. This included 
their usual communication patterns and how close and open they perceived those relationships 
to be (cohesion); family organisational and structural characteristics; and any health beliefs 
shared by family members. Therefore, eco-maps were included in the research interview to 
identify people that the participant communicated with during their day-to-day life, to assess 
how close their relationship was, and how open they perceived the communication to be. This 
allowed the researcher to understand who the various family members and friends were, and 
their relationships, as the participant spoke about his or her experiences of genetic testing and 
the family communication surrounding it.  
 
After discussion with the PhD supervisors and member of the Faculty of Health Science’s Ethics 
Committee, the decision was taken not to include copies of the eco-maps in this thesis. This is 
done to ensure confidentially for the research participants. Even though all the eco-maps have 
been anonymised and pseudonyms have been given to each person identified, the amount of 
information present on the family make up, for example number of children and their ages, 
number of siblings, etc., does significantly increase the chance of someone working out who the 
eco-map belongs to. This is coupled with the fact that participants were asked to score how 
open they perceived their communication with each person to be, which is potentially sensitive 
information that participants would probably prefer not to be shared with family members. 
Instead, where necessary, example eco-maps have been created based on a simulated 
participant.  
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Eco-maps were completed with 26 out of the 29 participants during the research interview. In 
the three cases where this activity was not done, this was because the participant started talking 
about their experiences without the interviewer having the opportunity to introduce the eco-
map. The interviewer made the decision not to stop the participant because she felt it may make 
the participants feel uncomfortable, or as if they had done something wrong. This may have 
altered the atmosphere of trust and openness the interviewer was trying to create (refer to 
section 3.4.5). The researcher felt confident that the same issues, as laid out in the interview 
guide (refer to appendix three), had been covered as in the other interviews.  
 
These three interviews were fairly well spread out throughout the data collection period, as seen 
by their research numbers, which were issued consecutively – participant 104, participant 109 
and participant 128. This would suggest that this deviation from the data collection protocol was 
not due to the interviewer having a lack of confidence in the interview guide (as might have 
been suggested if all three had been early interviews). Alternatively, it may be due to a 
heightened confidence that made the interviewer feel she did not need the security of 
introducing the eco-map as a way to get the interview started (as may have been suggested if all 
three had been later interviews). 
 
 
5.3.1   Who Do Participants Communicate With In Their Day-to-Day Lives? 
 
When asked ‘Who are the important people in your life?’ and ‘Is there anybody else you might 
speak to about things going on in your life?’, the 26 participants identified 468 contacts
19 
(average 18 per participant, range 6-44). Table 5 presents an overview of the composition of 
                                                           
19 Individuals or groups; when a participant mentioned a group of people as one, for example, a bible 
group, these were counted as one contact.  
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each study participant’s personal network as they identified them during the construction of the 
eco-map. As summarised in Figure16, 138 (30%) of these were first-degree relatives,
20 105 (22%) 
second-degree,
21 46 (10%) third-degree relatives,
22 75 non-blood relatives (16%) and 104 (22%) 
friends/colleague. This comprised an average of 5.3, 4.0, 1.8, 2.9 and 4.0 per participant 
respectively. 
 
As previously described in section 3.4.5, the emphasis at this stage of the research interview was 
on identifying who participants talked to as part of their normal life rather than about their 
genetic testing. To facilitate this, the questions posed by the interviewer were purposely 
phrased as ‘Who do you consider important in your life?’ and ‘Is there anybody else you might 
speak to about things going on in your life?’ However, as was revealed during the second part of 
the interview, many participants automatically included individuals in the construction of the 
eco-map who they were not necessarily emotionally close to, but who had played a role in their 
genetic testing. For example, this was particularly true of first cousins (a third-degree relative). 
This will be further explored in section 6.2.  
 
Despite the careful wording of the questions, the participants’ choice of who was included in 
their eco-maps was likely to have been influenced by the way the interviewer introduced the 
research topic to the participants during the recruitment and consent processes. The 
                                                           
20 A first-degree relative is defined as a close blood relative, which includes the individual's parents, full 
siblings, or children. 
21 A second-degree relative is defined as a blood relative, which includes the individual's grandparents, 
grandchildren, aunts, uncles, nephews, nieces or half-siblings. 
22 A third-degree relative is defined as a blood relative, which includes the individual’s first-cousins, great-
grandparents or great grandchildren. 
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participants knew the researcher was there to interview them about their genetic testing and, 
more specifically, how they talked to their relatives about it and so were presumably motivated 
to cover the topic from the outset.  
 
It is also possible that, because the topic under discussion related to family genetics, some 
participants were influenced by their experiences of having attended multiple genetic 
counselling appointments, where it is common to give a full family history and create a 
genogram. For example, Elizabeth (participant 103) and Annie (participant 105) both described 
their communication patterns in terms of their family tree and, perhaps due to her background 
in human genetics, the interviewer automatically sketched it out in the layout of a genogram 
rather than a true eco-map. These were also two of the first interviews to be completed when, 
perhaps, the interviewer was not quite so confident in the data collection protocol and was 
more easily led by the participant.  
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Table 5: Summary of family and social networks as reported by participants, showing the number of 
individuals identified broken down by relationship 
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Molly  5  5  2  1  4  17 
Eloise  5  4  4  2  2  17 
Elizabeth  9  10  17  7  1  44 
Arthur  4  5  3  2  2  16 
Faye  6  2  0  4  1  13 
Annabelle  4  5  0  1  3  13 
Brenda  4  1  2  3  3  13 
Laura  5  2  0  1  2  10 
Martine  6  4  0  4  4  18 
Joanna  3  2  0  1  0  6 
Julia  5  13  0  3  6  27 
Zena  6  7  1  1  9  24 
Karen  3  0  1  1  3  8 
Gina  8  4  0  3  3  18 
Sara  5  2  1  0  3  11 
Rachel  5  0  0  1  10  16 
Katherine  5  4  0  5  2  16 
Viv  5  3  3  13  8  32 
Robert  1  2  0  5  3  11 
Christina  0  1  7  0  3  11 
Carolyn  5  5  3  1  4  18 
Maya  8  6  0  3  1  18 
Gillian  9  9  1  2  8  29 
Tina  8  4  1  7  11  31 
Nicole  7  5  0  3  4  19 
Kerry  7  0  0  1  4  12 
TOTAL  138  105  46  75  104  468 
Average  5.3  4.0  1.8  2.9  4.0  18.0  
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 Figure 16: A breakdown, by relationship, of the 468 contacts participants identified as important people 
in their lives in their eco-maps 
 
 
5.3.2   How Open Is That Communication?  
 
Having identified those people participants felt were important in their day-to-day lives, they 
were then asked to score how close they felt to each person on the map and how open they felt 
their communication was with them (as a measure of cohesion). This was depicted using a 
multiple line technique (Ray and Street, 2005), where three lines meant really close with open 
and honest communication, and no lines meant did not really communicate. A dashed line 
represented a tenuous, stressful or conflict-laden relationship (Martino, 2006). Table 6 shows  
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the breakdown of how the cohesion with family and friends was scored by participants. The 
breakdown of scores for an individual participant’s eco-maps can be found in Appendix 9 
 
 
Table 6: Summary of family and social networks with scoring of closeness of relationship and openness 
of communication as a measure of cohesion, reported by participants 
 
 
 
  
Total
β 
(average 
per 
participant
¥) 
Scores of ‘closeness’ and ‘openness’ of 
communication
µ.  
  
3  2  1  0  Disrupted
π 
Not 
alive 
All participants 
First degree relatives 
138  
(5.3) 
46 
(1.8) 
42 
(1.6) 
23 
(0.9) 
3 
(0.1) 
11  
(0.4) 
11 
(0.4) 
Second degree relatives 
105  
(4.0) 
0 
(0.0) 
4 
(0.2) 
9 
(0.3) 
84 
(3.2) 
3 
(0.1) 
5 
(0.2) 
Third degree relatives 
46 
(1.8) 
3 
(0.1) 
9 
(0.3) 
4 
(0.2) 
29 
(1.1) 
0 
(0.0) 
1 
(0.0) 
Non blood relatives 
 (including partners & in-laws) 
75 
(2.9) 
23 
(0.9) 
16 
(0.6) 
14 
(0.5) 
22 
(0.8) 
0 
(0.0) 
0 
(0.0) 
Friends & work colleagues 
104 
(4.0) 
33 
(1.3) 
41 
(1.6) 
28 
(1.1) 
2 
(0.1) 
0 
(0.0) 
0 
(0.0) 
Total  
468 
(18.0) 
105 
(4.0) 
112 
(4.3) 
78 
(3.0) 
140 
(5.4) 
14 
(0.5) 
17  
(0.7) 
 
β Total number of individuals or contacts included on eco-maps by all participants. 
¥ Total number reported divided by 26 participants who completed an eco-map as part of 
research interview.  
µ A score of three (lines on the eco-map) meaning really close with open and honest 
communication and zero meaning do not really communicate. 
π Tenuous, stressful or conflict laden relationship 
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Figure 17 shows the breakdown of scores for all persons on the maps. One hundred and five 
(22%) were scored with three lines; 112 (24%) with two lines; 78 (17%) with one line; 140 (30%) 
no line; 14 (3%) with a dashed line; and 17 (4%) of those identified were dead and were not 
scored.  
 
 
 
 Figure 17: A breakdown of scores for how open participants felt their communication is using a multiple 
line technique 
 
 
As before, because the questions to identify these contacts were phrased as ‘Who do you 
consider important in your life?’ and ‘Is there anybody else you might speak to about things 
going on in your life?’, 30% being scored as little or no communication (no line) seems surprising. 
However, when the scores are broken down according to degrees of relationship, as in Figure 18, 
the majority of these are second-degree relatives. These are largely accounted for by the  
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presence of either nieces or nephews, who were mentioned in association with their parents, 
rather than as a contact in their own right, and were therefore not really part of the participant’s 
‘‘normal’’ communication pattern. Likewise, grandchildren were sometimes mentioned as being 
important, but were given a score of zero because they were too young for the communication 
to be considered open or not.  
 
 
 
 Figure 18: Scores for ‘openness of communication’ broken down by degrees of relationship 
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5.4   Stage One: Cancer in the Family 
 
The first stage of family communication begins well before genetic testing and is based on 
people’s experiences of cancer (Figure 19). Discussion in the family about the family history of 
cancer was prompted by personal experiences, for example, death and disease within the family, 
or undergoing regular screening. For participants, cancer was an ongoing theme throughout 
their lives, even if it is not a constant focus, and so was discussed regularly. This continued 
discussion about cancer and the family history is the first step to open discussion about genetic 
testing for BRCA1/2. It tended to include emotionally close relatives, such as first-degree 
relatives, partners and close friends.  
 
 Figure 19: Stage one: Family and personal history and experiences of cancer 
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5.4.1   Family and Personal History and Experiences of Cancer 
 
Experiences of cancer and, in particular, their family history of cancer, shaped how the 
participants and their families talked about the disease and genetic testing.  
 
A striking feature of the data was just how prominent a role cancer plays in many of the 
participants’ lives. At a basic level, there was a sense that ‘‘everyone’’ in the family, especially 
the females, had had cancer… 
 
‘Erm…well first off…erm, it was my grandma, my aunt, my mum and…my 
aunt would be like her sister. Erm, they all died of cancer.’ 
(Molly, 49y, PGT, Negative) 
 
Sara, the youngest participant, spoke about how she remembers cancer always being part of her 
family life as a child. Her Nan (maternal side) had died from ovarian cancer when she was 10 
years old and she was aware that several of her aunts (her mother’s sisters) had died of breast 
and ovarian cancer by that time: 
 
We are all just like – we remember Nan being ill and she came to live with 
us as soon as she found out she was ill. So she lived for about two years 
while she was dying, so we were all like really aware of it and I think we are 
quite an open family anyway, so we all discussed things’.  
(Sara, 23y, PGT, Negative)  
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She remembers various phone calls her mother made to the Genetic Service about the genetic 
testing, but admitted ‘I never really understood it when I was younger’. Sara felt her family were 
very open when it came to discussing cancer, particularly between herself, her two sisters and 
her mum, all of whom she gave three lines to on her eco-map. From her perspective, there was 
no evidence of her being excluded from these conversations because she was a child: ‘‘…me and 
my Mum and my sisters all just spoke about it all the time’’. It must be recognised, however, 
that, if asked, her mother may say these conversations were censored in some way that Sara 
was not aware of; however, there is no way to verify this within this research method. On the 
other hand, Sara was experiencing first-hand the death of a close relative due to cancer because 
her Nan came to live with them when she got sick, so some conversation on the topic was to be 
expected.  
 
Other participants also spoke about being aware of the family history from a young age and that 
they would potentially get cancer in the future:  
 
‘It was something that I’d kind of, from a teenager, always been told there’s a 
chance that you might get breast cancer later on as well. So it was something 
that I’d kind of grown up with.’  
(Annabelle, 51y, PGT, Negative) 
 
For many participants, there had always been an assumption that they themselves would get 
cancer one day. For some, this assumption was linked to genetics, often those with some kind of  
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medical background such as being (or had been) a doctor (n=1), nurse (n=3), midwife (n=1) and 
physiotherapist (n=1). But, for others, it was expressed more as ‘‘always knowing’’ there was 
‘‘something’’ in the family. This family trait was most often discussed horizontally across the 
family; in other words, between siblings, rather than vertically.
23 
 
So often in the interviews, this perceived knowledge that they were destined to get cancer was 
stated in a ‘matter of fact’ manner, as if it was just part of being a member of that family. And 
yet, when questioned further, the participants revealed just what a huge emotional burden this 
could be. For example, Zena’s mother had died of breast cancer when she was 16 years old (and 
her grandmother when her mother was 9 years old) and she was left with a very visual image of 
the risk from the way her father talked about it: 
 
 ‘So we knew already (my sister and I) that there was a very strong genetic 
link of some sort within our family. And, whilst my Dad didn’t talk a lot 
about it, the odd times that he did say anything, he just used the symbol of 
the Sword of Damocles hanging over you, basically, and that’s that vision 
I’ve always had growing up really and moving away.’ 
(Zena, 49y, DGT, Inconclusive) 
 
Like Sara before, many had experiences of caring for relatives with cancer and witnessing 
relatives dying from the disease. Many of the participants had experienced their mothers being 
diagnosed with cancer and, in many cases, die from it. For about half of these, maternal death 
                                                           
23 Vertical communication: up or down, the family as laid out in a genogram, for example down to 
offspring or up to parents.   
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had occurred when the participants were very young. These experiences could have an 
important psycho-social impact on the individual and the family as a whole and, as such, shaped 
the way participants’ felt about the disease and how they talked about it. For example, Eloise 
felt she had never really understood why her mother had died and so quickly when, in her young 
eyes, so little treatment was given: 
 
‘I suppose mum was the, the first, that I was really, that really affected me, 
coz she died, very soon after her diagnosis. Which I never really understood 
because, she was diagnosed, she had a lumpectomy, radiotherapy and 
tamoxifen. And I couldn’t understand why just over a year later she’d gone. 
And she was full of cancer… I was eleven when she died… So, so when mum 
got it, you know, there was nothing to suggest anything sinister, but I could 
never understand why, if it was such a trivial matter, that she only ever 
needed to have the lump removed, why she died’. 
(Eloise, 42y, PGT, Positive) 
 
During the interview, Eloise came across as a very warm and bubbly person who spoke very 
articulately about her family history and her genetic testing for BCRA1/2. She described having 
very close relationships with very good communication with those she identified on her eco-map 
(all being scored as either three or two-line, with the exception of one male cousin). At times, 
she obviously found the topics under discussion, such as her mother’s death, upsetting, but 
these experiences seemed to have given her a drive to do everything she can to protect herself 
and her family from this disease, including talking very openly about her experiences to her 
friends and family: ‘In fact, I would stand on the roof tops’, she said.  
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For some, the emotional burden of the family history can make talking about it really 
challenging. This was highlighted by the fact that, during the interviews, several of the women 
became tearful when talking about relatives who had been diagnosed with cancer or had died, 
and the emotional burden of a family history of cancer was evident. It does not seem 
unreasonable to assume that this may be even harder when talking to close relatives, where 
both parties are emotionally involved, compared to talking to an independent researcher. 
However, all the participants had spoken to some, if not the majority, of the people identified on 
their eco-map about their family history of cancer and genetic testing. For many, tensions arose 
between wanting to care for and protect loved ones whilst, at the same time, having to discuss a 
potentially threatening and emotionally laden topic. 
 
One participant, Elizabeth, had been aware that her family history was worth investigating since 
her breast cancer diagnosis in 1997. For her, pursuing genetic testing was about calming her 
teenage daughter Grace’s anxieties and fears. However, with this came the responsibility of 
making sure she timed it right so as not to cause her daughter more stress:  
 
‘It’s very much been in the back of my mind for quite a while that it may be 
something we needed to look at. I tended to sit on it when – there have been 
times when Grace is saying “I must know, I must know” and then “Mum, 
“cause I need to do something” you know. She’s quite a reactive sort of 
person, and so as she was going through the sort of teenage phases I was just 
trying to keep the lid on it really and say “well let’s just – we’ll leave it a bit 
and we’ll talk about it when you are a bit clearer”. Because one day she 
would be “Yes, let’s go for it” and the next day would be “No I’ll bury my head  
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in the sand and I don’t want anything”. So I think when she was coming up 
last year to – you know, she was almost through University and she felt – 
what she was saying felt a lot more stable and she said “Yes I think I would 
like to know”. So we felt that if I approached the GP who had talked with her 
as well as with me over the years (the same GP for both of us) perhaps we 
would see if I could be tested.’ 
(Elizabeth, 54y, DGT, Inconclusive) 
 
Elizabeth felt she often had to mediate when and how the topic was discussed. To avoid 
unnecessary upset and to keep the matter from blowing out of proportion, she took her cues on 
when to discuss it from Grace. However, she was very aware that, during her teenage years, 
Grace regularly changed her mind about whether or not she wanted to know if they carried the 
gene; therefore, Elizabeth tended to placate her fears rather than pursue it until she felt Grace 
was emotionally ready. That is not to say she avoided talking about the topic as she felt it was 
important to keep it out in the open, but it gave her a way of dealing with the tension she felt 
between wanting to be open about it and also wanting to protect her child from harm.  
 
 
5.4.2   Reactions to Family History 
 
Generally, the significant family history of cancers was dealt with in three ways within the family: 
normalising it; increased engagement with it; and/or disengagement. These could be from 
individuals or by the family unit as a whole, and were based on experiences of cancer in the  
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family and their shared health beliefs. Some communicated differently with different relatives 
and/or at different time points.  
 
1.  Normalising it  
Despite it being an emotional topic close to their hearts, with cancer playing such a prominent 
role in their lives it was a regular topic of conversation within these families. Really, for these 
participants and their families, this is an on-going experience, the effects of which they live with 
throughout their lives. This resulted in them talking openly about it, as just a normal part of 
being a member of that family: 
 
‘So – but me and my Mum and my sisters all just spoke about it [family 
history of cancer
24] all the time; we were just all quite savvy to cancer I 
think, like in our family because everybody’s got it. It’s like a family 
heirloom!’  
(Sara, 23y, PGT, Negative) 
 
Everything from a new diagnosis to engaging in regular screening could provide the stimulus for 
family communication about the topic, as described by Tina: 
 
‘I’ve always kept track of the family tree, so you know, I make a note every 
time someone has had it done, you know, and we talk about it. So it’s just – 
we just talk about it whenever it comes up really.’ 
                                                           
24 Square brackets denote additional information inserted by researcher for clarification.  
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(Tina, 49y, PGT, Positive) 
 
These were the kinds of discussions that occurred when the family sat around the table for 
dinner rather than as planned meetings or activities. In some cases, younger family members 
were excluded - or, more accurately, not engaged with - so as to protect them from something 
they would not understand or need to worry about. Or, if there were certain family members 
who did not want to discuss it (see disengagement below), then these discussions simply 
happened when that family member was not around.  
 
2.  Increased engagement  
One way of combating this risk of cancer and the associated feelings was to engage in regular 
surveillance, such as yearly mammograms. This was habitually coupled with a hyper-awareness 
of potential symptoms, which was also impressed on other family members, particularly 
offspring. This appeared to be a subconscious coping mechanism to deal with their fear of 
developing cancer. This hyper-awareness and attention to self-examination opened the dialogue 
about the potential risks with their children from a young age and increased their awareness of 
the family history.  
 
 ‘It’s like my son will say something “I feel I’ve got a pain here, I’ve got a lump 
there”. I always say to him “You do check yourself don’t you?” and he’ll say 
“Yes, yes, Mum I do!” That’s the sort of thing, and I say to Sarah [daughter] 
“Make sure you check yourself” and she’ll say “Yes, Mum I do!” So we do talk 
about it periodically; we do think when it comes up or she might say “Oh I’ve  
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got a funny feeling” I say “Well, make sure if you do find anything just go to 
the doctors and get it done straight away.’ 
(Julia, 58y, DGT, Inconclusive) 
 
‘I have always told them [her daughters], even when they first started getting 
their breasts and that, that you’ve got to check yourself. I mean, they’ve 
always done it and I've always done it. I've always made it a thing and I've 
always said to them, you know if you feel anything different or you think “Oh 
it’s not right”, I said, you let me know – coz when they were at home, 
obviously younger, I’d say “You tell me and we’ll be straight up the doctors”. 
I'm probably a bit paranoid about it. So, no, they’ve always checked 
themselves from a young age and they still do now.’ 
(Molly, 49y, PGT, Negative) 
 
3.  Disengagement 
Disengagement tended to happen only with or by certain relatives. There were several accounts 
of relatives or certain groups of family members who did not like to discuss such things, as 
demonstrated by Elizabeth, who knew one side of her family really did not like to talk about 
medically related things, especially cancer:  
 
 ‘But from a communication point of view, that [side of the] family [points to 
eco-map] are really funny about medical stuff, you know. You don’t use the 
‘C’ words still… Well yeah, they have a very different communication style 
within that family. You know, the parents and the three children and their  
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families, they just don’t talk health at all. They don’t talk health in a way 
that gives you anything you can sort of get your fingers into, you know. It’s 
all very vague, and I mean I didn’t know for years that my uncle had 
prostate cancer; I mean, I knew he took tablets and he was often off having 
little operations and things. But it wasn’t discussed, and he told me about 
his treatment after I’d had mine, which was fascinating.’  
(Elizabeth, 54y, DGT, Inconclusive) 
 
This was often associated with older generations, especially when it came to something as 
modern as genetics. Brenda’s experience represents that of many participants who had older 
relatives, who felt uncomfortable talking openly about the potential family risk and genetics:  
 
‘I’ve got an aunt (my mother’s sister) we tend not to talk about this because 
of the generation really; she’s gone into her 80s. I sort of keep her very 
loosely up to date if there are any developments, but tend not to talk about 
the genetics thing because I found, you know, they don’t really – they are 
not so open to that way of thinking about breast cancer!’ 
(Brenda, 58y, DGT, Inconclusive) 
 
To overcome this disengagement, participants simply did not include these family members and, 
in some cases, friends, in those discussions, but sought other people to discuss the family history 
of cancer and its implications with. At this stage in the process, before genetic testing, there was 
no need to ‘rock the boat’ by forcing others to talk about something they found distressing. This 
changed when they needed specific information on the family history for their genetic  
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counselling appointments (refer to section 6.2.2 in the next chapter), or once they had their test 
results and felt it was important to pass on risk information (refer to Chapter Eight).  
 
Other challenges came, not from the topic of discussion, but from individuals’ personalities and 
communication style, which made such discussions difficult. Certain family members were often 
accused of being hard to communicate with, such as Zena’s father below, because they had a 
reserved, shy or private personality: 
 
ZENA: [Dad] is a terrible communicator, absolutely awful; always has been, 
all my life. Better if I ring him up and talk to him, he’s better than face to 
face. 
INT: Why do you say he’s a bad communicator? 
ZENA: He’s a very, very private person. He’s not very good at showing his 
emotions, never has been. Never ever has been, and he’d be the first to 
admit that you know. You know, I was talking to my brother a while back 
about that (a few years back about it, now) and it’s funny, he’s got a way of 
hurting us all. He’s got a way of hurting all four children by showing very 
little interest in us, as it seemed when we were growing up. But I think that 
was his coping mechanism; he couldn’t show how he felt or anything and I 
just think he shut himself off quite a bit and he’s not able to communicate 
freely with us that well, except on neutral things really, yeah. And still isn’t, 
but we’re older now and accept that sort of thing. It’s not that he’s not 
interested, he doesn’t want to pry, you know, I think, he’s just such a private 
person.’   
 
178 
 
(Zena, 49y, DGT, Inconclusive) 
 
For Brenda, although she was interested in the implications of the family history of cancer and 
potentially genetic testing, it was not until her mother passed away that she felt she was able to 
pursue it, as she did not approve. Her mother’s different view meant Brenda avoided discussing 
it with her. 
 
‘My mother was never keen on that at all; she said breast cancer is 
something that you tend to get when you’re older; many old people develop 
it, just ‘cause they get older. There’s nothing wrong with our family, nothing 
wrong with our genes! And she really didn’t support us (or me) having any 
genetic testing. 
And it wasn’t until once she’d died that I felt I was able to – I was more free, 
in a way, to go ahead with genetic testing.’ 
(Brenda, 58y, DGT, Inconclusive 
5.4.3    Stimulus to Pursue Genetic testing  
 
Typically, there was ‘‘one more’’ diagnosis in the family that seemed to confirm their feelings 
about the significance of the family history of cancer, and which triggered either one member or 
several family members to take the matter further. This was certainly the case for Eloise, whose 
cousin’s diagnosis, especially at a relatively young age, really prompted her to consider seeking 
advice about her family history.  
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‘Erm, so we’d had Nan, and my aunt, and then Mum with it. They had all 
died from it and then Lyn [cousin] was diagnosed… erm, in 2004. And she 
was 41. I started to think about it then. I thought ‘Well hold on, Mum was 
early 50s’. I mean, well, she was... 50… she would have been 50… she was 
six weeks away from her 53
rd birthday. So, which I thought was young.’ 
(Eloise, 42y, PGT, Positive) 
 
Alternatively, rather than a new diagnosis specifically, it could be that further information about 
the family history was discovered that prompted further exploration.  
 
‘Dad started doing the history of the family tree thing and they managed to 
track down her Mum’s death certificate and it said on there that she’d had 
ovarian cancer. I was already been screened for breast cancer, you know 
because of the family thing. So I was having mammograms every year and 
all of that, so they were watching me with that anyway, but as soon as the 
ovarian cancer came up we were far more interested then about taking it 
further.’ 
(Kerry, 45y, PGT, Positive) 
 
Deciding to investigate genetic testing followed similar communication patterns to those 
described above. They engaged with those friends and family whom they thought would be 
interested, and invited any relevant family members to join them, while disengaging with those 
they knew or thought would not be interested or would disapprove.   
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Other participants were introduced to the genetic service as a result of another family member 
receiving a positive test result for BRCA1/2. Learning that a family member had been tested and 
received a positive result often changed the way the matter was discussed. Rather than talking 
about cancer and the family history, the focus shifted to genetics and specific risk. Family 
members tended to fall into three groups: those who automatically decided they wanted to be 
tested and openly talked about it; those who were undecided about undergoing genetic testing, 
but were willing to undergo genetic counselling for more information and to discuss it further; 
and those who were not interested and did not want to discuss the matter at all.  
 
‘My sisters rang me up. They just said that Rebecca [sister]  had been found 
to carry this gene, but the gene increased the likelihood of breast cancer by 
80% or prostate cancer by 10% in a man and that, if it went on through, if we 
were carriers, it could go on to our children and our children’s children. And I 
mean there was never a question to me. I immediately wanted to be tested to 
find out whether or not. I knew at that stage, and I knew I would have to have 
the test, so I contacted the people immediately because my son was getting 
married in late September/early October and I really wanted to be able to tell 
him whether he had to be aware of this risk in his life.’ 
(Arthur, 61y, PGT, Negative) 
 
‘And Frank [her cousin] phoned me up [after his daughter had been found to 
be a carrier] and said “Look Annie…” (and he felt really bad about it). He 
obviously felt really guilty, saying to me “Look, you’ll have to go– it would be  
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a good idea if you went to be tested” and I said “Well, I have no problem with 
that at all” and I didn’t. When we saw each other and shortly after that we 
talked a lot about it.’   
(Annie, 65y, PGT, Negative) 
 
 
5.5  How those undergoing genetic testing for BRCA1/2 talk to 
their friends and family during Stage One.  
 
Communication during this first stage, Cancer in the Family, concerns how participants and their 
family talk about cancer before genetic counselling and/or genetic testing even became an issue 
to them. These were unobtrusive conversations, which followed normal communication 
patterns within the family, and were prompted by diagnosis, disease and death within the 
family. For example, they talked about how common cancer was in the family, what that might 
mean for family members and where it might come from.  Communications were often coupled 
with a hyperawareness of risk and cautioning relatives, especially offspring, to the importance of 
self-awareness, such as, regularly checking for lumps in the breast.  
 
5.6   Conclusion 
 
This, the first of four results chapters, has reported the participant characteristics and the main 
features of the eco-maps. In order to answer the research question on when those undergoing 
genetic testing talk to their relatives, the primary findings of the qualitative interview have been  
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split into four stages, spread over four chapters. The first investigates how participants talked 
about their experiences of cancer and its implications, before their genetic testing.  
 
The key findings in this chapter show that, before genetic testing, participants talked about their 
family history of cancer and what it might mean for the family in a variety of ways: from 
discussions about being a normal part of life in a family where cancer is so prominent, to 
disengaging from those who did not want to talk about it or disapproved.  
Experiences of cancer, in particular their family history of cancer, and how the family viewed the 
cancer as a whole (shared health beliefs), shaped how the participants and their families talked 
about the disease and genetic testing. For some family members, it encouraged open 
communication to increase awareness of the dangers, particularly in the form of hyper-
awareness of symptoms, as a strategy to hopefully catch any disease early. For other family 
members, in particular older relatives, it made them nervous and reluctant to talk about such 
distressing things. There was evidence of participants mediating how and when the topic was 
discussed in order to protect family members from distress. Discussion was often prompted by 
diagnosis and treatment, but there was a need to negotiate personalities and communication 
styles.  
 
The next chapter will look at how participants talked about their experiences and genetic testing 
during their genetic counselling.  
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Chapter 6 – Stage Two: Undergoing 
Genetic Counselling 
 
6.1   Introduction 
 
This chapter investigates how those undergoing genetic testing for BRCA1/2 talked to their 
relatives when the participants or their relatives went to the Genetic Service for their genetic 
counselling (Figure 20). During this stage, communication opens up to include more distant 
relatives due to the need for information or assistance.  
 
 Figure 20: Stage two: Undergoing genetic counselling  
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6.2   Stage Two: Undergoing Genetic Counselling 
 
6.2.1   Initial Experiences of Communication About Undergoing Genetic Counselling 
 
In order to have genetic testing, you have to partake in genetic counselling. This process 
potentially opened up communication on the subject, especially with those who were already 
part of the stage one communications about cancer in the family.  
 
‘I mean everybody in the family read the booklet and what they sent, all 
that stuff, and the literature I had. And, you know, went “Ooooh oooh oooh” 
but you know “don’t let’s worry about this until I’ve had the blood test and 
then we can see what the options are”’. 
(Annie, 65y, PGT, Negative) 
 
Annie, like many, involved her family in her genetic testing by sharing the news and the 
literature she received. But she also played a role in managing the family’s reactions to it by 
encouraging them to wait for the results, as shown in the quote above.  
 
The data illustrated that the people identified as close and important (two or three lines on the 
eco-map, mainly first-degree adult relatives, partners and close friends) by the participants knew 
about the genetic counselling, and the opportunities for genetic testing, at this stage because it 
was perceived to be ‘something going on in their lives’, so it was discussed with others. For 
many, it was not so worrying, as they were not expressly seeking emotional support by  
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discussing their genetic counselling with others; rather, they found it as something different and 
interesting to talk about: 
   
‘And also you just generally talk – I would talk to people because people 
would say “How’s your Dad?” and I would say “Fine, but he’s going for 
genetic testing”. “Oh why?” der, der, der, der. And “Oh you might – Oooh 
and then what?” and it sows a seed, doesn’t it? (INT: What kind of people?) 
Friends and family mainly. 
(Nicole, 39y, PGT, Negative) 
 
For people like Eloise, who had had cancer,
25 going for genetic counselling felt like, and was 
perceived by others as, an extension of her treatment and, therefore, was discussed in much the 
same way.  
 
INT: You mentioned that your family knew at the various stages? 
ELOISE: Yeah 
INT: Did you talk to them at each stage?  
ELOISE: Yeah they all…I mean, with things like going for an MRI scan, going 
for a mammogram. They’d all know when I was going and they’d ring up to 
say, you know, ‘What’s happening next?’. And I’d say ‘Well next I’ve got to 
go for counselling’. ‘Well when’s that?’ And I’d tell them. And then it might 
go quiet, especially like from Dad. He might go quiet. But then on the day, 
he would ring up. ‘How did you get on?’ Or if he didn’t, then I would ring 
                                                           
25 Although Eloise had had cancer, she was not the first person in her family to have a BRCA1/2 test, hence 
she had a predictive genetic test rather than a diagnostic genetic test.   
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him. It was very open. Right from the start. Even when it was just like, ‘Oh, 
my doctor referred me’ initially to the Breast Team at [city]. They all knew.’ 
(Eloise, 42y, PGT, Positive) 
 
There did not seem to be a sense of secrecy around partaking in genetic counselling or genetic 
testing, unless a conscious decision was taken to not tell a particular individual because they 
were deemed too young or too vulnerable. One exception to this was Maya, who had concerns 
about telling her workplace in light of contract renewals, and so managed the time of disclosure 
until after her new contract had been approved: 
 
‘The only thing that slightly frightened me was work. I was just going on to 
a new contract and I needed my new contract to start in the January and I 
was having the test in December; I wanted to get my contract sorted 
because I thought I’d never been sick, but if I have to go for a mastectomy I 
need to make sure my contract…  So that was the only thing that I held back 
slightly, on telling them all the details till I knew my contract was all right. 
But otherwise, no there was no problem; there wasn’t anyone that we hid it 
from.’ 
(Maya, 47y, PGT, Negative) 
 
The genetic counselling process provided new information that the family were not aware of 
regarding cancer and what the risks might be to family members. For example, for Molly and her 
family, the knowledge that they could also be at increased risk for other cancers, in particular 
ovarian cancer, came as quite a shock to them. They were very anxious about their considerable  
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family history and experiences of breast cancer as it was and this new information was further 
cause for concern. 
 
‘[The Genetic Counsellor] said to my sister, because she had the gene, that 
she was at more risk of getting, erm, cer…cer… ‘cervaian’ cancer and did she 
know about that. And we thought, we didn’t, because we’d always assumed 
it was just breast cancer. Never worried about anything else, it was always, 
sort of, breast cancer. So they said that her options would be to have the 
other breast removed and have a full hysterectomy. Which was a bit of a kick 
in the stomach, because none of us thought about that, you know.’ 
(Molly, 49y, PGT, Negative) 
 
The link with ovarian cancer was also a surprise to Elizabeth. As mentioned previously in Chapter 
Five, she was undergoing genetic testing because of the concerns of her teenage daughter. As 
far as she was concerned, she’d already had breast cancer so there were no major consequences 
for her.  
 
INT: Did that surprise you? 
ELIZABETH: It did, yeah, because then she explained why there was an 
implication for me obviously and that I should – if it came back, as that then I 
had to think about my ovaries, which were no longer required! I suppose I 
was thinking about it in terms of Grace [her daughter] and I wasn’t – I 
thought, you know, the deed was done as far as I was concerned and it was – 
I thought I was in a watch, wait and see and I didn’t appreciate that there  
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might be something that I could actively do to prevent further events… I 
didn’t think that it was going to affect me at all, you know, in terms of my 
future health, and it was only that comment… ‘Your ovaries may –’. But it 
made me realise that perhaps I’d been a bit narrow on this, but I just didn’t 
have that knowledge. 
(Elizabeth, 54y, DGT, Inconclusive) 
 
This ‘new’ information had several implications for communication. Firstly, new information was 
perceived as interesting and, therefore, when they were discussing how their genetic counselling 
appointment had gone with close family and friends, it was recalled and discussed. Secondly, it 
sometimes adjusted the participants’ perception of who in the family the information was 
relevant to; for example, relatives who had previously had breast cancer now needed the 
information about ovarian cancer risk as well.  
 
 
6.2.2   The Need To Gain a Complete and Accurate Family History Opened New Lines 
of Communication. 
 
As part of the initial stages of any genetic counselling, patients are asked to complete a family 
history form, which acts as a prompt for discussion. In order to do this, they often sought the 
advice of other family members who had more knowledge of the exact details of the family 
history. 
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‘Rosa [cousin] seemed to sort of know more about the aunts than I did, 
because obviously she’s 10 years older and she sort of just remembered 
things. And she has – when my Mum died, she took all the paperwork and 
all sorts of things connected to my Mum because she was the eldest so she 
takes charge! She took charge, so she sort of knew a lot more than what we 
ever did.’ 
(Julia, 58y, DGT, Inconclusive) 
 
 ‘[My niece] rang me one day and explained that, because it was in the 
family for so many generations, they wanted to know if someone could give 
the details you see. So of course I wracked my brain and wrote it all down as 
far as I could and sent it off to her. And she took it to them.’ 
(Shirley, 78y, DGT, Inconclusive) 
 
Sometimes this information could easy gained by asking emotionally close relatives 
who were already involved in stage one discussions. However, especially in cases 
where matriarchal family members such as mothers had died, that was not always 
possible. This often opened communication with family members who the 
participant did not feel that, under normal circumstances, they were as close to, or 
had no regular contact with; but rather, they were included because they had 
knowledge of the information required. These included contacting either:  
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-  Otherwise emotionally close relatives who did not like to talk about the 
family history of cancer (refer to ‘Disengagement’ in section 5.4.2) and so 
were not normally involved in such discussions; or  
-  Emotionally distant relatives who were not part of participants’ normal 
communication patterns.  
 
Getting emotionally close relatives who were not usually involved in family discussion about 
cancer to engage. 
For some participants, gathering details of the family history was a hard subject to discuss with 
certain relatives, especially parents, as they did not want to cause them distress. As the quote 
below demonstrates, Zena found it hard to talk to her father; tensions arose between needing to 
know the information and not wanting to upset him.  
 
‘And I tell you what is hard, is finding out the family history! That’s quite 
tough if you are going too far back, you know, or sideways as well. That’s 
quite hard, especially with a dad that doesn’t tell you very much, that was 
very hard. And that’s where my sister did well. She actually got all the forms 
from her genetic team and actually took them all round to my dad the same 
day and said “Right give me all the family history”. 
She’s a sort of two feet in sort of person, you know, so we do laugh. Yeah, 
she’ll do that and she won’t worry that she’s ruffled feathers or anything you 
know whatever, but I don’t think he had much choice there. So that was quite 
good ‘cause she got all the information I didn’t know. 
 (Zena, 49y, DGT, Inconclusive)  
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Clearly, as well as finding it hard to talk to her father because he ‘wasn’t the sort of person’ she 
was comfortable asking, Zena’s own reported shyness played a significant part in making this a 
challenging situation for her. Luckily, her sister’s more outgoing personality allowed them to 
overcome this. This is a good example of negotiating with another to do the ‘hard’ talking, a 
strategy adopted by many of the participants.  
 
Conflict and rift within the family and family secrets made gathering details of the family history 
and generally discussing genetic testing harder. Discord in the family habitually meant 
genetically close relatives, i.e. first and second-degree relatives, were not in contact and often 
not willing to be in contact. Jan found that her parents’ divorce and subsequent estrangement 
from her father made gathering details of the family history even more challenging: 
 
‘I’ve found it very difficult to get the history, because my parents were 
divorced and my father’s in America. We had no contact with him after they 
divorced. So getting that information was difficult; I only actually started 
gleaning information once relatives started to die, which I suppose is 
probably how it happens. I don’t know. But three years ago my grandfather 
(my maternal grandfather) died. He was living in America so I went to deal 
with his estate and it was at that point that I found out information that I 
had a Jewish heritage… I had Hungarian Jewish maternal lineage, which I 
remember being brought up in the interview with the genetics lady. She 
asked did I have a Jewish background, and I came back to her and said 
‘Actually I did! I do have a Jewish background’ and she explained to me that  
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they believe that part of the breast cancer gene comes from that 
background’. 
(Jan, 44y, DGT, Inconclusive) 
 
It was only after the death of her grandfather that Jan discovered he had changed his surname in 
order to disguise his Jewish heritage, which was something that, as far as she was aware, had 
never been discussed within the family.  
 
Asking emotionally distant relatives for family history information.  
These contacts were more formal in nature than the ad hoc discussions referred to in stage one 
(Chapter Five) and tended to require a specific plan about who to contact and the best way to 
approach them.  
 
‘I wrote. Because my Dad hadn’t kept in touch with Mum’s side, you know, I 
wasn’t too sure whether they were still living at the address I had, so I wrote 
and got a reply back more or less straight away with lots of information in it 
[from maternal cousin, Nancy]. And then I think I must have rung Nancy just 
to say I’d got it, and ask her what she thought of the genetic testing 
(because obviously with her being in lineage she was quite interested in the 
family tree side of things, as well). So she said “Right, I’m going to go to 
Records Office and see what I can find basically” and that’s when she found 
my Mum’s grandmother having breast cancer, so she sent me over a  
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photocopy death certificate with it on there, so it was written on there. So 
she and I communicated quite a lot by letter and email and phone.’ 
(Tina, 49y PGT, Positive) 
 
In this way, the family history form acted as a facilitator of family communication. It was 
common to write to more distant relatives. In many cases, this was because the participant, or 
another family member, only had an address for the relative they needed to contact; but also a 
letter was less intrusive than a telephone call. Writing a letter gave them time to plan how they 
would introduce the topic and allowed them to structure their message. Once the channels of 
communication were open, then other, faster, forms of communication, such as telephone calls 
and emails, were used.  
 
Once contacted, that relative informed others, so information about the genetic testing naturally 
cascaded through the family.  
 
‘I rang him up, my uncle. Because he had information about my mum’s side 
of the family. Because you have to go back don’t you, like Grandma. So he 
helped me with all that, obviously because he knew more details. You sort of 
get, you’ve got to get all the dates and all that correct. So really in the 
process of gathering information people got invited.’ 
(Molly, 49y, PGT, Negative) 
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 For others, needing specific information gave them a ‘way in’ to discussions regarding the 
significance of the family history and potential risk information. For Elizabeth, being able to give 
her cousin a ‘task’ greatly relieved the pressure of having to open up the communication on the 
subject: 
‘Like talking to Olivia [cousin] and getting her to get the information on my 
grandmother, we were able to discuss it sensibly because there was actually 
something that she could do (she could contribute). She could scuttle off 
down to the cemetery and you know find dates because nobody has got 
death certificates. So that was involving her.’ 
(Elizabeth, 54y, DGT, Inconclusive) 
 
 
6.2.3    Experiences of Approaching a Relation about Diagnostic Genetic Testing 
 
When conducting genetic testing for BRCA1/2, it is usual to begin the testing in a family member 
who has already been affected by cancer (diagnostic genetic testing). In some cases, the person 
who initiated contact with the genetics team was not eligible for predictive genetic testing, as 
diagnostic testing had not yet been done. So, they needed someone else in the family who had 
already had cancer to agree to be tested first.  
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MAYA: I phoned my GP and we filled in some forms; and we were all called 
[to the Genetic Centre] at the same time. So we all went to the appointment 
together: my Mother and Father, Leon [husband] and I, and Nicole [sister]. 
INT: And how was that? 
MAYA: It was really helpful actually. Very helpful. We all reacted very 
differently to it… Quite early on it was obvious that Dad needed to have the 
test first because he was the one [who had had the cancer]. 
(Maya, 47y, PGT, Negative)  
   
Maya’s father was directly involved in the initial consultation at the Genetic Service but, in many 
cases, the person eligible for diagnostic genetic testing had to be contacted following the genetic 
counselling appointment and their consent sought. For some, this was their mother or another 
first-degree relative who had been involved in the stage one discussions; for others, however, it 
was necessary to contact more distant relatives that they were not normally in close contact 
with. As a result, when collecting details of the family history, making contact with such a 
relative opened up the communication to the wider family not involved in stage one and caused 
a subsequent cascade through another branch of the family. 
 
‘The Hospital in [City] said to my niece that it would be useful if I, because I 
was the last living person [who had had cancer], could give the blood to be 
tested to see if I was carrying the line you see, the gene. So she rang me up, 
we aren’t normally in that close contact – just the odd Christmas card. I was 
very, very willing to do that, particularly as she was terribly anxious, so I  
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said yes I was willing to do it. Now, a lady like yourself, a very nice person, 
came along and we had a lovely morning, and then I gave the blood and it 
was all very easy... I told Daphne [daughter] what I was doing… and 
because of the conversation that sometimes sons can be affected, I rang my 
son up’.  
(Shirley, 78y, DGT, Inconclusive) 
 
Within this study population, approaching the family member about potentially undergoing 
diagnostic genetic testing was done by the person that had sought the genetic counselling, 
rather than by a health care professional in all but one case. Many, including Molly below, felt it 
was their responsibility to talk to that person directly because they knew them, so it was more 
appropriate: 
‘At the time they [the Genetic Service] said, yes there is a test that they 
could do but they needed a person that was alive that had the cancer. 
‘Course then there wasn’t - my mother had already died. But in the 
meantime, Tonya [sister] got cancer and had her breast removed and blah, 
blah, blah. So I contacted them again, coz they said any changes to your 
family let us know. So obviously I did. So I went back with my husband. And 
they said they could do the test now if Tonya was in agreement. So I said, ok 
then, I’ll speak to her - because they couldn’t contact her just out of the 
blue. I said I’d talk to her. So I went over and spoke to my sister’.  
(Molly, 49y, PGT, Negative) 
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While contacting more distant relatives for family history, information tended to be initiated by 
letter, while contacting someone to ask them to undergo diagnostic genetic testing was done 
over the phone (as in Shirley’s case) or in person (as in Molly’s case). The closer the relationship, 
the more personal the contact tended to be. For example, Molly approached her sister who, 
whilst she reported not being that close to (one line on the eco-map), she does have contact 
with; therefore, she made the request face to face. Whereas, it was Shirley’s niece who made 
the request of her, whom she was not normally in contact with – ‘just the odd Christmas card’ – 
and this was done over the telephone.  
 
Numerous tactics were used to encourage relatives to undergo diagnostic genetic testing. For 
example, when Molly went to ask her sister Tonya, who had had cancer, if she would be tested 
first, she used emotive arguments by drawing on the potential risk to her sister’s offspring. For 
example:  
‘I said: would she have this blood test done? I said: if not for yourself, 
because she’s got three boys and a girl, then for your daughter.’ 
(Molly, 49y, PGT, Negative) 
 
In another case, Kerry felt that her sister purposely ‘played down’ the significance of what a 
positive test result would mean when approaching their mother, who was dying from ovarian 
cancer at the time and was highly confused: 
‘There was no point talking to Mum about figures (percentages or anything 
like that) because (a) she wasn’t very well and (b) she didn’t really 
understand I think mentally.... [My sister] Gillian said to her: “It’s only a  
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blood test Mum that’s all it is”, that sort of thing and: “they’ll only go and 
find out whether – it’s just a blood test and it will show whether the breast 
cancer is linked to the ovarian cancer”.’ 
(Kerry, 45y, PGT, Positive) 
 
Following this, Kerry and her sister had made a pact not to tell their mother they had received 
their results as they felt she was too vulnerable and likely to be upset by them. Despite this, 
when their mother asked, Kerry disclosed both her and her sister’s results to her. At this stage, 
her mother was in the last stages of her life after a difficult battle with ovarian cancer and Kerry 
reported she was highly confused and so did not really react to the news. It could be 
hypothesised that the guilt Kerry felt about encouraging her to undergo diagnostic genetic 
testing for them, without really understanding what she was doing, made her want to be as 
open as possible with her at the later stages.  
 
Many expressed concerns about how best to approach the matter of diagnostic genetic testing 
with relatives. Often, these concerns were linked to their assumptions about the relative’s 
emotional and or physical state and how they would react. Some relatives were not even 
considered, as the participant felt there was no way they would agree and, therefore, not worth 
the tension that would potentially occur if they were to react badly and refuse to be involved. 
Eloise had concerns about approaching her cousin, as she perceived her to be too emotionally 
frail and without support in the form of a partner. Once again, a conflict arose between needing 
the information and not wanting to cause harm or distress: 
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‘They did explain that, if it was to go any further, Lyn [her cousin who had had 
cancer] would have to be the one to be tested and whether she would agree 
to that. I did find it quite difficult approaching Lyn because… she, erm… she 
was still sort of coming to terms with her own illness and getting over it and 
she doesn’t have a partner. So she is alone with it and, you know, she lived 
alone. I sort of felt like she’d been through enough. She doesn’t like hospitals, 
and she is not comfortable in hospitals … And so I thought “Oh God… I want 
to know, but how do I ask her?” And in the end I just thought you have just 
got to ask her, explain. So I did. And she was absolutely fine. She said “of 
course”.’ 
(Eloise, 42y, PGT, Positive) 
 
From the perspective of Eloise, it was challenging to raise the subject with Lyn because of the 
difficult personal circumstances, but it went better than she had anticipated because she was 
able to explain fully the reasons for her request.  
 
 
6.2.4   Experiences of Being Approached about Diagnostic Genetic Testing 
 
As discussed above, those participants that needed to ask another to undergo testing first 
preferred to do it themselves rather than have the geneticist do it. However, Julia was on the 
receiving end of such a request; rather than being contacted in person, she received a letter ‘out 
of the blue’ from the genetic service asking her if she would come to discuss diagnostic genetic 
testing so more distant relatives could access predictive genetic testing. To this date, she does  
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not know who started the process, or which relative that information was for. She reported that 
she had been happy with the way she was approached and willing to go along and be tested. 
However, when asked if, in the case of her immediate family, she felt it was better for 
information to come from a health professional or from a family member, she said she felt that 
ideally a family member should make the initial contact, followed by a professional, so that the 
person had the option to say no. 
 
INT: Is there a particular reason you think it’s important that you do it 
initially? 
JULIA: Yes I think it is because it’s your family, so then they’ve got a choice 
to say to you ‘I don’t want to know anything about it’ or ‘yes’ they do want 
to go. But then, if they still got seen by a professional, then they would 
explain it more. I don’t think people can explain it better than a 
professional; they know what they are talking about – you get the gist of it, 
but really I can’t explain to my children what it’s all about. All I can say is 
that it’s a gene in that blood that will tell you if you’ve got cancer or you 
haven’t got cancer, that’s the basic I know, where they can probably explain 
a lot more and they probably understand more than I did.  
I think initially you talk to them, but I think that the doctors or professionals 
explain more. I think so, well personally anyway, I would like that. 
(Julia, 58y, DGT, Inconclusive) 
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In fact, Julia had limited understanding of the genetic testing and, in the discussion, she 
admitted she was not one hundred per cent sure of the details: 
‘I went there and she talked to me about the testing. I did not really quite 
understood it; I understood you take the blood and they can find out if it’s in 
the children or not (that’s how I sort of understood it).’ 
(Julia, 58y, DGT, Inconclusive) 
 
Although she was able to convey the essential information to her son and daughter, Julia was 
not confident in her ability to relay it accurately. She relied heavily on giving them the 
information booklets and them going to see the genetic counsellors themselves to ensure they 
received accurate information. This may explain why the aforementioned follow-up by a 
professional was so important to her. In fact, even those that reported they were confident they 
had understood the genetic information still used information leaflets and letters summarising 
the discussion with professionals to back up what they were saying to relatives (refer to section 
6.2.6). This approach increased their confidence in their abilities to discuss genetic testing for 
BRCA1/2 with relatives.  
 
Being asked by a relative to have the test done could be emotionally demanding. For Katherine, 
being asked by her daughter triggered feelings of guilt about potentially being a carrier and 
passing the mutation on to her children: 
‘It was our second daughter, Marian. She is a nurse and she approached me 
about it. I don’t know where she heard about it, but then she went to [her 
local hospital] and saw someone there and then she got in touch with me.  
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She asked if I minded if I [had the genetic test], because she said with [the 
risk of] ovarian cancer she hasn’t got children and if it proved that I had the 
gene for it, she wouldn’t mind having her ovaries removed because it didn’t 
matter to her. I felt a bit upset about it at first, because I hadn’t thought 
that I might have passed the gene on to my children, and it suddenly hit me I 
could be a carrier and my other daughter died from breast cancer, so it 
could be me that had passed the gene on to her. Or, I could have passed it 
on to my other children. Even my son, you know, he could have been – or 
grandchildren.’ 
(Katherine, 79y, DGT, Inconclusive) 
 
Two separate participants spoke of the immense pressure they felt put under by close family 
members to have a diagnostic genetic test almost as soon as their cancer was diagnosed. Brenda 
felt her younger sister and female cousin were putting a lot of pressure on her to go and have 
the genetic test done as soon as possible so they would know if they were eligible for testing. 
When they were all together at a wedding, her cousin used the opportunity to have a face-to-
face discussion, but that just added to the pressure Brenda felt under.  
 
INT: So how did you feel about that? 
BRENDA: Uuum – slightly not annoyed –I didn’t want that sort of pressure, 
‘cause I knew I was going to have it done; I wanted to have it done when it 
suited me, not when it suited others. And it may have only been a matter of 
a few months or whatever. You know, they’re the sort of people who down 
tools and do something now, straight away when it’s got to be done and I’m  
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not. I would sort of fit it in a bit more carefully with other things that are 
going on in my life, which may make them think that perhaps I’m delaying. 
But that’s not what it was – if any of that makes sense!  
INT: Yes, it does. Don’t worry. So was it a regular topic of conversation? 
BRENDA: Yes, especially with the cousin... At Kai’s wedding she collared me 
and I really couldn’t get away very easily and she had a really in-depth 
discussion about the breast cancer in the family. And I know why she chose 
that time because we don’t see each other a great deal, but it was the 
opportunity there that, you know – son’s wedding! 
(Brenda, 58y, DGT, Inconclusive) 
 
Zena had a similar experience with her sister, who wanted to start genetic testing as soon as she 
had received her cancer diagnosis. However, she was not ready and needed to deal with her 
cancer treatment first.  
 
‘It was my sister, really. She was not causing problems, I wouldn’t say it was 
problems as such, but it was causing a bit of hassle because when I told my 
sister [about her cancer diagnosis] she then went to her GP and started 
flapping about all the genetic tests and everything (‘cause obviously she’s 
concerned for herself and her daughter and her granddaughter)... So Faye 
wanted some sort of genetic testing going on and she felt now that 
somebody living was diagnosed that they could get the ball rolling... So 
she’s trying to get things sorted from that point of view, and I’m trying to 
deal with chemotherapy and she’s on the phone, and it wasn’t a good time  
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because I couldn’t cope with that at the time, I can only do one thing at a 
time. I wanted to get through the initial diagnosis, the initial treatment, and 
once you’ve gone through that, if everything was going ok, then it was time 
to sit back and look at the genetics. And I felt that that was the right time 
for me rather than right at the beginning; it was too much to cope with, too 
much at once.’ 
 (Zena, 49y, DGT, Inconclusive)  
 
Both Brenda and Zena needed time to come to terms with their cancer diagnoses and deal with 
their treatments before pursuing genetic testing. However, they found it very hard to express 
these feelings to family members who, they felt, were putting them under pressure. This lack of 
understanding actually acted as a barrier to family communication regarding genetic testing for 
BRCA1/2, as both Brenda and Zena started to experience feelings of resentment and annoyance 
towards their family members. 
 
 
6.2.5   Communications about the Decision to Proceed With Testing  
 
During and following genetic testing, there was also a decision-making process: they had to 
decide if they actually wanted the test. The process of genetic counselling is designed to make 
patients think: to consider all the options and likely outcomes so that they can make a well-
informed choice. As a result, it was often discussed with the family as a source of support and 
guidance, for example, asking others for their opinions. When deciding whether or not to 
actually have the genetic test, participants drew on a range of experiences and family  
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discussions on the topic. Talking through the option of genetic testing and weighing up the pros 
and cons was common; this was especially with partners, who did not tend to express strong 
opinions of whether or not the participant should do the test, but acted more in a supportive 
role, and siblings and/or parents, who were also considering testing or had already been tested, 
and who did have strong opinions and tended to use the conversations to influence the decision.  
 
For example, Gina discussed having the genetic test with her husband, Aiden. He was happy to 
let her make the decision; however, she still found having the conversations with him helpful 
and supportive: 
INT: You mentioned that, when you were making the decision about 
whether to have the testing or not, you spoke to Aidan [husband] about 
that. Could you tell me some more about that? 
GINA: Oh yeah, yeah, absolutely because you know it has an impact on 
all our family life, but Aidan was very much – ‘well, if you think that’s 
the right thing to do, then that’s the right thing to do’. And I went away 
and I did my research and I got booklets and pamphlets and everything 
else. I used to say to him ‘we need to sit down so you know what you’re 
letting yourself in for’… It was very helpful because, you know, we are a 
close couple and we go through everything together – there’s no way, I 
would never have entertained doing this without him being fully in 
agreement.  
 (Gina, 41y, PGT, Positive)  
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On the other hand, when she spoke to her mother and sister, they were far more opinionated 
and directive about telling her what she should do. They presented, what they perceived to be, 
the positive side of the testing. For example, that knowledge is power and that they were being 
given an opportunity not available to everyone. These persuasive arguments influenced Gina’s 
decision to be tested: 
 
INT: Was there anybody else you talked to about the option of having 
the test with? 
GINA: My Mum, I talked to my Mum (I talked to my Mum and Dad) and 
to her there was kind of like no debate, ‘You should go and have it, 
because information, knowledge is power isn’t it? You can then make 
decisions based on the knowledge that you have.’ 
I also talked to my sister about it, and she was very much ‘Oh yeah, you 
know, I don’t see why you wouldn’t.’  
I think everyone was very positive [about having the test done]– and 
again it kind of brought home to me how many people out there [are] 
walking around who don’t know that they’ve got inherited genetic 
conditions or BRCA1 or BRCA2; and, you know, you have to come at it 
from that perspective I think. You have to think ‘Yes I’m very lucky that 
actually I know this and I’m being given the chance to do something 
about it and to potentially prolong my life, you know, because otherwise 
the outcome might be very different.’  
(Gina, 41y, PGT, Positive)   
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Molly found it particularly helpful to talk to friends outside of her family, as they were removed 
from the situation and did not know any of the people involved. This meant they could give her 
impartial advice as well as a level of confidentiality that what she said would not get back to the 
family: 
 
‘I think, because they were outside and they only know me. They haven’t 
met any of my family. They only know about me, same about you at work if 
you talk about your family, that’s the only part of the family that they know. 
So I think because they didn’t know any of them, it did help me. I think 
because they let me talk and blubber, they might have only just said, ‘Oh 
yeah yeah, you'll be alright, you'll be alright’. But I think it was just being 
able to talk to them without them knowing anybody else in the family that I 
knew, it didn’t matter what I said to them, no one else would find out about 
it.’ 
    (Molly, 49y, PGT, Negative) 
 
 
6.2.6  Materials To Support Communication Regarding Genetic Counselling 
 
Throughout the genetic counselling process, the participants increased their knowledge base 
about genetics; they were being given information from the genetics team including leaflets, 
booklets and letters documenting their discussions. This was repeatedly described as useful and  
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was often used as a tool for sharing the process with family members or friends. For example, 
letters were often photocopied and passed on. This ensured that people were receiving the 
correct information, rather than the informant relying on memory-recall of what can be quite 
complex genetic information for a lay person.  
 
ZENA: So the fact that the letters were all written out as well, I was able to 
give a copy to my sister, because I felt that helped her along as well and she 
could take that back to her GP... the good thing was that I was able to have 
a copy of the letter which I was able to pass on to my sister, which makes it 
a lot easier if you’ve got it in writing, and then she can take that information 
and deal with it as she wants to deal with it. 
INT: Were they specific letters for her or literally copies of your letters? 
ZENA: No, I copied it for her. At least I felt I was able to give her all my 
information and not be secretive. I don’t want to be secretive about it all. 
(Zena, 49y, DGT, Inconclusive) 
 
It was common for participants and family members to seek other sources of information, for 
example, searching on the internet. Several participants talked of the importance of only seeking 
information from ‘trusted’ sources, such as well-known cancer charities like Cancer Research UK, 
Macmillan Cancer Support and Breast Cancer Campaign.  
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6.3   How those undergoing genetic testing for BRCA1/2 talk to 
their friends and family during Stage Two. 
 
For discussions during Stage Two, participants described how they considered the personal 
attributes and characteristics of family members so they could adapt how they approached the 
subject as required. For example,  Christina spoke about how she played a “bit of a game” to 
draw out of people their own perceptions of genetics and genetic testing were before she 
moved on to sharing with them, so she had some idea of how they were likely to feel about it. 
She reported saying things like “well did you see such and such a thing on Panorama the other 
night when they were talking about ……” in order to find out what their perceptions of the issues 
were. 
 
It was important for participants to make discussion about genetic counselling “a positive thing, 
don’t make it into a doom and gloom thing!”(Eloise). This was a serious issue for participants; 
however, they acknowledged it was important to talk to family members about their experience 
of visiting the genetic service in ways that were going to make them listen. For example, Gillian 
spoke about “selling it”. She used examples of selling the benefits of genetic testing to her family 
on the basis that medicine was always moving on and how, in her opinion, the chances of them 
having to be bothered about this gene in ten or 15 years was minimal, but the information was 
available now and it could be so useful to the family. For her, it was about giving people the 
positive before the negative: “sell the top end first, talk about medicine first and that they are 
doing some fantastic things” (Gillian). In fact, many participants emphasised how medicine was 
constantly moving on and they often expressed to family members a confidence that this would  
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not be an issue in the future. These kind of persuasive arguments were frequently used in 
discussions with relatives.  
 
Generally, participants felt that it was better if people were forewarned so no information-, like 
a positive result- came as complete shock ,therefore they saw a great advantage of including as 
many relatives, with whom they were close, to during this stage. In addition to which, they 
found it easier to talk to those family members who were aware of the genetic testing from the 
beginning, rather than those they contacted afterwards.  
 
Often, despite their initial concerns and preparations, participants were surprised at how well 
their requests for information or involvement were received by family members during this 
stage.  For example, Eloise was worried about asking her cousin Lynn if she would undergo 
diagnostic genetic testing because she felt Lynn “was still sort of coming to terms with her own 
illness and getting over it and she doesn’t have a partner….. And I felt like, she doesn’t like 
hospital, and she is not comfortable in hospitals”. Eloise said she did not know how to ask Lynn, 
but in the end, “I just thought you have just got to ask her, explain. So I did, I explained calmly 
why it was important and how it would help Barry [brother] and I, and our children. And she was 
absolutely fine. She said ‘of course’ ”.  
 
6.4  Conclusion 
 
This second findings chapter has reported how participants talked to others about their genetic 
testing during the genetic counselling process. This stage of family communication regarding  
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genetic testing takes place in the context of participants understanding and relaying the 
complexity of genetic information. Discussions also started with more distant relatives, 
specifically for information or help.  
 
Barriers to family communication during this stage included: 
  Participants, or their relatives, making a conscious decision not to discuss genetic 
counselling with certain family members; 
  Not wanting to cause distress; 
  Conflict and rift within the family; 
  Participants, or their relatives, making judgements on whether individual relatives would 
want to know and/or anticipating their reactions as to how they would handle the 
information; 
   A lack of understanding and/or support from relatives (sometimes leading to feelings of 
resentment, which acted as a further barrier to communication). 
 
However, factors such as perceiving the genetic counselling as new and/or interesting 
information that was worth sharing; receiving information booklets and summary letters from 
the genetic counselling appointments; and needing further information from specific relatives, 
such as details of the family history or asking a relative to undergo diagnostic genetic testing, 
acted as facilitators. Those undergoing genetic counselling were also more likely to talk about 
their situation if they wanted support and/or guidance to help them make decisions about 
whether or not to pursue genetic testing.  
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The findings presented specifically look at how participants communicated. For example, with 
close friends and family the conversations were an extension of those happening in Stage One. 
Genetic counselling and the information learnt through the process were something interesting 
going on in their lives to be talked about. For those who had had cancer, it was often perceived 
as an extension of their treatment and was discussed in the same manner as that had been. 
Often, the participant took on the task of managing people’s reactions, for example offering 
reassurances and encouraging them to wait and see what the genetic test results would be 
before acting.  
 
When information was needed, for example in order to complete the family history form, from 
more emotionally distant relatives or from relatives who found it hard to talk about these things, 
a more strategic and proactive approach was adopted. This may include writing a letter or 
negotiating with other family members to broach the subject.  
 
Conversely, a more personal approach was adopted when asking relatives to undergo diagnostic 
genetic testing so other family members could access predictive genetic testing. This was 
relative to how close they were to that person to start with. For example, with emotionally close 
relatives, this approach would be done face-to-face rather than over the telephone; whereas, 
with emotionally distant relatives, this approach would be done over the telephone rather than 
by letter. If possible, family events, such as weddings, were used as an opportunity to have face-
to-face discussions with those they were not normally in contact with.  
 
Participants felt the best approach was to be open and honest when discussing genetic 
counselling and to explain everything as fully as possible to relatives. However, there was  
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evidence of participants ‘playing up’, for example, by using emotive language and giving 
examples or risks to offspring, or ‘playing down’ the significance in order to get family members 
to agree to be involved. Clinical information leaflets and summary letters of genetic 
consultations, as well as online sources of information, were regularly used to support 
explanations and to provide family members with further information. Using these resources 
significantly increased participants’ confidence in their ability to relay the information accurately 
and in the best possible way.  
 
The next chapter will look at how participants talked about genetic testing when they, and 
others, received their results.  
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Chapter 7 – Stage Three: Receiving the 
Test Result  
 
7.1   Introduction 
 
Receiving the test result prompted family communication regarding the genetic testing as 
participants shared their results. This occurred in two distinct waves (Figure 21). The first wave 
was motivated by a sense of urgency and involved telling those who were ‘waiting to hear’. To 
be included in the group of those relatives told, it was not enough just to know about the 
testing. These people had to have some emotional investment in the process; specifically, those 
first-degree relatives and close friends involved in Stage One and Two communications were 
told. The second wave, involved telling those who were ‘in the know’ and needed to be ‘kept in 
the loop’ but with whom the participant was not particularly close. For example, those relatives 
contacted for information or to access predictive genetic testing during Stage Two.  
 
Some participants had to wait a long time for their results. The testing system has changed in 
the last few years (due to the patent expiring) and through-put time has decreased dramatically. 
These participants had all received their genetic test results 8-18 months prior to the interview; 
however, some of them had had their blood taken for the test up to two years previously.  
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 Figure 21: Stage three: Receiving the test result 
 
7.2   Stage Three: Receiving The Test Result  
 
7.2.1   Wave One: Telling Those Who Are Waiting 
 
All participants who tested positive (a mutation was found in their BRCA1/2 gene) were 
informed of their result during a specific ‘results’ appointment at the Genetic Service. Whereas, 
those receiving an inconclusive result (in the case of diagnostic genetic testing, no known BRCA  
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mutation was found) or negative result (in the case of predictive genetic, the specific mutation 
known to exist in the family was not found) were informed either during a ‘results’ appointment 
or by letter.  
 
Having a pre-booked ‘results’ appointment meant that close family and friends, specifically 
those involved in the stage one discussions, were likely to know of the event in advance. 
Participants spoke of how these people were ‘waiting’ to hear from them, often reporting them 
as waiting in a state of anxiety or worry.  
 
‘And I know [Mum] was just waiting for the result. In fact, I didn’t tell 
her the time of the appointment, I just told her it was on that day ‘cause 
I didn’t want her sitting there waiting for the phone to ring. You know, if 
I told her it was say 10.30, you know 11 o’clock, she would have been 
sitting there waiting by the phone. And I didn’t want her to do that, I 
wanted her to just sort of carry on as normal, so I said “I’ll tell you what 
day it is but I’m not telling you the time”.’ 
(Annabelle, 51y, PGT, Negative) 
 
The anxiety being shared by others meant the participants felt a huge sense of urgency to 
contact these people as soon as possible and let them know the outcome of the appointment. 
This was usually done over the phone at the first possible opportunity.  
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‘Well, Aidan [husband] was with me when I found out. The next person I 
spoke to in the car [from her mobile] in the hospital car park was my 
mum (because I knew she was waiting by the phone) and I had to tell 
her.’  
(Gina, 41y, PGT, Positive)  
 
Because those participants receiving an inconclusive or negative result had the added 
motivation of being able to alleviate their relatives’ anxiety or worry, one might expect them to 
communicate their results faster than those receiving a positive result. In reality, result status 
had little or no effect on speed or style of disclosure. Rather, the fact that close friends and 
family were waiting in a state of anxiety meant there was no less sense of urgency from those 
receiving a positive result.  
 
‘I let my parents know straight away; a phone call straight away. 
Actually, it was in the lift outside the [Genetic Service] office, yeah. They 
were delighted because they were obviously on tenterhooks. Because I 
think it must be a horrible thing as a parent, a horrible thing to feel that 
you’ve given something horrible to your children.’  
(Maya, 47y, PGT, Negative) 
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‘And, you know, the day that I went to get the results, of course, they 
were just sort of sitting by the phone waiting for me to ring them. In fact, 
I went to [Hospital] to get the results and went straight to… My daughter 
has a house in [Town], so I went straight round there and we had a glass 
of wine together to celebrate!’ 
(Arthur, 61y, PGT, Negative) 
 
These people were contacted in a variety of ways, often as soon as the appointment had 
finished; for example, ringing them from the car-park or hospital coffee shop; texting them from 
the elevator at the hospital; and popping round to see them on the way home. Not a huge 
amount of thought was given to how the news was delivered, or when the news was delivered, 
but rather the importance was that it was shared as soon as possible.  
 
Despite getting different results, both Faye and Annabelle reported feeling afterwards that 
perhaps they should have told their mothers their results face-to-face, but the sense of urgency 
took over: 
 
ANNABELLE: We were going to go and see my Mum after the 
appointment but Tim [Husband] said to me ‘Phone her up and tell her’. 
So I’m sitting in the car and he’s driving along and I phoned her up... So 
yeah, I told her by phone, unfortunately; I should have told her face-to-
face. But we did go and see her straight afterwards and make sure she 
was all right.  
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INT: You say you suppose you should have done it face-to-face? 
ANNABELLE: Yeah, I should have really told her face-to-face. I mean, she 
was thrilled to bits; it didn’t matter because I then got there quite soon 
afterwards and we talked about it, anyway. But the initial sort of ‘guess 
what, Mum, I haven’t got this gene’ it was probably the wrong way to 
do it. But we were just so pleased that we wanted to tell her. And I know 
she was just waiting for the result.  
(Annabelle, 51y, PGT, Negative) 
 
‘I’d just come back from the hospital and rang Mum at work. She said: 
“Oooh are you all right?” and I said: “Yeah, yeah, well I’ve got it”. And 
she just burst into tears and I was just like “Oh, don’t be upset, I’m fine, 
I’m fine, honestly you know...” And then I just said to Nicki [Sister-in-Law 
who drove her to appointment], “Oh, I’ll have to walk round and see her 
‘cause she’s upset now” and I thought “Well, I should have maybe 
waited until later” but you know, I knew she would have been conscious 
of the time when she hadn’t heard anything.’ 
(Faye, 29y, PGT, Positive) 
 
In both of these cases, the urgent news of the result was followed up by face-to-face discussions 
to ‘make sure she was alright’. There was much evidence of participants working to manage the 
responses of family members; for example, offering reassurance and comfort if someone got 
upset. This was particularly true when people experienced feelings of guilt (see section 7.2.4).  
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Receiving the genetic test result by letter did not seem to lessen the sense of urgency to share 
the results immediately. Those participants that received their results by letter also contacted 
close friends and family that had been involved in the Stage One communications in order to 
share their results immediately.  
 
‘It was a weekday and I think the first person I told – I think I emailed 
my cousin, because obviously, I mean, there’s like five kids on the other 
side so she was worried. I think I emailed her and then we talked about 
it when everybody else [husband and children] got in that night.’ 
(Karen,52y, DGT, Inconclusive) 
 
ROBERT: The letter arrived and told me I was not carrying the gene 
anyway. So immediately I told my daughter. She was in the process of 
arranging to be tested... Having got the result I also let Nick [Son] know 
because he was waiting, I let me daughter know, I let Deborah [former 
sister in law] know, I let my niece know as they were waiting too.  
INT: Ok, and how did you do that?  
ROBERT: Well, the phone first, and I sent a copy of the result actually. 
INT: And was that the next time you happened to speak to them, or was 
it a specific phone call to give them the results?  
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ROBERT: No it was specific. It was specific, yes, and almost straight 
away. 
 (Robert, 68y, PGT, Negative) 
 
Even though there was no specific date by which the results would arrive, Robert still reported 
his children as ‘waiting’. Once again, like those receiving their results in an appointment at the 
genetic service, the first urgent contact to share the result was followed up by the participant; in 
Karen’s case, by a phone call and, in Robert’s case, by sending a copy of the results.  
 
There was no notable difference between how those who had undergone diagnostic shared 
their results compared to those who had undergone predictive genetic testing, nor between the 
status of those results. Consequently, it can be theorised that neither the type of testing 
(diagnostic or predictive), result status (positive, negative or inconclusive), nor how the result is 
delivered
26 impacts this wave of communication.
27 Rather, at this stage at least, family 
communication is motivated by a sense of urgency to share the results with people who know 
about the testing and are emotionally invested in the outcome and are subsequently ‘waiting’ to 
hear about the results, almost as much as the participant themselves. This emotional investment 
was predetermined by the closeness of their relationship with the participant and principally 
included those who had been involved in the earlier stage one discussion, explicitly friends and 
family with whom the participant had a close personal relationship and open communication 
(those scoring two or threee lines on the eco-map).  
 
                                                           
26 Although only negative and inconclusive results were received by post.  
27 However, these factors may affect how things are communicated in stage four, and this will be 
discussed later (see Chapter Eight).  
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‘I told most people over the phone. My brother because he knew I was 
going for the test so they were itching for me to get the results. So I told 
my brother over the phone. Told my dad over the phone. Wendy [her best 
friend] over the phone. Wendy [her neighbour], I told face to face coz 
she’s always over. My step-dad I called straight away. Lyn [close cousin, 
who had had DGT for her] I did over the phone. I would say all on the 
same day. It would have been the same day. Coz they were the ones that 
knew I was going for the test and they’d all been with me, all before I’d 
gone for the test. So they were all like waiting for me to come home with 
the result.’  
(Eloise, 42y, PGT, Positive)  
 
 
7.2.2   Wave Two: Keeping Those Who Know In The Loop 
 
The next group to be told were those who were ‘in the know’ about the participants’ 
involvement with genetic testing and who needed to be ‘kept in the loop’. Unlike the first wave, 
this communication tended to take place the next time there was normal communication 
pattern contact, rather than as specific contact in order to share the results. There was not the 
same sense of urgency as with the first group, but it was still seen as important to share the 
results with those who knew about the test; these were likely to be the distant relatives who 
had been contacted for information, or to access diagnostic genetic testing in stage two, as in 
the case of Elizabeth and her cousin: 
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‘Olivia, my cousin who helped get the family info, and I speak every few 
weeks, so I just told her when I was on the phone to her. It wasn’t a 
special call to tell her, nothing dramatic like that!’ 
 (Elizabeth, 54y, DGT, Inconclusive) 
 
First-degree relatives were not automatically told in the first wave. Therefore, it was emotional 
rather than genetic distance/closeness that determined whether relatives were told in this wave 
or previous wave. For example, despite being first-degree relatives, Molly and her sister are not 
very close, so she was told about Molly’s result in the second wave: 
 
‘I didn’t really speak to Tonya [sister] until later. She’s... well, she’s 
difficult... I mean, this sort of circle [points to other sisters and daughter 
on eco-maps] is very close, anyway. I mean, we are close to Tonya but 
she’s not, sort of, in our club, so I didn’t phone her up straight away. In 
fact, I can’t remember if I told Tonya or if my dad told her, ‘cause he 
sees her once a week so he might have told her. She definitely knows, 
though.’ 
(Molly, 49y, PGT, Negative) 
 
This quote illustrates another point, in that the motivation for this wave of communication was 
to ensure that the participant’s test result was shared with others who previously knew they had 
opted for genetic testing. This did not mean that the participant themselves necessarily engaged 
in the direct communication with those family members. There were several examples where  
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the responsibility to keep those relatives involved was assigned to someone else, usually either 
the person perceived to be the matriarch of the family and/or someone who had had cancer and 
was pivotal to the whole genetic testing process… 
 
GINA: I said to my Mum, ‘Tell Keira [Sister]. Tell the family’. So, 
gradually, after that it kind of just filtered down and it wasn’t 
necessarily me telling people. 
INT: So your Mum played quite a central role in it, then? 
GINA: Oh yeah, yeah, very much so. Mum’s been very central because I 
think obviously because she’s been through it [cancer] so she probably 
above anybody else can totally understand... She’s great, my Mum. 
She’s a Mum and, like she always says to me, ‘it doesn’t matter how old 
you all are, you are still my children, you always will be’. She always 
wants what’s best, so she is happy to do things like that for us. 
(Gina, 41y, PGT, Positive) 
 
…or to a relative thought to be in a better position, usually because they were in more regular 
contact: 
‘I told Pat [Cousin she was in the most contact with] and I said “Oh 
make sure that Joanne and Claire [other Cousins] know about this”.  
 Yes, so I told Pat and it was left to Pat to tell the other cousins and her 
daughters. I am not in constant communication with my cousins, so it 
made more sense for her to do it.’  
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(Viv, 58y, PGT, Negative) 
 
 
7.2.3   Perceptions of a ‘Female Disease’ 
 
Generally, those family members who participants reported as being emotionally close to, with 
open communication (two or three lines on the communication map), were involved in stage 
one conversations about cancer in the family (see Chapter Five) and were told about test results 
in wave one. The exception to this was male relatives, in particular sons. Although those 
participants with sons reported being emotionally close to them and having open 
communication, they were less likely to be told in the first wave than daughters or other female 
relatives. For example, Annabelle told her sons, both of whom she scored with three lines on her 
eco-map, as part of her wave two communications: 
 
‘When I got the results I just said to my boys, “You’ll be pleased to know 
that there’s no chance that you’ll have it ‘cause I haven’t...” I didn’t go 
out of my way to tell them on the phone. I waited until the next time I 
saw them, so it was sometime within the next week. They weren’t sort 
of waiting for the results themselves. I mean, their lives are so full they 
probably had forgotten anyway! So it was “Oh by the way I’ve got my 
test results” and they said “Oh yeah? How did you get on?” and that 
was it. “Yeah, ok, fine”. 
(Annabelle, 51, PGT, Negative)  
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Annabelle, like many other participants who had sons, attributes only telling her sons as part of 
this second wave to their apparent disinterest. In fact, the data suggests that both this 
disinterest, and the disparity between sharing with female and male relatives, may be due to the 
fact that male relatives are less likely to be involved in stage one and/or two communications as 
a result of perceptions on both sides of this being a ‘female disease’.  
 
Participants were often motivated to undergo genetic testing by a wish to provide risk 
information for relatives, but in particular to provide information to female relatives because 
they saw it as directly affecting them. This meant they were more likely to talk to the female 
family members than the male relatives about their genetic testing for BRCA1/2.  
 
‘I mean, I told my son what was happening and he’s very supportive you 
know, but obviously I’m more concerned for my daughter, and she’s 
more concerned, you know. It is something that’s more likely to affect 
her than it would him.’ 
(Martine, 65y, DGT, Inconclusive) 
 
When they went for their genetic counselling, many participants reported being surprised to 
learn that the family history of cancer in men was relevant; and that, if found, the presence of a 
mutation in the family could also mean an increased risk of cancer to males.  
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‘I was quite surprised when – almost, I wasn’t prepared for it when 
[Genetic Counsellor] said that Jack’s [cousin] prostate cancer made her 
concerned that there might be a BCRA2; because, prior to me revealing 
that (which I’d almost forgotten to do), she was not going to give a 
testing. She said she didn’t think there was enough, but she changed her 
view during our discussion... I would never have had that knowledge. 
And I wonder in the general population whether that knowledge is 
common. It’s very much perceived as a female disease, isn’t it?’  
(Elizabeth, 54y, DGT, Inconclusive) 
 
‘I filled in the thing all about our medical history throughout the family 
as much as I could remember. And, they came back and said: ‘yes, we 
think it would be worth discussing’. Erm, so I went and had an 
appointment with [the Genetic Service]  and that’s when I found out 
that the boys could be at risk, coz I didn’t know at that point that they 
could also be at risk.’  
(Eloise, 42y, PGT, Positive) 
 
Even having learnt that men could also carry a mutated BRCA1/2 gene, which would put them at 
increased risk of cancer, the participants were more likely to engage in communications about 
their genetic testing with female rather than male relatives. 
 
‘I’ve got one other cousin, Neil, who is the son of my aunt. He’s aware of 
it but he’s not been involved in the discussions. I know you can get male 
breast cancer, but the view of the others was that he’s not really – you  
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know, for us as girls they all felt it was very personal to us rather than to 
him. I mean, he discussed it with his mother, you know, and that’s as far 
as it’s gone.’ 
(Christina, 49y, PGT, Positive) 
 
When male relatives were included in discussions, participants often justified this by stating that 
the male relatives had daughters who may be affected. During the course of the research 
interview, Gina became aware of the fact that she had not discussed the topic with her 
brother;
28 however, her attention was automatically drawn to the fact that there might be 
implications for his daughter, her niece, rather than him: 
 
‘I haven’t really spoken to my brother about it. I actually don’t even 
know if Lara [niece] is aware; I don’t even know if they’ve had that 
conversation with her, so I probably would need to talk to my brother 
about that. It’s important that she knows.’ 
(Gina, 41y, PGT. Positive) 
 
When male family members were included, several participants reported either a lack of interest 
from them or a belief that the information was not really relevant to them. Where female 
participants had decided that the information was relevant to male and female family members, 
it was often necessary to be quite proactive to engage them. For example, Annabelle made 
copies of her mother’s letter and directed her brother to take them to his GP: 
 
                                                           
28 Because his name appeared on her eco-map.   
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‘Like with my brother, you know, it was “wow, it doesn’t really affect 
me” and we both (myself and my Mum) said to him “well, it does 
because you could have passed it on to your children. And men do get 
breast cancer but you’ve got to think of your daughter as much as 
anything”. I made photocopies of my mum’s letter and sent one up to 
him in the post and said “take that to your doctors” and he said “Oh, I 
don’t need to do that, I’ll keep it”. I said “No, take it to your doctors and 
show them”.’ 
(Annabelle, 51y, PGT, Negative) 
 
 
7.2.4    Feelings of Guilt 
 
One of the challenges faced by several participants when sharing their test results was dealing 
with feelings of guilt, which could impact on how they discussed their testing with other family 
members. For some, this centred on having received a negative test result when other close 
family members had received a positive test result.  
 
In Annabelle’s case, the guilt she felt at having received a negative test result when her cousins 
received positives ones led to her making contact with them, even though they were outside of 
her normal communication patterns. This contact was facilitated though a letter, a method 
regularly used by participants to contact someone they did not already have a relationship with, 
which was passed on by her Aunt and Uncle.   
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‘And after [my cousins] had had their tests and they were positive and I 
had my negative result, I wanted to contact them. I could have phoned 
them, but because I hadn’t spoken to them since they were little, there 
was no actual contact there between me and them… So I sent them a 
letter saying how brave I thought they were because they decided they 
were going to have the double mastectomies and everything. [My Aunt 
and Uncle] passed the letter on to one of my cousins and she phoned me 
up and we had… It was really quite nice ’cause we’d never spoken to 
each other since she was like, that high, and she was really lovely. 
Absolutely lovely about it, and I think there is still a certain amount of 
guilt there with me.’ 
(Annabelle, 51y, PGT, Negative) 
 
Molly had been the one in her family who had initiated contact with the Genetics Centre 
because of her fears following her mother’s early death from breast cancer. Having spoken to 
the genetic counsellor, she approached her sister, Tonya, who had had breast cancer, to ask her 
if she would be willing to undergo diagnostic genetic testing first. Both her sisters received a 
positive BRCA result and she herself a negative one. During her interview, Molly became quite 
upset several times when talking about her feelings of guilt associated with this: 
 
MOLLY: I still feel guilty because my other sisters have got it and I made 
them do it. And they said to me, yeah but you shouldn’t feel like that. 
It’s not your fault if you haven’t got it. Which I know makes sense, but at  
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the time you don’t think about sense, do you, or anything like that. And 
even when… I don’t think I felt guilty at the time, in that five minutes or 
whatever it was when I was in the room and they told me. I don’t think I 
felt guilty. But now I do and when I went up to see Tonya [her sister, 
BRCA positive]… sorry [BEGINS TO CRY AGAIN] 
INT: It’s okay, don’t worry. Are you okay talking about it? 
MOLLY: Yeah. 
INT: Okay. Just take your time. Don’t worry.  
MOLLY: Yeah, so I know I did [feel guilty] when I spoke to my sister and 
my niece because she’d been told she’d got it. And I was all happy and 
she came out crying. 
INT: Did it ever make you think you would have preferred not to have 
told them? 
MOLLY: No, I don’t think so. Because I think… well, they said they were 
pleased for me, but I will never know if that’s true or not, obviously. But 
I would, I would always have told them.  
(Molly, 49y, PGT, Negative) 
 
The different results within Molly’s family had an impact on future communications. Molly 
reported how she tries to steer family conversations away from her negative results.  
 
For others receiving a positive result, guilt was associated with knowing they could have passed 
the BRCA1/2 mutation on to future generations; or, that their positive result would reaffirm the 
guilt felt by their parent at having passed the gene onto them.   
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FAYE: I think I mostly feel bad for telling – like my Mum. I mean, my 
Mum just burst into tears. I said ‘Oooh, don’t be upset, there’s nothing 
anyone can do about it’ and I remember talking to Mum’s younger 
sister. I don’t talk to her much really, but she ‘Oh well, your Mum 
probably feels guilty because, you know, she’s passed it to you’. And I 
just thought ‘What a stupid thing to say’ and I said ‘Well, at the end of 
the day what’s the point of being guilty?’ Because then that would have 
to go right back to Nan, because she’s passed it on to Mum, so there’s 
just no point. And, you know, it’s not going to change it. That was 
decided the moment I was conceived, so you know, what is the point of 
trying to pass guilt? To me, I don’t feel guilty, I don’t think. My Mum 
shouldn’t feel guilty, she hasn’t done it purposely. 
(Faye, 29y, PGT, Positive) 
 
INT: Were you worried about telling anyone? 
GINA: My Mum. Really worried about my Mum, because I knew that she 
would be devastated and, you know, just knowing what she’s like, I 
knew the guilt that she was feeling. I so wanted to phone her up and say 
‘Mum, I haven’t got it’ but, you know, it would have been fantastic! But 
yeah, I think my Mum was the one I was really worried about, just 
because I knew that she would react very badly, which she did. But 
that’s because of her own – she feels that she was the one that passed it 
on. It doesn’t matter that it’s come, you know, from generations back or  
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where it started, but… I got in the car and my Mum was kind of (my 
Mum being the devout catholic she is) lit every candle that she had in 
the house; and I remember phoning her and my Mum never swears, but 
she did swear that day when I told her. 
(Gina, 41y, PGT, Positive) 
 
Both Faye and Gina reported ‘feeling bad’ and being ‘worried’ respectively about sharing their 
positive results with their mothers, who also carried the gene. Yet, they both followed the 
communication patterns discussed in section 7.2.1; rather than considering the best optimum 
way by which to share the news, they both made contact immediately as part of their wave one 
communications because they knew their mothers were waiting anxiously for news. In both 
cases, this was followed up by an immediate face-to-face visit to calm and reassure their upset 
mothers.  
 
As well as feelings of guilt, participants often reported that they found the task burdensome or 
challenging, largely because they felt they were passing on bad news. 
 
‘It’s quite a burden because you are passing on bad news, aren’t you, 
you know, to a certain extent… You are passing the responsibility on to 
them, and it’s not yours anymore as long as you are the one passing it 
on. It can be quite a burden at times.’ 
(Tina, 49y, PGT, Positive) 
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Eloise, like many participants, felt better sharing her results if she knew that the person she was 
telling had a partner or other family members who could support them: 
  
ELOISE: ‘I mean, they’ve all got somebody. Barry [her brother] with his 
Jan. You know, that little family, they’ve got each other they could chat 
to. Erm, Lyn [her cousin] had me, coz we’re like sisters. My step-father 
had remarried so he was with somebody. Dad is with a partner. 
Wendy’s married. So I felt, you know, if they’d had a problem with it 
they didn’t have to talk to me about it.  
INT: So you felt everyone was supported? 
ELOISE: Yeah. And if they had any sort of wobbles going on in the 
background they didn’t show it to me.  
(Eloise, 42y, PGT, Positive) 
 
Eloise also felt she made a point of always looking on the positive side of the experience and 
making sure she sold it to others in that light, which helped her share her results with her family 
and friends:  
 
 
‘I didn’t ring them up in floods of tears. I rang up and said “I'm going to 
get a new pair of knockers [LAUGHS] and then my periods will stop. Can  
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someone still tell me where the downside is?” And I'm still trying to find 
where the downside is. It’s just fantastic.’ 
(Eloise, 42y, PGT, Positive) 
 
 
7.3  How those undergoing genetic testing for BRCA1/2 talk to 
their friends and family during Stage Three. 
 
As has been discussed, during this stage participants felt a sense of urgency to share their 
genetic test result with emotionally close relatives who were waiting in a state of anxiety. As a 
result, not a huge amount of thought was given to how the news was delivered, or when the 
news was delivered, but rather the importance was that it was shared as soon as possible. This 
was then followed up with more in-depth discussions about what the results meant and what 
should happen next.  
 
According to Molly, it was important to share genetic test results “in order”. She, and many 
other participants, felt there was a natural pecking order in the family and it was important to 
make sure they informed people accordingly. For example, it was important to tell those you 
were close to, people outside the family and siblings should be told in order of their age. 
 
Several participants expressed that they had had concerns about transmitting complex genetic 
information accurately to their relatives, as it was “very, very easy to misunderstand” (Sara).  
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There was evidence that some participants had taken the time to think about which aspects of 
their genetics appointments they thought were important and how much of the information 
they needed to give people so they could understand everything. Annabelle  reported trying not 
to give relatives too much detail: “I would have just virtually told them ‘Look there’s 50% chance 
that you could have this gene as well and I think it would be sensible of you to go and have the 
genetic testing, but I’m not going to make you’.  I would have given them as much information as 
they wanted: like the implications if they had been tested positive, like they are at a higher risk of 
getting breast cancer or they could pass the genetic fault on to their children”.  
 
Those asked, found it was important to have lots of information at their disposal when talking 
about their visit(s) to the genetic service and their genetic testing. A common strategy used was 
to photocopy the information from the genetic centre, such as letters from the appointments, 
and give that to family members to read. There was also an emphasis on advising family 
members to contact the genetic service and talk to a professional as to the best way to proceed. 
 
When asked for tips for talking to families about genetic testing for BRCA1/2 common words 
used by study participants included “Honesty”, “Openness” and “Respect”. Whilst, it may seem 
obvious, much emphasis was put on the way to communicate with family members by 
participants.  They felt their family histories of cancer, and more significantly seeing loved ones 
suffer with these diseases, made the whole topic very emotive and, as such, often needed to be 
approached gently. Many people said that the most important thing was to be as open and as 
honest as possible. As Brenda described it: ““I would want to know that the person telling me 
wouldn’t hide anything from me and they would be fairly straightforward in what they said.  You 
know, they would give me facts and information but in a very sympathetic and really kind way.”  
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7.4  Conclusion 
 
This third findings chapter has reported how participants talked about their genetic testing when 
they received their BRCA1/2 test results. Sharing one’s test results was driven by a sense of 
urgency (from close relationships and emotional investment); wanting to give female relatives 
potential risk information; and male relatives having female offspring who may be at risk.  
 
Participants used strategies such as assigning the task of talking to certain relatives to another 
family member, and having a positive frame of mind and using positive language to make these 
communications easier. First wave disclosures were done quickly, usually over the telephone, in 
order to relieve feelings of anxiety with little thought being given to when or how would be best. 
This was then followed up by a more personal contact to discuss the implications and offer 
reassurance and support.  
 
Many of the challenges to family communication during this stage were associated with negative 
feelings. For example, feeling the burden of having to share ‘bad news’ or feelings of guilt for 
having received a negative result when other relatives have received a positive test result; 
passed (or potentially) passing the mutation on to children; and/or to confirm to a parent that 
they had passed on the mutated gene to their child. These feelings could impact future 
communications with family members, censoring conversations so as not to upset other people.  
 
Male relatives were often left out of discussions; if they were included, this was usually as part 
of wave two communications. There was evidence of a lack of appreciation of the potential risks  
 
239 
 
to male relatives and their offspring. This was often accompanied by assumptions that male 
relatives would not be interested information about genetic testing for breast and ovarian 
cancer, which also hindered family communication on the topic.  
 
The next chapter will look at how participants talked about genetic testing when following up 
longer term.  
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Chapter 8 – Stage Four: Following up 
Longer Term 
 
8.1   Introduction 
 
Receiving the genetic results inspired participants to immediately contact those who were 
emotionally invested, and who were waiting to hear about the results, and then to keep others, 
who were aware that the testing was taking place, informed regardless of whether the result 
was positive, negative or inconclusive. The final stage involved communicating with those who 
required a specific plan of action on how best to approach the topic (Figure 22). For example: 
 
-  Distant relatives with whom contact was infrequent and had not needed to contact until 
now. 
-  Those that did not want to know or from whom a negative response had been received. 
-  Telling children, who were deemed too young to be told at the time of testing.  
  
 
242 
 
 
 Figure 22: Stage Four: Following up 
 
 
8.2  Stage Four: Following Up Longer Term 
 
This stage was more commonly associated with receiving a positive result. For those undergoing 
diagnostic genetic testing, the confirmation that a BRCA mutation was present in the family  
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meant that others may carry it also and participants felt it was important to warn them. A 
positive result from the predictive genetic testing of further relatives tended to reinforce this, 
probably because the more relatives that received a positive result somehow made the threat 
seem more real. However, receiving an inconclusive or negative result did not mean individuals 
were no longer involved in the family communication. At this stage, the process tended to 
become a ‘family affair’, with each member playing their role in ensuring the job got done, 
regardless of their own risk status. What is more, a negative result from predictive genetic 
testing often had a similar effect in encouraging the family to tell other relatives about the 
mutation and/or encouraging them to undergo testing. This may be because participants often 
held a [misguided] belief that, for example, an individual receiving a negative result would 
automatically mean their sibling would have an increased risk of receiving a positive result; 
therefore, it became even more important to the family that that person was tested, especially if 
they had children who could also be at risk. 
 ‘Erm, I wasn’t that bothered about telling Lianne [her younger sister] 
because at the time she hadn’t had the test done. So I thought, if I 
haven’t got it… so she’s got two sisters and one’s got the gene and one 
hasn’t got the gene, her chances are still quite good of not having it. 
That, that… it made sense to me at the time. I think I actually said to 
her, well you know you’re still half and half coz you’ve got one sister 
that’s got the gene and one sister that’s hasn’t, so it might have missed 
you as well. So I thought, well there’s a little bit of hope somewhere, you 
know, in that little part. But she had the test done and she has got the 
gene.’ 
(Molly, 49y, PGT, Negative) 
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The time span for this stage could be over many weeks, months or potentially years in the 
future. Generally, the participants felt these were the hardest groups to communicate with as, 
rather than naturally evolving over time, the information needed to be shared at a discrete 
event. More thought went into how these people should be contacted: When was the right 
time? What they should be told? Who should the information come from?  
 
 
8.2.1   Dealing With More Distant Relatives 
 
In this study, there were three measures of distance: 
1.  Geographic distance (for example, how far away a relative lived). 
2.  Genetic distance (for example, differences between first or second-degree relatives).  
3.  Emotional distance (for example, how close the relationship is between two family 
members).  
 
No one form necessarily excluded another; for example, modern technology, such as email and 
telephone, could mean a participant could be emotionally closer to a sister that lived in Australia 
than she was to a sister who lived five miles down the road. The data suggest that it is, in fact, 
the emotional closeness of being first-degree relatives, for example living or growing up in the 
same house, rather than the genetic closeness itself that predicts communication about genetic 
testing. For instance, being a first-degree relative did not automatically mean genetic 
information was discussed, as it all depended on the pre-existing relationships. By the same 
token, more genetically distant relatives were included just as much as first-degree relatives if  
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there was an emotional closeness at the start of the process. A good example would be where 
one participant was much closer to her cousins than she was to her brother.  
 
Emotional closeness meant people were included in earlier stage discussions; whereas 
emotional distance (in other words, the absence of emotional closeness or a pre-existing 
relationship at the start of the process) meant relatives were unlikely to be contacted before 
stage four, if at all. The exception to this rule would be when one contacts a more distant 
(emotionally, geographically or genetically) relative for something specific, such as for family 
history information, or to access predictive genetic testing through diagnostic genetic testing, as 
seen in stage two. Here, no pre-existing relationship or emotional closeness at the start of the 
process was necessary. Instead, stage two contact actually created a transitional relationship, 
meaning that, despite this, test results and risk information was likely to be shared with these 
family members during stage three rather than stage four. 
 
Therefore, during stage four, communications regarding genetic testing were instigated with 
relatives who fell into two groups:  
 
1.  Genetically close but emotionally distant.  
2.  Genetically and emotionally distant.  
 
Many felt it was harder to contact relatives they were not normally in contact with compared to 
those they had a closer relationship to; as a result, this was frequently left until after they had 
received their results (stage four). Habitually, they had developed strategies to make this easier,  
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such as delegating the job to the family member who had the most contact with those relatives, 
or by photo-copying the letters they had received from the Genetic Service and posting them to 
them.  
 
BRENDA: I always write to Julia [Cousin] at Christmas and she to me, 
you know, just general things about what people in the family are 
doing. And that would be an opportunity to let her know (if I felt I 
should), but Bonnie [Other Cousin] is very good at keeping in touch with 
her so I leave it to Bonnie. 
INT: Why is that? 
BRENDA: Because Bonnie knows Julia best because they’re sisters, and 
she is in close contact, even though she’s half way round the world! And 
I don’t myself have instant phone access to Julia. I’ve got her phone 
number, but I wouldn’t pick up the phone and start talking breast 
cancer with her! Or genetics, or anything.  
(Brenda, 58y, DGT, Inconclusive) 
 
‘I was put in charge of telling my Uncle. We’ve never been that close to him. But I 
do see him more often than any of the others do. So I just sort of gave him the 
letter. I mean, all the information was there, all the phone numbers was there. And 
I did say to him, they are very good. They’re very good. If you just want to go and 
talk to them for a chat, they don’t mind. And, erm, so I said, you know if you tell 
Pat and Jenny, the cousins’.  
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(Molly, 49, PGT, Negative) 
 
Having passed the information on to one distant relative, they often relied on the news being 
filtered down through that branch of the family. There was also likely to be little or no follow-up 
to see if the information had been passed on or acted upon.  
 
‘I think it was 12 in my mother’s family. She was the eldest, but all the 
Aunts are dead now (bless them), but there are cousins knocking around 
up in Northern Ireland. I told my cousin Frank. Now Frank’s dealing with 
that because he’s still in full contact with the cousins in Northern 
Ireland. You know, he goes over there every now and then. It’s up to him 
now, I just need to worry about my brood’.  
(Annie, 65y, PGT, Negative) 
 
The data suggests that contact with more distant relatives was more likely to occur if prompted 
by a health care professional, such as the genetic counsellor.  
 
‘I only spoke to my Uncle [to tell him that her mum and sisters had been 
found to carry a BRCA mutation] really, erm, because when we went for 
the last meeting with the genetics people they said [that he may be at 
risk also]... So they said, well yeah you can sort of let him know. ‘Course 
after you’ve been to see them, they write all the notes down and they 
write to you to confirm what they told you at the meeting and  
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whatever. So I showed that to my uncle, because he was mentioned in 
it. So he went to his doctors.’ 
(Molly, 49, PGT, Negative) 
 
In fact, for several participants, even just discussing the topic of more distant relatives during the 
research interview lead to them identifying family members who may be at risk and who had not 
been informed. In each case, they reported an intention to follow them up after the interview. 
This suggests that some kind of follow-up by a health care professional may be advantageous to 
ensuring more distant relatives who may also be at risk are told.  
 
ZENA: I don’t talk to my two brothers very much. They’re not so – they 
just don’t figure highly in my day to day life, really; I think that’s just 
distance... Do you know, I don’t know whether I actually told them 
about the genetic test. They all know I’ve had another mastectomy that 
I elected to have. Percy [Brother] hasn’t had a copy of the letter. I know 
he hasn’t had that. Maybe he should ‘cause he has two girls, but then 
he’s not that close to his two girls now. It’s difficult isn’t it? They all split 
up and everything. I think you’ve shown me that there’s a gap there 
that I haven’t followed up, to be honest yeah! Yeah! 
INT: How do you feel about that? 
ZENA:  I would hope I would have. I do speak to his ex-wife (well, I send 
her Christmas cards and what have you). It might be an idea to drop her 
a line, just to give her a copy of [the letter], so she has the info for the  
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girls. That’s why it’s useful to have the letter ‘cause it’s all set out and 
it’s all clear, it’s all in the proper language and everything. And then the 
ball is taken out of your court and it’s given to them; what they do with 
it is up to them, you know. And I don’t think I have passed it on to them. 
I think there is a bit of a gap. Thank you very much! That needs to be 
done, actually, yeah. 
(Zena, 49y, DGT, Inconclusive) 
 
In some cases, the health care professionals played a more direct role by contacting the relatives 
on the participant’s, or their family’s, behalf. For example, an ongoing rift in Gina’s family meant 
that neither she nor her mother felt comfortable contacting one branch of the family; however, 
they felt there was a moral obligation that they should be informed. So, instead, they gave 
consent to the Genetic Service to do this.  
 
‘I think my Mum had my Aunt’s address and somebody from the genetic 
department wrote a letter. I think it might even have been a doctor. You 
know, written a letter just saying that you need to be aware of this; 
there is this risk that has been identified and you and members of your 
family should seek having the test... So yeah, I think Mum and I felt a 
huge responsibility, even though we’re not speaking to them and I don’t 
really know where they all are or what they’re doing. I just couldn’t 
sleep at night knowing that I’m in possession of this information and 
they are not. Well, I think most decent human beings would, you know.’  
(Gina, 41y, PGT Positive)  
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There were several examples of estranged relationships in the dataset. Two participants in 
particular spoke quite candidly about why the hurt and/or pain caused by the breakdown in the 
relationship with a first-degree relative meant they were not willing to contact a particular 
relative.  
 
‘There’s no way I would contact Jonathan [Estranged Brother]. Um – 
which is a long story… I don’t care whether it affects him.’ 
(Annie, 65y, PGT, Negative) 
 
Jan, on the other hand, felt that even though her brother and she were estranged, the 
information was too important not to be shared, even if this meant the health care professionals 
made contact with him without her consent.  
 
‘Well, certainly if I had come out positive, and the consultant had said 
it’s important that our family know that, I would just do it. No matter 
that we are estranged... It’s possibly life-sustaining information and I 
think, as far as the consultant is concerned, that they should have a 
right to tell the family without my consent because it’s like possibly (this 
sounds dramatic, but it’s the only expression I can think of) a “loaded 
gun”. If we have that gene that’s our loaded gun, and if I say “No, I’m 
estranged, I don’t talk to anybody, I don’t want to tell anybody” I think 
that’s holding important medical information and it should be shared.  
 
251 
 
So, I personally think that even without my consent the medical side 
should be able to go ahead and tell my family. I think that’s important.’ 
(Jan, 44y, DGT, Inconclusive) 
 
Unfortunately, few of the other participants were aware that the Genetic Service team could 
write to family members who the person being tested was not comfortable contacting for any 
reason.  
 
 
8.2.2   Dealing With Relatives Who Did Not Want To Know 
 
Interestingly, when talking about more distant relatives, many participants expressed the 
sentiment that, once the information about genetic risk in the family had been passed on, it was 
up to the recipient to act on, that it was an individual choice and that their opinions regarding 
genetic testing should be respected. However, when discussing members of their immediate 
family who had opted not to follow up with the genetic counselling, the consensus was that they 
were ‘wrong’. This was especially true if they had children (in particular, daughters) who could 
potentially be at risk, and so discussions would continue until they could be persuaded. In other 
words, participants held a theoretical principle of what was ethical and right, but when it came 
to their own family that rule fell apart.  
 
‘This comes down to the freedom of the individual; I think everyone has 
a right to decide what’s best for them. But I still do feel very strongly  
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that he [Brother] should be tested and I am going to go on keeping the 
pressure on.’ 
(Arthur, 61y, PGT, Negative) 
 
SARA: Oh, like Sue was positive as well and her daughter doesn’t want 
to know. She doesn’t want to find out ‘cause she’s already got children 
(which I think is a stupid idea).  
INT: What makes you say that? 
SARA: Because she’s got a child, so she should be tested so that she 
knows what she’s got to do, and if she has got it she can take the 
precautions to prolong her life. But I think  her Mum and my Mum are 
encouraging her to get tested. 
(Sara, 23y, PGT, Negative) 
 
Many participants found it hard to understand why relatives would not want to know.  
 
‘When I told my daughter, Daphne, what I was doing and she was 
horrified (which is absolutely amazing). I tell you, it doesn’t matter how 
close you are to people, you never know how they are going to react to 
things. She even phoned my niece and was angry with her for even 
approaching me about the genetic testing! But anyway, I explained how 
I felt. I explained that I was really quite pleased to do it for them, my  
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own family, and pleased to think that I could maybe help in research 
generally. So Daphne said “Well, Mum, I don’t want to know anything 
about it whatsoever”. So that was that. I was worried about Daphne, 
but I thought “Well, I’ll deal with it again when the opportunity arises. 
I’ll approach it gently when things have simmered down and see what 
it’s all about”. But she was adamant the whole way through. Now, of 
course, immediately a psychiatrist would say it was fear, and I would 
think it’s a deep-down fear really. Because she’s a most practical, 
outgoing, busy kind of person. She’s not a fearful sort of person. But I 
think with cancer and remembering her grandmother and everybody 
dying – and, of course, in those days the illness was horrific –it is really 
hard for her. But there’s help now.’ 
(Shirley, 78y, DGT, Inconclusive)   
 
‘My older brother just went into, and still remains in, complete denial. He 
doesn’t acknowledge it at all. And we’ve had big discussions about it – 
arguments even. He’s older than me so doesn’t think it affects him. But you 
know, his daughter and his son (his son has two children already) are 
desperate for him to have the test... Ella, his daughter, talks to me about 
the fact that her father won’t have the test, and she’s the one that’s 
probably pushing me all the time saying “Please try and get my Dad to do 
it, will you?”  But I got the feeling that she [the Genetic Counsellor] said it 
was quite common for people to do what Percy is doing. I was surprised. I 
was really surprised and I still am, because I can’t see the reason for it,  
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especially as a fella (a man), you know. I think you haven’t got a great deal 
to lose, but you’ve got a lot to gain for your children.’  
(Arthur, 61y, PGT, Negative) 
 
In fact, Arthur expressed concern that perhaps the negative reaction from his brother was as a 
direct result of how they communicated the issue with him initially.  
 
ARTHUR: I’m not sure – I mean, maybe we mishandled it with him, I 
don’t know the answer to that. 
INT: What makes you say that? 
ARTHUR: Well, I don’t know. I don’t know how to tell someone. I’ve 
never been trained! I mean, I have not got a clue what to do or how we 
should have told him. 
(Arthur, 61y, PGT, Negative) 
 
Whereas, Annie wondered if her willingness to be tested meant she loved her family more than 
her siblings, who refused to be tested.  
 
‘But as I say, none of them [her siblings] have done anything about it 
except myself. But maybe as I said because I worry about my grandsons 
and my son more than Catherine does about hers or something. But I 
can’t understand why Catherine didn’t go and do it, because she could  
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have taken the pressure off the whole family - she’s got 14 
grandchildren, grown up now, you know... I want to say to Catherine 
‘Well, I really feel that you ought to have done this, you know it’s your 
responsibility as the matriarch of your family’, but that would go down 
like a lead balloon, I can tell you! ‘ 
(Annie, 65y, PGT, Negative) 
 
Many participants were particularly concerned about siblings (brothers in the majority of the 
cases) who refused to engage in communications about genetic testing, thus blocking the 
information from reaching their children.  
 
 ‘My brother’s reaction, not wanting to know, surprises me because he’s 
got three daughters and I think it’s important for him to know whether 
he could have passed it on to them.’ 
(Nicole, 39y, PGT, Negative) 
 
Yet, when these participants were asked if they thought there would ever be a situation where 
they would consider telling their nieces or nephews themselves, the answer was always no. The 
argument being that it would be inappropriate to side-step the parents, as this would be likely to 
cause upset in the family. These were clear examples of family ‘rules’ about who can tell what to 
whom, as seen in the systematic review (refer to Chapter Two).  
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‘Uuuum. I doubt it because I think it’s probably – I feel that it’s a 
conversation they [her parents] should have with her [niece]. I would be 
very open to discuss it with her, but I think probably she should hear it 
from her parents. That’s my own personal view. But I would happily 
discuss it with her, after she’d been told, but I don’t think I would be in a 
position to tell her... But I don’t know, oooh, I don’t know. If he came to 
me and said “Look, could you sit down and tell her?” Then yeah I would. 
But I wouldn’t go over his head, you know, I’d always go through him 
first.’ 
(Gina, 41y, PGT, Positive) 
 
‘No. No. Not in a million years... If Isaac [brother] doesn’t listen, I might 
talk to their step mother, Lucy, because she would listen... You run the 
risk of upsetting the family and blowing it apart, you can’t do that. I 
wouldn’t want someone to go and tell Anne or Claire [her own 
daughters] something. You have to work on that principle.’ 
(Gillian, 49y, PGT, Negative) 
 
However, although Gillian felt it was inappropriate for her to tell her niece about the potential 
risk in the family, she had a back-up plan involving her daughters if she had not been told by a 
certain age:  
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‘But I think by the time she [niece] is 25 [years old], if they’ve [her 
parents] not told her, I would get one of her cousins to tell her! But I 
won’t do it. I will get one of the girls to tell her by accident, but not at 19 
[years old]. She doesn’t need it right now.’   
(Gillian, 49y, PGT, Negative) 
 
Communicating with relatives who did not want to know was acknowledged to be particularly 
difficult. Various tactics were engaged, such as repeated attempts to engage with them and/or 
passing on written information, which they could process in their own time. It often became a 
family affair with many relatives, siblings and parents, in particular, targeting that individual. 
 
‘I think probably try harder to talk to them if they don’t want to know. 
But you have to. I think perhaps a letter is the answer to explain a little 
bit, to make them a little bit more aware and just sort of talking to them 
more. But if somebody’s absolutely adamant that they’re not going to 
do it, I don’t think there’s any way you can coax them into it. You just 
have to hope that the more you explain, and the more you talk to that 
person, that eventually they will perhaps go and have the test. Just 
keeping on being a pain! I don’t think it’s an overnight job, I think it’s 
just picking your times and just talking nicely.’ 
(Julia, 58y, DGT, Inconclusive) 
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8.2.3   Telling Younger Children 
 
One further group that would fit into these stage four communications would be those sharing 
positive results with children who were deemed too young at the time of testing to be told, but 
then who needed to be told at a later date (for example, when they are at the age of making life-
decisions).  
 
Almost all adult offspring (those aged over 18 years old) were informed about their parent’s – 
check this I am not sure parents’ genetic test results and were included in discussions about 
cancer in the family to some degree, although it is important to note that, when told, sons and 
daughters did show the same level of interest in the information. Table 7 gives a breakdown of 
those participants with children under the age of 18 years old, including the children’s ages, and 
whether or not they were informed about their parent’s genetic test result. Six of the 24 
children, aged 14-17, were told about their mother’s genetic testing and were included in 
communications about cancer in the family, although one of these, Kerry’s daughter Katie, was 
not told intentionally (refer to section 8.2.3). Eighteen children, aged 2-15, were not included in 
such conversations and were not informed about their mother’s genetic testing. There is no 
difference in the disclosure of test results by gender as, in all cases, except Kerry’s, the 
information was either given to all siblings under the age of 18 years or none. 
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Table 7: A breakdown of those participants with children under the age of 18 years old 
 
For many mothers, telling younger was one of the biggest challenges they faced and one that 
started early in the process:  
 
MAYA: The thing that I found the hardest about all of this was the fact 
that I might have to then have that conversation with the children, and I 
think that was always the thing that got everybody. I think that is the 
one that gets everyone, isn’t it? And you can, from a distance (that’s 
probably not the right word) but you can say ‘Ok, well they are in their 
teens now, and what’s happened in the last 10 years and what is going 
to be happening in the next 10 years, and how well breast cancer is 
doing and what else are they going to find meanwhile’. You can do all 
that, but when it actually comes to the emotion of actually having to tell 
Participant  Age (years) of sons 
17 years old and 
under 
Age (years) of 
daughters 17 years old 
and under 
Told about parent’s 
genetic test for 
BRCA1/2 
Eloise  15  10  No 
Faye  2  10  No 
Laura    17  Yes 
Karen  14  16  Yes 
Gina  3  6, 9  No 
Rachel  8    No 
Maya  10  12, 13, 16  No 
Gillian  10, 11    No 
Tina    15, 17  Yes 
Nicole  11, 13  8  No 
Kerry    12, 15  No, Yes 
Total =  n = 10 
Average age = 9.7 y 
n =14 
Average age = 12.6 y 
6 told 
18 not told  
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your children, then you’ve got an 80% chance of this or they need to 
have – you know, where do you go with it? And it’s just as well we didn’t 
have to, really. But it was quite a… We hadn’t thought out how we’d do 
it. 
 (Maya, 47y, PGT, Negative) 
 
‘And I remember, when I went to the initial appointment, when we were 
doing the family tree, and I said then “Oh, I am so concerned about my 
children” and the nurse was lovely and she did totally put it in 
perspective and she said “Look, they’re children, they’re not going to get 
breast cancer. Medicine moves on, genetics moves on so quickly that by 
the time they’re adults it will be a whole different ball game”. And she 
said “they will be adults and they will have to make their own 
decisions”. Ok, fair enough!’ 
(Gina, 41y, DGT, Positive) 
 
For Maya (quote above), and many others, receipt of a negative test result meant they no longer 
had to have these difficult conversations with their children, which was a great relief to them. 
However, all the participants with young children (pre-teen,) as well as many with teenage 
children, who had received a positive result had taken the decision not to tell their children at 
this time, the reason being that they were too young to emotionally cope with or understand 
the information. There was an emphasis on childhood being important and that it should be 
protected from this news. Many also found comfort in the fact that science is constantly 
changing and, therefore, what they told their children now may not be relevant by the time they  
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reached adulthood. Several participants reported difficulties in deciding when ‘the right time’ 
was. Eloise’s comments echo those of many: 
 
‘Erm, for my kids I think, well, I don’t want to have this around them 
until they’re of an age when they can cope with it. And I want them to 
have their childhood and I want them to have their fun years, and then I 
don’t know when the time will be right. Depends what they want to do 
with their lives, I mean if they are going to go on into university. Shani 
doesn’t need to worry about it before she is 30, anyway. I would like to 
tell her… in an ideal situation, if she gets in, I’d love her to go off to 
university, get herself sorted out with what she wants to do with her 
life, and then maybe at that point tell her before she meets somebody, 
so then she is equipped to tell her partner. I don’t want her to meet 
somebody and then to give it to her, coz it’s like, oh my god, you’re just 
trying to break-, you know, I don’t know what that would do to their 
relationship. I just think if she knows from the start then it’s up to her 
what she does with it. But I don’t want it hanging over her when she 
should be having fun and enjoying herself, there is plenty of time. And, 
besides which, when she needs to know, who knows what her options 
are going to be? And that’s why I don’t want to, the same with Ben, you 
know. I’d like to get him to go through, do what he wants to do. They’re 
both bright kids. I hope they go on, but whatever they want to do I don’t 
want their young lives ruined with something that they’re not really 
going to understand anyway, yet. And, as I say, it just changes all the  
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time. So what I sit down and tell them today might be completely 
irrelevant even in five years’ time.’ 
(Eloise, 42y, PGT, Negative) 
 
When asked, many reported they had thought about what they would say when the time comes, 
albeit in general terms:  
 
INT: Have you had any thoughts about how you will tell Shani and Ben 
when the time comes? 
ELOISE: Erm… I have. I’ve thought about it a lot. And I just think that 
there’s nothing yet I can do other than be matter of fact. Say ‘Now look, 
do you remember when I had this surgery? Can you understand why?’ 
And then just say ‘Well, you both are at a 50% risk of inheriting the 
same gene’. But then I would like to back it up with some more 
information… I’d have to sit and say to Shani, ‘Look honey, you know, 
you may want to consider this in the future, what I’ve had done’. It’s not 
a big deal… I mean… I didn’t have any pain. I didn’t have anything. I 
mean, it’s uncomfortable. But it wasn’t horrendous; I have sunburn and 
hangovers worse than that. I really have [LAUGHS].  
(Eloise, 42y, PGT, Negative) 
 
However, having made that decision not to tell their children at this time, it did not mean it was 
necessarily an easy secret to keep. Eloise’s brother had received a negative result and her sister-
in-law had shared the information about the family genetic testing with her own children. For  
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Eloise, this resulted in new fears that perhaps the cousins would tell her children before she was 
ready:  
 
‘She did tell hers why I was having the op. And so I was a bit cross about 
that. But… I said I don’t care, they are fine to know, but if they let on to 
my children then I will be cross because I want to tell them when I think 
they’re ready to handle it. And I don’t want their childhood ruined. 
Because they won’t understand it in an adult way. They are not adults 
yet. It’s bad enough when you are an adult to sort of get your head 
round things… I just wanted to slap her, frankly. And I am not a violent 
person, I just wanted to say ‘oh for heaven’s sake, nobody’s been given 
a death sentence here’. I just pray her two don’t tell them!’  
(Eloise, 42y, PGT, Negative) 
 
For Kerry, it was her risk-reducing surgery and her daughter overhearing adult conversations 
that brought the subject out in the open. She had been discussing her upcoming surgery on the 
phone with her sister, not realising she was being overheard by her youngest daughter.  
 
‘I went back up and I looked at her and she just looked at me and I said 
‘I’ve got to talk to you, haven’t I?’ and she just burst out crying.  
And she thought I had breast cancer; she thought that’s why I was going 
to the hospital all the time, she thought that’s why I was having all the 
mammograms and suddenly I was faced with that ‘what do I tell her? 
What do I say?’ and nowhere along the line has anybody talked to me,  
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told me how, when, what. All I was told before we had the testing was 
that having daughters (and a son, obviously, because he can have it as 
well) they won’t even consider screening them or doing anything until 
they are in their 30s, early 30s and whatever.  
But how do you explain it? I don’t know. I just – it doesn’t – it didn’t help 
me at all, and it is a dilemma that I had to make at that time, and she 
thought I had breast cancer and I looked at her and I said “Oh Katie no, I 
don’t, I don’t” and in the end I told her and her first question to me was 
“Well, will I get it?” So, you know, how can you tell a 16 year old girl 
who’s just starting in her own life… but I am so worried, so concerned 
that she’s holding all of that and I don’t know what to say to her. I don’t 
know who to talk to or just to leave it now and just hope that it will sit in 
the back of her mind and it won’t affect her.’ 
(Kerry, 45y, PGT, Positive) 
 
In fact, Kerry was very surprised by the lack of discussion and support available to her on the 
matter. In light of her experience with her daughter, it is understandable why she thought this 
was an area that would warrant further support: 
 
KERRY: And I don’t think [Genetics Counsellor], I don’t think anybody 
helped me at all…You need to – definitely something – some advice on 
what to say to the children. I know each person is different, but if – I 
don’t know. I don’t know. That’s my biggest fear all the way along. Not 
about me dying, or me getting anything, it’s about what am I going to 
tell the girls? I don’t want them to go through their teens and their early 
life; they don’t deserve that, they need to have a normal life, like I  
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did. ...kept asking about the kids. I kept asking ‘Well, what do we do? 
How do we tell the children? What do we say? What sort of effect will it 
have on their life? Will it be on my records? Will it be’ – You know, all 
those sort of questions that just kept coming up. 
No. I naively assumed there would be like (not four of us), but I assumed 
there’d be like groups where you’d go and talk to people who’d been 
through it before and they’d be able to tell you, you know, ‘This is how I 
did it’. 
INT: Do you think that’s something that would be useful? 
KERRY: On reflection, yeah. Probably, not straight afterwards, but 
definitely now, I think as you go further along the chain, definitely.’  
(Kerry, 45y, PGT, Positive) 
 
 
8.2.4   Identifying Who Should Be Told 
 
The findings show that those undergoing genetic testing for BRCA1/2 are not good at identifying 
who they should include in discussions in order to pass on relevant information to at risk 
relatives. Instead, communication is based around normal patterns of communication with 
emotionally close relatives and a need for information from more distant relatives. As a result, 
male relatives and more distant relatives are often excluded.  
 
For example, Figure 23 shows a family tree for Jane, as it would be drawn in a genetic 
counselling appointment. It maps out all the family members who may be affected by Jane’s  
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positive BRCA1 result. This is the tool a genetic counsellor would use to identify who, in Jane’s 
family, is at risk and should ideally be informed about genetic counselling and testing.  
 
 
 Figure 23: Jane’s family tree for a BRCA1 family as drawn in a medical genetics clinic 
 
 
However, Figure 24 shows Jane’s communication eco-map in which Jane reports having close 
emotional relationships and good communication (three green lines) with many family 
members. The orange arrows show the flow of communication about Jane’s BRCA test result. 
This shows the reality of who is actually included in discussions. 
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 Figure 24: Jane’s communication eco-map 
 
 
Much is revealed when the communication eco-map is laid over the family tree, as seen in Figure 
25. All those highlighted in red are relatives that the information about the genetic testing was 
not shared with. The important thing that this study shows us is that the relatives being missed 
out are not random, but are clear patterns. For example, Jane communicates readily with those 
she is emotionally close to; those that are missed are men and relatives who she is not 
emotionally close to, namely her cousins.  
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Potentially at-risk male relatives are often left 
out of family communications regarding 
genetic testing for BRCA1/2 due to 
perceptions of it being a ‘female disease’.  
Not being emotionally 
close to relatives means 
they are less likely to be 
told about genetic testing.   
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Figure 25: Jane’s communication eco-map laid over her family tree identifies those at-risk relatives who 
were not engaged in family communication regarding genetic testing. 
 
 
It is clear that one of the ways to improve family communication regarding genetic testing for 
BRCA1/2 is to help those undergoing genetic testing to use their family tree rather than their 
normal communication patterns (shown on the eco-map) when identifying who, in the family, 
the information is relevant to.  
 
 
8.3  How those undergoing genetic testing for BRCA1/2 talk to 
their friends and family during Stage Four. 
 
It is harder to give specific examples of how those undergoing genetic testing for BRCA1/2 talk to 
their friends and family during this final stage because for many these were conversations 
planned for the future. For example, how they would share their results with their children when 
they were older.  
 
However, this stage also involved trying to pass information on to relatives that are more distant 
and with those whom had not wanted to be involved at the earlier stages.  One common 
technique used to engage such relatives was for participants to use their own stories, in other 
words using their own personal experiences. They felt their lived examples with actual people 
providing expert testimony and made the information more accessible for relatives. For 
example, Eloise made an effort to speak very positively but honestly and openly about her  
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genetic testing with her relatives. She told them how, from the age of 11, her life had been 
affected by cancer; how losing her mum at such a young age had a deep impact on her and then 
to have her sister diagnosed with the same disease at a young age was very distressing. She told 
them participating in genetic counselling and having a genetic test for BRCA1/2 gave her some 
understanding about her family history and closure about her mum’s death; and allowed her to 
take matters into her own hands and manage her increased risk of cancer. Eloise reported how 
by telling her story in this way she put her decision to undergo genetic testing in perspective 
others could understand and relate to. In her own words, “it’s a real human experience rather 
than some abstract science!”. As a result of communicating in this way, she found relatives were 
very receptive to her discussions.  
 
 
8.4  Conclusion 
 
At this stage, communication became more of a family affair, with each family member playing 
their role to ensure at-risk relatives were aware of the situation; this made the process simpler 
for some participants. Techniques such as delegating the task of contacting more distant 
relatives to one family member and photocopying letters from the Genetic Service to send also 
made family communication easier. Other facilitators included: being prompted to engage with 
family communication regarding genetic testing by a health care professional, or the Genetic 
Service making direct contact with those relatives that the individuals or the family did not feel 
they could contact (however, not being aware of this option was also a potential barrier). For 
some, feeling that they had a moral obligation to inform potentially at-risk relatives fostered 
family communication, despite a family rift. 
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Barriers to family communication seen at this stage included: not feeling they could make 
contact with certain relatives, either due to emotional distance or family rift and estrangement; 
reliance of information filtering down through more distant branches of the family, with little or 
no follow-up; family ‘rules’ about who was allowed tell what to whom; and children being too 
young at the time of testing, but then having to make decisions about when and how to share 
information with them later. Participants were particularly concerned by how to approach or 
engage those family members who had previously said they were not interested, especially if 
participants were worried that that person’s offspring may also be at risk and access to risk 
information for them was being blocked. In some cases, there was a  perceived lack of discussion 
and support from the Genetic Service; and many were not made aware of what support and 
guidance the Genetic Service could have given (for example, directly contacting certain relatives 
on their behalf).  
 
Future interventions could be developed to help families identify emotionally, geographically 
and genetically distant relatives who may potentially be at risk and encourage them to consider 
how they may be informed about that risk. There may also be merit in the Genetic Service 
offering a later ‘follow up’ appointment with those receiving a positive test result (and their 
family, if acceptable) to review who has been told and offer support and guidance with the task 
(and/or offering more direct involvement). There should also be regular long-term contact with 
mutation carriers with children.  
 
Chapters Five to Eight have presented the findings of an interpretive descriptive, qualitative 
study that explored individuals’ experiences of talking to relatives regarding genetic testing for 
BRCA1/2. The findings have been reported as a longitudinal view, providing an explanation of  
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the process of family communication with a focus on when, how and why such communications 
occur. The key barriers and facilitators to family communication regarding genetic testing for 
BRCA1/2 have been highlighted for each stage and potential areas of support identified. The 
final chapter will provide a discussion and conclusions to this research.  
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Chapter 9 – Discussion & Conclusion 
 
9.1  Introduction 
 
This chapter will present a discussion around the six Key Findings and examine the contribution 
this study makes to the existing literature. The chapter will also provide a critical review of the 
strengths and weaknesses of the work. It concludes by looking at the implications of the work 
and suggestions for future research that is needed. 
 
 
9.2   Summary of Study 
 
Research to date has focused far more on with whom and why (motivations) family 
communication regarding genetic testing occurs, rather than when or how it is occurring (refer 
to Chapters One and Two). What is more, the research tends to focus on communication with 
specific family members at the point of result disclosure only. Therefore, the work presented in 
this thesis set out to address the following research question:  
 
How and when do those undergoing genetic testing for BRCA1/2 talk to their relatives about a 
family history of cancer, associated risks and genetic testing? 
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The aim of the work was to gain insight into participants’ experiences of discussing their 
participation in genetic testing, their test results and potential risk information following genetic 
testing for BRCA1/2 with their family (not just with first-degree relatives or specific family 
members), with particular focus on how these families discuss genetic testing for cancer risk and 
when.  
 
This work is a top research priority, because, how those undergoing genetic testing for BRCA1/2 
talk to their relatives about their family history of cancer, associated risks and genetic testing can 
be critical in ensuring all family members have access to genetic services.  The existing literature 
shows that talking about such things can be potentially difficult for concerned individuals and 
their relatives and, despite a wide range of literature, it is clear that the nature of interactions 
regarding genetic information remains poorly understood (Gaff et al. 2007).  
 
The resultant study, as described in Chapters Three and Four, was qualitative in nature, 
employing in-depth interviews as the method for data collection and utilising the technique of 
constructing eco-maps (Ray and Street 2005) as a method of identifying relevant family 
members and guiding the researcher through the family structure and relationships. The work 
was grounded in a conceptual model adapted from Peterson’s (2005) family systems model, for 
conducting family-based research in hereditary risk and genetic testing; and Carter and 
McGoldrick’s (1989) ‘Family Life Cycle’, which allows the study of how individuals within a family 
and, by association, the family as a whole, adapt to chronic illness. These methods were chosen 
in line with the interpretive description methodology (Thorne et al., 1997;Thorne et al., 2004b) 
to ensure depth and richness in analysis and reporting of findings. 
 
There has been a call for research that acknowledges family communication regarding genetic 
testing as a process rather than a discrete event (Forrest et al., 2003;Hallowell et al., 2005a;Gaff  
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et al., 2007a). This has been achieved in this study by analysing the longitudinal view of family 
communication; examining when family communication regarding genetic testing occurs, 
throughout the whole process of genetic counselling and genetic testing and not just disclosure 
of test results. The longitudinal view presented in Chapters Five to Eight gives a deep insight into 
how and when certain family members were included in family communications regarding 
genetic testing for BRCA1/2. 
 
Whilst family communication regarding genetic testing can be intellectually and emotionally 
challenging (Sermijn et al., 2004), for the participants in this study it was seen as a positive thing; 
spreading the word meant more awareness by family and friends, leading to increased detection 
and, thereby, less disease. However, there were a series of issues that arose for these 
participants, which will be discussed within this chapter.  
 
 
9.3  Discussion 
 
In order to discuss the findings of the study, it is important to explore them in relation to both 
the existing literature, as examined in Chapters One and Two, and the broader literature which 
exists beyond genetic testing for BRCA1/2. Therefore, this discussion section will identify the six 
Key Findings of the study and position them within the current evidence. Whilst some of the 
findings from the data reflect the existing literature, there are a number of new findings, which 
both challenge and add to the existing body of knowledge.  
 
The Key Findings are as follows: 
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1.  Communication regarding genetic testing from BRCA1/2 between emotionally close 
relatives is different to communication with emotionally distant relatives;  whilst family 
communication regarding genetic testing for BRCA1/2 with emotionally close family and 
friends is about sharing and supporting; communication with emotionally distant family 
is about gaining and imparting information   
2.  A family’s engagement in communication regarding genetic testing is implicitly linked to 
their experiences of cancer burden, and how openly this topic is discussed in the family. 
3.  There is a lack of understanding of risks to men and their offspring based on perceptions 
of hereditary breast and ovarian cancer being a female disease.  
4.  Emotionally distant and male relatives are only contacted selectively. Those undergoing 
genetic testing for BRCA1/2 are not good at identifying all at-risk family members in 
order to share the implications of the genetic test with them. 
5.  As far as the family are concerned, members do not have the right to make an informed 
decision to decline.   
6.  Plans for telling people in the future, especially children, is a cause of worry and concern 
for those undergoing testing and needs further support, especially in the longer term. 
 
 
Key Finding One: Communication regarding genetic testing from BRCA1/2 between 
emotionally close relatives is different to communication with emotionally distant relatives. 
 
The literature reviewed in Chapters One and Two has already demonstrated that people are 
more likely to share their BRCA1/2 genetic test results with first-degree relatives (FDRs) (Koehly 
et al. 2003; Claes et al. 2003; Wagner et al. 2003; McGivern et al. 2004; Finlay et al. 2008; Blandy 
et al. 2003; Patenaude et al. 2006) and those they have close emotional relationships with 
(Chivers Seymour et al. 2010; Julian-Reynier et al. 2000; Hughes et al. 2002; Claes et al. 2003;  
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Peterson et al. 2003). However, the findings of this doctoral study go beyond telling us that 
participants are simply more likely to communicate with these groups by showing how that 
communication differs.  
 
In order to get a sense of the organisational and structural characteristics, and to identify the 
normal patterns of communication between the participant and family members, the family 
functioning construct of cohesion, or ‘closeness’, was measured. According to Koehly et al. 
(2003), cohesive relationships are supportive relationships that involve those whom the 
participant feels close to, and are characterised by behaviours such as support-seeking during a 
crisis and/or minor everyday upset, or the sharing of confidences. Therefore, as part of their eco-
map construction, participants were asked to score how close they perceived their relationship 
to be and how open they felt the communication was with each person they had identified. The 
findings reveal that participants were more likely to involve those they scored three or two 
(cohesive relationships) in discussion about their genetic testing and cancer risk. This supports 
previous research; however, further analysis of qualitative data revealed much more.  
 
Emotionally close friends and family 
In this sample, family communication regarding genetic testing for BRCA1/2 occurs with 
emotionally close friends and family through normal communication patterns and evolves over 
time. Koehley et al. (2003) suggest that family functioning may play a more important role than 
mutation status or type of testing in determining when these discussions occur. For example, 
patterns of communication associated with discussions about genetic counselling and testing 
may be characterised by support-seeking and advice-seeking relationships (Koehly et al., 2003) . 
 
This is supported in the findings of this doctoral study. For these participants, patterns of 
communications started, long before genetic testing, with conversations about cancer and what  
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it means to, and for, family members and was stimulated by their shared experiences of cancer 
within the family. These were the kind of conversations that happened around the dinner table 
and during evenings together, and were prompted by diagnosis, treatment and death in the 
family. Cancer played a huge role in the lives of the participants, both because of its personal 
impact and its impact on family relationships and functioning. Cancer has already been shown to 
shape families’ norms and expectations about the family life cycle. For example, Peterson et al. 
(2005) found that, as an individual approached the age when cancer was diagnosed in previous 
generations, their own sense of vulnerability may increase which, in turn, may often lead to 
them seeking support and advice from others. 
 
As one, or more, family member(s) entered into genetic counselling, these conversations 
continued, but the focus shifted to sharing the experience of, and knowledge gained, during 
genetic appointments. At this stage, the person being tested did not seek out family members 
the results may be relevant to and inform them of potential risk information, but rather shared 
their experience with those who offered advice and/or support as part of their pre-existing 
relationship. This further supports the thinking that family functioning dictates who is included; 
for example, Kenen et al. (2004a) found that women may be less likely to talk to their brothers 
or spouses about hereditary breast and ovarian cancer risk, possibly because women expect 
limited support from these male relatives in terms of coping with cancer risk information.  
 
Participants in the present study communicated the genetic information though sharing leaflets 
and consultation summary letters. Whilst they may have been disappointed or surprised that 
someone did not want to know or disagreed with the activity, they did not force their 
involvement but simply found others to talk to about it.  
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Inclusion during these stages meant these family members knew about the genetic testing and 
became emotionally invested. According to the study participants, with that investment came a 
level of anxiety regarding the outcome of the genetic test. Knowing that others were waiting to 
hear in a state of anxiety prompted rapid disclosure of results, regardless of what that result 
may be, with little thought as to how, when or where it was shared. For example, this happened 
from the hospital car-park or on the way home from the genetic service, usually by telephone. 
There was no discussion or explanation about what the result meant, what had happened before 
and continues after; communication at that moment was about a dichotomised ‘I carry the gene’ 
or ‘I don’t’. Other studies, such as Gaff et al. (2005), have described how participants reported 
sharing their actual result with close relatives as being straightforward, because it was just part 
of an on-going process that was regularly discussed. However, it is important to note that many 
participants in the present study later expressed regret at sharing their results quickly with close 
family members in this manner because they were worried they had caused distress and/or 
were not able to offer the right amount of support or information. This may be an area where 
genetic counsellors, if they are not already, should build time into their consultations to 
encourage patients to consider how they may share their results and how they will feel about it 
afterwards.  
 
Generally, having an answer to a genetic test did not end the conversations for the study 
participants regardless of their result. A positive result gave some insight into the family history, 
but brought the risk to others into sharper focus. Support and advice-seeking discussions 
became about risk-reducing strategies and informing others about the mutation within the 
family. Those who had not wanted to be involved before now became the focus and conflicts 
may arise as other family members feel not being tested is no longer an option. As Peterson 
(2005) also found, families may influence testing decisions through support or coercion, and may  
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also affect decisions indirectly by influencing attitudes related to testing outcomes (refer to Key 
Finding five). 
 
An inconclusive diagnostic genetic testing (DGT) result left a level of uncertainty. Dorval et al. 
(2005) found no evidence that women receiving an inconclusive BRCA1/2 genetic test result felt 
falsely reassured, compared to those receiving a true negative result from predictive genetic 
testing. The findings from this present study suggest that this may be because the family still 
share their significant experiences of cancer within the family, but were now without the means 
to explain it; therefore, conversations may return back to a pre-genetic testing status of 
wondering where the cancer in the family comes from and how it will impact future generations. 
This may be a cause for concern, as little is known about the psychosocial consequences of 
receiving an inconclusive BRCA1/2 genetic test result (Dorval et al., 2005). 
 
A negative predictive genetic testing (PGT) result may have brought relief to the individual 
receiving it and mean their offspring are not at risk, but that good news sits within a family 
where others are receiving positive results and where cancer still dominated the conversations. 
Other researchers have reported non-carriers describing themselves as feeling guilty, often 
termed ‘survivor’s guilt’, that they had been found not to carry a BRCA1/2 mutation when their 
relatives had been identified as carriers (Dorval et al., 2000;Ardern-Jones et al., 2010;Hallowell 
et al., 2006).The present study suggests this can create tension and feelings of guilt, which may 
impact future communications . In the most extreme case, this may mean that those receiving a 
negative result, whilst others in the family receive positive results, may feel they no longer 
‘belong’  and begin to distance themselves; meaning they are no longer giving or being given 
emotional support.  
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Conversations 
continue but now with 
knowledge of genetic 
basis of disease 
General conversations 
influenced by, and 
revolving around, 
cancer in the family.  
Sharing the experience 
of, and knowledge 
gained, during genetic 
counselling with family 
members  
Share genetic test 
results quickly with 
little thought to how, 
when or where. 
The findings of this study demonstrate that family communication regarding genetic testing for 
BRCA1/2 with emotionally close friends and family is an on-going process, starting with, 
returning to and always situated within the shared experience of cancer within the family. This is 
depicted in Figure 25.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 26: Family communication regarding genetic testing for BRCA1/2 with emotionally close friends 
and family is an on-going process; starting with, returning to and always situated within the shared 
experience of cancer within the family. 
 
 
Of course, emotional closeness does not automatically mean completely open communication 
with all family members. For some, emotional closeness could create as much of a barrier as 
emotional distance. For example, some participants found it hard to talk to particular relatives,  
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despite emotional closeness, in case they upset them or caused them distress meaning it was 
hard to discuss their genetic testing for BRCA1/2.  
 
As one, or more, family members(s) go through genetic counselling and genetic testing, they 
share their experiences, and the family’s knowledge and understanding increases and shifts the 
conversations. However, having the results of the genetic test may change who is affected: 
those receiving a positive result may feel the burden falls more on them, while those receiving a 
negative or inconclusive result may experience feelings of guilt, or that they are no longer 
entitled to have a say. Actually, the familial nature of the conversations continues because it is 
rooted within health-related cognitions and beliefs shared within a family that are shaped by the 
collective experiences and the traditions of its members (Peterson, 2005). 
 
The exceptions to this pattern of communication are male relatives, especially sons, and young 
children who, despite participants reporting being emotionally close to, were often not included 
in discussion (see Key Findings Three and Six). 
 
 
Emotionally distant family 
Many studies have reported that communication about genetic testing and inherited cancer risk 
is less likely to occur in relationships that were both relationally and emotionally more distant 
(Claes et al., 2003;McGivern et al., 2004;Peterson et al., 2003). Whilst the findings of the present 
study support that, for example, participants were less likely to involve those they consider 
themselves less emotionally close to (scoring one or zero on their eco-maps), the findings go 
beyond that, by demonstrating how and why communication with more distant relatives differ. 
In summary, whilst family communication regarding genetic testing for BRCA1/2 with  
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emotionally close family and friends is about sharing and supporting, communication with 
emotionally distant family is about gaining and imparting information.  
 
As family members became involved with genetic counselling, they needed to gain information, 
for example about family history, in some cases asking more distant relatives who had already 
had cancer if they would be willing to have a diagnostic genetic test. Such requests required 
them to seek outside of their normal communication patterns, or to have conversations with 
those who may have preferred not to discuss such a topic with. Many felt it was harder to 
contact relatives they were not normally in contact with, compared to those they had a closer 
relationship to. This required a plan, not only for how the contact would be made, and by whom, 
but also what would be said. Letters were commonly used, as they were reported as being less 
intrusive and gave the opportunity to plan and structure the message. The family member with 
the most contact, even if it was just a yearly Christmas card, or the most outgoing personality, 
was often nominated to make the approach. Participants reported the most success when they 
were honest and open about their needs. 
 
Sobel and Cowan (2000) describe how genetic testing for Huntington’s disease can change 
notions of family membership. Participants in the present study reported similar experiences. 
Providing information, or agreeing to have a diagnostic genetic test, brought family members 
into the loop and created a transitional relationship whereby they, too, were invested in the 
genetic counselling/testing process. During this time, participants adjusted, albeit temporarily, 
who they considered to be family, so definitions of family membership and/or family roles and 
leadership shifted depending on who became involved.  
 
When the genetic test results came in, it was important to share them with these people, but 
not with the same sense of urgency as close friends and family. It was done at the next point of  
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contact or by sending copies of letters from the genetic service. Once the test result had been 
shared, the transitional relationship normally ended and contact returned to its previous status 
before genetic counselling. Periodically, more substantial relationships and friendships would 
arise, but this was not common.  
 
Those who had received a positive BRCA1/2 result may then inform other more distant relatives, 
such as cousins or aunts, especially if prompted to do so by a health care professional such as 
the genetic counsellor. Other studies have shown that the endorsement of the health care 
professional can be an important stimulus to talking to relatives (Mesters et al., 2005;Chivers 
Seymour et al., 2010), and health professionals may be relied upon as a source of technical 
information or to legitimise the word of the informant (Mesters et al., 2005;Forrest et al., 2003). 
Participants in the present study often felt obliged to make contact, usually with the closest 
family member, impart the information, and then rely on them to pass the information on to 
their side of the family; what they chose to do with the information was then their business. This 
task could be delegated to another family member, either the matriarch or the person with the 
closest relationship; strategies such as sending photocopies of letters from the genetic service 
were used to ensure accurate transmission of information. However, unlike nuclear families 
(McGivern et al., 2004;Wilson et al., 2004), this is not done in a systematic way, which often 
means some potentially at-risk distant relatives are just never contacted. If potentially at-risk 
distant relatives are not told they may not have access to genetics services and subsequently the 
ability to make informed decisions about their own health (see Key Finding Four). 
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Key Finding Two: A family’s engagement in communication regarding genetic testing is 
implicitly linked to their experiences of cancer burden, and how openly cancer is discussed in 
the family.  
 
Previous studies have examined how beliefs about a family’s risk of an inherited condition, 
gained either through personal experience or as a result of genetic testing and often shared 
across families, may influence health-related decisions and other outcomes (Peterson, 2005). 
One of the key findings of this present study was how a family’s engagement in communication 
regarding genetic testing was implicitly linked to their experiences of cancer burden and how 
openly this is discussed in the family. Foster et al. (2002) describe ‘Cancer burden’ as the 
experiences of having cancer in the family. It relates to the nature of the family history and the 
emotional burden of witnessing relatives with cancer undergoing treatment or dying. Foster et 
al. (2002) suggest that experiences of cancer in the family play an important role in formulating 
beliefs about one’s own risk and motivation for predictive genetic testing. This study takes that 
concept further and proposes that these experiences and, importantly, how openly they are 
discussed, also play an important role in how family members talk about genetic testing and 
cancer risk information.  
 
To be eligible for diagnostic genetic testing for BRCA1/2, a person must have been diagnosed 
with an associated cancer, for example breast, ovarian or prostate cancer. There must also be a 
relevant family history that alerts the genetic practitioner to the fact that there might be a 
mutation within one of the known BRCA genes. As BRCA1/2 mutations are inherited in an auto-
somal dominant pattern, one would expect to see multiple cancers across several generations in 
the family history. Once a BRCA1/2 mutation is identified in this family member, then the testing 
can be extended to other family members who could potentially be at risk in the form of 
predictive genetic testing (Lerman and Shields, 2004). Therefore, by definition, the participants  
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in this study have had some experience of cancer, either because they themselves have had 
cancer or because relatives have had cancer.  
 
For so many of the study participants, cancer had a huge emotional and psychosocial impact. It 
was an omnipresent feature of their lives and so was part of their normal conversation. The high 
emotional burden of being a member of a family where hereditary breast and ovarian cancer is 
present, especially for female, has been discussed in the literature. Foster et al. (2002) attribute 
this to their familial experiences of cancer, high bereavement rates and their own fears of 
developing the disease. 
 
Crotser and Dickerson (2010) found that white, young and middle-aged women, from New York, 
who had received news of a family BRCA1/2 mutation from a biological relative, felt family risk 
communication began early in their life, before the technology of genetic testing was even 
available. They lived with the expectation that they would share the fate of their mothers and 
grandmothers before them, and recalled their mothers ingraining a sense of risk and need for 
vigilance from an early age so cancer was caught early (Crotser and Dickerson, 2010). These 
findings are also similar to those of Hamilton and Bowers (2007), whose theory of genetic 
vulnerability places ‘experiencing the family disease’ as a key concept in the experience of adult 
testing. 
 
For the participants of this present study, their experiences of and attitudes towards cancer and 
how comfortable they felt discussing the family history with certain family members mirrored 
their attitudes towards family communication regarding genetic testing. For relatives with whom 
participants felt cancer in the family was a regular, open topic of conversation, talking about 
genetic testing and its implications was much easier, mainly because it was about sharing their 
experience of genetic counselling and testing (see Key Finding one). However, for relatives with  
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whom it was difficult to discuss or acknowledge the family history of cancer, it was equally hard 
to engage them in discussions about genetic counselling and testing. It is important to 
acknowledge that experiencing difficulties discussing these topics was not restricted to 
emotionally-distant relatives or those participants were not in regular contact with. In some 
cases, the close nature of the relationship itself created barriers, for example not wanting to 
cause relatives harm or distress, meant cancer in the family was not an open topic of 
conversation.  
 
Kenen et al. (2004b) note that families often follow family scripts, which guide their interactions 
and communication about a range of topics, and a family history of cancer may be such a topic. 
Other studies have found that risk communication was more straightforward when the family 
history of cancer had been a regular topic of family communication (Gaff et al., 2005;Crotser and 
Dickerson, 2010). Another way to express this would be to say that the degree of engagement in 
open dialogue about cancer in the family, and what it might mean, influences the approaches 
and reactions to family communication regarding genetic testing for BRCA1/2.  
 
This relates to McAllister’s (2002) Theory of Engagement (TE), which suggests that a process of 
engaging with cancer risk occurs in HNPCC family members over time as they interpret their 
family history and thus become cognitively and emotionally involved with their risk of cancer. 
Also, the degree of engagement that has occurred at the time of genetic testing influences the 
approaches and reactions to test results. 
 
The theory of engagement (TE) is constructed around the core category of ‘engagement’ and the 
associated ‘engaging’ with cancer risk. McAllister (2002) defines engagement as a constructed 
concept reflecting ‘the degree of cognitive and emotional involvement with one’s increased risk 
of developing cancer as a result of one’s family history of cancer’ (p. 496). Figure 27 depicts  
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engagement and action in relation to HNPCC risk
29. Engagement is a ‘dynamic process that 
occurs initially at the cognitive level (partial engagement). With the passage of time and events, 
engagement may progress at the affective level leading to intense engagement (and sometimes 
disengagement)’ (McAllister, 2002). As a theoretical construct, ‘engagement’ may have 
explanatory power with regards to variations in attitude towards one’s risk status, and the 
degree of engagement may vary over time and in relation to cancer-related events in family life 
(McAllister 2002). It may involve dealing with painful memories and so may be avoided or take 
place slowly over one’s lifetime. The study identifies a series of psychological factors that 
influence the process of engagement with HNPCC risk, including:  
1.  Causal conditions: such as personal experience of the family history of cancer and family 
communication on the topic. 
2.  Intervening conditions that block the process: such as ignoring the family history, other 
life stress and experiences of sporadic cancer.  
3.  Individual psychological factors: theories of how cancers are inherited through the 
family and individual coping strategies.  
 
One limitation of McAllister’s work is that TE emerged from a grounded theory study with a 
sample size of only 12 participants and, therefore, it is difficult to generalise to other 
populations. However, the phenomena identified as potentially influencing attitudes towards 
predictive genetic testing for HNPCC are well supported in the current literature; for example, 
family experiences of the disease, higher perceived risk, and lay beliefs of how the disease is 
inherited (Richards, 1996;Dudok de Wit, 1997;Geller et al., 1999;Rolland, 1994). More research 
is needed to allow further development and confirmation of its value.  
 
                                                           
29 Permission to reprint copyright material kindly granted by SAGE publications.  
 
289 
 
 
 Figure 27: Engagement and action in relation to cancer risk (McAllister 1999; McAllister 2002).  
 
 
McAllister proposes that the degree of engagement with cancer risk at the start of genetic 
testing is consistently associated with approaches and responses to predictive genetic testing for 
HNPCC. For example, those who receive a mutation positive test result, and who have been only 
partially engaged with the cancer risk, will have poor adjustment one to two weeks post-test; 
whereas, those who receive a positive result, and who have been intensely engaged, will have 
good adjustment.  
 
Similarly, this present study suggests the degree of engagement at the time of genetic testing 
may influence family communication on the topic; and that the degree of engagement may be 
measured by how openly cancer is discussed within the family. All the participants except one in 
this study reported positive experiences of genetic testing (perhaps this is not surprising, given  
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that they each self-selected themselves to be involved in a study exploring their experiences). 
From this, although no specific data were collected, it does not seem unreasonable to assume 
that this group of individuals were generally intensely engaged with the process of genetic 
testing. They also reported their overall experiences of talking to their families and friends about 
their genetic testing and risk information as being positive. There were individual examples of 
challenges, such as certain relatives not wanting to be involved or worries related to telling their 
younger children in the future, and wider issues of lack of understanding about potential risk for 
male relatives and who in the wider family was a risk. Essentially, however, the research 
participants in this group cannot be described as having struggled with family communication 
regarding genetic testing. 
 
Therefore, these data may provide preliminary support that the two are linked. In other words, 
that someone who is intensely engaged with the cancer risk, through open discussion, is more 
likely to become actively involved with sharing risk information – and, essentially, promoting 
genetic counselling and testing - with other family members, whereas someone who is only 
partially engaged may be less involved with these activities. The hypothesis may be further 
supported by the example of one participant, Kerry, who reported only getting involved with 
genetic testing because her sister ‘rail-roaded’ her into it and she ‘just went along with it’ (in 
other words, Kerry could be described as only partially engaged with the process). At the time 
she was interviewed, Kerry was feeling totally overwhelmed by having to talk to her daughter 
about her forthcoming risk-reducing surgery and felt that no one from the genetic service had 
offered her any support or prepared her for her positive result. Obviously, further research 
would be needed for further evidence-based research and development to confirm whether this 
has the potential to provide a psychosocial model for explaining variations in behaviour around 
family communication for cancer risk. However, TE does provide a useful framework for this Key 
Finding.   
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If further research is able to support this key finding, then there would be implications for 
offering different types of support to those undergoing genetic testing for BRCA1/2, depending 
on the level of engagement. This subsequently raises the issue of how genetic professionals, 
such as genetic counsellors, measure clients’ ‘engagement’. It may be necessary to look at 
developing a measurement tool or questionnaire that could be introduced into clinical practice 
to stratify those undergoing genetic testing to their required level of support.  
 
 
Key Finding Three: There is lack of understanding of risk to men and their offspring based on 
perceptions of female disease 
 
Cancer risk for male carriers 
In reality, perceptions of female disease is a major theme affecting family communication 
regarding genetic testing for BRCA1/2. Perhaps it is not surprising that participants perceived 
hereditary breast and ovarian cancer as being a woman’s issue, given that, in 2006, there were 
45,822 new cases of breast cancer diagnosed in the UK, of which over 99% (n= 45,508) were 
women and less than 1% (n= 314) were men (Cancer Research UK, 2011b). In this study, 
participants reported 72 cases of cancer in their families. Of these, only nine occurred in men (of 
which only three were male incidences of breast cancer).  
 
While men and women have an equal chance of inheriting a mutation in one of their BRCA 
genes, the risks of developing cancer are much greater in women (Hallowell et al., 2005b). Table 
8 summarises the estimated cancer risk to male BRCA1/2 mutation carriers available in the  
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literature.
30 Prostate cancer risk is the most consistent finding for male carriers of BRCA1/2 
mutations in families with cancer (Liede et al., 2000).  
 
 
   
BCRA 1 
 
 
BRCA 2 
Breast 
Cancers 
BRCA1 mutation-positive 
men have an additional 1.2% 
risk of developing breast 
cancer 
(Brose et al., 2002;Evans et 
al., 2010;Ottini et al., 
2003;Tai et al., 
2007;Thompson and Easton, 
2002) 
BRCA2 mutation-positive men have an 
additional 6-10% risk of developing 
breast cancer until age 70 (Lux et al., 
2006;Easton et al., 1997;Levy-Lahad 
and Friedman, 2007;Evans et al., 
2010;Ottini et al., 2003;Tai et al., 
2007;Thompson and Easton, 2001) 
 
 
Prostate  
Cancers 
Male BRCA1 gene carriers 
have an estimated relative 
risk [RR] of developing 
prostate cancer of 3.33% 
91.78-6.20). (Ford et al., 
1994) 
 
Although accepted for non-
Jewish BRCA1 and BRCA2 
carriers, several studies of 
male Ashkenazi Jewish 
BRCA1/2 carriers have not 
shown an increased risk for 
prostate cancer (Nastiuk et 
al., 1999;Vazina et al., 2000) 
BRCA2 mutation-positive men have an 
additional lifetime risk of prostate 
cancer of between 6 and 35% in the 
age group of 65-70 years (Lux et al., 
2006;Easton et al., 1997;The Breast 
Cancer Linkage Consortium, 
1999;Levy-Lahad and Friedman, 2007) 
 
A more rapid progression of prostate 
cancer has also been reported in men 
with BRCA2 mutations (Mitra et al., 
2011;Narod et al., 2008;Mitra et al., 
2008) 
 
Other 
Cancers 
BRCA1 mutations in men 
have been associated with 
elevated risks of colorectal, 
pancreatic, and male breast 
cancers (Ford et al., 
1994;Borg et al., 
2000;Moslehi et al., 2000) 
 
Male BRCA2 gene carriers have been 
shown to have an increased risk of 
developing pancreatic, stomach, bile-
duct and gall-bladder cancers, and of 
cutaneous malignant melanoma (The 
Breast Cancer Linkage Consortium, 
1999) 
 
 
Table 8: The estimated cancer risk to male BRCA1/2 mutation carriers 
  
 
   
                                                           
30 Section 1.2.2 in Chapter One described the estimated cancer risk to female BRCA1/2 mutation carriers.  
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Men and BRCA1/2 Genetic Testing  
Although variable, rates of predictive testing in men are lower than in women (Bodd et al., 
2003;Goelen et al., 1999;Julian-Reynier et al., 2000b). For example, male participants accounted 
for only 24% of participants in a UK nationwide study of predictive BRCA1/2 testing (Foster et al., 
2002). However, it is not just the testing itself that men are less engaged in; evidence suggests 
male members of breast/ovarian cancer families are less likely to participate at every level of the 
genetic counselling, testing, and communication process (Daly, 2009;Finlay et al., 2008). In fact, 
Evans et al. (2002) estimate that 50% of eligible women take a BRCA1/2 genetic test when 
available compared to only 11% of eligible men.  
 
Hallowell et al. (2005b) propose this gender difference may reflect not only the fact that the 
risks of developing breast cancer are much lower in men than women, but also the limited 
preventative measures available to men. Media portrayal of female breast cancer and ‘breast 
and ovarian cancer genes’ also often reinforces the common misconception that hereditary 
breast and ovarian cancer is primarily a ‘gendered’ disease (Claes et al., 2003). 
 
Alternatively, significant differences in general health practices reported between men and 
women may explain the differences in attitudes towards genetic testing for BRCA1/2 between 
males and females. Women have traditionally assumed the role of health maintenance within 
the family, including genetics (D'Agincourt-Canning, 2001;Hallowell et al., 2005a;Hallowell et al., 
2005b). They are more likely to actively seek health-promoting behaviours, whereas men are 
more likely to avoid them (Courtenay, 2000;Marteau et al., 1997;Schofield et al., 2000). Such 
avoidance in men has been associated with social perceptions of masculinity, and male illness 
has been linked to a sign of personal weakness (Beare and Priddy, 1999;Connell and 
Messerschmidt, 2005;Courtenay, 2000;Hyde, 2005). 
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In 1996, Dudok deWit et al. reported on the psychological impact of undergoing predictive 
testing on four men from families with breast cancer. All four participants reported difficulties 
with the genetic-counselling process, exhibiting avoidance behaviours and a tendency to either 
miss appointments or withdraw from testing. McAllister et al. (1998) and Dudok deWit et al. 
(1996) suggest such avoidance is linked to a fear of developing cancer and is a coping strategy 
for men in hereditary breast and ovarian cancer families. However, evidence concerning 
psychological implications in men is limited by the few, small-scale, mostly qualitative studies 
(Shiloh et al., 2011). 
 
Research does suggest that female relatives often initiate the male counselling and genetic 
testing process (Liede et al., 2000). It has also been suggested that explicit pressure exerted by 
family members may mean, in some cases, men undergo genetic testing against their will 
(Hallowell et al., 2005b). Many studies have reported men describing their reason for having 
predictive testing as ‘family recommendation’ (Hallowell et al., 2005b;Liede et al., 2000) and 
that women have a strong influence upon male decision-making regarding genetic testing 
(Strømsvik et al., 2011). For example, Hallowell et al. (2005b) reported that all female partners 
of men who were offered BRCA1/2 predictive genetic testing indicated that they felt they had a 
right to help make the decision because it was their children (or their partner) who were directly 
implicated by the test outcome.  
 
The literature available suggests that men primarily undergo genetic testing out of an obligation 
to their children, in particular daughters (Liede et al., 2000;Daly et al., 2003;Goelen et al., 
1999;Lodder et al., 2001). A qualitative study of 22 men from 16 high-risk families in Ireland 
revealed that men who have a family history of hereditary breast and ovarian cancer were 
particularly worried about their daughters’ risk status, and that more men in the study with 
daughters were tested than men without daughters (McAllister et al., 1998). This makes sense in  
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that, as seen in Table 8, males with a BRCA1/2 mutation are not at greatly increased risk for 
cancer compared to female relatives who carry the mutation (Lodder et al., 2001). However, as 
carriers they have a 50% chance of passing that significant increased risk on to their daughters 
(and sons), who in turn if gene carriers have a 50% chance of passing on the gene mutation to 
their offspring. 
 
Male involvement in family communication about cancer risk and genetic testing 
Like the female participants of this current study, the published literature suggests that cancer 
amongst their family members may influence how male relatives feel about cancer risk 
(McAllister et al., 1998). McAllister et al. (1998) concluded that men from families with 
hereditary breast cancer are affected emotionally by their female relatives’ diagnoses. However, 
these men reported little communication with relatives about the illness, with some men feeling 
excluded from discussion about cancer among female family members (McAllister et al., 1998). 
McAllister (1999) found that family cancers, including colorectal cancer, were discussed more by 
women than men in families with HNPCC, suggesting that their exclusion is not because of the 
female nature of breast cancer. Given that Key Finding two suggests that there is a relationship 
between level of engagement with cancer risk and how openly it is discussed, it may be that not 
including male relatives in early discussion about cancer in the family is why they are not so 
likely to undergo genetic counselling and/or testing compared to women.  
 
In contrast, in a study of 59 men testing positive for a BRCA1/BRCA2 mutation, Liede et al. (2000) 
found that the majority (52/59) of men had participated in past family discussions of risk of 
development of breast and/or ovarian cancer. Hallowell et al. (2005a) also found there was little 
evidence that men had been excluded from discussions about cancer in their family in their 
study exploring the influences on male patients’ genetic test decisions, with 29 carrier and non-
carrier men and immediate family members (17 male patients, 8 female partners, and 4 adult  
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children). In all cases, the men reported that the cancer in the family was common knowledge 
(Hallowell et al., 2005b).It is worth noting, however, that the studies reporting male involvement 
in family discussion about cancer risk before genetic testing is self-reported by men, who 
subsequently went on to be tested. There is no evidence available from those who do not go on 
to have testing, either because they decline or are simply not informed, as to whether they feel 
they are included in such discussions. Significantly more women take up genetic testing then 
men and so it may be those men involved in family discussion are over-represented within these 
samples.  
 
It has been proposed that women are the ‘housekeepers’ of genetic knowledge (Richards, 1996). 
Early studies looking at family communication about inherited cancers describe women as being 
the ‘kin-keepers’ (Richards and Green, 1996;Green et al., 1997) and that the key providers of 
information are mothers (Green et al., 1997). In 2009, Daly (2009) conducted a literature review 
on the experiences of males in families with positive BRCA1/2 mutations. While acknowledging 
that the data are limited, Daly concluded that men are considerably less likely to participate in 
communication regarding genetics at every level, including the counselling and testing process, 
compared to female relatives (Daly, 2009). Studies involving patients undergoing genetic testing 
and/or counselling for hereditary breast and ovarian cancer have consistently highlighted that 
responsibility for communicating information within families is more likely to be taken by 
women rather than men, even if they are not at risk themselves (Claes et al., 2003;Foster et al., 
2004a;Wagner et al., 2003;Forrest et al., 2003;D'Agincourt-Canning, 2001). Women are more 
likely to communicate genetic test results (d’Agincourt-Canning 2001; Forrest et al. 2003; 
Hughes et al. 1999; Lerman et al. 1998) and female relatives are more likely to be informed 
about hereditary breast and ovarian cancer (Hughes et al. 1999; Julian-Reynier et al. 2000; 
Lerman et al. 1998). Similar findings have also been seen with communication about carrier-
testing in Haemophilia A families, a chromosome X-linked disorder carried by females (Sorenson  
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et al., 2003;Varekamp et al., 1992). So, it may be that female family members are not necessarily 
well-informed of the risks to males, meaning they are less likely to include them in discussions 
(Green et al., 1997). 
 
In a qualitative interview study exploring how information about BRCA1/2 genetic testing is 
disseminated within the families of at-risk men who undergo genetic testing, Hallowell et al. 
(2005a) found that, although both parents reported sharing the responsibility for initially telling 
their children about their father’s intention to undergo testing and/or disclosing the genetic test 
results, on-going discussions about the health implications for offspring tended to take place 
between children (particularly daughters) and their mothers. This held true regardless as to 
whether the father was found to be a mutation carrier or not (Hallowell et al., 2005a).  
 
Authors have suggested that the reason women play such a dominent role in family 
communication is because these are ‘female’ diseases. However, studies of family 
communication regarding genetic diseases that are carried by and affect both sexes offer no 
conclusive evidence to support this. For example, some studies looking at family communication 
and genetic testing for cystic fibrosis (Ormond et al., 2003) and hereditary non-polyposis colon 
cancer testing (Peterson et al., 2003), have suggested dissemination of  genetic information 
within the family is undertaken by both men and women relatively equally. Whereas, other 
HNPCC communication studies have reported women as being the key providers of information, 
even if their husband is the one at-risk (Koehly et al., 2003;McAllister, 1999). 
 
It is clear that something needs to be done to increase the awareness of risks to male relatives 
and their offspring so they are included in family communications regarding genetic testing (see 
Key Finding four). Further research is also needed into the best way to present the information 
to male relatives so they can make informed decisions about genetic risk. Gaff et al. (2005)  
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looked into how the genetic counselling process and communication aids could be utilised to 
help those undergoing genetic testing for cancer risk in order to inform relatives that predictive 
genetic testing is available. They found there were clear gender differences. For example, 
women reported that it was normal for family members to communicate about these issues, 
whereas no men reported that it was normal to communicate about these issues. Most of the 
male participants expressed a need for guidance or professional support in communicating to 
relatives, and they found advice about which family members should be informed helpful (Gaff 
et al., 2005). 
 
 
Key Finding Four: Emotionally distant and male relatives are only contacted selectively. Those 
undergoing genetic testing are not good at identifying all at-risk family members in order to 
share the implications of the genetic test with them. 
 
The conceptual model for the theoretical basis of this work, introduced in section 3.4.4, held 
that family functioning, namely family health beliefs about hereditary breast and ovarian cancer 
and family organisational and structural characteristics, would affect family communication 
regarding BRCA1/2 genetic testing. This has consistently been supported in the findings of the 
study.  
 
This work also shows that, because of the shared health beliefs and structural characteristics, 
those undergoing genetic testing for BRCA1/2 are not good at identifying who they should 
include in discussions in order to pass on relevant information to at-risk relatives. Instead, 
communication is based on existing norms and patterns within a family that establish how its 
members generally interact with each other.  
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However, as Peterson (2003) points out, from a clinical point of view the function of 
communication may be focussed on accurately disseminating health risk and disease 
information among potentially at-risk family members; from the perspective of the individual 
undergoing genetic testing for BRCA1/2, it may also serve as a social support function to build 
interpersonal ties and to facilitate coping. The findings of this present study show that, for 
participants, it was their emotionally close, female relatives who offered such social support and 
regular dialogue. As a result, male relatives and more distant relatives are often excluded.  
 
In section 8.2.4, laying the communication eco-map (which showed who was actually told) over 
the family tree (which showed who should ideally be told) revealed potentially at-risk relatives 
who were not given information about genetic testing. The important thing this doctoral study 
demonstrates is that the relatives being missed out are not random, but that there are clear 
patterns. For example, those undergoing genetic testing for BRCA1/2 readily talk to relatives 
they are emotionally close to; those that are missed are men (refer to Key Finding three) and 
more emotionally distant relatives (refer to Key Finding one). 
 
It is clear that one of the ways to improve family communication regarding genetic testing for 
BRCA1/2 is to help those undergoing genetic testing use their family tree rather than their 
existing norms and communication patterns within the family when identifying who, in the 
family, the information is relevant to in terms of genetic risk. That is not to say they will not 
continue to talk to particular relatives in order to seek support throughout the process, but 
rather, in addition to that, they are aware of who in the family may also be at risk.  
 
The findings in Chapters Five to Eight, and the Systematic Review presented in Chapter Two, 
would suggest that endorsement from the clinical staff at the genetic services leads to increased 
family communication. Those participants who remembered discussions about communicating  
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with relatives during the genetic counselling process described it as an important, necessary 
task. However, others reported not remembering talking to the genetic practitioners about 
communicating their results to family members; in these cases, there was less evidence of 
discussions with people outside of their normal communication patterns. This would suggest 
that the encouragement of the genetic practitioner was an important factor in influencing 
whether relatives were informed. Therefore, one recommendation for the practical 
implementation of this work would be to encourage genetic practitioners to actively engage 
patients in more discussions about the consequences of the genetic test results for other family 
members, and how this may be communicated with them. That is not to say that genetic 
practitioners should directly tell clients they must inform all at-risk relatives, which would be 
contradictory to the non-directive principles of genetic counselling. But rather, the evidence 
suggests that, by introducing the topic and offering support to those undergoing genetic 
counselling to identify who, in the family, the information may be relevant to, it would be hugely 
beneficial in promoting family communication regarding genetic testing for BRCA1/2. According 
to Peterson (2005), practitioners can play an important role in helping encourage prospective 
consideration of  barriers and difficulties in sharing genetic information, as well as to support 
identification of strategies for addressing potential problems.  
 
The success of using the eco-maps in this study would also endorse using an eco-map or 
genogram in a therapeutic way in clinical practice to point out support networks or possible 
difficulties within the family. Daly (1999) found that the genogram can serve as a tool to 
members of a multidisciplinary clinical genetics team to provide a recorded memoir of a family’s 
past and present attitudes and beliefs about genetic risk, as well as a record of the quality of 
relationships and dynamics within the family. Eunpu (1997) also supports the use of the 
genogram to incorporate the exploration of family relationships within the genetic counselling  
 
301 
 
setting. It may be that other, external tools,
31 such as leaflet or an online resource, could be 
developed to support those undergoing genetic testing to identify potentially at-risk relatives.  
 
 
Key Finding Five: As far as family are concerned, members do not have the right to make an 
informed decision to decline.  
 
The literature consistently reports one of the primary motivations for undergoing genetic testing 
is to learn more about their health risks for other family members (Hallowell et al., 2003). During 
their family communication regarding genetic testing, almost all participants came across at 
least one family member who did not want to know about the testing, the results, or who was 
not prepared to act on the news. This was often a cause for concern. In these instances, the 
decision was made, sometimes in consultation with the clinician, to wait until the results came 
back before pursuing it further. Participants in this study were interviewed eight to 18 months 
after receiving their BRCA1/2 test result and, for many of them, the family were still struggling 
with immediate family members, mostly sons and brothers, who did not want to go for genetic 
counselling or genetic testing, but who they believe should. As mentioned in Chapter Eight, this 
often became a family affair, with several generations of family members getting involved with 
talking that person round. 
 
Paradoxically, when talking about more distant relatives, many participants expressed the 
sentiment that, once the information about genetic risk in the family had been passed on, it was 
up to the recipient to act on, that it was an individual choice and that their opinions regarding 
genetic testing should be respected. However, when discussing members of their immediate 
                                                           
31 Accessible outside genetic counselling appointments.  
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family who had opted not to follow up with the genetic counselling, the consensus was that they 
were ‘wrong’. This was especially true if they had children (in particular, daughters) who could 
potentially be at risk, and so discussions would continue until they could be persuaded. As far as 
family are concerned, members do not have the right to make an informed decision to decline. 
 
Limited data are available about at-risk individuals who decline genetic testing. Foster et al. 
(2004b) conducted a cohort study of 315 adults eligible for predictive genetic testing for 
BRCA1/2 from nine UK centres. The aim of the cohort study was to investigate the psychosocial 
impact of predictive genetic testing for BRCA1/2. However, 34 (11%) of the 315 cohort declined 
the offer of predictive genetic testing, allowing the authors to conduct some research around 
this group. Seventy-nine per cent of the test decliners were women; 76% were married or living 
with a partner; 53% had a college or university education; and 76% had children. There was no 
difference in sex distribution, marital status or employment status among test decliners and test 
acceptors. However, the decliner group were significantly younger than the test acceptors 
(p=0.03; MW), and had fewer (p=0.001; MW) and younger (p=0.006; MW) children. However, as 
the authors note, due to the small numbers, this should be interpreted with caution (Foster et 
al., 2004b). 
 
While 78% of test decliners felt that their health was at risk, they reported not wanting a genetic 
testing because, if they were found to carry a BRCA1/2 mutation, they would worry: about their 
children's health (76%), their life insurance (60%), and their own health (56%). When asked 
about whether or not they would think about having a BRCA1/2 test in the future, 77% said that 
they might want the test in the future, 18% were undecided, and only one (5%) reported that 
she definitely never wanted the BRCA1/2 test (Foster et al., 2004b).  
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Few studies have prospectively compared cancer-related distress in decliners and testers and 
the research to date is limited by small decliner groups and/or uncontrolled analyses. Lodder et 
al. (2003) reported no differences in cancer-related distress between decliners and testers using 
nine of the 15 items of the impact of event scale (IES)
32, where all participants had received 
counselling or education before deciding to decline testing. The sample, however, only included 
13 decliners (Lerman et al., 1998). Foster et al. (2004) found test decliners had lower levels of 
cancer worry, using the 6-item Cancer Worry Scale-Revised,
33 compared to those women who 
had accepted the test. Reichelt et al. (1999) found unaffected women (n = 301) who declined 
BRCA1/2 testing had significantly lower levels of HADS
34-defined depressive symptoms, 
compared to testers, although other potential confounders were uncontrolled. In contrast, two 
studies (Thompson et al., 2002;Lerman et al., 1998) found lower distress in decliners; however, 
in these cases, the decliners either did not receive counselling/education, or measures were 
completed before counselling sessions. 
 
For example, Lerman et al. (1998) reported higher rate of cancer worry (Intrusion Subscale of 
the Revised Impact of Event Scale) and depression (the Centre for Epidemiologic Studies 
Depression (CES-D) Scale
35) amongst men and women participating in a research study who did 
not wish to learn their BRCA1/2 predictive test result, compared to those that requested testing. 
Likewise, Thompson et al. (2002) found African-American women who declined both counselling 
and testing for BRCA reported the lower levels of cancer-specific distress (Intrusion Subscale of 
the Revised Impact of Event Scale)  compared to those who underwent counselling. However, 
the participants who declined counselling did have: significantly less knowledge of breast cancer 
                                                           
32 Impact of event scale (IES)  [Horowitz et al. 1979]. 
33 The 6-item Cancer Worry Scale-Revised (Foster et al. 2002b; Lerman & Schwartz 1993). 
34 Anxiety and Depression Scale (HADS). 
35 The Centre for Epidemiologic Studies Depression Scale (CES-D; (Radloff 1977)).  
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genetics; significantly higher perceived barrier scores; greater anticipation of negative emotional 
responses to testing; and more concern about stigmatisation. 
 
Questions remain as to why individuals decline genetic testing for BRCA1/2 and what the 
consequences of this action are. Barriers for cancer genetic counselling and reasons to decline 
genetic testing reported in the literature include: anxiety; anticipation of negative emotional 
reactions to the test result; travelling to the genetics clinic; taking time away from work/family; 
concerns for health insurance; no perceived benefit; and time commitment (Codori et al., 
1999;Decruyenaere et al., 1997;Foster et al., 2004b;Geer et al., 2001;van der Steenstraten et al., 
1994). Of course, such barriers can be discussed in genetic counselling. However, it is important 
to appreciate that not all eligible individuals reach genetic services in order to discuss them. This 
was certainly the case for the participants’ relatives, who decided not to pursue genetic testing 
themselves in this present study; in most cases, their decision was based on the second-hand 
information provided to them by other relatives who had attended genetic counselling sessions.  
 
The genetic counselling process is designed to allow those individuals eligible for predictive 
genetic testing to make informed risk management decisions and minimise psychological 
distress experienced, whether or not they proceed with predictive genetic testing (Foster et al., 
2004b). However, if these relatives are not even reaching genetic counselling, can they be said to 
making an ‘informed’ decision? The ’declining’ relatives, with whom the participants in this 
study, and their family, are battling with because they do not agree with their decision not to 
pursue genetic testing, are largely those who have not had direct contact with the genetic 
service. Instead, their information and knowledge has been communicated to them though the 
family members that have attended and opted for genetic testing.  
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It may be that they feel they have had enough accurate information from their family to make 
an ‘informed’ decision and, therefore, from a professional opinion that is their choice and should 
be respected. However, if, as these findings suggest, the information is being communicated 
haphazardly and some individuals are declining testing for less well-informed reasons, then 
further research is needed on how to support this group and to improve family communication 
regarding genetic testing. Also, as Foster et al. (2004b) point out, ‘whilst genetic counselling aims 
to be non-directive, relatives may be far from impartial’ (p. 25). 
 
 Similar to the findings of this present study, Foster et al. (2002) reported that relatives with 
children not interested in BRCA1/2 testing were described as selfish by individuals tested, and 
women have described encouraging relatives to have BRCA1/2 testing. Tension may arise within 
these families and continue long-term, potentially resulting in some individuals eventually 
feeling coerced into testing against their will. This is an area where further research is needed; 
the problem being that those who do not reach genetic services are a difficult, if not impossible, 
group to assess (Foster et al., 2004b), thus making future research challenging.  
 
 
Key Finding Six: Plans for telling people in the future, especially children, is a cause of worry 
and concern and needs further support, especially long term. 
 
Participants in this study had 35 adult children (over the age of 18 years old). Almost all of them 
were informed about their parent’s genetic test result and were included in discussions about 
cancer in the family to some degree (refer to Chapter Five). Twelve of the 29 participants had 
offspring under the age of 18 years, totalling 24 children (refer to section 5.2). The mean age 
was 12.6 years for girls and 9.7 years for boys. Six of the 24 children aged 14 to 17 were told  
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about their mother’s genetic testing (giving a disclosure rate of 25%), compared to 18 children, 
aged 2-15, who were not informed. 
 
From the findings presented in Chapter Five, it could be hypothesised that older children (those 
over 15 years old) are more likely to be told than younger children (those under 14 years old). 
Also, the children’s gender has little impact on disclosure of test results as, in all cases except 
one, the information was either given to all siblings under the age of 18 years or none. However, 
as there were only a few children reported in this study, it is difficult to draw any definite 
conclusions. There is evidence in the current literature to support this thinking.  
 
A number of studies have reported on whether parents communicated BRCA1/2 genetic test 
results to at-risk offspring (Wagner et al., 2003;Patenaude et al., 2006;Claes et al., 
2003;Bradbury et al., 2007;Hughes et al., 1999;Tercyak et al., 2001;Tercyak et al., 
2002;McGivern et al., 2004;Hallowell et al., 2005a). These studies give an average disclosure rate 
of approximately 50% for offspring aged between 4 and 25 years old. However, few studies 
break down disclosure rates by age, e.g. adult versus child offspring, which may explain the 
higher rate than found in this present study, which only includes offspring aged 17 years old and 
younger. Only a handful of studies specifically discuss disclosure to young children (Tercyak et 
al., 2002;Bradbury et al., 2007;Bradbury et al., 2012;Tercyak et al., 2001). 
 
Several studies have shown that the age of offspring is an important factor in parental decisions 
as to whether or not to disclose test results. Segal et al. (2004) found that, out of 31 mothers 
disclosing their BRCA test results to offspring, 50% of offspring aged 20 to 29 years were 
informed of the results, whereas approximately 25% of those aged 19 years or younger were 
told (similar rates found in this present study). However, unlike this study, sons and daughters 
were not notified equally (Segal et al., 2004). Likewise, Bradbury et al. (2007) reported 83% of  
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offspring over 18 years old were told of their mother’s positive BRCA mutation results, 
compared to only 21% of those aged 13 years or younger. 
 
Interestingly, Bradbury et al. (2007) reported that almost half the parents reported that their 
child did not appear to understand the significance of a positive BRCA1/2 test result, with older 
children seeming to have a better understanding. Level of understanding was measured by 
parents' qualitative perception rather than quantitatively, using a standard tool.  
 
In 2012, Bradbury et al. conducted semi-structured interviews with 253 parents (61% response 
rate), who had BRCA1/2 testing and at least one child under the age of 25 years. Of the 505 
offspring, 334 (66%) were told about their parent's test result. Children were more likely to be 
told if they were older (P ≤ .01), were female (P = .05), or if the parent's test result was negative 
(P = .03). Parents most frequently reported their offspring’s initial response was neutral (41%) or 
relief (28%). However, 13% of offspring were reported to experience concern or/and 11% 
distress; this was associated with parents receiving a BRCA1/2 positive or inconclusive result 
(Bradbury et al., 2012). 
 
Hallowell et al. (2005a) observed that parents adopted one of three strategies when 
communicating information about a father’s genetic risk for BRCA1/2 to their children. These 
were complete openness, limited disclosure, or total secrecy, in which the timing and content of 
disclosure varied. Parents justified the adoption of a particular strategy by reference to 
children’s rights to information versus parental duty to avoid causing children. The authors 
found parents were more hesitant about discussing genetic testing and its implications with sons 
and younger children (those less than 18 years old) prior to receiving the result. However, unlike 
the findings of this study, which found that whilst the majority of adult children were informed, 
only 25% of child offspring were, by the time Hallowell et al.’s research interviews occurred  
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(median time since receipt of results = 26 months; range 8-74 months) nearly all of the offspring, 
including child offspring, had been informed about their father’s test result. It is worth noting 
that only eight out of 16 fathers included in the study had children under the age of 18 at the 
time (Hallowell et al., 2005a). 
 
Tercyak et al. (2002) found that participants who told their children younger than 13 years about 
their genetic test result said their children had increased distress, compared to participants that 
did not tell their young children, who experienced a slight decrease in distress.  
 
The findings presented in Chapter Eight show that those participants with young children, and 
who had received a positive BRCA1/2 test result, had given some consideration as to how and 
when their children should be told in the future; and this matter caused them anxiety to a 
greater or lesser degree, depending on the personality and how much support they perceived 
themselves to have. 
 
Several studies have shown that parents regard the disclosure of genetic information to their 
children as their personal responsibility rather than the responsibility of health professionals 
(Claes et al., 2003;Forrest et al., 2003;Hallowell et al., 2005a). This was true of these 
participants; however, several suggested that they would seek advice from a genetic counsellor 
when they decided the time was right to share the information.  
 
Previous studies have looked at the kind of support people undergoing genetic testing would like 
when talking to their children about the genetic test and its implications. For example, Tercyak 
et al. (2007) found mothers undergoing BRCA1/2 testing, who had children aged 8-12 years, 
most-to-least frequently cited information resource needs regarding communication to be: 
literature (93.4%), family counselling (85.8%), prior participants (79.0%), support groups (53.9%)  
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and other (28.9%). Similarly, Segal et al. (2004) found that those who had disclosed their 
BRCA1/2 results and those who had not, respectively, indicated that they would have 
appreciated further follow-up meetings with a genetic counsellor (50.0% vs. 46.2%), family 
counselling (38.9% vs. 38.5%), peer support groups of carriers and their children (33.3% vs. 
38.8%), professional-led support group (22.2% vs. 38.5%), educational forum for families (46.2% 
vs. 38.8%), or information pamphlets on ‘how to disclose and cope’ with genetic test results. 
 
Many of the participants in this situation felt that the ‘right’ time to share their genetic test 
results and its implications was when their children were ‘grown up’ and emotionally equipped 
to deal with the information. Predictive genetic testing for adult-onset diseases, such as breast 
and ovarian cancer, is generally discouraged until the age at which interventions, such as risk-
reduction measures and screening, are believed to be helpful, which is usually not before 25 
years old (Bradbury et al., 2007;Bradbury et al., 2012).  
 
This Key Finding would support a call for further research looking at the experiences of parents 
telling their young children about their genetic testing, both at the time and, for those who 
choose to, at a later date; and looking at how they could best be supported by genetic 
professionals. 
 
 
9.4  Limitations of Work 
 
Naturally, there are some limitations to this study. The work presented in this thesis represents 
not only the development of knowledge on the topic of how those undergoing genetic testing 
for BRCA1/2 talk to their family, but also the development of the author’s competence and  
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capabilities as a researcher. The work was undertaken by an apprentice researcher and, as such, 
the learning curve associated with it was huge. The strengths and weaknesses of the work are 
inextricably linked to these two parallel processes and the journey of learning that took place 
over the years of its development.  
 
The sample was purposively sampled and, therefore, does not represent the entire population 
for whom genetic testing for BRCA1/2 would be appropriate. However, as this was a piece of 
exploratory qualitative research, this was never the intention of this work. Individuals who were 
considered by the geneticists as too vulnerable to participate were excluded (refer to 4.3), and 
affected families who did not come into contact with clinical genetic services were not 
represented. The response rate was 37.7% of those eligible patients invited to participate (see 
section 5.2). Many of the participants reported to the interviewer that their relatives had also 
received an invitation to participate and intended to do so. However, only three sets of relations 
were included in the final interviews (two sets of sisters, and one aunt and niece). This suggests 
that, despite potentially showing interest to their family, many potential participants did not 
return their forms to the researcher. As a term of the ethical approval, no reminder letters were 
sent to individuals who did not send back a reply slip, which may have limited the response rate.  
 
The participants were predominately Caucasian women with at least one child. Most 
participants had an inconclusive or negative mutation status. Although not evident in the 
findings, it is possible that those receiving a positive result found talking to their relatives more 
challenging, which would be under-represented in this population. Only two men were included 
in this sample (although this is proportional to the number of men who undergo genetic testing 
for BRCA1/2 at the Genetics Centre compared to women). Even so, Gaff et al. (2005) found that 
men had a greater need for professional support than women when communicating genetic  
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testing results for Hereditary Non-Polyposis Colorectal Cancers (HNPCC), suggesting that this 
population would warrant further research. 
 
From the outset, potential participants were aware that the study aimed to examine family 
communication following genetic testing, and so it may have appealed more to those who felt 
they had had positive experiences of this, were more confident, and/or willing to talk. Also, 
there were complicated cases of family communication at the time this study was being 
conducted as reported by the staff at the Genetics Service. It may be that some or all 
participants wanted to present themselves in certain ways, and therefore under-reported 
complicated or difficult situations. As such, those who found the experience of communicating 
with relatives more challenging may be under-represented, thereby introducing a sample bias.  
 
As with all studies that employ a retrospective design, it is possible that the participants’ 
accounts may have been tainted by hindsight or the need to present themselves as responsible 
parents.  
 
The work could be criticised for the lack of triangulation given that only one data source was 
used. However, the focus of the study was to concentrate on the experiences of the individual's 
themselves within their own life world. The inclusion of multiple data sources would have 
introduced alternative perceptions, which would have been contradictory to this focus. Had 
multiple sources been used, then the depth of the data that was attained could not have been 
achieved due to the breadth which would have been required. Also, the utility of other sources 
of data, with the exception perhaps of other family members, would not have contributed to the 
aims of the study.  
  
 
312 
 
This work is arguably weakened by not adhering solely to a predefined and validated method of 
data analysis. The difference between reading and understanding how to conduct qualitative 
data analysis, and actually putting that into practice without losing either the depth or breadth 
of the data, was one of the hardest challenges to overcome as a novice researcher, as describing 
how to conduct qualitative data analysis is so often over simplified in the reporting in the 
literature. That said, although the data analysis was influenced by many sources, the final 
method used was logical and transparently reported, meaning that it could be repeated by 
another researcher.  
 
If the study had been conducted with family, rather than individual, interviews it might have 
yielded different results and recruited a different sample. To meet the family together would 
allow the researcher to observe the interactions between members, including their roles, 
agreements, disagreements, efforts to expose or protect each other  (Sobel and Cowan, 2000). 
This would have been in keeping with a systems framework, which recognises that the whole 
family is more than the sum of its parts and would have meant the family as a unit would be the 
focus of the analysis. However, this approach was not chosen because, as discussed in section 
3.4.4, whilst talking about genetic testing and its risk implications may be viewed as a ‘family 
affair’, the individuals undergoing the genetic testing for BRCA1/2 may need to interact with 
their families in a new and unfamiliar manner (Peterson, 2005). In order to explore how and 
when those undergoing testing talk to their family, it was important to capture the experience of 
the individual, and their definition of who constitutes their family, within that. Therefore, a 
conceptual model, adapted from Peterson’s (2005) family systems model , and Carter and 
McGoldrick’s (1989) ‘Family Life Cycle’, which allows the study of how individuals within a family, 
and by association the family as a whole, adapt to chronic illness, was used as theoretical basis 
of this work.  
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Finally, the extent to which this study has succeeded in meeting its objectives depends not only 
on the sample of participants, but also the data collection and analysis strategy. This study was 
conducted from within an interpretive paradigm utilising an interpretive descriptive 
methodology. However, it is important to acknowledge that a different theoretical perspective, 
such as a phenomenological or ethnographical perspective, might have resulted in different 
findings.  
 
 
9.5   Contributions to Knowledge, Implications and Future 
Research 
 
The longitudinal view of family communication regarding genetic testing for BRCA1/2 presented 
in this thesis is a new way of examining how those undergoing the genetic testing talk to their 
family as an on-going process. Gaining an understanding of the process of how and when, those 
undergoing genetic testing for BRCA1/2, talk to their relatives means the development of future 
interventions to support such family communication can be specifically targeted, not only to the 
most appropriate time point(s), but also to be in accordance with how these families are already 
communicating. Presenting the longitudinal view in this way, it endorses the need for 
prospective, longitudinal research looking at the experiences of individuals and families at each 
stage of the process.  
 
Section 9.3 has identified some specific areas, relating to the six Key Findings of this work, where 
further research is needed. For example:  
1.  Further evidence-based research and theoretical development would be required to 
support whether the Theory of Engagement (McAllister 2002) has the potential to  
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provide a psychosocial model for explaining variations in behaviour around family 
communication for cancer risk (see Key Finding two). 
2.  Work is needed to increase the awareness of risks to male relatives and their offspring, 
and accuracy of transmission, so they are included in family communications regarding 
genetic testing (see Key Finding three).  
3.  The findings support that how those undergoing genetic testing for BRCA1/2 talk to their 
relatives is influenced by preexisting structures and belief systems within the family. 
Future research is necessary to examine the most effective way to appropriately utilise 
these in order to improve family communication on the topic (Harris et al., 2010). 
4.  It is also necessary to identify the most suitable way(s) for those undergoing genetic 
testing for BRCA1/2 to present the information about genetic testing and its implications 
to male relatives, so they can make informed decisions about genetic risk (see Key 
Finding three). 
5.  It is clear that one of the ways to improve family communication regarding genetic 
testing for BRCA1/2 is to help those undergoing genetic testing use their family tree 
rather than their normal communication patterns (as identified on their eco-maps)  
when identifying who in the family the information is relevant to (see Key Finding four).  
6.  Little is known about those family members who decline a genetic test and whether that 
decision is a fully informed one; also, whether some decliners eventually feel coerced 
into testing against their will by other family members (see Key Finding five). 
7.  Plans for telling people in the future once regular contact with the genetics service has 
stopped, especially children, is a cause of worry and concern and needs further support, 
especially long term (see Key Finding six). 
8.  The findings would support a call for further research looking at the experiences of 
parents telling their young children about their genetic testing, both at the time of  
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testing and, for those who choose to, at a later date; and looking at how they could best 
be supported by genetic professionals (see Key Finding six). 
 
Very few of the research participants were aware of the support mechanisms available to them 
from the Genetics Service; for example, contacting relatives directly on their behalf or producing 
customised letters to send to family members. Subsequently, this should be highlighted as an 
area where extra support and future research should be targeted. It is important that genetic 
practitioners take time to identify if this is a service that could be useful to the individual and 
offer it accordingly so a family member does not slip through the net. These findings are 
supported by Barsevick et al. (2008), who emphasise the need for genetic counsellors to devote 
more time and attention to help prepare individuals to communicate genetic test results to 
those relatives from whom they are distanced or estranged. The findings of Wiseman et al. 
(2010) also suggest that genetic practitioners would benefit from obtaining a clear 
understanding of the ‘personal beliefs of those undergoing genetic testing about sharing genetic 
risk information and the relationships that that person has with each relative in order to identify 
areas of difficulty and support accurate communication’ (p. 701). 
 
Overall, the findings suggest that the developing interventions to help manage problems 
associated with family communication regarding genetic testing for cancer risk should be a top 
research priority, especially as the numbers of people affected by these issues is set to rise as 
more genes are discovered. The longitudinal view identified gives deep insight into how and 
when genetic testing for BRCA1/2 and its implications are discussed within these families. This 
understanding will allow future interventions to be targeted where they are most helpful. 
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9.6  Conclusion  
 
This research presented in this PhD thesis is particularly important because, as has been 
demonstrated, family communication regarding genetic testing for BRCA1/2 can play a major 
role in ensuring relatives get access to genetic services and risk information. Nevertheless, the 
evidence suggests it can cause considerable distress and poses many challenges for those 
undergoing genetic testing. As a result, there have been numerous calls for interventions and 
support mechanisms from the clinical and academic communities. However, the critical review 
of the existing literature at the beginning of this PhD journey suggested this is not yet achievable 
because the nature of interactions regarding genetic information in families remains poorly 
understood. Therefore, this work strives to fill some of the gaps identified in the literature, 
which would also allow the improvement and development of future genetic services.  
 
The work presented provides three key contributions that develop existing knowledge further. 
Firstly, this is the first piece of qualitative research that looks at how those undergoing genetic 
testing for BRCA1/2 talk to their friends and family throughout the whole process before, during 
and beyond genetic counselling and genetic testing. This longitudinal view of family 
communication regarding genetic testing will allow future interventions to be specifically 
targeted where they will be most useful and to give the necessary level of support at the right 
time during what is now recognised as an on-going process.  
 
Secondly, the work goes beyond the current literature by demonstrating how communication 
between emotionally close- and emotionally distant relatives differs, and why. In summary, with 
the first group, communication is focused around sharing and supporting; whereas with the 
latter it is about gaining and imparting information. As a result, the findings also demonstrate  
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the differences in expectations and follow up. Communication with emotionally close relatives is 
an on-going process that may have long last effects on the family; for example, relatives may not 
have the right to decline genetic testing in the eyes of other family members. On the other hand, 
communication with emotionally distant relatives is more haphazard and largely relies on 
information being cascaded down through the family.  
 
Finally, despite participants being engaged and open to informing potentially at-risk relatives, 
there are clear pattern of whom those undergoing genetic testing for BRCA1/2 are not 
communicating with. In particular male and more distant relatives with whom they are not 
normally in regular contact with. It would appear that the current model of genetic counselling 
offered to these participants is not enough to overcome participants’ reliance on their normal 
communication patterns and pre-existing health beliefs and attitudes often shared by the family 
when discussing genetic testing and genetic risk to at-risk relatives. From this, the findings can 
be used to make specific recommendations on how to improve support, for example the 
development of interventions that encourage those undergoing genetic counselling/testing for 
BRCA1/2 to use their family tree rather than their normal pattern of communication, as shown 
on their eco-maps, to identify who the information is relevant to.  
 
The original research question for this PhD thesis, as described in Chapter Three, was focussed 
on how and when those undergoing genetic testing for BRCA1/2 talk to the relatives about 
family history of cancer, associated risk and genetic testing.  The extent to which the thesis 
addresses the research question should be considered. The longitudinal view presented in the 
findings does examine family communication at four difference stages throughout an on-going 
process and so does address the ‘when’ element of the research question directly.  
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The findings also give insight in to how communication differs at each stage. For example, stage 
one communications are based on normal communication patterns with emotionally close 
relatives and are influenced by cancer burden, in particular by death, diagnosis and life stage. 
During stage two communications with those same relatives continues in the form of sharing 
experiences and now knowledge from genetic counselling because it is viewed as new and 
interesting. This is also the stage where family communication with emotionally distant relatives 
may begin in the form of needing family history information and/or accessing predictive genetic 
testing through the diagnostic genetic testing of a relative who has already had cancer. Stage 
three communications occurred in two distinct waves: firstly rapid disclosure of test results to 
emotionally close relatives to alleviate anxiety with little thought or preparation; followed by 
keeping those in the known in the loop. Stage four communication could be an issue years in to 
the future and revolved around sharing a positive result, however was not limited to the person 
receiving that result, but rather became a family affair. Participants relied on sharing leaflets and 
clinic summary letters to ensure accurate transmission of genetic information; and often-
delegated tasks to certain family members to ensure the job got done.  
 
The discussion provided in the final chapter of this PhD thesis focusses on six key findings that 
are over-arching themes across how those undergoing genetic testing for BRCA1/2 talk to their 
relatives rather than ‘how’ the information was transmitted, in terms of who said what and how 
it was received. This slight shift in focus away from the original research question strengthens 
the work in two strategic ways:  
1.  It provides evidence that data analysis went beyond just describing the events that 
occurred as reported by participants to providing an interpretive understanding that 
exposes the characteristics, patterns and structure in some clinically and theoretically 
useful way.   
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2.  It allows the researcher to make significant and meaningful recommendations for future 
research and implications for clinical practice and intervention development that will 
help families talk about these issues.   
 
The work was always intended to have a pragmatic emphasis. The very nature of “here is a 
problem that real people using the genetic services in the National Health Services are facing 
and something could be done to improve that situation” was the thing that appealed most as an 
area of study.  In fact, the initial PhD proposal was for a two-phase study: a short exploratory 
study looking at the how those undergoing predictive genetic testing shared their test results 
with their at-risk relatives, followed by the development and piloting of an intervention to 
support these activities. Unluckily for the plans for a short PhD, but fortunately for the author’s 
continued development and training in qualitative methods, during the literature and proposal 
development it became clear that the first phase, if it was to be done rigorously with the 
required depth, would be ample to produce "an original and substantial contribution to 
knowledge”. 
 
Although the majority of this PhD thesis represents a piece of qualitative research, there is 
evidence of a researcher whose roots lie in quantitative and lab-based research. For example, 
the eco-maps have been analysed quantitatively resulting in a measure of cohesion with the 
family. The methods chosen, such as: - Jones’ methods of conducting systematic reviews and 
meta-synthesis, Miles and Huberman’s sourcebook of data analysis and Ritchie and Spencer’s 
Framework Approach, all provide a clear and logical, practically step-by-step instructions,  for a 
novice qualitative researcher to work through in what otherwise could have been a unruly depth 
of data. As well as giving structure and order to the proceedings, these methods have the major 
benefit of providing a very clear and coherent audit trail for the researcher, and others. That is  
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not to say that purist qualitative researchers do not work logically or are unable to provide an 
audit trail to their work, but rather to acknowledge how  the personal qualities of this, now most 
definitely a ‘mixed methods’ researcher, bring strength to the work.  
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Appendices 
Appendix 1: Quality Assessment Tool for Qualitative Papers. 
 
1. Abstract and title: Did they provide a clear description of the study? 
Rating  Criteria  Score 
Good  Structured abstract with full information and clear title.  3 points 
Fair  Fair abstract with most of the information.  2 points 
Poor  Inadequate abstract.  1 point 
Very 
poor 
No abstract.  0 points 
 
2. Introduction and aims: Was there a good background and clear statement of the aims of the 
research? 
Good  Good full but concise background to discussion/study containing up-to date literature 
review and highlighting gaps in knowledge. Clear statement of aim AND objectives 
including research questions. 
3 points 
Fair  Some background and literature review. 
Research questions outlined. 
2 points 
Poor  Some background but no aim/objectives/questions,  
OR Aims/objectives but inadequate background. 
1 point 
Very 
Poor 
No mention of aims/objectives. 
No background or literature review. 
0 points 
 
3. Method and data collection: Is the method appropriate and clearly explained? 
Good  Method is appropriate and described clearly (e.g. interview guide included). Clear 
details of the data collection and recording. 
3 points 
Fair  Method appropriate, description could be better. Data collection described. 
 
2 points 
Poor  Questionable whether method is appropriate. Method described inadequately. Little 
description of data collection. 
1 point 
Very 
Poor 
No mention of method, AND/OR method inappropriate, AND/OR no details of data 
collection. 
0 points 
 
4. Sampling: Was the sampling strategy appropriate to address the aims? 
Good  Details (age/gender/race/context) of who was studied and how they were recruited. 
Why this group was targeted. The sample size was justified for the study. Response 
rates shown and explained. 
3 points 
Fair  Sample size justified. Most information given, but some missing.  2 points 
Poor  Sampling mentioned but few descriptive details.  1 point 
Very 
Poor 
No details of sample.  0 points 
 
5. Data analysis: Was the description of the data analysis sufficiently rigorous? 
Good  Clear description of how analysis was done. Description of how themes derived/ 
respondent validation or triangulation. 
3 points 
Fair  Descriptive discussion of analysis.  2 points 
Poor  Minimal details about analysis.  1 point 
Very 
Poor 
No discussion of analysis.  0 points 
 
6. Ethics, bias and rigour: Have ethical issues been addressed, and what has necessary ethical 
approval gained? Has the relationship between researchers and participants been adequately 
considered? 
Good  Ethics: Where necessary issues of confidentiality, sensitivity, and consent were 
addressed. Bias: Researcher was reflexive and/or aware of own bias. Rigour: 
Attempts made to ensure the rigour of the research 
3 points 
Fair  Lip service was paid to above (i.e. these issues were acknowledged).  2 points 
Poor  Brief mention of issues. At least, evidence that ethical approval has been sought.  1 point 
Very 
Poor 
No mention of issues. 
 
0 points  
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7. Results: Is there a clear statement of the findings? 
Good  Findings explicit, easy to understand, and in logical progression. Tables, if present, 
are explained in text. Discussion of results relate directly to aims. Sufficient data are 
presented to support findings. 
3 points 
Fair  Findings mentioned but more explanation could be given. Data presented in 
discussion relate directly to results. 
2 points 
Poor  Findings presented haphazardly, not explained, and do not progress logically from 
results. Qualitative data presented with stats or percentages with only limited 
suggestion that results were used within a qualitative paradigm. 
1 point 
Very 
Poor 
Findings not mentioned or do not relate to aims. Qualitative data presented as stats 
or percentages only (e.g. 4/8, 50% participants said…). 
0 points 
 
8. Transferability or generalisability: Are the findings of this study transferable (generalisability) to a 
wider population? 
Good  Context and setting of the study is described sufficiently to allow comparison with 
other contexts and settings, plus high score in Question 4 (sampling). 
3 points 
Fair  Some context and setting described, but more needed to replicate or compare the 
study with others, PLUS fair score or higher in Question 4. 
2 points 
Poor  Minimal description of context/setting.  1 point 
Very 
Poor 
No description of context/setting. 
 
0 points 
 
9. Implications and usefulness: How important are these findings to policy and practice? 
Good  Contributes something new and/or different in terms of understanding/insight or 
perspective. Suggests ideas for further research. Suggests implications for policy 
and/or practice. 
3 points 
Fair  Two of the above.  2 points 
Poor  Only one of the above.  1 point 
Very 
Poor 
None of the above.  0 points 
 
10. Limitations: Are the limitations of the study discussed? 
Good  Clear description of limitations with critical analysis of impact.  3 points 
Fair  Descriptive list of study limitations.  2 points 
Poor  Minimal details of study limitations.  1 point 
Very 
Poor 
No mention of study limitations.  0 points 
 
11.  Quotes: Are direct quotes of participants used to illustrate qualitative findings? 
Good  Directs quotes used with full explanation of context and meaning and who they were 
made by (e.g. male, carrier). Quotes linked back to results to clearly illustrate points. 
3 points 
Fair  Direct quotes used with some explanation of meaning.   2 points 
Poor  Minimal quotes used with little or no explanation   1 point 
Very 
Poor 
No quotes used. 
 
0 points 
 
12.  Relevance to Systematic Review research question. 
Good  Study explicitly based on family communication following GT with at least one aim to 
investigate factors that facilitate or impede family communication following GT. 
3 points 
Fair  Study based on experiences family communication following GT.  
 
2 points 
Poor  Study based on experiences of genetic testing generally, which included 
issues/experiences of with family communication following GT. 
 
1 point 
Very 
Poor 
Study based on experiences of genetic testing where issues of family 
communication arise but were not explicitly asked about by the researcher.  
0 points 
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Appendix 2: Standard Pro form used to review full papers for inclusion or exclusion in 
Systematic Review 
 
Systematic Review – Filter for Full Papers 
 
Paper  
Reference 
  Primary  
Author 
  Year of 
Publication 
 
 
Inclusion Criteria 
 
Details 
Meets 
Criteria 
Published primary qualitative 
research studies.  
Mixed methods included only if the 
qualitative findings are reported 
and discussed separately from the 
non-qualitative findings.  
 
 
 
 
 
 
 
 
 
 
The participants or a close family 
member (partner, parent or sibling) 
had undergone genetic testing for 
cancer risk. 
 
 
 
 
 
 
 
 
 
 
The outcome measures included 
data relating to factors which 
facilitated or impeded family 
communication following the 
testing. 
 
 
 
 
 
 
 
 
 
These factors are either stated by 
the authors or appeared from the 
published data to be an important 
element in the study findings. 
 
 
 
 
 
 
 
 
 
 
 
Exclusion Criteria 
 
Details 
Meets 
Criteria 
Include other forms of genetic 
testing, such as carrier testing, or 
genetic testing for other conditions 
than late onset cancer. 
 
 
 
 
 
 
 
 
 
Paper Included    Paper NOT Included    
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Appendix 3: Interview Guide for Researcher 
 
1.  Welcome and thank them for participating. Introduce researcher and study 
(including assurances of confidentiality). 
 
2.  Ask if the participant has any questions. 
 
3.  Ask participant to sign consent form (three copies: for hospital notes, for 
researcher, for themselves). 
 
[TURN AUDIO-RECORDER ON] 
 
4.  Demographic Data 
‘I would like to start with a bit of background, so can you tell me a bit about 
yourself?’ 
  Age 
  Occupation 
  Marital status 
  Children 
  General health status 
 
5.  Construct Communication Eco-Map:  
  Explain what map is and its purpose (stress this is about everyday life, not 
necessary genetic testing). 
  ‘Who would you say are the most important people in your life?’ 
 
6.  Experiences of genetic testing and family communication 
  ‘Could you tell me about your genetic testing and how that came about? I 
am particularly interested in who you spoke to about it, when and why.’ 
 
7.  Clarification and follow up 
May include details on:  
  Family communication patterns  
  Type of testing/Mutation status 
  Motives/reasons for GT 
  Coping strategies 
  General process of GT  
  Introduction by genetic service 
  General emotions towards telling family 
  Thought/preparation beforehand 
  People’s reactions  
  Health beliefs 
  Anyone who didn’t want to know 
  Help from Genetic Service 
  Thoughts now (regrets?) 
  Support would have liked 
  Top tips to others in situation 
 
8.  Round up interview, anything they would like to add? 
 
9.  Thank participant for time and effort. Reassurances of confidentiality. Remind 
them that support available from genetic service if they wish.   
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 Appendix 4: Letter of Invitation from the Genetics service  
 
[To be printed on headed note paper] 
 
 
Dear [name of participant] 
 
Re: Invitation to participate in a research study 
 
I am writing to you on behalf of the School of Nursing and Midwifery at the University of 
Southampton to invite you to take part in a research study looking at whether and how 
people who have had genetic testing for hereditary breast or ovarian cancer talk to their 
relatives  about  their  results  and  its  implications,  and  how  the  health  service  could 
support them in doing this. 
 
A  researcher  from  the  University,  Kim  Chivers,  would  like  to  talk  to  you  about  your 
experience of talking to your relatives about your genetic test results. This interview will 
last about one hour, depending on how much you have to say, and with your permission 
it will be audio-recorded. It will take place at a time and place suitable for you, probably 
in your own home. Anything you say will be treated with complete confidence. Please 
read the enclosed information sheet, which provides further detail about the study. 
 
Once you have read the information sheet, if you choose to take part in this study please 
complete the form included and return it to the researcher, Kim Chivers, in the stamped 
address envelope provided. Once Kim has received your form, she will ring you to ask if 
you have any further questions about the research and to arrange a good time for the 
interview. 
 
In the meantime, please do not hesitate to contact Kim if you have any further questions 
about the research. Her telephone number can be found at the end of the Information 
Sheet. 
 
Yours sincerely 
 
 
 
Professor Anneke Lucassen 
Consultant & Professor in Clinical Genetics 
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Appendix 5: Participant Information Sheet  
 
[To be printed on headed note paper] 
 
 
Title of Project: Family Communication Following Genetic Testing  
 
 
Why am I receiving this information sheet? 
We would like to invite you to take part in a research study. Before you decide, you need 
to understand why the research is being done and what it would involve for you. Please 
take time to read the following information carefully. Talk to others about the study if you 
wish. Part I tells you the purpose of this study and what will happen if you take part. Part 
II gives you more detailed information about the conduct of the study. Please ask if there 
is anything that is not clear or if you would like more information. Take time to decide 
whether or not you wish to take part.  
 
Part I 
 
What is the purpose of the study? 
Some people have said that it can be difficult to talk about genetic testing with their 
family.  We  would  like  to  understand  how  people  who  have  had  genetic  testing  for 
hereditary breast and/or ovarian cancer talk to their family about their results so that 
people can be helped to do this in the future. 
 
Why have I been invited?  
You have been invited to take part in this study as you have been identified by the 
Genetic Centre as having had a genetic test for hereditary breast and/or ovarian cancer 
within the last 6-18 months. We hope to talk to up to 30 men and women.  
 
Do I have to take part? 
You do not have to take part; it is up to you to decide if you want to. This information 
sheet describes the study so you can make your decision. If you do decide to take part, 
you can withdraw at any time, without giving a reason. This would not affect the standard 
of care you receive.  
 
What will I have to do? 
Taking part in this study will involve one face-to-face interview with our researcher, Kim 
Chivers, at a place of your choosing. This interview should last about one hour and will 
explore  whether  you  talked  to  your  family  about  your  genetic  testing  results;  your 
experiences of doing so; whether you would have liked more support with this and, if so, 
what  kind  of  support  would  have  been  helpful.  During  the  interview,  you  and  the 
researcher will create a ‘communication map’ – this is similar to a family tree, but may 
include friends and family members not related by blood. This will help us see who, if 
anyone, you have shared your genetic information with.  
 
What should I expect if I decide to take part? 
If you choose to take part in this study we will telephone you to arrange the interview at a 
time and place that is good for you. If the interview is more than one week ahead, we will 
telephone you a few days before the interview to check the arrangement is still suitable.  
 
On the day of the interview we will check you have read the information sheet and give 
you a chance to ask any more questions you may have. We will then ask you to sign a 
consent  form  which  says  you  are  happy  to  take  part,  that  we  can  audio-record  the  
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interview and can use the information you give, which will be made totally anonymous so 
you cannot be recognised, in our write-up of the study.  
 
Expenses and payments 
If you have to travel to the interview we will reimburse all your travelling expenses. 
 
What are the possible disadvantages and risks of taking part? 
While we do not foresee any harm or disadvantages to you by taking part in this study, 
we do understand that you may feel the things we discuss are sensitive and/or personal. 
So we aim to be supportive and open  with you and you  will be encouraged to only 
discuss the things which you are happy to talk about. We will also make sure that, should 
you need it, support is available to you afterwards.  
 
What are the possible benefits of taking part?  
This study may not benefit you directly, but the information you give may help improve 
the service provided for people undergoing genetic testing for hereditary breast and/or 
ovarian cancer in the future. 
 
What happens when the research study stops? 
We hope to be able to use the information provided by you and the other participants to 
develop a way of helping patients talk to their families about genetic risk if they want it.  
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any possible 
harm you might suffer will be addressed. The detailed information on this is given in Part 
II. 
 
Will my taking part in the study be kept confidential? 
Yes.  We  will  follow  ethical  and  legal  practice  and  all  information  about  you  will  be 
handled in confidence. The details are included in Part II.  
 
 
 
This completes Part I. If the information in Part I has interested you and you are 
considering participation, please read the additional information in Part II before 
you make any decisions.  
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Part II 
 
What will happen if I don’t want to carry on with this study? 
It is totally within your right to withdraw from the study at any time without having to give 
any reason. If you withdraw from the study, we will destroy any contact details. 
 
What if there is a problem or I have a complaint?  
If  you  have  a  concern  about  any  aspect  of  this  study,  you  should  speak  to  the 
researcher, Kim Chivers, who will do her best to answer your questions. If you remain 
unhappy and wish to complain formally, you can do this through the NHS or University 
Complaints Procedure. Details can be obtained from the hospital.  
 
In the event that something does go wrong and you are harmed during the research and 
this is due to someone’s negligence, then you may have grounds for a legal action for 
compensation against the University of Southampton, but you may have to pay your 
legal costs. The normal NHS complaints mechanisms will still be available to you.  
 
Will my taking part in the study be kept confidential? 
Yes.  We  will  follow  ethical  and  legal  practice  and  all  information  about  you  will  be 
handled in confidence. All procedures for handling, processing, storage and destruction 
of  data  will  match  the  Caldicott  principles  and  the  Data  Protection  Act  1998.  All 
information which is collected about you during the course of the research will be kept 
strictly confidential, and any information about you which leaves the hospital will have 
your name and address removed and pseudonyms or codes will be used so that you 
cannot be recognised. 
 
All details, including copies of your consent forms, will be kept in locked filing cabinets in 
secure  office  space  within  the  School  of  Nursing  and  Midwifery.  All  recordings  and 
transcriptions will be kept on a password protected computer which is backed up daily. 
Written  field  notes,  memos  and  printed  transcriptions  will  be  kept  in  a  locked  filing 
cabinet  separate  from  any  identifying  data.  All  primary  data  (audio-recordings, 
communication maps, written field notes, memos and transcriptions) will be kept for 15 
years in accordance with University policy.  
 
What will happen to the information I give? 
With your permission, all interviews will be audio-recorded with a digital recorder. Then 
the interview recordings will be transcribed into text for data analysis.  
 
What will happen to the results of the research study? 
We have several plans for dissemination activities for this research, including: 
  A PhD thesis 
  Presentations (or similar event) within departmental research group at the University 
of Southampton 
  Presentations at local, national and international conferences 
  Papers for publication in service user, professional and peer-reviewed academic 
journals. 
 
 
Who is organising and funding the research? 
This work is funded by a studentship grant from Cancer Research UK and will contribute 
towards the researcher’s PhD.  
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Who has reviewed the study? 
All  research  in  the  NHS  is  looked  at  by  an  independent  group  of  people  called  a 
Research Ethics Committee to protect your safety, rights, wellbeing and dignity. This 
study  has  been  reviewed  and  given  favourable  opinion  by  the  Research  and 
Development  Office  and  the  Isle  of  Wight,  Portsmouth  &  South  East  Hampshire 
Research Ethics Committee. 
 
Can I get independent advice about taking part in research? 
Yes, if you have any concerns or need independent advice, you can contact the Patient 
Advice  and  Liaison  Service  (PALS)  by  calling  023  8079  8498  or  by  calling  into  the 
Information Point just inside the main entrance of the General Hospital. Alternatively, you 
can email them at PALS@suht.swest.nhs.uk 
 
Further information and contact details of the researcher 
 
Kim Chivers 
Doctoral Research Student 
Nightingale Building (67) 
School of Nursing and Midwifery 
University of Southampton 
Highfield Campus 
Southampton 
S017 1BJ 
 
Tel: 023 8059 8203 
Email: kc02@soton.ac.uk 
 
 
 
 
 
This information sheet is for you to keep. If you decide to participate you will be 
asked to sign a consent form and given a copy of this to keep for your records 
 
 
Thank you for taking the time to read this information sheet 
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Appendix 6: Opt-In Form  
 
[To be printed on headed note paper] 
 
 
Title of Project: Family Communication Following Genetic Testing  
 
 
Name of  
Researcher:  
Kim Chivers 
 
 
I am returning this form to indicate that I am willing to consider taking part in the above 
study.  
 
I understand the researcher will contact me to ask if I have any further questions about 
the research and to arrange a suitable time for the interview. 
 
 
Name:   
 
 
Address:   
 
 
 
 
 
 
Telephone Number:   
 
 
Most convenient time to 
be contacted:  
 
 
 
 
 
 
 
 
 
 
Name of Participant 
(Block capitals) 
 
  Date    Signature 
 
When completed please return in the self-addressed envelope provided or to Kim 
Chivers, Nightingale Building (67), School of Nursing and Midwifery, University of 
Southampton, Highfield Campus, Southampton, S017 1BJ.  
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Appendix 7: Consent Form  
[To be printed on headed note paper] 
 
Title of Project: Family Communication Following Genetic Testing  
 
 
Name of  
Researcher:  
  Study identification 
code: 
 
 
Please complete this form by placing your initials in the box next to each question. It is a 
statement that you fully understand the study and are willing to take part. 
 
1.  I confirm that I have read and understood the information sheet dated Sept 2007 
(Version 5 – 1
st Sep 2007) for the above study. I have had the opportunity to 
consider the information and ask questions, to which I have received satisfactory 
answers. 
 
 
2.  I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my medical care and legal rights 
being affected.  
 
 
 
3.  I understand that data collected during the study may be looked at by individuals 
from the University of Southampton, from regulatory authorities or from the NHS 
Trust. I give permission for these individuals to have access. 
 
 
 
4.  I give permission for anonymous quotes of things I say in this interview to be used 
in dissemination activities related to this study. 
 
   
5.  I agree for the interview to be audio-recorded.    
 
 
6.  I agree to take part in the above study.   
 
 
 
 
 
       
Name of Participant    Date    Signature (before interview) 
 
 
       
 
 
        Signature (after interview) 
 
 
 
       
Name of Person taking 
consent 
  Date    Signature 
When completed: 1 for patient; 1 for researcher site file; 1 (original) to be kept in medical notes 
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Appendix 8: An extended example of the data matrix for four participants 
 
Code  Molly  Eloise  Gillan 
Sister of 131 
Jan 
1.1: General 
family 
awareness 
-  Good to have other people’s opinions 
when deciding whether or not to be 
tested. 
-  some people said she shouldn’t do it 
for her girls but for herself 
-  not an easy decision 
-  Evidence of hyper br awareness due to 
FH, passed on to daughters 
-  happened to mention concerns re 
FH to GP during routine smear 
-  regular MRI/mammograms due to 
FH => family awareness & 
discussions 
-  Talked about FH w sister & “penny 
dropped” 
-  FH “a bit grim” 
-  Thinks mother lived a high-risk 
life style 
-  So has adjusted own life style to 
lower risk, e.g. veg, exercise, low 
stress, not smoking 
-  Always lived convinced she will 
get br ca one day 
1.2: 
Motivations 
to pursue 
genetic 
testing 
-  final decision came when daughters 
said they would have test anyway 
-  decided to be “brave” 
 
-    -    -  Mother died so young, felt at 
even greater risk 
-  Small family with very little info 
on FH so wanted more info 
1.3: 
Experience of 
cancer 
-  grandma, aunt, mum, sister 
 
-  mum died when 13y => huge ps 
impact 
-  nan, aunt, mum, sister 
-  Mum br ca (52y) and then ov ca 10y 
later 
-  “tended to tolerate mummy & forget 
she’d been through br ca” 
-  She would mention check up & 
everyone would brush away as clear 
for 10 years 
-  Never really understood she was 
living w fear of it coming back 
-  Died from the ov ca, terrible quality of 
life w chemo & pain 
-  Went into help w caring as needed to 
help & have chance to be w her 
-  “all had breast ca on maternal 
side” 
-  Mum died br ca 42y 
-  Felt mum’s was very out of blue 
(never really understood => 
↑fear) but later discovered secret 
letters to grandmother saying had 
found cysts 10y previously 
-  Couldn’t deal w mothers death, 
could stay in hospital & watch her 
die (NB Young) 
-  Grandmother had br ca in early 
60ys   
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2.1: 
Gathering 
details of 
family 
history 
-  rang Uncle for info on FH 
-  during info gathering => people got 
invited 
-  genetic team suggested “family” 
meeting 
 
-    -  Sister and her got referred to WGC  -  Difficult to gather FH 
-  little contact with dad after 
parents divorce (living in US) 
-  “only actually started gleaming 
info once relatives started to die” 
-  Death of maternal grandfather 
revealed Hungarian-jewish 
maternal linage which everyone 
had denied 
2.2: 
Accessing 
DGT through 
PGT 
 
-  needed someone for DGT 
-  sister got ca, she would speak to her so 
gen team didn’t contact out of blue 
-  “if not for yourself, for 3 sons and 
daughter EMOTIVE ARGUMENT 
-  Found gene => PGT for others 
-  Needed sister for DGT 
-  Found it difficult to approach as felt 
she was still dealing with ca 
diagnosis and had no partner 
importance of support 
-  Know needed mum to consent to 
DGT but not sure what she would 
say 
-  When GC came out to explain 
testing, mum was so focused on her 
own diagnosis/treatment felt she 
didn’t really get it was about 
daughters risk 
-  When blood was taken was 
confused about what it was for  
-  Just happy it wasn’t about her being 
worse 
-  ?Is this really informed consent 
-  Read that needed blood from 
relative w ca 
-  Mum had died and was only 
child 
-  G/mother elderly & never very 
well 
-  Think she may have been DGT 
despite not having had ca, is this 
an option when testing 
privately?? 
2.3: Making 
decisions 
about GT 
(getting 
support & 
advice) 
 
- support from dad,hasband, daughters, 
family friend re decision 
- FF about so included NOT SECRETIVE 
- friends useful as outside family and only 
knew her Not so emotionally invested 
=> safe space 
-  Husband often came to 
appointments, especially initial info 
and results (not test) 
-  Mums result came back positive so 
sister and her decided to be tested 
-  Paid to have test done privately  
-  Discussed w wife & step father 
-   
2.4:  
Learning 
-  explanations in “plain English” 
-  Letters not as clear 
-  Had not heard of BRCA before 
counselling 
-  Found out men could be at risk too 
-  Written info helpful for processing 
at home 
-  Had plan for positive results as” 
All done with a lot of humour (as is 
normal in family) – not sure GC 
-  Not eligible for GT on NHS 
-  But personally felt there wasn’t 
enough evidence to rule out 
mutation in family (very few 
relatives) and convinced mothers 
age was a significant factor 
(despite being told otherwise by 
GC) 
-  Considered having elective 
double mastectomy so offered 
GT privately  
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about 
genetic risk 
-  still not clear what gene is 
-  “cervarian” ca risk came as shock, “kick 
in the stomach” 
-  All 99% sure of being carrier 
-  Neg result hadn’t entered head 
-  Firm plans for 
mastectomy/hysterectomy ?mental 
prep for bad news, arming oneself 
-  Awareness of risk of prostate ca (but 
not br ca) by hcp so specifically 
followed up uncle (4.2) ?because HCP 
didn’t discuss br ca or not seen as 
important as prostate ca 
had time to prepare”  approved 
-  Convinced statistically one sister 
had to be positive 
-   Wanted it to be her as “can cope 
with it better” than sister 
-  Worked out in mind how to reduce 
risks by RRS 
-  Worked out in mind “worst case 
scenario” 
-  Sister said she wanted it to be both 
of them or neither (“She hadn’t really 
looked at the percentages”) Own 
understanding actually incorrect  
-   
2.5: 
Materials to 
support 
communicati
on 
 
-  Daughter printed off extra info from 
websites but couldn’t understand 
-  Trusted websites only  -    -   
3.1: Telling 
those who 
are waiting 
to know  
-  1. Husband present, 2. Rang daughters 
outside hospital (”phones ready”), 3. 
Went to ward to tell sister (DGT), 4. 
dad came round when got home as 
waiting  
-  Brother knew going so waiting to 
hear 
-  All over phone Normal CP 
-  Reassured knowing everyone had 
“someone” – importance of 
support 
-  Told daughters on the phone asap 
“stop worrying, I’m not carrying the 
gene” 
-  All waiting for results 
-  Told step-parents straight away 
-  Such a relief 
-  NB very small family so hardly 
anyone to tell 
3.2: Keeping 
those in the 
know in the 
loop 
-  “difficult sister” and cousin not “in our 
club” so no rush to tell NORMAL 
PATTERNS OF COMMUNICATION 
-    -  Telephoned brothers and GC sent a 
letter with details 
 
3.3: Personal 
reaction to 
results and 
telling people 
-  Guilt re: other positive family vs. relief 
daughters were fine 
-  “still got to go through it” with sisters 
-  Knew she would feel bad about being 
neg before got results 
-  Brief “crumble” at result 
-  Though positive result answered 
so many questions (re mum etc) 
-  Would have been worse to have 
been told got ca 
-  ↑ contact w brother during process 
but now back to normal 
-  SinL very neg, had to deal with 
that on top of all else 
-  Sister wanted a joint appointment 
-  She didn’t, saw her role as support, 
so secretly rang GC for her results 
the week before 
-  Neg result => “shit, that means 
sister has it” 
-  Thinks it would have been better if 
GC had given result to each on 
paper rather than verbally one after 
the other 
-  Sister said she saw her relief she 
was neg, but that’s not true as 
she already knew & was just sad 
her sis was pos 
-  Received neg result by letter 
-  Very surprised but please. 
-  Not really thought about it since 
-  Has changed feelings about 
ca, now thinking she may not 
get it as opposed to all 
consuming fear she would  
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4.1 Distant 
relatives 
-  Rang uncle re: results as had more 
contact with him that sisters 
-  Prompted to do so by HCP and 
reinforced by mention in letter !!! 
-  Told him to tell cousins 
-  No follow up though ?not emotionally 
invested 
-  Sister spoke to cousin as although 
not close has slightly more contact 
= nominated person 
-  Cousin doesn’t want test, causes 
worry as has two daughters but 
not following up ?not enough 
emotionally invested   
  Knows of some paternal cousins but 
never been in contact 
Wrote to her father so he could pass 
on details 
-   
4.2: Those 
who did not 
want to 
know 
 
-    -    -  All agreed they wouldn’t tell mum so 
she wouldn’t worry (See notes 
about her confusion in 2.2) 
-  But Sister actually did. 
No huge reaction but thinks she doesn’t 
really understand the implications 
especially for brothers or grandkids 
-  Would never talk to brothers kids 
without his consent  
-  “too young and not my place” 
-  “you run the risk of upsetting the 
family and blowing it apart” 
-  “I wouldn’t want someone to tell my 
girls and I work on that principle” 
-  However if by the time she’s 25 
they’ve not told her, “I would get one 
of the cousins to tell her! I wont do it 
but I will get one of my girls to tell 
her by accident!” 
-  Estranged brother 
-  Step father acts as a 
go between and may 
have mentioned it 
Not made any effort to tell him about 
testing as “suppose I didn’t think of 
him as a likely candidate fro br ca 
because I think of it more of an 
female thing” 
4.3:  
Children 
Talking to 
male 
relatives 
  -  Children too young, (10,15) wait 
until age when they can cope w 
info 
-  There’s plenty of time 
-  Don’t want to ruin childhood by 
something they wont understand 
yet anyway 
-  SinL told her children (n&n) vague 
concern a cousin will tell her 
children 
-  Will revisit gen team for more info 
when time comes 
-  Its not really about the grandchildren 
at the moment (they’ve got 10y 
before they need to worry).  
-  At the moment its about sister (pos), 
she is “carrying all this” 
-    
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Appendix 9: Number of individuals and frequency of scores of cohesion given by each participant during construction of Eco-maps. 
 
  Total  Cohesion Score  Deceased 
    3  2  1  0  Disrupted   
114               
First degree relatives  3  0  0  2  0  1  0 
Second degree relatives  0  0  0  0  0  0  0 
Third and fourth degree relatives  1  1  0  0  0  0  0 
Non-blood relatives (including partners & in-laws)  1  0  0  0  1  0  0 
Friends & work colleagues  3  1  2  0  0  0  0 
Total   8  2  2  2  1  1  0 
               
125               
First degree relatives  5  3  1  1  0  0  0 
Second degree relatives  5  0  0  0  5  0  0 
Third and fourth degree relatives  3  0  3  0  0  0  0 
Non-blood relatives (including partners & in-laws)  1  1  0  0  0  0  0 
Friends & work colleagues  4  2  1  1  0  0  0 
Total   18  6  5  2  5  0  0 
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127               
First degree relatives  9  1  6  2  0  0  0 
Second degree relatives  9  0  0  0  9  0  0 
Third and fourth degree relatives  1  0  0  1  0  0  0 
Non-blood relatives (including partners & in-laws)  2  1  0  0  1  0  0 
Friends & work colleagues  8  2  2  3  1  0  0 
Total   29  4  8  6  11  0  0 
               
131               
First degree relatives  7  5  1  1  0  0  -1 
Second degree relatives  0  0  0  0  0  0  0 
Third and fourth degree relatives  0  0  0  0  0  0  0 
Non-blood relatives (including partners & in-laws)  1  1  0  0  0  0  0 
Friends & work colleagues  4  1  1  2  0  0  0 
Total   12  7  2  3  0  0  -1 
               
110               
First degree relatives  6  2  0  1  0  0  3 
Second degree relatives  4  0  0  0  4  0  0 
Third and fourth degree relatives  0  0  0  0  0  0  0 
Non-blood relatives (including partners & in-laws)  4  0  1  0  3  0  0 
Friends & work colleagues  4  1  3  0  0  0  0 
Total   18  3  4  1  7  0  3 
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118               
First degree relatives  5  3  1  1  0  0  0 
Second degree relatives  0  0  0  0  0  0  0 
Third and fourth degree relatives  0  0  0  0  0  0  0 
Non-blood relatives (including partners & in-laws)  1  1  0  0  0  0  0 
Friends & work colleagues  10  1  4  5  0  0  0 
Total   16  5  5  6  0  0  0 
               
111               
First degree relatives  3  1  1  0  0  1  0 
Second degree relatives  2  0  0  0  2  0  0 
Third and fourth degree relatives  0  0  0  0  0  0  0 
Non-blood relatives (including partners & in-laws)  1  1  0  0  0  0  0 
Friends & work colleagues  0  0  0  0  0  0  0 
Total   6  2  1  0  2  1  0 
               
123               
First degree relatives  1  0  0  0  0  1  0 
Second degree relatives  2  0  1  1  0  0  0 
Third and fourth degree relatives  0  0  0  0  0  0  0 
Non-blood relatives (including partners & in-laws)  5  1  1  2  1  0  0 
Friends & work colleagues  3  1  2  0  0  0  0 
Total   11  2  4  3  1  1  0 
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119               
First degree relatives  5  2  1  0  0  1  1 
Second degree relatives  4  0  0  2  2  0  0 
Third and fourth degree relatives  0  0  0  0  0  0  0 
Non-blood relatives (including partners & in-laws)  5  1  2  2  0  0  0 
Friends & work colleagues  2  0  0  2  0  0  0 
Total   16  3  3  6  2  1  1 
               
129               
First degree relatives  8  5  0  1  0  1  1 
Second degree relatives  4  0  0  2  2  0  0 
Third and fourth degree relatives  1  0  0  0  1  0  0 
Non-blood relatives (including partners & in-laws)  7  3  0  2  2  0  0 
Friends & work colleagues  11  5  6  0  0  0  0 
Total   31  13  6  5  5  1  1 
               
117               
First degree relatives  5  3  0  0  0  2  0 
Second degree relatives  2  0  0  0  1  1  0 
Third and fourth degree relatives  1  0  0  0  1  0  0 
Non-blood relatives (including partners & in-laws)  0  0  0  0  0  0  0 
Friends & work colleagues  3  1  1  1  0  0  0 
Total   11  4  1  1  2  3  0 
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130               
First degree relatives  7  1  4  1  0  1  0 
Second degree relatives  5  0  1  0  4  0  0 
Third and fourth degree relatives  0  0  0  0  0  0  0 
Non-blood relatives (including partners & in-laws)  3  1  1  0  1  0  0 
Friends & work colleagues  4  0  2  2  0  0  0 
Total   19  2  8  3  5  1  0 
               
126               
First degree relatives  8  1  6  0  0  1  0 
Second degree relatives  6  0  1  2  3  0  0 
Third and fourth degree relatives  0  0  0  0  0  0  0 
Non-blood relatives (including partners & in-laws)  3  1  0  1  1  0  0 
Friends & work colleagues  1  0  1  0  0  0  0 
Total   18  2  8  3  4  1  0 
               
115               
First degree relatives  8  1  5  0  2  0  0 
Second degree relatives  4  0  0  0  4  0  0 
Third and fourth degree relatives  0  0  0  0  0  0  0 
Non-blood relatives (including partners & in-laws)  3  1  0  2  0  0  0 
Friends & work colleagues  3  3  0  0  0  0  0 
Total   18  5  5  2  6  0  0 
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112               
First degree relatives  5  3  2  0  0  0  -1 
Second degree relatives  13  0  0  0  13  0  0 
Third and fourth degree relatives  0  0  0  0  0  0  0 
Non-blood relatives (including partners & in-laws)  3  0  1  1  1  0  0 
Friends & work colleagues  6  0  4  1  1  0  0 
Total   27  3  7  2  15  0  -1 
               
113               
First degree relatives  6  3  0  1  1  1  0 
Second degree relatives  7  0  0  0  7  0  0 
Third and fourth degree relatives  1  0  0  0  1  0  0 
Non-blood relatives (including partners & in-laws)  1  1  0  0  0  0  0 
Friends & work colleagues  9  7  2  0  0  0  0 
Total   24  11  2  1  9  1  0 
               
122               
First degree relatives  5  2  2  0  0  0  1 
Second degree relatives  3  0  0  0  3  0  0 
Third and fourth degree relatives  3  0  0  0  3  0  0 
Non-blood relatives (including partners & in-laws)  13  2  2  3  6  0  0 
Friends & work colleagues  8  2  3  3  0  0  0 
Total   32  6  7  6  12  0  1 
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101               
First degree relatives  5  2  2  1  0  0  0 
Second degree relatives  5  0  1  0  4  0  0 
Third and fourth degree relatives  2  0  0  0  2  0  0 
Non-blood relatives (including partners & in-laws)  1  1  0  0  0  0  0 
Friends & work colleagues  4  1  0  3  0  0  0 
Total   17  4  3  4  6  0  0 
               
106               
First degree relatives  6  0  0  6  0  0  0 
Second degree relatives  2  0  0  0  0  2  0 
Third and fourth degree relatives  0  0  0  0  0  0  0 
Non-blood relatives (including partners & in-laws)  4  0  3  1  0  0  0 
Friends & work colleagues  1  1  0  0  0  0  0 
Total   13  1  3  7  0  2  0 
               
102               
First degree relatives  5  2  1  1  0  0  1 
Second degree relatives  4  0  0  0  3  0  1 
Third and fourth degree relatives  4  1  0  1  2  0  0 
Non-blood relatives (including partners & in-laws)  2  1  1  0  0  0  0 
Friends & work colleagues  2  1  1  0  0  0  0 
Total   17  5  3  2  5  0  2 
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105               
First degree relatives  4  1  1  1  0  0  1 
Second degree relatives  5  0  0  0  1  0  4 
Third and fourth degree relatives  3  0  1  0  1  0  1 
Non-blood relatives (including partners & in-laws)  2  1  1  0  0  0  0 
Friends & work colleagues  2  1  1  0  0  0  0 
Total   16  3  4  1  2  0  6 
               
103               
First degree relatives  9  2  1  0  0  1  5 
Second degree relatives  10  0  0  1  9  0  0 
Third and fourth degree relatives  17  0  0  1  16  0  0 
Non-blood relatives (including partners & in-laws)  7  1  1  0  5  0  0 
Friends & work colleagues  1  0  1  0  0  0  0 
Total   44  3  3  2  30  1  5 
               
107               
First degree relatives  4  1  2  1  0  0  0 
Second degree relatives  5  0  0  0  5  0  0 
Third and fourth degree relatives  0  0  0  0  0  0  0 
Non-blood relatives (including partners & in-laws)  1  1  0  0  0  0  0 
Friends & work colleagues  3  0  1  2  0  0  0 
Total   13  2  3  3  5  0  0 
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108               
First degree relatives  4  1  3  0  0  0  0 
Second degree relatives  1  0  0  1  0  0  0 
Third and fourth degree relatives  2  0  1  0  1  0  0 
Non-blood relatives (including partners & in-laws)  3  1  2  0  0  0  0 
Friends & work colleagues  3  1  2  0  0  0  0 
Total   13  3  8  1  1  0  0 
               
109               
First degree relatives  5  1  2  2  0  0  0 
Second degree relatives  2  0  0  0  2  0  0 
Third and fourth degree relatives  0  0  0  0  0  0  0 
Non-blood relatives (including partners & in-laws)  1  1  0  0  0  0  0 
Friends & work colleagues  2  0  0  2  0  0  0 
Total   10  2  2  4  2  0  0 
               
124               
First degree relatives  0  0  0  0  0  0  0 
Second degree relatives  1  0  0  0  1  0  0 
Third and fourth degree relatives  7  1  4  1  1  0  0 
Non-blood relatives (including partners & in-laws)  0  0  0  0  0  0  0 
Friends & work colleagues  3  1  1  1  0  0  0 
Total   11  2  5  2  2  0  0 
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  Total  Cohesion score  Deceased 
    3  2  1  0  Disrupted   
All participants               
First degree relatives  138  46  42  23  3  11  11 
Second degree relatives  105  0  4  9  84  3  5 
Third and fourth degree relatives  46  3  9  4  29  0  1 
Non-blood relatives (including partners & in-laws)  75  23  16  14  22  0  0 
Friends & work colleagues  104  33  41  28  2  0  0 
Total   468  105  112  78  140  14  17 
  18             
All participants – average               
First degree relatives  5.3  1.8  1.6  0.9  0.1  0.4  0.4 
Second degree relatives  4.0  0.0  0.2  0.3  3.2  0.1  0.2 
Third and fourth degree relatives  1.8  0.1  0.3  0.2  1.1  0.0  0.0 
Non-blood relatives (including partners & in-laws)  2.9  0.9  0.6  0.5  0.8  0.0  0.0 
Friends & work colleagues  4.0  1.3  1.6  1.1  0.1  0.0  0.0 
Total   18.0  4.0  4.3  3.0  5.4  0.5  0.7 
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